data_2fce_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fce _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -100.75 168.52 9.61 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.95 0.881 . . . . 0.0 111.245 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.2 m -51.16 -31.19 19.09 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.45 0.643 . . . . 0.0 109.96 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -52.17 -37.92 56.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.709 -0.62 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.59 -47.11 85.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.9 m-85 -76.03 -40.0 54.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.7 t -61.5 -51.84 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.244 -0.91 . . . . 0.0 110.588 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -56.96 -32.55 66.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.28 -59.92 4.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.503 -0.748 . . . . 0.0 111.934 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -76.63 -53.67 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.188 -0.945 . . . . 0.0 111.951 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -48.16 -38.52 18.25 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.26 -0.9 . . . . 0.0 112.791 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.5 t -59.62 -34.81 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.801 -1.187 . . . . 0.0 109.602 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.14 -41.01 97.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.4 81.41 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.448 -0.782 . . . . 0.0 111.083 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.26 -41.63 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.642 -0.661 . . . . 0.0 110.425 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -91.46 16.18 10.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.333 -0.854 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 t 38.42 61.7 1.11 Allowed 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.8 p -90.5 -33.48 15.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.146 -0.971 . . . . 0.0 109.31 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.07 9.98 55.33 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.925 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -132.84 154.82 49.97 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.021 -1.282 . . . . 0.0 110.274 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.02 159.92 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.258 -0.901 . . . . 0.0 109.964 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.1 p -81.38 144.21 31.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.8 p -56.92 -39.98 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.562 -0.711 . . . . 0.0 110.857 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.82 -41.58 96.13 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.59 -39.67 27.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.939 . . . . 0.0 110.453 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.97 -49.88 75.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.687 -0.633 . . . . 0.0 110.168 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -65.87 -29.52 69.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.401 -0.812 . . . . 0.0 111.005 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -65.58 -48.29 72.85 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.093 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.111 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 4.1 tp -55.69 -44.74 77.65 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.266 -0.896 . . . . 0.0 108.702 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -60.85 -30.25 70.0 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.545 0.688 . . . . 0.0 109.622 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.59 -13.83 66.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 7.7 45.38 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.31 -1.112 . . . . 0.0 112.406 -177.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.39 31.67 5.17 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 12.2 tp10 -113.25 119.93 39.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.873 -0.781 . . . . 0.0 110.281 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -122.39 59.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.955 0.883 . . . . 0.0 109.386 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.99 148.62 22.28 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 m -111.01 141.89 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -40.08 -27.24 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.226 -0.921 . . . . 0.0 112.899 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -53.18 59.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.202 -0.936 . . . . 0.0 108.975 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.72 -42.68 40.37 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.531 -0.73 . . . . 0.0 110.414 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.01 -36.66 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.604 -0.685 . . . . 0.0 110.272 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -63.33 -38.37 90.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.207 -0.933 . . . . 0.0 109.069 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -62.95 -49.82 73.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.626 -0.671 . . . . 0.0 109.365 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.91 -49.43 77.74 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.576 0.703 . . . . 0.0 110.237 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.34 -15.99 51.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.938 -0.476 . . . . 0.0 111.257 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -57.26 -17.16 10.51 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.264 -0.897 . . . . 0.0 111.853 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.03 -10.19 14.46 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.071 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.4 135.9 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.989 -1.301 . . . . 0.0 110.765 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -104.62 100.63 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.412 0.625 . . . . 0.0 111.267 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.27 158.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -95.34 -179.06 4.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -0.805 . . . . 0.0 111.36 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 m -70.72 -1.55 11.77 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.942 -0.474 . . . . 0.0 112.032 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -107.14 -11.15 15.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 0.0 110.421 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.73 26.02 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -110.61 137.92 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.96 . . . . 0.0 111.14 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.81 168.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.14 112.33 24.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 109.891 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 48.1 p90 -62.68 -29.12 70.41 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.729 . . . . 0.0 111.632 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 15.7 mttt -73.1 -34.63 66.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.25 -0.906 . . . . 0.0 110.615 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -70.16 -45.98 65.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.689 -0.632 . . . . 0.0 112.183 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -70.68 -28.37 64.72 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 0.0 110.8 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.58 -45.98 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.48 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -60.06 -27.43 66.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.68 -12.33 42.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.7 t -95.71 -40.68 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.415 HD12 ' CD2' ' A' ' 86' ' ' PHE . 4.4 mp . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.948 -0.47 . . . . 0.0 111.301 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.8 0.333 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -102.17 160.01 14.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.713 0.768 . . . . 0.0 110.843 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 m -51.13 -30.65 17.06 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.701 0.762 . . . . 0.0 109.337 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -52.24 -37.47 55.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.955 -0.466 . . . . 0.0 111.168 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -60.58 -50.04 75.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.592 -0.693 . . . . 0.0 109.856 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.445 ' CD1' HD12 ' A' ' 113' ' ' LEU . 1.2 m-85 -75.91 -40.06 55.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.783 -0.573 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 83.5 t -61.92 -49.89 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.322 -0.861 . . . . 0.0 110.606 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -59.75 -34.33 72.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.566 -0.709 . . . . 0.0 110.801 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.06 -51.82 66.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.677 -0.64 . . . . 0.0 111.628 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -77.23 -54.92 5.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 111.802 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -48.04 -35.57 11.39 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.504 -0.747 . . . . 0.0 112.954 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.87 -29.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.679 -1.263 . . . . 0.0 109.122 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -92.81 23.16 4.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.679 -0.638 . . . . 0.0 109.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -132.02 78.47 1.82 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 0.0 108.941 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -63.56 -45.48 90.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.765 -0.584 . . . . 0.0 111.435 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.99 17.68 5.55 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.014 -1.054 . . . . 0.0 111.389 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 t 38.27 39.82 0.3 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 t -63.47 -34.16 77.16 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.586 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.43 14.58 50.26 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.384 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -132.93 153.84 51.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.081 -1.246 . . . . 0.0 110.643 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -150.29 160.02 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.6 p -84.74 147.34 26.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.0 109.711 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 m -63.35 -34.02 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.289 -0.882 . . . . 0.0 110.268 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.29 -42.49 99.79 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.49 -41.43 27.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.653 -0.91 . . . . 0.0 109.493 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.9 tt -59.96 -49.23 78.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -63.63 -32.51 74.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.693 -0.63 . . . . 0.0 110.543 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.72 -48.91 67.72 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -36.41 74.79 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.889 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 19.9 tp -53.72 -45.02 70.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -66.27 -18.77 65.55 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.018 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.7 -14.15 65.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.445 HD12 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -95.03 8.28 43.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 112.67 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.3 31.19 5.07 Favored Glycine 0 N--CA 1.503 3.104 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 49.5 mm-40 -114.88 121.76 44.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.957 -0.731 . . . . 0.0 110.165 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -122.83 61.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 109.899 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.5 mt -91.96 148.87 21.87 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 m -110.6 144.26 39.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 109.989 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -39.43 -29.28 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.361 -0.837 . . . . 0.0 112.598 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.95 49.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.35 -0.844 . . . . 0.0 108.847 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -76.44 -39.93 52.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.616 . . . . 0.0 110.284 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.2 -35.95 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.585 -0.697 . . . . 0.0 110.653 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.0 -39.92 87.45 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.075 -1.016 . . . . 0.0 108.927 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.71 -43.89 81.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.708 -0.62 . . . . 0.0 109.397 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.17 -50.04 74.77 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.657 0.741 . . . . 0.0 109.856 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mt -67.67 -22.15 65.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.779 -0.575 . . . . 0.0 110.831 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -57.4 -19.72 25.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.501 -0.749 . . . . 0.0 111.358 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.65 -14.86 5.57 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.25 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.1 p -66.19 128.83 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 118.897 1.348 . . . . 0.0 110.517 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.05 99.86 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.407 0.623 . . . . 0.0 111.226 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.21 157.08 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -96.68 -174.35 2.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 111.206 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.2 m -71.67 -0.7 11.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.839 -0.538 . . . . 0.0 111.853 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -106.95 -11.32 15.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.19 25.32 44.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -111.7 139.52 47.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.555 -0.968 . . . . 0.0 110.998 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.56 146.48 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -69.09 114.38 7.31 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 49.9 p90 -67.55 -38.88 84.79 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.544 -0.722 . . . . 0.0 111.548 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.8 mttt -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.0 110.102 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -70.02 -42.32 73.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 110.927 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.88 -28.13 63.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.54 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.411 HG21 ' CG ' ' A' ' 86' ' ' PHE . 92.3 mt -85.05 -52.25 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.324 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -87.63 -13.91 41.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -0.914 . . . . 0.0 110.56 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.96 -38.29 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.42 HD13 ' CD2' ' A' ' 86' ' ' PHE . 22.3 mt . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.896 -0.502 . . . . 0.0 111.258 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.857 0.36 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -103.43 162.23 13.2 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 110.969 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 m -51.33 -30.69 19.26 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.608 0.718 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.66 -38.15 59.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.843 -0.535 . . . . 0.0 111.162 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.69 -50.18 74.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 109.871 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -74.29 -38.35 63.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.782 -0.573 . . . . 0.0 110.999 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.99 -48.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.231 -0.918 . . . . 0.0 110.678 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -60.02 -35.75 75.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.628 -0.67 . . . . 0.0 111.019 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.95 -52.16 66.61 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 111.245 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -77.0 -53.3 8.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.378 -0.826 . . . . 0.0 111.249 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -48.7 -38.69 22.1 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.8 t -59.17 -31.03 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 120.565 -1.334 . . . . 0.0 109.193 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.95 23.6 4.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -131.57 78.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.0 109.399 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -70.5 -10.46 59.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.767 -0.583 . . . . 0.0 111.355 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.22 11.65 15.21 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.125 -0.985 . . . . 0.0 110.963 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m 37.54 37.55 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 p -63.88 -34.53 78.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.424 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.07 14.91 53.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -133.6 156.41 47.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.178 -1.19 . . . . 0.0 110.435 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -151.61 160.02 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -82.61 144.94 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.905 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.3 -39.92 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.746 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.01 -41.89 96.64 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.01 -42.6 23.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.528 -0.983 . . . . 0.0 110.336 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.01 -49.75 76.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -64.89 -33.66 76.54 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -67.16 -49.04 66.18 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -34.84 71.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.54 -0.725 . . . . 0.0 110.523 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 30.8 tp -54.66 -45.28 73.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.413 -0.804 . . . . 0.0 109.116 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.0 m -63.96 -19.04 64.85 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.346 0.593 . . . . 0.0 110.789 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.31 -14.57 63.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -94.13 7.38 45.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -1.03 . . . . 0.0 112.649 -177.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.8 4.84 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 6.4 mm-40 -114.79 121.02 42.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.941 -0.741 . . . . 0.0 110.116 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -122.23 59.64 1.01 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.138 0.971 . . . . 0.0 109.755 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.99 148.83 22.13 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.5 m -111.06 141.63 44.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -39.63 -29.14 0.05 Allowed 'General case' 0 N--CA 1.513 2.701 0 O-C-N 121.417 -0.802 . . . . 0.0 112.487 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.84 -52.62 63.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.368 -0.833 . . . . 0.0 108.953 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -77.01 -42.61 37.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.632 -0.668 . . . . 0.0 110.295 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.02 -35.21 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 110.378 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.52 -38.8 92.5 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 109.041 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.77 -45.5 93.64 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.692 0.758 . . . . 0.0 110.143 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.65 -18.45 63.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.899 -0.501 . . . . 0.0 111.304 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -56.67 -18.24 11.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.196 -0.94 . . . . 0.0 111.68 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.14 -9.62 15.29 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.944 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.13 133.78 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.926 -1.338 . . . . 0.0 110.988 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -99.59 99.41 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.365 0.602 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.13 155.77 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.89 -176.9 3.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 111.18 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.04 -0.96 12.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.819 -0.55 . . . . 0.0 111.805 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -108.0 -14.02 14.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 0.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.04 28.98 16.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -110.51 134.94 51.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.677 -0.896 . . . . 0.0 111.073 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 4.8 mp -125.28 142.63 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.66 112.41 6.12 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.247 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 41.5 p90 -68.11 -34.11 75.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.531 -0.731 . . . . 0.0 111.531 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 mttt -69.8 -32.73 71.33 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.272 -0.893 . . . . 0.0 110.426 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -73.2 -43.29 61.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.702 -0.623 . . . . 0.0 111.643 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -70.73 -28.16 64.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.488 -0.758 . . . . 0.0 110.695 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.5 mt -75.18 -45.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.758 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.55 -26.83 65.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.91 -11.74 43.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.46 -0.775 . . . . 0.0 110.327 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.97 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 N--CA 1.498 1.96 0 O-C-N 121.913 -0.492 . . . . 0.0 111.379 178.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -109.22 161.47 15.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.931 0.872 . . . . 0.0 111.319 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.3 m -51.18 -30.32 16.6 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.663 0.744 . . . . 0.0 109.674 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.93 -37.64 32.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.717 -0.614 . . . . 0.0 111.146 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -59.12 -50.4 74.2 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.18 -38.38 56.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.8 t -57.34 -55.39 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.177 -0.952 . . . . 0.0 110.49 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -59.99 -33.27 71.74 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.633 -0.667 . . . . 0.0 110.553 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.29 -51.88 67.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.682 -0.636 . . . . 0.0 111.429 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 33.4 m-85 -78.74 -54.94 5.57 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 0.0 111.508 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -49.19 -39.98 31.51 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.585 -0.697 . . . . 0.0 112.69 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.38 -38.57 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.071 -1.018 . . . . 0.0 110.072 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -69.07 -44.83 71.78 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -61.74 82.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.516 -0.74 . . . . 0.0 111.018 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -69.1 -15.35 63.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.11 12.87 20.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.2 -0.937 . . . . 0.0 110.5 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m 38.27 62.8 0.93 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -91.28 -34.18 15.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.161 -0.962 . . . . 0.0 109.359 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.66 11.67 54.88 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -132.21 154.66 49.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.262 . . . . 0.0 110.339 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.4 m -150.77 160.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.407 -0.808 . . . . 0.0 110.182 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.7 p -85.75 147.84 26.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 110.118 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.9 t -57.16 -40.2 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.336 -0.852 . . . . 0.0 110.531 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.16 -42.04 95.03 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.45 -44.17 19.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.512 -0.993 . . . . 0.0 110.4 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.417 ' HG ' ' CE2' ' A' ' 90' ' ' PHE . 8.2 tt -60.03 -49.96 75.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.714 -0.616 . . . . 0.0 110.001 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -64.08 -32.21 73.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -68.08 -47.83 67.21 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.516 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.33 95.45 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.144 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.405 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.98 -44.79 78.9 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 m -59.89 -30.5 69.06 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.59 0.71 . . . . 0.0 109.789 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.44 -14.62 63.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 7.3 46.6 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.301 -1.117 . . . . 0.0 112.602 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.4 4.76 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 21.2 tp10 -114.01 120.13 39.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.884 -0.774 . . . . 0.0 110.005 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -122.09 59.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.142 0.972 . . . . 0.0 109.518 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.5 mt -92.18 149.36 21.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 144.19 40.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.917 . . . . 0.0 109.663 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -40.13 -27.4 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.254 -0.904 . . . . 0.0 112.809 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.66 62.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.278 -0.889 . . . . 0.0 109.028 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.59 -42.79 41.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 110.382 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.93 -35.55 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.519 -0.738 . . . . 0.0 110.419 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -64.49 -37.74 88.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -60.05 -47.24 86.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 0.0 109.717 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.13 -50.13 74.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.631 0.729 . . . . 0.0 109.947 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.45 -19.58 56.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.893 -0.504 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -57.32 -22.01 39.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.486 -0.758 . . . . 0.0 111.203 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -113.81 -13.87 9.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.05 126.3 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.14 -1.212 . . . . 0.0 110.128 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -89.89 99.96 12.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.201 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 p -83.32 155.67 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -96.6 -175.6 3.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.377 -0.827 . . . . 0.0 111.182 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -72.02 -0.85 12.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.829 -0.544 . . . . 0.0 111.863 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.23 -12.58 15.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.104 . . . . 0.0 110.351 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.92 26.69 30.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -111.92 136.12 51.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.491 -1.005 . . . . 0.0 110.963 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.71 142.55 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 39.2 p-10 -69.74 109.07 4.19 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.378 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 49.9 p90 -65.28 -36.87 85.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.454 -0.779 . . . . 0.0 112.266 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 29.1 mttt -60.09 -31.52 70.1 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.337 -0.852 . . . . 0.0 111.904 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -84.2 -38.15 20.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.483 -0.76 . . . . 0.0 112.036 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -70.42 -28.84 65.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.445 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.6 mt -83.49 -50.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 110.326 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -62.88 -26.24 68.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.749 . . . . 0.0 110.993 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.78 -15.83 33.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 111.014 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.72 -41.66 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.058 -1.026 . . . . 0.0 108.709 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.835 -0.541 . . . . 0.0 111.662 179.569 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.781 0.324 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -109.22 162.0 14.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.97 0.89 . . . . 0.0 111.213 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 m -50.54 -30.69 13.63 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.596 0.712 . . . . 0.0 109.777 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -52.56 -36.19 55.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.916 -0.49 . . . . 0.0 111.107 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.35 -50.01 74.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 109.92 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.412 ' CE2' HD23 ' A' ' 147' ' ' LEU . 5.6 m-85 -75.87 -40.01 55.41 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.707 -0.621 . . . . 0.0 111.254 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.51 -50.01 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.267 -0.896 . . . . 0.0 110.365 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -57.95 -32.75 68.13 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.897 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.27 8.29 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.565 -0.709 . . . . 0.0 111.867 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.446 ' CE1' ' CD1' ' A' ' 106' ' ' LEU . 95.7 m-85 -78.81 -55.85 4.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.203 -0.936 . . . . 0.0 112.105 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -48.58 -38.64 21.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.421 -0.8 . . . . 0.0 112.808 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -56.5 -38.6 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.993 -1.067 . . . . 0.0 110.222 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' LYS . 23.4 m-85 -67.13 -42.5 84.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.77 83.1 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PHE . 67.4 mmtt -68.57 -16.82 63.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -113.53 15.73 18.93 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.0 110.445 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.55 37.08 0.1 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 t -63.57 -33.14 74.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.626 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.35 53.59 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.121 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -132.83 153.57 51.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.044 -1.268 . . . . 0.0 110.368 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.7 m -150.06 160.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.8 p -83.69 146.27 28.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.555 -0.715 . . . . 0.0 109.654 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 m -61.76 -34.81 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.303 -0.873 . . . . 0.0 110.283 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.43 99.79 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -79.62 -41.23 27.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.705 -0.879 . . . . 0.0 109.813 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.446 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 28.9 tp -60.04 -48.6 81.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -64.38 -30.98 72.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.67 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -65.52 -48.53 72.2 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.141 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -39.95 74.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.015 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 tp -54.17 -39.51 66.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.453 -0.779 . . . . 0.0 111.024 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.8 t -73.01 -17.86 61.4 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.471 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.76 -13.94 66.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 8.52 42.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -1.121 . . . . 0.0 112.23 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.12 30.14 5.2 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -114.17 121.48 43.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.81 -0.817 . . . . 0.0 110.273 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -123.02 61.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.095 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.6 mt -91.45 148.87 22.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -110.14 143.11 40.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -38.5 -31.38 0.05 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.557 -0.715 . . . . 0.0 112.406 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.05 50.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.97 -41.97 40.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.647 . . . . 0.0 110.324 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.61 -36.33 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.037 -1.039 . . . . 0.0 108.945 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.72 -43.72 80.88 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.62 -0.675 . . . . 0.0 109.57 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.92 -53.47 55.29 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.503 0.668 . . . . 0.0 110.253 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.36 -21.13 65.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.793 -0.567 . . . . 0.0 111.032 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.37 -20.9 32.25 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 111.334 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.85 -14.2 8.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.24 126.27 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.094 -1.239 . . . . 0.0 110.102 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -92.58 102.19 14.62 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.103 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -86.47 159.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -95.68 -173.25 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.94 -0.64 9.69 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.878 -0.514 . . . . 0.0 111.913 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -106.09 -9.82 16.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.935 -1.103 . . . . 0.0 110.272 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.01 25.25 49.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -111.45 143.0 42.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.483 -1.01 . . . . 0.0 111.135 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.0 170.64 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -94.41 117.62 30.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.421 -0.799 . . . . 0.0 110.344 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 49.0 p90 -68.47 -37.2 79.96 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.645 -0.659 . . . . 0.0 111.737 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 6.8 mttt -67.04 -41.0 87.27 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.58 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -69.94 -42.54 73.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.756 -0.59 . . . . 0.0 111.428 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -70.7 -29.36 65.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.502 -0.749 . . . . 0.0 110.348 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.405 HD12 ' CE2' ' A' ' 90' ' ' PHE . 94.8 mt -85.35 -50.99 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 110.235 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.77 -26.68 68.83 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.528 -0.733 . . . . 0.0 110.85 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.25 -15.46 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.816 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.1 t -95.98 -42.42 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 108.695 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.412 HD23 ' CE2' ' A' ' 86' ' ' PHE . 1.7 mm? . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 111.693 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.807 0.337 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -109.92 161.98 14.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.859 0.838 . . . . 0.0 111.184 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 m -50.98 -30.86 16.17 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.59 0.709 . . . . 0.0 109.73 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -36.93 41.23 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.875 -0.516 . . . . 0.0 111.189 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -60.03 -50.06 75.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.598 -0.689 . . . . 0.0 109.996 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 143' ' ' ILE . 3.6 m-85 -76.35 -39.6 53.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 111.025 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.22 -53.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.25 -0.906 . . . . 0.0 110.665 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -59.45 -33.15 70.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.608 -0.682 . . . . 0.0 110.955 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -62.49 -51.69 66.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.508 -0.745 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.55 -54.87 6.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 111.505 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -48.46 -37.29 16.92 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.485 -0.759 . . . . 0.0 112.83 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.29 -36.94 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.843 -1.16 . . . . 0.0 109.715 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.59 -46.98 65.07 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -62.28 82.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.507 -0.746 . . . . 0.0 110.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -64.13 -40.01 95.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.0 110.447 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -91.54 16.7 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.5 36.31 0.13 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.8 p -63.75 -34.6 78.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.076 -1.015 . . . . 0.0 109.37 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.81 11.28 55.4 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.131 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -132.39 153.95 50.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.044 -1.268 . . . . 0.0 110.402 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.8 m -149.98 161.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.344 -0.848 . . . . 0.0 110.09 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 p -83.85 145.77 28.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.035 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.94 -38.3 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.395 -0.816 . . . . 0.0 110.675 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.76 97.3 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.6 -39.96 26.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.602 -0.94 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.89 -49.87 75.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.64 . . . . 0.0 110.025 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -64.66 -29.94 70.95 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.502 -0.749 . . . . 0.0 110.652 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.5 -47.68 69.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.424 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -39.19 93.65 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.016 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.406 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -55.59 -45.29 77.45 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.1 m -59.65 -30.42 68.73 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.571 0.7 . . . . 0.0 109.917 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.3 63.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.425 HD11 ' CE1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 6.83 47.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.322 -1.105 . . . . 0.0 112.736 -177.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.66 32.35 4.83 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 19.9 tp10 -114.16 120.25 39.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 122.034 -0.686 . . . . 0.0 109.896 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -122.06 59.5 1.0 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.203 1.001 . . . . 0.0 109.364 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.38 148.44 23.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -111.05 143.1 42.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -39.98 -28.26 0.05 Allowed 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.318 -0.864 . . . . 0.0 112.486 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.41 59.29 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.4 -29.32 59.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 110.584 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.85 -32.6 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.99 -41.93 77.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.328 -0.857 . . . . 0.0 110.454 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 125' ' ' LEU . 9.1 pt-20 -60.0 -40.06 87.93 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.139 -0.975 . . . . 0.0 109.898 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.403 ' N ' ' HG3' ' A' ' 124' ' ' GLU . 0.2 OUTLIER -70.34 -44.06 68.97 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.394 -0.816 . . . . 0.0 110.354 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 mt -60.18 -16.11 30.07 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.841 -0.537 . . . . 0.0 111.775 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -57.64 -19.24 25.06 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.276 -0.89 . . . . 0.0 111.304 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.64 25.09 9.26 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.7 124.5 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.301 -1.117 . . . . 0.0 109.549 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.03 105.85 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.474 0.654 . . . . 0.0 111.874 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -88.81 163.2 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -93.41 -175.05 3.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.794 . . . . 0.0 111.015 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 m -71.24 -1.35 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.899 -0.5 . . . . 0.0 111.776 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -108.26 -11.89 15.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.937 -1.102 . . . . 0.0 110.726 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.72 27.55 26.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -109.94 137.81 47.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.969 . . . . 0.0 111.108 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.68 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -69.33 110.65 4.77 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.941 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.449 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 45.6 p90 -62.84 -30.96 71.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.48 -0.763 . . . . 0.0 111.89 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.449 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 24.3 mttt -71.28 -33.41 69.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.333 -0.855 . . . . 0.0 110.466 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -72.34 -46.17 56.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.751 -0.593 . . . . 0.0 111.493 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -71.15 -29.0 64.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.467 -0.771 . . . . 0.0 111.329 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -79.28 -44.62 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.163 -0.961 . . . . 0.0 110.366 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.29 -26.25 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.126 -0.984 . . . . 0.0 109.856 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.42 -12.56 45.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.434 -0.791 . . . . 0.0 110.099 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.5 t -96.36 -41.8 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.429 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.9 tp . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.379 0.609 . . . . 0.0 110.758 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -107.3 158.88 16.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.838 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.7 m -51.26 -30.28 17.26 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.799 0.809 . . . . 0.0 109.329 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.17 -39.09 63.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.907 -0.496 . . . . 0.0 111.286 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -61.77 -50.03 74.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.551 -0.718 . . . . 0.0 109.918 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.6 m-85 -72.82 -36.58 67.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.743 -0.598 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.36 -46.15 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.16 -0.963 . . . . 0.0 110.79 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.27 -36.48 75.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.573 -0.704 . . . . 0.0 111.549 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.75 -57.52 12.57 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 111.592 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -77.64 -53.63 7.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.278 -0.889 . . . . 0.0 112.028 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 139' ' ' TYR . 37.5 mm-40 -48.36 -38.71 19.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.175 -0.953 . . . . 0.0 113.14 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.14 -34.54 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.754 -1.216 . . . . 0.0 110.164 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -68.38 -43.33 77.57 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.3 80.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.359 -0.838 . . . . 0.0 110.901 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.26 -39.92 92.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 0.0 110.482 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -92.44 20.14 6.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.343 -0.848 . . . . 0.0 110.811 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 m 38.14 65.04 0.63 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -91.43 -33.78 15.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.17 -0.956 . . . . 0.0 109.148 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 15.12 57.48 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -131.93 153.1 50.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -1.217 . . . . 0.0 110.06 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.98 159.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.313 -0.867 . . . . 0.0 110.047 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -81.85 144.8 30.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.624 -0.672 . . . . 0.0 110.083 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.41 -38.66 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.492 -0.755 . . . . 0.0 110.702 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.1 -40.6 97.36 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.52 -40.04 26.75 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.569 -0.959 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.96 -49.62 77.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.667 -0.646 . . . . 0.0 110.212 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -64.95 -29.6 70.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.705 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -67.93 -48.08 66.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.389 -0.82 . . . . 0.0 110.684 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -37.68 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.22 -0.925 . . . . 0.0 111.041 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 tp -55.33 -42.85 74.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.222 -0.924 . . . . 0.0 109.388 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -66.45 -20.5 66.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.45 -14.87 62.99 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -94.09 8.41 41.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.321 -1.105 . . . . 0.0 112.507 -177.318 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.08 31.31 4.77 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -113.97 120.27 40.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.985 -0.715 . . . . 0.0 109.734 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -122.07 59.33 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -0.964 . . . . 0.0 109.909 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.0 mt -91.68 148.82 21.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 p -111.06 142.28 43.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -39.61 -29.21 0.05 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.422 -0.799 . . . . 0.0 112.482 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.03 -52.89 62.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.341 -0.849 . . . . 0.0 108.852 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.78 -43.18 37.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.714 -0.616 . . . . 0.0 110.304 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.32 -34.9 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.549 -0.719 . . . . 0.0 110.405 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -64.17 -37.44 87.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.216 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.99 -46.67 88.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 110.086 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.72 -41.18 99.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.524 -0.735 . . . . 0.0 110.367 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.98 -17.13 61.72 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.826 -0.546 . . . . 0.0 111.569 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -56.57 -22.51 34.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.259 -0.9 . . . . 0.0 111.084 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.98 25.29 8.94 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.363 -1.081 . . . . 0.0 109.911 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -102.38 102.94 13.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.448 0.642 . . . . 0.0 111.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.27 158.97 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -95.92 -177.54 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.355 -0.84 . . . . 0.0 111.333 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -71.22 -2.06 14.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.832 -0.543 . . . . 0.0 111.971 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.82 -10.52 16.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.994 -1.066 . . . . 0.0 110.241 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.98 32.37 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.13 139.2 46.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.913 . . . . 0.0 111.14 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 5.0 mp -128.42 142.22 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.92 113.88 6.73 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.731 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 91' ' ' GLN . 30.9 p90 -63.95 -36.16 83.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.617 -0.677 . . . . 0.0 111.887 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.421 ' HG2' ' CE2' ' A' ' 139' ' ' TYR . 2.5 mmtt -70.01 -37.02 75.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.27 -45.37 66.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.634 -0.667 . . . . 0.0 111.702 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -71.3 -29.2 64.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.418 -0.801 . . . . 0.0 110.767 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.6 -47.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.484 -0.76 . . . . 0.0 109.611 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -60.31 -26.77 66.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.017 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.14 -12.28 44.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.414 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.2 t -95.57 -38.91 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.925 -0.484 . . . . 0.0 111.181 178.533 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.8 0.333 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -109.96 158.89 17.76 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.788 . . . . 0.0 111.021 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -49.96 -29.99 9.54 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.533 0.682 . . . . 0.0 110.286 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -46.57 -32.47 3.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.822 -0.549 . . . . 0.0 112.144 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -62.48 -43.79 97.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.378 -0.826 . . . . 0.0 110.543 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -77.45 -40.22 44.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.489 -0.757 . . . . 0.0 110.704 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.53 -57.46 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.411 -0.806 . . . . 0.0 111.077 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -60.03 -34.35 73.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.815 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -60.42 -54.29 47.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.703 . . . . 0.0 111.645 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.416 ' CZ ' ' HG ' ' A' ' 106' ' ' LEU . 24.5 m-85 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.219 -0.926 . . . . 0.0 111.615 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -48.69 -39.68 25.41 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.369 -0.832 . . . . 0.0 112.814 -177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.05 -38.07 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.876 -1.14 . . . . 0.0 109.754 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -67.48 -44.89 77.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -61.36 82.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.558 -0.714 . . . . 0.0 111.04 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.714 -0.616 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -94.05 18.18 11.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.179 -0.951 . . . . 0.0 110.507 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.1 m 38.7 63.0 0.95 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.3 p -90.83 -34.77 15.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.981 . . . . 0.0 109.122 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.49 62.25 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.307 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -129.83 150.03 51.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.113 -1.227 . . . . 0.0 110.074 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.2 m -150.15 164.69 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -0.828 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 p -85.39 147.08 26.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.688 -0.633 . . . . 0.0 109.293 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.43 -33.17 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.295 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.94 -42.25 99.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.9 -39.91 29.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.664 -0.903 . . . . 0.0 109.624 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HG ' ' CZ ' ' A' ' 90' ' ' PHE . 9.9 tt -59.9 -49.19 78.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.827 -0.546 . . . . 0.0 109.527 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -63.9 -29.44 70.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.24 -48.41 67.85 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.391 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -40.03 95.77 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.682 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -55.95 -44.29 78.28 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.0 m -60.04 -31.08 69.63 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.577 0.703 . . . . 0.0 109.754 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.14 -14.79 63.72 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -96.53 7.27 46.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -1.124 . . . . 0.0 112.557 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 31.53 5.05 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -113.52 120.17 40.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.877 -0.778 . . . . 0.0 109.952 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.5 60.3 1.01 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 0.0 109.879 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.41 148.8 22.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -110.76 142.75 42.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -39.37 -29.27 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 O-C-N 121.376 -0.827 . . . . 0.0 112.571 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.87 -53.04 61.24 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -0.855 . . . . 0.0 108.808 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -76.75 -42.83 39.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.624 -0.673 . . . . 0.0 110.169 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.25 -35.82 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.568 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.63 -38.41 87.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.184 -0.947 . . . . 0.0 109.115 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.63 -45.36 92.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.591 -0.693 . . . . 0.0 109.527 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.33 -51.47 68.7 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.587 -0.696 . . . . 0.0 110.151 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mt -59.99 -19.04 50.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.634 -0.667 . . . . 0.0 110.962 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -57.06 -24.0 50.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.501 -0.75 . . . . 0.0 110.93 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.27 25.41 8.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.0 t -106.74 120.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -1.113 . . . . 0.0 109.659 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.52 103.0 15.45 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.487 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 m -86.74 161.38 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -95.87 -171.98 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 110.946 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 p -72.08 -0.21 11.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.84 -0.537 . . . . 0.0 111.752 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.68 -11.09 15.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.944 -1.098 . . . . 0.0 110.257 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.89 24.55 52.49 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.96 141.62 44.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.392 -1.064 . . . . 0.0 110.966 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 3.4 mp -127.05 147.22 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.311 0.577 . . . . 0.0 109.657 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.23 116.29 9.5 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.227 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 140' ' ' LYS . 7.2 p90 -68.15 -34.14 75.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.653 -0.654 . . . . 0.0 111.983 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 13.8 mttt -69.97 -28.85 65.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.342 -0.849 . . . . 0.0 111.278 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -80.42 -43.22 21.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 112.254 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -70.9 -30.72 67.14 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.0 111.727 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 144' ' ' GLU . 18.2 pt -83.69 -44.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.114 -0.991 . . . . 0.0 110.579 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 143' ' ' ILE . 65.3 mt-10 -67.33 -26.53 66.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.72 -13.98 46.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.273 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 70.4 t -95.31 -37.82 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.293 0.568 . . . . 0.0 110.933 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.824 0.345 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -109.21 160.71 15.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.81 0.814 . . . . 0.0 110.79 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.2 m -51.32 -31.08 20.42 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.698 0.761 . . . . 0.0 109.542 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -51.39 -37.43 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.854 -0.529 . . . . 0.0 111.152 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -64.64 -45.55 86.3 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.682 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.458 ' CD1' HD11 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.65 -38.39 62.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.729 -0.607 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.56 -47.09 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.141 -0.974 . . . . 0.0 111.041 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -60.06 -35.32 74.9 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.582 -0.699 . . . . 0.0 111.419 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.74 -52.8 62.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.456 -0.777 . . . . 0.0 111.816 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.48 -53.61 7.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 111.367 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -48.09 -36.19 12.7 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.291 -0.88 . . . . 0.0 112.854 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.25 -35.74 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 109.981 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.05 -50.97 35.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.363 -0.835 . . . . 0.0 109.276 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.67 82.39 4.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.214 -0.929 . . . . 0.0 109.663 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -61.16 -26.86 67.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.817 -0.552 . . . . 0.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.65 17.97 5.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.17 -0.956 . . . . 0.0 111.015 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.6 t 38.5 37.11 0.16 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.1 p -63.9 -34.91 79.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.082 -1.011 . . . . 0.0 109.24 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.85 59.59 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -131.77 153.38 50.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.266 . . . . 0.0 110.176 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 m -150.37 161.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.381 -0.825 . . . . 0.0 110.28 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -83.08 145.85 29.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.502 -0.749 . . . . 0.0 109.923 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.26 -39.99 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.423 -0.798 . . . . 0.0 110.741 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.67 -41.47 97.44 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -80.08 -41.87 24.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.512 -0.993 . . . . 0.0 110.539 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -60.06 -49.76 76.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.639 -0.663 . . . . 0.0 109.959 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -64.24 -31.65 72.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 110.265 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -67.45 -48.83 66.07 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -33.57 65.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.804 . . . . 0.0 110.583 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 27.7 tp -54.57 -44.32 72.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.4 m -67.41 -15.87 63.92 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.061 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.98 -14.51 64.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.458 HD11 ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -94.82 8.02 44.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -1.055 . . . . 0.0 112.583 -177.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 31.0 5.05 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 58.5 mm-40 -114.18 120.72 41.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.929 -0.748 . . . . 0.0 109.638 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -122.8 60.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.39 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.6 mt -89.95 148.26 23.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.3 m -110.6 141.66 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -0.903 . . . . 0.0 110.16 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -39.2 -30.83 0.06 Allowed 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.566 -0.709 . . . . 0.0 112.161 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.63 -51.75 67.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -77.28 -40.73 43.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.722 -0.611 . . . . 0.0 110.454 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.55 -35.36 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.607 -0.683 . . . . 0.0 110.466 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -64.21 -38.03 89.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -59.97 -46.86 88.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.619 -0.676 . . . . 0.0 109.521 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.3 -46.95 86.47 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.659 0.742 . . . . 0.0 109.944 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.97 -18.96 60.21 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.85 -0.531 . . . . 0.0 111.205 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.75 -21.32 27.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.218 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.43 -12.04 11.14 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.89 134.24 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.08 -1.247 . . . . 0.0 110.242 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -102.4 102.96 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.602 . . . . 0.0 111.804 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.69 157.31 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.05 -179.17 4.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.288 -0.883 . . . . 0.0 111.287 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -71.0 -2.61 15.95 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.874 -0.516 . . . . 0.0 111.854 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -107.33 -12.19 15.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.429 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.15 27.09 22.0 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -110.87 135.65 51.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.938 . . . . 0.0 111.068 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.2 mp -128.32 140.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -68.93 111.29 4.87 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.657 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 140' ' ' LYS . 18.6 p90 -64.48 -32.51 74.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.481 -0.762 . . . . 0.0 112.095 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.2 mtmp? -71.22 -35.93 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.258 -0.901 . . . . 0.0 111.067 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -70.41 -44.51 67.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.684 -0.635 . . . . 0.0 111.659 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -70.02 -29.15 66.13 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.431 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 143' ' ' ILE . 32.4 pt -80.27 -43.68 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 110.197 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.437 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.7 mt-10 -62.59 -26.84 68.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.266 -0.896 . . . . 0.0 109.929 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.1 -12.31 44.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.355 -0.841 . . . . 0.0 110.276 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.92 -39.94 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.7 mt . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.941 -0.474 . . . . 0.0 111.565 178.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -109.07 160.17 16.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.849 . . . . 0.0 111.001 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -51.15 -30.5 16.81 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.612 0.72 . . . . 0.0 109.54 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -52.3 -37.27 55.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.871 -0.518 . . . . 0.0 111.275 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -60.04 -51.05 71.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.56 -0.713 . . . . 0.0 109.865 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.429 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -75.62 -39.69 57.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 110.814 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.25 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.26 -0.9 . . . . 0.0 110.282 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -60.07 -36.16 76.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.651 -0.656 . . . . 0.0 110.923 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.04 77.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.708 -0.62 . . . . 0.0 111.565 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -77.41 -56.07 4.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 111.751 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -48.16 -34.27 9.7 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.84 -34.55 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.814 -1.178 . . . . 0.0 109.657 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -72.58 -52.1 16.95 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.66 81.77 8.72 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -60.39 -21.16 61.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.688 -0.632 . . . . 0.0 111.002 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.97 18.91 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.147 -0.971 . . . . 0.0 111.044 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.5 m 38.73 37.43 0.19 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.5 p -64.24 -35.6 81.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.0 12.52 60.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -131.74 151.61 51.52 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.247 . . . . 0.0 110.155 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.1 t -149.84 162.51 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.349 -0.844 . . . . 0.0 109.97 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.9 p -84.95 148.16 26.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.517 -0.74 . . . . 0.0 109.991 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.1 t -56.23 -40.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.34 94.03 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -81.05 -42.75 20.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.238 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -49.92 75.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 110.222 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -67.04 -31.01 71.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.581 -0.699 . . . . 0.0 110.792 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.7 -47.81 65.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.67 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -40.61 92.33 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.508 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -45.07 77.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.474 -0.89 . . . . 0.0 108.675 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -59.94 -28.36 67.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.538 0.685 . . . . 0.0 109.9 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.59 63.38 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.77 6.9 47.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.295 -1.12 . . . . 0.0 112.76 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.11 31.46 5.03 Favored Glycine 0 N--CA 1.501 3.009 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -114.13 121.0 42.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.792 -0.828 . . . . 0.0 109.871 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -122.33 59.89 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.051 0.929 . . . . 0.0 109.598 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.13 148.92 22.04 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.0 p -110.77 142.21 43.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 0.0 110.024 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -39.87 -28.46 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 O-C-N 121.297 -0.877 . . . . 0.0 112.543 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.95 -52.59 63.43 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.7 -43.01 39.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 110.312 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.04 -35.53 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.497 -0.752 . . . . 0.0 110.562 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -63.21 -37.32 86.76 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.216 -0.927 . . . . 0.0 109.275 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.81 -46.03 90.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.559 -0.713 . . . . 0.0 109.578 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.19 -48.44 81.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.541 -0.724 . . . . 0.0 109.825 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.33 -21.34 66.58 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.859 -0.526 . . . . 0.0 111.05 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -57.19 -22.23 39.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.497 -0.752 . . . . 0.0 111.104 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.69 -14.32 8.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.4 t -68.37 134.11 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.044 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.91 99.1 11.2 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 111.71 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.33 156.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.51 -177.79 4.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -71.46 -0.92 11.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.773 -0.579 . . . . 0.0 111.954 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -107.5 -12.52 15.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.843 -1.161 . . . . 0.0 110.442 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.4 25.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -111.91 136.14 51.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.962 . . . . 0.0 111.086 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.98 141.38 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -69.41 106.67 3.03 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.433 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.459 ' CE1' ' CG ' ' A' ' 140' ' ' LYS . 54.4 p90 -62.51 -35.8 80.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.301 -0.874 . . . . 0.0 112.128 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.459 ' CG ' ' CE1' ' A' ' 139' ' ' TYR . 19.4 mtpp -58.44 -56.57 20.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.278 -0.889 . . . . 0.0 111.052 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -59.91 -39.1 84.27 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.786 -0.572 . . . . 0.0 111.585 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -70.05 -28.98 65.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 0.0 109.685 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.417 HG23 ' CG ' ' A' ' 86' ' ' PHE . 69.3 mt -83.27 -50.03 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.713 . . . . 0.0 109.725 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.72 -27.01 67.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.466 -0.771 . . . . 0.0 110.11 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -87.85 -12.98 43.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.861 . . . . 0.0 110.466 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.7 t -95.82 -39.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.318 0.58 . . . . 0.0 110.679 178.563 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.752 0.311 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -109.58 159.66 16.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 111.084 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.3 m -50.89 -30.43 14.59 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.695 0.76 . . . . 0.0 109.564 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.62 -37.01 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.842 -0.536 . . . . 0.0 111.279 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.98 -50.5 73.49 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.418 ' CD1' HD12 ' A' ' 113' ' ' LEU . 2.0 m-85 -76.48 -40.57 49.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.687 -0.633 . . . . 0.0 110.944 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.8 t -60.34 -57.21 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.83 . . . . 0.0 110.958 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -54.45 -32.55 57.83 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.451 -0.781 . . . . 0.0 111.022 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -65.17 -44.77 87.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.743 -0.598 . . . . 0.0 111.89 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 14.3 m-85 -80.61 -56.88 3.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.916 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -36.56 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.01 -35.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.01 -1.056 . . . . 0.0 109.655 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -71.62 -47.41 54.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 80.6 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.444 -0.785 . . . . 0.0 110.593 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -60.52 -38.22 83.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.569 -0.707 . . . . 0.0 110.738 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.54 20.44 5.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t 37.98 36.85 0.12 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.1 p -64.17 -34.47 78.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.209 -0.932 . . . . 0.0 109.519 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.04 13.31 57.86 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -132.47 151.89 51.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.095 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.8 t -148.41 159.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.39 -0.818 . . . . 0.0 109.494 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -79.82 144.3 33.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.773 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.1 p -55.81 -38.76 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.417 -0.802 . . . . 0.0 110.542 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.69 97.29 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -81.15 -40.0 24.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.885 . . . . 0.0 110.511 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HG ' ' CE2' ' A' ' 90' ' ' PHE . 9.7 tt -59.18 -49.82 76.41 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.63 -0.668 . . . . 0.0 110.173 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -67.03 -28.87 68.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.787 . . . . 0.0 111.075 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.18 -48.51 70.46 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.372 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -40.78 98.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.06 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.95 -44.64 78.61 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.7 m -60.06 -31.44 69.99 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.502 0.668 . . . . 0.0 109.619 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.79 64.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.418 HD12 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -96.15 7.85 45.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -1.136 . . . . 0.0 112.475 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 31.78 4.91 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -113.22 119.88 39.28 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.742 -0.858 . . . . 0.0 110.28 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.77 59.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.798 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.02 148.72 22.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 m -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.04 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -40.06 -27.47 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 O-C-N 121.231 -0.918 . . . . 0.0 112.95 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.09 60.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.195 -0.941 . . . . 0.0 109.072 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.54 -41.95 44.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.97 -35.92 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 110.258 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.71 -37.11 86.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.085 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -63.71 -49.88 71.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.577 0.703 . . . . 0.0 109.978 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.1 mt -61.87 -16.64 52.0 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.826 -0.547 . . . . 0.0 110.985 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -56.8 -20.58 23.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.398 -0.814 . . . . 0.0 111.173 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 25.65 8.29 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.32 129.98 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.294 -1.121 . . . . 0.0 109.783 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 100.54 11.38 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.885 0.85 . . . . 0.0 112.418 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.47 158.88 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -95.62 -179.04 4.6 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.835 0.826 . . . . 0.0 111.423 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.4 m -70.97 -1.67 12.74 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.833 -0.542 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -107.66 -11.96 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.998 -1.064 . . . . 0.0 110.434 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.94 28.79 17.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -111.15 135.58 51.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.931 . . . . 0.0 111.153 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.35 168.55 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -98.19 112.02 24.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.448 -0.782 . . . . 0.0 110.148 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 43.9 p90 -65.92 -34.22 77.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.471 -0.768 . . . . 0.0 112.171 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.456 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 mttt -70.04 -40.02 75.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.075 -1.016 . . . . 0.0 110.946 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.19 -43.82 81.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.629 -0.669 . . . . 0.0 111.391 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -71.66 -27.87 63.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.578 -0.701 . . . . 0.0 110.993 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.42 HD12 ' CE1' ' A' ' 90' ' ' PHE . 96.6 mt -83.93 -51.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.812 . . . . 0.0 110.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -61.93 -26.4 68.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 111.016 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.14 -16.44 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 76.8 t -97.19 -42.88 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.14 -0.975 . . . . 0.0 109.187 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.498 1.933 0 O-C-N 121.703 -0.623 . . . . 0.0 111.721 -179.899 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -108.56 154.48 21.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 110.94 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.3 m -50.75 -30.41 13.91 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.415 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 44.0 mt-10 -50.49 -35.87 31.15 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.687 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.89 -47.22 75.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.595 -0.691 . . . . 0.0 110.326 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CD2' HD13 ' A' ' 147' ' ' LEU . 21.3 m-85 -77.42 -39.95 45.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.656 -0.653 . . . . 0.0 112.692 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 84' ' ' GLU . 33.4 m -68.22 -41.87 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.826 -1.171 . . . . 0.0 110.801 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -60.05 -33.7 72.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.487 -0.758 . . . . 0.0 110.187 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.75 -56.5 21.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.64 -0.663 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CE1' ' HA ' ' A' ' 106' ' ' LEU . 56.0 m-85 -77.34 -53.14 8.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 111.048 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -49.03 -42.71 39.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.497 -0.752 . . . . 0.0 112.436 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.91 -39.26 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.861 -1.149 . . . . 0.0 109.611 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.03 -43.65 87.0 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.61 81.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -62.15 -37.38 84.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.606 -0.684 . . . . 0.0 110.868 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -89.94 17.06 7.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.9 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.3 t 37.69 37.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.6 p -63.78 -33.29 75.34 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.12 -0.988 . . . . 0.0 109.465 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.17 54.69 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.187 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -132.19 153.41 50.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -1.191 . . . . 0.0 109.9 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.6 m -148.86 159.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.283 -0.886 . . . . 0.0 110.388 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.8 p -84.75 147.66 26.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.575 . . . . 0.0 110.222 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.36 -39.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.366 -0.834 . . . . 0.0 110.238 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.42 -41.61 95.34 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.31 -39.79 28.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.579 -0.954 . . . . 0.0 110.216 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.408 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 28.7 tp -60.04 -49.0 79.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.75 -0.594 . . . . 0.0 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -66.77 -29.83 69.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 111.036 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.76 -48.85 62.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.078 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -38.57 77.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.368 -0.832 . . . . 0.0 110.667 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tp -55.09 -44.2 74.65 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -61.49 -25.21 67.11 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.511 0.672 . . . . 0.0 110.081 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.39 -14.52 63.72 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.55 7.88 44.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.317 -1.108 . . . . 0.0 112.214 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.63 32.5 4.78 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -113.98 119.94 38.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.99 -0.712 . . . . 0.0 110.342 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -122.32 59.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.0 109.579 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -90.97 148.78 22.19 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 p -111.18 141.62 44.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -40.09 -27.79 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 O-C-N 121.311 -0.868 . . . . 0.0 112.84 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.1 -52.56 63.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.294 -0.878 . . . . 0.0 109.16 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.62 -42.92 40.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.99 -35.42 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.669 -0.644 . . . . 0.0 110.608 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.76 -38.09 89.81 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.294 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.01 -46.36 89.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.615 -0.678 . . . . 0.0 109.71 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -50.02 74.1 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.559 0.695 . . . . 0.0 109.884 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.41 -18.98 43.64 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.772 -0.58 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.05 -21.96 35.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.471 -0.768 . . . . 0.0 111.161 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.23 -12.91 10.36 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.3 t -68.98 130.02 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.098 -1.237 . . . . 0.0 110.169 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -99.15 103.64 15.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.437 0.637 . . . . 0.0 111.589 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -87.77 159.69 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.37 -177.05 4.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.8 p -69.58 -2.39 11.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.933 -0.479 . . . . 0.0 112.159 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -105.07 -6.26 20.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.948 -1.095 . . . . 0.0 110.225 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.83 23.23 60.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -110.41 145.91 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 110.984 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.55 170.09 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.24 116.91 29.38 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 47.8 p90 -65.47 -39.83 92.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.56 -0.712 . . . . 0.0 111.751 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.2 mttt -64.56 -40.03 94.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.529 -0.732 . . . . 0.0 110.469 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -68.17 -43.94 77.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.779 -0.575 . . . . 0.0 111.225 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -69.89 -28.67 65.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.523 -0.736 . . . . 0.0 110.357 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 42.8 mt -76.15 -46.89 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.521 -0.737 . . . . 0.0 109.133 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.6 -28.78 69.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.41 -0.806 . . . . 0.0 110.496 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -88.37 -12.0 44.59 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.861 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.0 t -95.12 -38.15 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 86' ' ' PHE . 5.1 mp . . . . . 0 N--CA 1.497 1.877 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.167 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.919 0.39 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -108.81 161.62 14.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 110.895 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -50.91 -31.35 17.31 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -50.97 -35.94 36.35 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.854 -0.529 . . . . 0.0 111.079 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -59.96 -50.61 73.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.62 -0.675 . . . . 0.0 109.834 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.423 ' CG ' HG22 ' A' ' 143' ' ' ILE . 0.7 OUTLIER -76.53 -40.08 51.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.708 -0.62 . . . . 0.0 110.79 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.09 -53.3 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.272 -0.893 . . . . 0.0 110.344 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -59.99 -34.24 73.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.681 -0.637 . . . . 0.0 110.402 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.94 -54.27 48.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 111.026 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.404 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 47.7 m-85 -77.63 -54.43 6.4 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.371 -0.83 . . . . 0.0 111.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -48.91 -39.56 26.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.503 -0.748 . . . . 0.0 112.922 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.2 -37.69 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.852 -1.155 . . . . 0.0 109.652 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -69.44 -46.46 66.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -64.34 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.0 110.641 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -60.01 -39.34 85.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.5 -0.75 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -91.61 20.7 5.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.314 -0.866 . . . . 0.0 110.899 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 p 38.36 37.95 0.2 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 p -64.06 -34.72 78.67 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.254 -0.979 . . . . 0.0 109.384 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 14.48 55.24 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -132.93 154.88 50.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.054 -1.263 . . . . 0.0 110.528 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 m -150.08 159.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.402 -0.811 . . . . 0.0 109.783 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -81.98 144.57 30.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.0 110.007 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.4 p -56.75 -38.9 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.538 -0.726 . . . . 0.0 110.772 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.82 -41.32 97.6 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.53 -39.1 28.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.547 -0.972 . . . . 0.0 110.527 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.404 ' HG ' ' CE2' ' A' ' 90' ' ' PHE . 7.5 tt -60.08 -49.95 75.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 110.108 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -63.44 -29.61 70.87 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.517 -0.74 . . . . 0.0 110.313 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.32 -47.48 67.44 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -39.71 87.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.39 -0.819 . . . . 0.0 110.574 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -44.82 74.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 m -60.83 -26.54 67.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.49 0.662 . . . . 0.0 109.966 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.06 -15.21 63.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 86' ' ' PHE . 21.7 tp -95.65 8.08 44.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 112.399 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.91 33.48 4.34 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -114.25 119.81 38.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.02 -0.694 . . . . 0.0 110.174 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -122.1 59.43 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.074 0.94 . . . . 0.0 109.612 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.5 mt -90.53 148.76 22.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 p -110.83 141.59 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -39.69 -28.89 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.35 -0.844 . . . . 0.0 112.62 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.73 -51.79 66.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -76.78 -43.12 38.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.581 -0.7 . . . . 0.0 110.549 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.0 t -59.97 -34.9 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 110.592 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -64.98 -36.82 85.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.138 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.76 -47.33 86.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.15 -46.63 88.15 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.69 0.757 . . . . 0.0 109.879 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.2 -19.52 63.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.907 -0.496 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -56.74 -21.03 25.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 0.0 111.191 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.34 -11.95 11.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.36 130.48 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.091 -1.241 . . . . 0.0 110.211 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -101.82 104.17 14.92 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.409 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.9 m -87.96 161.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.22 -176.2 3.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.59 -0.92 9.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.834 -0.541 . . . . 0.0 111.901 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -107.73 -10.06 15.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.923 -1.111 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.29 25.89 38.34 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -109.72 139.98 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.573 -0.957 . . . . 0.0 110.973 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.64 140.98 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -68.88 110.77 4.55 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.813 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 43.8 p90 -62.76 -34.02 76.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.491 -0.755 . . . . 0.0 112.004 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.7 mtmt -69.31 -38.67 78.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.272 -0.893 . . . . 0.0 110.581 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.33 -45.01 70.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.744 -0.597 . . . . 0.0 111.587 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -70.56 -28.8 65.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.449 -0.782 . . . . 0.0 110.645 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.423 HG22 ' CG ' ' A' ' 86' ' ' PHE . 85.5 mt -79.28 -47.95 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.509 -0.744 . . . . 0.0 109.646 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -60.41 -26.5 66.74 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.499 -0.75 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.0 -13.29 39.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.373 -0.829 . . . . 0.0 110.656 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.23 -43.22 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.795 -0.565 . . . . 0.0 111.546 179.099 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -110.03 160.02 16.8 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.878 0.847 . . . . 0.0 111.188 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -50.58 -30.95 14.44 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.706 0.765 . . . . 0.0 109.738 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -51.1 -36.45 40.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.752 -0.592 . . . . 0.0 111.322 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.44 -44.97 85.63 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.603 -0.686 . . . . 0.0 109.711 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.41 ' CD1' HD13 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -76.63 -41.12 47.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.734 -0.604 . . . . 0.0 111.131 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.5 t -63.7 -52.83 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 111.011 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -55.73 -32.21 63.18 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.538 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.22 -39.94 82.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.581 -0.699 . . . . 0.0 112.344 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -80.11 -58.0 3.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.043 -1.036 . . . . 0.0 110.959 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -48.52 -32.76 8.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -61.55 -31.38 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.804 -1.185 . . . . 0.0 109.716 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.35 -49.0 29.68 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 80.15 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -62.29 -34.5 76.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.518 -0.739 . . . . 0.0 110.647 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.37 18.51 8.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.233 -0.917 . . . . 0.0 110.657 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.1 m 37.83 35.27 0.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.3 p -63.95 -33.74 76.4 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.198 -0.939 . . . . 0.0 109.316 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 12.08 58.99 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -131.72 153.65 49.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -1.182 . . . . 0.0 109.933 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 m -149.98 159.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.308 -0.87 . . . . 0.0 110.018 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 144.85 31.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.09 -38.96 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.455 -0.778 . . . . 0.0 110.699 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.68 97.29 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.29 -42.25 23.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.545 -0.974 . . . . 0.0 110.574 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -60.04 -49.91 75.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 109.979 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -64.45 -33.06 75.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.537 -0.727 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -66.24 -48.03 71.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -25.74 59.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.489 -0.757 . . . . 0.0 110.68 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 29.8 tp -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.8 p -66.14 -16.73 64.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.301 0.572 . . . . 0.0 110.695 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.42 65.51 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.41 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.57 7.45 45.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.416 -1.05 . . . . 0.0 112.102 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.59 32.99 4.61 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 12.4 mm-40 -114.73 120.98 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.897 -0.766 . . . . 0.0 110.851 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -122.19 59.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.088 0.947 . . . . 0.0 109.297 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.73 149.08 21.79 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -110.87 142.84 42.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -39.83 -27.8 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.814 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.72 62.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.228 -0.92 . . . . 0.0 108.932 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.7 -43.3 38.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.588 -0.695 . . . . 0.0 110.425 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.99 -35.64 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.05 -39.1 93.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.24 -0.912 . . . . 0.0 109.171 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.437 -0.789 . . . . 0.0 109.641 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.32 -48.4 81.89 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.984 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.62 -18.14 51.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.799 -0.563 . . . . 0.0 111.191 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.56 -21.47 26.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.23 25.77 8.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 65.8 t -107.67 129.84 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -1.103 . . . . 0.0 109.855 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -102.59 103.03 13.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.751 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.05 161.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -95.28 -177.08 3.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 111.281 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.7 p -70.23 -0.8 8.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.907 -0.496 . . . . 0.0 112.01 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -107.5 -9.08 16.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.94 -1.1 . . . . 0.0 110.365 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.59 28.41 29.72 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.48 139.27 45.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.955 . . . . 0.0 110.969 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.407 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 4.6 mp -127.63 143.37 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.3 115.23 8.33 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.037 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.421 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 10.7 p90 -67.2 -35.26 79.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.723 -0.611 . . . . 0.0 111.769 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 25.3 mttt -70.98 -39.98 72.17 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.352 -0.842 . . . . 0.0 111.032 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.15 -44.57 83.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 111.705 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -70.02 -28.0 65.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.491 -0.756 . . . . 0.0 110.42 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 86' ' ' PHE . 96.3 mt -79.57 -48.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.382 -0.824 . . . . 0.0 110.133 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -59.99 -27.74 67.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.486 -0.759 . . . . 0.0 110.278 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.4 -16.1 31.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 110.64 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.1 t -97.52 -48.07 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.128 -0.983 . . . . 0.0 108.87 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.7 -0.625 . . . . 0.0 111.222 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.47 160.28 15.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.87 . . . . 0.0 110.973 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -51.18 -30.58 17.34 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.702 0.763 . . . . 0.0 109.487 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -52.46 -37.07 56.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.841 -0.537 . . . . 0.0 111.28 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -61.05 -50.06 74.85 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.573 -0.704 . . . . 0.0 109.919 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.428 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.5 m-85 -75.97 -38.87 57.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.771 -0.581 . . . . 0.0 111.264 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.17 -50.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.213 -0.929 . . . . 0.0 110.678 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -59.95 -34.17 72.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.547 -0.721 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -67.39 -44.28 79.25 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.664 -0.648 . . . . 0.0 111.736 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -78.49 -58.91 3.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.093 -1.005 . . . . 0.0 111.654 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -48.35 -28.97 3.5 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.13 -32.68 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.999 -1.063 . . . . 0.0 109.848 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -71.53 -50.87 27.07 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.33 81.35 6.66 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.377 -0.827 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -63.1 -17.16 62.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.83 16.11 7.36 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.05 -1.031 . . . . 0.0 110.945 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.4 p 39.1 35.84 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 t -63.11 -33.99 76.65 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.097 -1.002 . . . . 0.0 109.588 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.52 9.66 58.72 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.014 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -132.16 154.94 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.239 . . . . 0.0 110.382 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.8 m -151.04 160.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.371 -0.831 . . . . 0.0 109.914 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -82.04 144.86 30.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.574 -0.704 . . . . 0.0 109.956 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.07 -40.0 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.493 -0.755 . . . . 0.0 110.836 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.4 96.89 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.14 -39.84 28.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.579 -0.954 . . . . 0.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.94 -49.73 76.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.67 -0.644 . . . . 0.0 110.102 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -64.46 -30.26 71.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.697 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -67.89 -48.01 67.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.591 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -41.0 97.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.11 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.406 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 2.5 tp -55.78 -44.77 78.04 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.9 m -60.12 -30.61 69.39 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.616 0.722 . . . . 0.0 109.704 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.52 -14.65 63.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.42 7.09 47.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 112.762 -177.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.79 4.94 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 12.0 tp10 -113.75 119.97 39.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.925 -0.75 . . . . 0.0 109.992 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -121.96 59.22 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.002 0.906 . . . . 0.0 109.598 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.5 mt -90.85 148.58 22.4 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -111.17 141.36 44.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -39.9 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 O-C-N 121.353 -0.842 . . . . 0.0 112.726 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.0 61.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.434 -0.791 . . . . 0.0 109.0 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -76.71 -42.94 39.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.692 -0.63 . . . . 0.0 110.384 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.02 -35.25 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.587 -0.695 . . . . 0.0 110.466 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.01 -39.44 94.78 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.255 -0.903 . . . . 0.0 109.004 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.09 -49.38 77.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.624 -0.673 . . . . 0.0 109.537 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.19 -49.97 75.51 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.571 0.7 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.96 -17.22 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.915 -0.491 . . . . 0.0 111.333 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -57.47 -16.77 10.48 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.306 -0.871 . . . . 0.0 111.895 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.12 -11.06 11.22 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.051 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.51 133.95 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.94 -1.329 . . . . 0.0 110.854 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -103.3 102.48 12.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.393 0.616 . . . . 0.0 111.093 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 m -86.38 160.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -94.91 -176.39 3.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.473 -0.767 . . . . 0.0 111.114 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -69.95 -0.99 8.37 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.866 -0.521 . . . . 0.0 112.055 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -107.28 -7.74 16.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.949 -1.095 . . . . 0.0 110.438 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.08 27.2 38.02 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -108.62 140.07 42.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.598 -0.942 . . . . 0.0 111.125 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 4.4 mp -128.42 169.02 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -96.98 114.05 25.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.368 -0.833 . . . . 0.0 110.134 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 47.6 p90 -66.12 -35.42 80.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.558 -0.714 . . . . 0.0 111.643 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.3 mttt -69.22 -37.05 77.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.308 -0.87 . . . . 0.0 110.661 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -70.06 -44.12 69.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.602 -0.687 . . . . 0.0 111.62 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -70.36 -28.59 65.24 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.512 -0.743 . . . . 0.0 110.61 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 97.6 mt -76.46 -45.78 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.508 -0.745 . . . . 0.0 109.518 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.72 -26.74 65.88 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.262 -0.899 . . . . 0.0 109.738 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -88.97 -11.64 43.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 110.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 62.3 t -96.01 -42.08 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.895 -0.503 . . . . 0.0 111.395 178.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 164.06 13.55 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.104 0.954 . . . . 0.0 111.225 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m -50.23 -30.37 11.5 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.396 0.617 . . . . 0.0 110.215 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -53.17 -36.86 61.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.719 -0.613 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.49 -50.88 71.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.53 -0.731 . . . . 0.0 109.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.428 ' CE2' HD12 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -76.44 -39.62 52.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 0.0 111.086 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.5 t -59.98 -47.82 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.166 -0.959 . . . . 0.0 109.901 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -59.42 -31.95 69.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.713 -0.617 . . . . 0.0 110.368 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.93 -59.33 5.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.732 . . . . 0.0 112.016 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -77.12 -54.3 6.7 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.0 112.342 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -47.97 -37.87 15.56 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.365 -0.834 . . . . 0.0 113.163 -176.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.1 -31.35 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.71 -1.244 . . . . 0.0 109.752 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -70.0 -45.46 67.22 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -63.25 81.27 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.458 -0.777 . . . . 0.0 110.892 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -62.81 -40.06 96.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.672 -0.643 . . . . 0.0 110.94 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -91.0 17.0 8.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -0.902 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.6 m 38.05 35.58 0.09 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.8 p -63.73 -33.99 76.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.13 -0.981 . . . . 0.0 109.428 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.78 9.97 53.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.951 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -132.86 154.98 49.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.068 -1.254 . . . . 0.0 110.349 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -150.16 160.08 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.028 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 p -82.72 145.64 29.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.515 -0.741 . . . . 0.0 110.077 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.6 p -56.95 -39.66 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.475 -0.766 . . . . 0.0 110.649 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.11 96.87 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -80.41 -43.3 21.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.534 -0.98 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.97 -50.02 75.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.641 -0.662 . . . . 0.0 109.951 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -63.57 -31.88 73.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -66.06 -47.87 72.9 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.088 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.19 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.904 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.428 HD12 ' CE2' ' A' ' 86' ' ' PHE . 9.9 tp -56.2 -44.68 79.71 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.9 m -60.83 -31.39 70.82 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.577 0.704 . . . . 0.0 109.529 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.15 -13.87 67.86 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 86' ' ' PHE . 29.1 tp -95.09 8.44 42.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -1.086 . . . . 0.0 112.123 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.6 4.15 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 17.8 tp10 -114.91 120.4 39.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.952 -0.734 . . . . 0.0 110.769 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -122.27 59.67 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.063 0.935 . . . . 0.0 109.208 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.2 mt -92.0 149.74 21.37 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.3 m -110.86 144.14 40.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -40.11 -27.3 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.195 -0.941 . . . . 0.0 112.973 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.61 -52.1 64.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.33 -0.856 . . . . 0.0 109.279 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.35 -46.06 29.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 0.0 110.984 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.15 -33.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.352 -0.843 . . . . 0.0 110.513 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.85 -36.85 85.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -0.928 . . . . 0.0 109.001 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.75 -48.02 81.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.39 -28.36 69.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.544 -0.722 . . . . 0.0 110.884 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.1 mt -79.67 -15.78 56.95 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.653 . . . . 0.0 112.12 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -18.74 20.94 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.259 -0.9 . . . . 0.0 111.654 -177.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.55 -11.63 11.43 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.665 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.92 129.51 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.083 -1.245 . . . . 0.0 109.936 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -106.03 105.7 15.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.346 0.593 . . . . 0.0 111.623 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 m -88.86 161.52 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -93.12 -171.89 2.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.29 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -0.96 15.02 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -108.57 -11.14 15.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 110.453 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.19 28.42 28.08 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -109.08 138.04 46.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.909 . . . . 0.0 110.999 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 4.9 mp -129.25 140.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -69.54 108.61 3.88 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.816 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CE1' ' CG ' ' A' ' 140' ' ' LYS . 50.7 p90 -60.57 -29.47 69.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.432 -0.793 . . . . 0.0 111.871 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' CG ' ' CE1' ' A' ' 139' ' ' TYR . 61.2 mttt -69.01 -39.99 78.95 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.222 -0.924 . . . . 0.0 110.598 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.87 -43.87 82.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.801 -0.562 . . . . 0.0 111.502 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -70.46 -27.72 64.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 110.256 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 23.5 mm -80.29 -50.38 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.59 -28.72 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.69 -13.72 39.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.207 -0.933 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.97 -38.21 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.496 1.852 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.468 178.733 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.745 0.307 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -113.25 163.17 15.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 111.007 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.8 m -51.2 -31.29 19.85 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.485 0.66 . . . . 0.0 110.211 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -53.55 -38.68 64.08 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.648 -0.658 . . . . 0.0 111.111 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.52 -45.07 84.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.68 . . . . 0.0 109.571 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.417 ' CD1' HD11 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.63 -36.6 62.91 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.819 -0.551 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.1 t -70.9 -43.14 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 110.64 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.68 -35.84 73.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.455 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.75 69.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 111.989 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -79.19 -57.73 3.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.049 . . . . 0.0 111.681 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -48.9 -37.26 19.26 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.464 -0.773 . . . . 0.0 112.826 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.05 -37.73 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.156 -0.965 . . . . 0.0 109.988 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -66.1 -42.03 89.81 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.481 -0.762 . . . . 0.0 111.069 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -65.75 -24.99 67.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.563 -0.711 . . . . 0.0 110.479 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -106.15 15.69 25.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.661 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.7 t 38.2 63.06 0.88 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -91.65 -33.66 14.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.76 10.9 58.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.88 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -132.27 154.49 49.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.13 -1.218 . . . . 0.0 110.071 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -150.36 160.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 p -82.35 145.95 29.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.652 -0.655 . . . . 0.0 109.974 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.1 p -56.43 -39.67 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.461 -0.775 . . . . 0.0 110.629 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.9 -40.8 97.32 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.0 -40.31 28.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.978 . . . . 0.0 110.392 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.1 tp -59.95 -49.79 76.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 109.934 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -63.87 -32.28 73.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 110.375 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -67.77 -47.51 68.97 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.192 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -30.55 63.07 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.825 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 tp -60.06 -42.04 93.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.862 . . . . 0.0 109.068 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.7 p -68.03 -18.81 64.8 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.49 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.46 -14.72 63.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.417 HD11 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -93.1 7.15 45.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.381 -1.07 . . . . 0.0 112.362 -177.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.82 4.51 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.92 120.68 40.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 122.03 -0.688 . . . . 0.0 110.131 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.1 59.64 1.0 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.137 0.97 . . . . 0.0 109.815 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -91.05 148.91 22.06 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.4 m -110.87 142.55 42.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.908 . . . . 0.0 110.086 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -39.4 -29.73 0.05 Allowed 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.402 -0.811 . . . . 0.0 112.406 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.6 62.53 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -76.67 -41.93 43.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.63 -0.669 . . . . 0.0 110.227 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.06 -34.44 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.599 -0.688 . . . . 0.0 110.312 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.31 -36.62 84.61 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.221 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.76 -48.85 77.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.462 -0.774 . . . . 0.0 109.37 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.22 -47.14 87.45 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.615 0.721 . . . . 0.0 109.905 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.33 -17.28 41.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.842 -0.536 . . . . 0.0 111.207 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -56.39 -20.36 19.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.243 -0.911 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.73 27.92 7.31 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.6 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.9 p -107.23 128.72 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.132 -1.216 . . . . 0.0 110.182 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -103.52 105.29 15.5 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.332 0.587 . . . . 0.0 111.575 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 m -89.43 161.26 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -92.26 -176.51 4.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.419 -0.801 . . . . 0.0 111.064 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 m -69.7 -1.61 9.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.798 -0.564 . . . . 0.0 111.973 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -107.71 -8.4 16.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.936 -1.102 . . . . 0.0 110.655 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.83 38.41 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -109.06 139.84 43.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.964 . . . . 0.0 110.906 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.03 168.81 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -96.54 112.84 24.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.413 -0.805 . . . . 0.0 109.719 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.468 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 42.8 p90 -62.78 -22.32 66.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 111.857 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 46.6 mtpt -83.18 -32.85 26.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.142 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.21 -46.85 66.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.662 -0.649 . . . . 0.0 111.604 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -70.02 -28.6 65.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.542 -0.724 . . . . 0.0 111.572 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 144' ' ' GLU . 36.3 pt -79.13 -42.67 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' ' 143' ' ' ILE . 63.9 mt-10 -65.09 -26.46 68.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.209 -0.932 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -88.1 -12.46 44.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.0 110.646 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.11 -41.1 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' A' ' 86' ' ' PHE . 3.6 mp . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.881 -0.512 . . . . 0.0 111.543 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.842 0.353 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -107.75 160.2 15.91 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.878 0.847 . . . . 0.0 110.992 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -50.83 -30.6 14.75 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.666 0.746 . . . . 0.0 109.522 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -52.28 -37.49 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.839 -0.538 . . . . 0.0 111.209 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -61.26 -49.29 77.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE1' HD11 ' A' ' 113' ' ' LEU . 1.8 m-85 -76.02 -39.97 54.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.765 -0.584 . . . . 0.0 111.047 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.5 -51.29 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -58.49 -32.7 69.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.642 -0.661 . . . . 0.0 110.547 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.405 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -63.48 -55.35 24.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.788 -0.57 . . . . 0.0 111.725 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -78.74 -56.76 4.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.098 -1.001 . . . . 0.0 111.737 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.67 -37.84 19.57 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.561 -0.712 . . . . 0.0 112.819 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.86 -36.84 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.066 -1.021 . . . . 0.0 109.924 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -67.67 -43.41 80.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.5 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.483 -0.76 . . . . 0.0 110.761 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -61.17 -39.78 91.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 0.0 110.621 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.41 20.1 6.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.257 -0.902 . . . . 0.0 110.829 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t 38.15 36.51 0.12 Allowed 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 42.1 p -63.83 -34.66 78.43 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 12.53 58.04 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -132.42 154.68 49.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.036 -1.273 . . . . 0.0 110.475 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.07 160.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.365 -0.835 . . . . 0.0 109.896 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.1 p -80.5 144.06 32.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.2 p -57.21 -40.07 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 0.0 110.883 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.25 96.63 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -80.45 -39.24 28.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.984 . . . . 0.0 110.4 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.05 -49.97 75.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.715 -0.616 . . . . 0.0 110.121 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -63.21 -28.95 70.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.51 -47.84 68.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.366 -0.833 . . . . 0.0 110.619 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -40.75 96.12 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 3.4 tp -55.85 -44.59 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -60.35 -30.1 69.33 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.557 0.694 . . . . 0.0 109.65 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.13 -14.21 64.79 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.12 7.38 46.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.299 -1.118 . . . . 0.0 112.552 -177.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.58 31.89 5.03 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -113.82 120.32 40.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.988 -0.713 . . . . 0.0 110.249 178.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -122.45 59.74 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.042 0.925 . . . . 0.0 109.498 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.92 148.65 22.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.4 m -111.09 141.84 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.331 -0.855 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -39.87 -28.29 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.283 -0.886 . . . . 0.0 112.685 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.43 -52.84 62.91 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.37 -0.831 . . . . 0.0 109.059 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -77.01 -42.2 39.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.628 -0.67 . . . . 0.0 110.431 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.34 -36.36 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.602 -0.686 . . . . 0.0 110.295 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -63.19 -39.92 96.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.06 -47.51 85.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.63 -0.669 . . . . 0.0 109.839 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.94 -40.03 96.4 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.614 0.721 . . . . 0.0 110.669 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 68.7 mt -67.84 -15.97 63.87 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.779 -0.575 . . . . 0.0 111.856 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -57.55 -17.02 11.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.197 -0.939 . . . . 0.0 111.877 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.65 -10.93 12.07 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.221 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.7 p -70.65 132.36 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.953 -1.321 . . . . 0.0 110.522 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.48 100.06 10.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.367 0.603 . . . . 0.0 111.363 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.82 159.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -95.88 -179.51 4.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.415 -0.803 . . . . 0.0 111.502 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.2 m -70.41 -1.49 10.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.849 -0.532 . . . . 0.0 112.13 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -107.83 -11.49 15.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.863 -1.148 . . . . 0.0 110.411 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.02 29.05 16.17 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -110.43 135.7 50.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.649 -0.912 . . . . 0.0 111.328 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.35 169.0 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -97.83 114.75 26.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.44 -0.787 . . . . 0.0 110.468 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 46.6 p90 -68.32 -36.22 78.96 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.511 -0.743 . . . . 0.0 111.676 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.5 mttt -68.51 -40.0 81.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.294 -0.879 . . . . 0.0 110.798 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -67.3 -43.26 82.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.694 -0.629 . . . . 0.0 111.299 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -70.74 -27.76 64.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.494 -0.753 . . . . 0.0 110.46 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 20.3 mm -78.5 -49.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.477 -0.764 . . . . 0.0 109.585 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -60.04 -27.51 66.99 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 0.0 110.384 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.06 -12.3 44.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 110.502 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.24 -39.14 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.912 -0.492 . . . . 0.0 111.204 179.015 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.51 159.55 16.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.813 0.816 . . . . 0.0 111.009 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 m -50.97 -30.81 16.0 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.666 0.746 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.73 -36.89 38.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.851 -0.53 . . . . 0.0 111.274 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -57.64 -54.11 50.57 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -76.59 -38.51 54.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.606 -0.684 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.9 t -57.12 -51.55 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -0.992 . . . . 0.0 110.328 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -60.07 -32.13 70.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.687 -0.633 . . . . 0.0 110.255 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.21 -56.56 20.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.643 -0.66 . . . . 0.0 111.805 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.02 -53.54 7.68 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.307 -0.871 . . . . 0.0 111.813 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -48.58 -40.24 26.63 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.424 -0.798 . . . . 0.0 112.759 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.7 t -59.8 -37.93 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.773 -1.205 . . . . 0.0 109.663 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -68.97 -45.97 69.29 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -62.12 82.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.431 -0.793 . . . . 0.0 110.937 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -62.57 -41.24 98.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -91.64 18.88 6.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.278 -0.889 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.1 p 38.48 37.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.3 p -63.72 -34.99 79.1 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.089 -1.007 . . . . 0.0 109.311 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.86 12.75 55.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.007 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -132.63 154.84 49.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.133 -1.216 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.2 m -150.72 160.4 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.389 -0.82 . . . . 0.0 109.855 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 p -83.21 145.55 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.96 -39.21 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.471 -0.768 . . . . 0.0 110.715 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.04 96.48 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -80.53 -39.96 26.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.616 -0.932 . . . . 0.0 110.394 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.9 -50.01 75.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.698 -0.626 . . . . 0.0 110.145 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -64.89 -29.57 70.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 110.551 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -69.0 -47.97 64.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.437 -0.789 . . . . 0.0 110.773 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.62 88.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.321 -0.862 . . . . 0.0 110.445 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.36 -44.76 76.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.5 m -59.99 -27.87 67.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.546 0.688 . . . . 0.0 110.051 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.09 -14.62 64.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.55 8.3 42.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.33 -1.1 . . . . 0.0 112.287 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 33.01 4.52 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -114.03 119.85 38.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.982 -0.716 . . . . 0.0 110.298 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -121.98 59.28 1.0 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.198 0.999 . . . . 0.0 109.236 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.5 mt -90.11 148.7 22.85 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -111.05 143.9 41.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.252 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -40.33 -27.03 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.199 -0.938 . . . . 0.0 112.817 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.9 55.5 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 18.3 mp0 -75.15 -28.48 60.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.455 -0.778 . . . . 0.0 110.592 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.69 -33.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.819 . . . . 0.0 110.348 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -65.83 -45.12 83.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 11.2 pt-20 -56.63 -42.39 78.77 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.168 -0.958 . . . . 0.0 109.83 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.05 -47.22 81.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 0.0 109.648 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 mt -60.59 -18.04 50.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.888 -0.508 . . . . 0.0 111.07 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -56.79 -21.57 29.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.461 -0.775 . . . . 0.0 111.056 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 26.32 7.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.2 t -107.9 129.88 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -1.109 . . . . 0.0 109.671 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.96 101.87 13.09 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.437 0.637 . . . . 0.0 111.935 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.04 158.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -95.85 -177.72 4.13 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.383 -0.823 . . . . 0.0 111.286 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.09 -1.27 14.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.941 -0.474 . . . . 0.0 111.805 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -108.21 -15.02 14.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.423 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.78 29.2 12.19 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.03 133.7 53.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.624 -0.927 . . . . 0.0 111.167 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.8 mp -124.77 139.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -69.79 112.48 6.26 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.73 -0.606 . . . . 0.0 110.502 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.449 ' CG ' ' N ' ' A' ' 140' ' ' LYS . 32.7 p90 -69.96 -41.64 74.24 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.391 -0.818 . . . . 0.0 112.222 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 4.0 mttt -60.22 -29.87 69.02 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.605 -0.684 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -84.12 -39.48 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 111.649 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -70.01 -29.88 67.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.444 -0.785 . . . . 0.0 111.349 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.429 HG13 ' N ' ' A' ' 144' ' ' GLU . 27.8 pt -83.17 -43.43 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.429 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.9 mt-10 -68.91 -27.44 65.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.322 -0.861 . . . . 0.0 110.715 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -85.1 -15.79 42.73 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.319 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 76.6 t -95.48 -37.41 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.2 mt . . . . . 0 N--CA 1.497 1.889 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.305 178.753 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -110.18 161.0 16.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 111.283 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.2 m -51.04 -30.37 15.33 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.636 0.731 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -51.01 -37.61 46.17 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.883 -0.511 . . . . 0.0 111.222 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.18 -47.24 85.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 147' ' ' LEU . 1.2 m-85 -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.75 -49.99 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.368 -0.833 . . . . 0.0 110.658 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.58 -34.96 73.38 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.583 -0.698 . . . . 0.0 111.388 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.413 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.26 -56.61 18.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.605 -0.685 . . . . 0.0 112.005 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -76.7 -54.1 7.1 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.188 -0.945 . . . . 0.0 111.976 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -48.41 -37.21 16.46 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.31 -0.869 . . . . 0.0 113.045 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.94 -36.36 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 120.843 -1.16 . . . . 0.0 109.89 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.91 -42.78 89.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -62.1 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.43 -0.794 . . . . 0.0 111.249 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -61.44 -41.05 96.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.557 -0.714 . . . . 0.0 110.048 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.3 20.58 7.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.44 -0.787 . . . . 0.0 110.44 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 38.2 36.68 0.12 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 t -63.46 -33.39 75.46 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.128 -0.983 . . . . 0.0 109.566 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.17 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.31 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -131.58 152.73 50.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -1.216 . . . . 0.0 109.736 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.89 160.0 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.9 p -81.37 145.93 30.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.1 p -54.46 -39.52 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.484 -0.76 . . . . 0.0 110.658 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.04 96.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.58 -43.16 21.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.633 -0.922 . . . . 0.0 110.8 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.0 -50.07 75.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.48 -0.762 . . . . 0.0 110.057 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -63.32 -31.64 72.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.724 . . . . 0.0 110.165 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -67.73 -47.7 68.56 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.401 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -40.4 95.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 tp -55.73 -44.81 77.87 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.5 m -60.45 -29.68 69.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.33 -14.25 64.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.413 ' CD1' ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -94.74 7.33 46.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -1.087 . . . . 0.0 112.545 -177.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.77 32.11 4.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -113.87 120.16 39.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.932 -0.746 . . . . 0.0 110.204 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -121.92 59.51 0.99 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.203 1.002 . . . . 0.0 109.304 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.03 148.96 21.79 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 p -110.95 143.25 41.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.261 -0.899 . . . . 0.0 109.854 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -40.08 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 O-C-N 121.213 -0.929 . . . . 0.0 112.805 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.99 61.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 108.982 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -76.69 -42.83 40.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.598 -0.689 . . . . 0.0 110.433 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.41 -35.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.73 -38.38 90.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.229 -0.919 . . . . 0.0 109.208 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.01 -47.62 85.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.614 . . . . 0.0 109.739 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.83 -49.88 75.68 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.508 0.67 . . . . 0.0 110.052 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.98 -18.72 47.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.888 -0.507 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -57.04 -21.03 28.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.447 -0.783 . . . . 0.0 111.136 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.92 9.08 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.45 132.82 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.041 -1.27 . . . . 0.0 109.982 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -102.51 102.34 12.6 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.389 0.614 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -85.4 159.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.85 -176.79 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -71.67 -1.14 12.69 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.794 -0.566 . . . . 0.0 111.834 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -107.43 -12.07 15.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.13 . . . . 0.0 110.403 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.61 27.09 28.04 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -110.89 140.1 45.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.619 -0.93 . . . . 0.0 111.245 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.407 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 5.1 mp -130.86 142.39 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.89 113.04 5.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.971 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 26.0 p90 -62.84 -33.26 74.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.642 -0.661 . . . . 0.0 111.706 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 20.5 mttt -69.97 -35.05 74.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 110.712 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -69.95 -44.11 70.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.72 -0.613 . . . . 0.0 111.518 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -74.33 -27.69 60.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.762 . . . . 0.0 111.077 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.33 -51.8 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.447 -0.783 . . . . 0.0 109.884 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -63.77 -26.43 68.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.439 -0.788 . . . . 0.0 110.791 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.34 -13.39 43.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.217 -0.927 . . . . 0.0 110.746 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.83 -38.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.41 HD13 ' CD2' ' A' ' 86' ' ' PHE . 14.3 mt . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.954 -0.466 . . . . 0.0 111.406 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.8 pttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.611 0.72 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.45 148.93 24.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.797 -0.564 . . . . 0.0 110.445 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -100.75 168.52 9.61 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.95 0.881 . . . . 0.0 111.245 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.2 m -51.16 -31.19 19.09 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.45 0.643 . . . . 0.0 109.96 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -52.17 -37.92 56.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.709 -0.62 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.59 -47.11 85.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.9 m-85 -76.03 -40.0 54.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.7 t -61.5 -51.84 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.244 -0.91 . . . . 0.0 110.588 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -56.96 -32.55 66.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.28 -59.92 4.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.503 -0.748 . . . . 0.0 111.934 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -76.63 -53.67 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.188 -0.945 . . . . 0.0 111.951 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -48.16 -38.52 18.25 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.26 -0.9 . . . . 0.0 112.791 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.5 t -59.62 -34.81 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.801 -1.187 . . . . 0.0 109.602 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.14 -41.01 97.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.4 81.41 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.448 -0.782 . . . . 0.0 111.083 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.26 -41.63 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.642 -0.661 . . . . 0.0 110.425 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -91.46 16.18 10.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.333 -0.854 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 t 38.42 61.7 1.11 Allowed 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.8 p -90.5 -33.48 15.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.146 -0.971 . . . . 0.0 109.31 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.07 9.98 55.33 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.925 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -132.84 154.82 49.97 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.021 -1.282 . . . . 0.0 110.274 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.02 159.92 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.258 -0.901 . . . . 0.0 109.964 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.1 p -81.38 144.21 31.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.8 p -56.92 -39.98 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.562 -0.711 . . . . 0.0 110.857 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.82 -41.58 96.13 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.59 -39.67 27.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.939 . . . . 0.0 110.453 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.97 -49.88 75.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.687 -0.633 . . . . 0.0 110.168 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -65.87 -29.52 69.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.401 -0.812 . . . . 0.0 111.005 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -65.58 -48.29 72.85 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.093 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.111 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 4.1 tp -55.69 -44.74 77.65 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.266 -0.896 . . . . 0.0 108.702 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -60.85 -30.25 70.0 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.545 0.688 . . . . 0.0 109.622 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.59 -13.83 66.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 7.7 45.38 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.31 -1.112 . . . . 0.0 112.406 -177.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.39 31.67 5.17 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 12.2 tp10 -113.25 119.93 39.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.873 -0.781 . . . . 0.0 110.281 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -122.39 59.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.955 0.883 . . . . 0.0 109.386 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.99 148.62 22.28 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 m -111.01 141.89 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -40.08 -27.24 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.226 -0.921 . . . . 0.0 112.899 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -53.18 59.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.202 -0.936 . . . . 0.0 108.975 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.72 -42.68 40.37 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.531 -0.73 . . . . 0.0 110.414 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.01 -36.66 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.604 -0.685 . . . . 0.0 110.272 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -63.33 -38.37 90.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.207 -0.933 . . . . 0.0 109.069 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -62.95 -49.82 73.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.626 -0.671 . . . . 0.0 109.365 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.91 -49.43 77.74 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.576 0.703 . . . . 0.0 110.237 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.34 -15.99 51.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.938 -0.476 . . . . 0.0 111.257 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -57.26 -17.16 10.51 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.264 -0.897 . . . . 0.0 111.853 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.03 -10.19 14.46 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.071 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.4 135.9 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.989 -1.301 . . . . 0.0 110.765 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -104.62 100.63 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.412 0.625 . . . . 0.0 111.267 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.27 158.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -95.34 -179.06 4.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -0.805 . . . . 0.0 111.36 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 m -70.72 -1.55 11.77 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.942 -0.474 . . . . 0.0 112.032 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -107.14 -11.15 15.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 0.0 110.421 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.73 26.02 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -110.61 137.92 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.96 . . . . 0.0 111.14 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.81 168.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.14 112.33 24.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 109.891 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 48.1 p90 -62.68 -29.12 70.41 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.729 . . . . 0.0 111.632 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 15.7 mttt -73.1 -34.63 66.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.25 -0.906 . . . . 0.0 110.615 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -70.16 -45.98 65.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.689 -0.632 . . . . 0.0 112.183 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -70.68 -28.37 64.72 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 0.0 110.8 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.58 -45.98 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.48 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -60.06 -27.43 66.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.68 -12.33 42.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.7 t -95.71 -40.68 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.415 HD12 ' CD2' ' A' ' 86' ' ' PHE . 4.4 mp -55.49 -20.88 14.12 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.948 -0.47 . . . . 0.0 111.301 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -59.14 -40.02 84.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.381 -0.824 . . . . 0.0 110.364 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.195 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.6 tttm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.682 0.753 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.17 155.11 23.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.946 -0.471 . . . . 0.0 110.255 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -102.17 160.01 14.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.713 0.768 . . . . 0.0 110.843 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 m -51.13 -30.65 17.06 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.701 0.762 . . . . 0.0 109.337 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -52.24 -37.47 55.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.955 -0.466 . . . . 0.0 111.168 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -60.58 -50.04 75.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.592 -0.693 . . . . 0.0 109.856 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.445 ' CD1' HD12 ' A' ' 113' ' ' LEU . 1.2 m-85 -75.91 -40.06 55.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.783 -0.573 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 83.5 t -61.92 -49.89 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.322 -0.861 . . . . 0.0 110.606 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -59.75 -34.33 72.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.566 -0.709 . . . . 0.0 110.801 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.06 -51.82 66.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.677 -0.64 . . . . 0.0 111.628 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -77.23 -54.92 5.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 111.802 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -48.04 -35.57 11.39 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.504 -0.747 . . . . 0.0 112.954 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.87 -29.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.679 -1.263 . . . . 0.0 109.122 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -92.81 23.16 4.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.679 -0.638 . . . . 0.0 109.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -132.02 78.47 1.82 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 0.0 108.941 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -63.56 -45.48 90.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.765 -0.584 . . . . 0.0 111.435 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.99 17.68 5.55 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.014 -1.054 . . . . 0.0 111.389 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 t 38.27 39.82 0.3 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 t -63.47 -34.16 77.16 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.586 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.43 14.58 50.26 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.384 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -132.93 153.84 51.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.081 -1.246 . . . . 0.0 110.643 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -150.29 160.02 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.6 p -84.74 147.34 26.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.0 109.711 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 m -63.35 -34.02 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.289 -0.882 . . . . 0.0 110.268 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.29 -42.49 99.79 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.49 -41.43 27.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.653 -0.91 . . . . 0.0 109.493 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.9 tt -59.96 -49.23 78.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -63.63 -32.51 74.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.693 -0.63 . . . . 0.0 110.543 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.72 -48.91 67.72 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -36.41 74.79 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.889 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 19.9 tp -53.72 -45.02 70.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -66.27 -18.77 65.55 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.018 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.7 -14.15 65.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.445 HD12 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -95.03 8.28 43.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 112.67 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.3 31.19 5.07 Favored Glycine 0 N--CA 1.503 3.104 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 49.5 mm-40 -114.88 121.76 44.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.957 -0.731 . . . . 0.0 110.165 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -122.83 61.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 109.899 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.5 mt -91.96 148.87 21.87 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 m -110.6 144.26 39.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 109.989 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -39.43 -29.28 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.361 -0.837 . . . . 0.0 112.598 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.95 49.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.35 -0.844 . . . . 0.0 108.847 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -76.44 -39.93 52.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.616 . . . . 0.0 110.284 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.2 -35.95 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.585 -0.697 . . . . 0.0 110.653 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.0 -39.92 87.45 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.075 -1.016 . . . . 0.0 108.927 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.71 -43.89 81.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.708 -0.62 . . . . 0.0 109.397 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.17 -50.04 74.77 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.657 0.741 . . . . 0.0 109.856 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mt -67.67 -22.15 65.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.779 -0.575 . . . . 0.0 110.831 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -57.4 -19.72 25.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.501 -0.749 . . . . 0.0 111.358 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.65 -14.86 5.57 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.25 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.1 p -66.19 128.83 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 118.897 1.348 . . . . 0.0 110.517 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.05 99.86 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.407 0.623 . . . . 0.0 111.226 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.21 157.08 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -96.68 -174.35 2.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 111.206 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.2 m -71.67 -0.7 11.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.839 -0.538 . . . . 0.0 111.853 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -106.95 -11.32 15.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.19 25.32 44.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -111.7 139.52 47.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.555 -0.968 . . . . 0.0 110.998 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.56 146.48 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -69.09 114.38 7.31 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 49.9 p90 -67.55 -38.88 84.79 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.544 -0.722 . . . . 0.0 111.548 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.8 mttt -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.0 110.102 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -70.02 -42.32 73.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 110.927 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.88 -28.13 63.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.54 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.411 HG21 ' CG ' ' A' ' 86' ' ' PHE . 92.3 mt -85.05 -52.25 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.324 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -87.63 -13.91 41.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -0.914 . . . . 0.0 110.56 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.96 -38.29 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD13 ' CD2' ' A' ' 86' ' ' PHE . 22.3 mt -59.71 -19.82 52.38 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.896 -0.502 . . . . 0.0 111.258 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -58.18 137.8 56.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.34 -0.85 . . . . 0.0 110.272 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.202 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.652 0.739 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.46 154.59 26.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 122.018 -0.426 . . . . 0.0 110.252 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -103.43 162.23 13.2 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 110.969 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 m -51.33 -30.69 19.26 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.608 0.718 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.66 -38.15 59.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.843 -0.535 . . . . 0.0 111.162 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.69 -50.18 74.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 109.871 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -74.29 -38.35 63.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.782 -0.573 . . . . 0.0 110.999 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.99 -48.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.231 -0.918 . . . . 0.0 110.678 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -60.02 -35.75 75.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.628 -0.67 . . . . 0.0 111.019 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.95 -52.16 66.61 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 111.245 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -77.0 -53.3 8.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.378 -0.826 . . . . 0.0 111.249 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -48.7 -38.69 22.1 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.8 t -59.17 -31.03 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 120.565 -1.334 . . . . 0.0 109.193 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.95 23.6 4.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -131.57 78.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.0 109.399 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -70.5 -10.46 59.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.767 -0.583 . . . . 0.0 111.355 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.22 11.65 15.21 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.125 -0.985 . . . . 0.0 110.963 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m 37.54 37.55 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 p -63.88 -34.53 78.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.424 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.07 14.91 53.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -133.6 156.41 47.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.178 -1.19 . . . . 0.0 110.435 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -151.61 160.02 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -82.61 144.94 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.905 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.3 -39.92 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.746 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.01 -41.89 96.64 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.01 -42.6 23.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.528 -0.983 . . . . 0.0 110.336 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.01 -49.75 76.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -64.89 -33.66 76.54 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -67.16 -49.04 66.18 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -34.84 71.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.54 -0.725 . . . . 0.0 110.523 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 30.8 tp -54.66 -45.28 73.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.413 -0.804 . . . . 0.0 109.116 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.0 m -63.96 -19.04 64.85 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.346 0.593 . . . . 0.0 110.789 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.31 -14.57 63.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -94.13 7.38 45.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -1.03 . . . . 0.0 112.649 -177.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.8 4.84 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 6.4 mm-40 -114.79 121.02 42.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.941 -0.741 . . . . 0.0 110.116 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -122.23 59.64 1.01 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.138 0.971 . . . . 0.0 109.755 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.99 148.83 22.13 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.5 m -111.06 141.63 44.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -39.63 -29.14 0.05 Allowed 'General case' 0 N--CA 1.513 2.701 0 O-C-N 121.417 -0.802 . . . . 0.0 112.487 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.84 -52.62 63.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.368 -0.833 . . . . 0.0 108.953 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -77.01 -42.61 37.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.632 -0.668 . . . . 0.0 110.295 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.8 t -60.02 -35.21 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 110.378 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.52 -38.8 92.5 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 109.041 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.77 -45.5 93.64 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.692 0.758 . . . . 0.0 110.143 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.1 mt -63.65 -18.45 63.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.899 -0.501 . . . . 0.0 111.304 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -56.67 -18.24 11.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.196 -0.94 . . . . 0.0 111.68 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.14 -9.62 15.29 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.944 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.13 133.78 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.926 -1.338 . . . . 0.0 110.988 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -99.59 99.41 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.365 0.602 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.13 155.77 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.89 -176.9 3.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 111.18 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.04 -0.96 12.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.819 -0.55 . . . . 0.0 111.805 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -108.0 -14.02 14.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 0.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.04 28.98 16.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -110.51 134.94 51.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.677 -0.896 . . . . 0.0 111.073 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 4.8 mp -125.28 142.63 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.66 112.41 6.12 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.247 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 41.5 p90 -68.11 -34.11 75.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.531 -0.731 . . . . 0.0 111.531 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 mttt -69.8 -32.73 71.33 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.272 -0.893 . . . . 0.0 110.426 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -73.2 -43.29 61.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.702 -0.623 . . . . 0.0 111.643 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -70.73 -28.16 64.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.488 -0.758 . . . . 0.0 110.695 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.5 mt -75.18 -45.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.758 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.55 -26.83 65.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.91 -11.74 43.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.46 -0.775 . . . . 0.0 110.327 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.97 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 87.2 mt -54.47 -21.33 9.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.913 -0.492 . . . . 0.0 111.379 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 -58.62 -39.96 81.98 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.212 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.6 mttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.722 0.772 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.65 156.0 21.61 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.984 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -109.22 161.47 15.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.931 0.872 . . . . 0.0 111.319 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.3 m -51.18 -30.32 16.6 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.663 0.744 . . . . 0.0 109.674 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.93 -37.64 32.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.717 -0.614 . . . . 0.0 111.146 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -59.12 -50.4 74.2 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.18 -38.38 56.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.8 t -57.34 -55.39 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.177 -0.952 . . . . 0.0 110.49 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -59.99 -33.27 71.74 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.633 -0.667 . . . . 0.0 110.553 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.29 -51.88 67.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.682 -0.636 . . . . 0.0 111.429 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 33.4 m-85 -78.74 -54.94 5.57 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 0.0 111.508 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -49.19 -39.98 31.51 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.585 -0.697 . . . . 0.0 112.69 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.38 -38.57 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.071 -1.018 . . . . 0.0 110.072 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -69.07 -44.83 71.78 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -61.74 82.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.516 -0.74 . . . . 0.0 111.018 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -69.1 -15.35 63.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.11 12.87 20.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.2 -0.937 . . . . 0.0 110.5 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m 38.27 62.8 0.93 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -91.28 -34.18 15.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.161 -0.962 . . . . 0.0 109.359 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.66 11.67 54.88 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -132.21 154.66 49.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.262 . . . . 0.0 110.339 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.4 m -150.77 160.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.407 -0.808 . . . . 0.0 110.182 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.7 p -85.75 147.84 26.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 110.118 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.9 t -57.16 -40.2 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.336 -0.852 . . . . 0.0 110.531 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.16 -42.04 95.03 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.45 -44.17 19.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.512 -0.993 . . . . 0.0 110.4 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.417 ' HG ' ' CE2' ' A' ' 90' ' ' PHE . 8.2 tt -60.03 -49.96 75.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.714 -0.616 . . . . 0.0 110.001 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -64.08 -32.21 73.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -68.08 -47.83 67.21 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.516 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.33 95.45 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.144 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.405 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.98 -44.79 78.9 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 m -59.89 -30.5 69.06 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.59 0.71 . . . . 0.0 109.789 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.44 -14.62 63.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 7.3 46.6 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.301 -1.117 . . . . 0.0 112.602 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.4 4.76 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.405 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 21.2 tp10 -114.01 120.13 39.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.884 -0.774 . . . . 0.0 110.005 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -122.09 59.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.142 0.972 . . . . 0.0 109.518 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.5 mt -92.18 149.36 21.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 144.19 40.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.917 . . . . 0.0 109.663 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -40.13 -27.4 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.254 -0.904 . . . . 0.0 112.809 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.66 62.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.278 -0.889 . . . . 0.0 109.028 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.59 -42.79 41.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 110.382 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.93 -35.55 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.519 -0.738 . . . . 0.0 110.419 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -64.49 -37.74 88.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -60.05 -47.24 86.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 0.0 109.717 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.13 -50.13 74.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.631 0.729 . . . . 0.0 109.947 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.45 -19.58 56.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.893 -0.504 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -57.32 -22.01 39.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.486 -0.758 . . . . 0.0 111.203 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -113.81 -13.87 9.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.05 126.3 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.14 -1.212 . . . . 0.0 110.128 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -89.89 99.96 12.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.201 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 p -83.32 155.67 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -96.6 -175.6 3.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.377 -0.827 . . . . 0.0 111.182 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -72.02 -0.85 12.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.829 -0.544 . . . . 0.0 111.863 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.23 -12.58 15.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.104 . . . . 0.0 110.351 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.92 26.69 30.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -111.92 136.12 51.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.491 -1.005 . . . . 0.0 110.963 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.71 142.55 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 39.2 p-10 -69.74 109.07 4.19 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.378 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 49.9 p90 -65.28 -36.87 85.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.454 -0.779 . . . . 0.0 112.266 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 29.1 mttt -60.09 -31.52 70.1 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.337 -0.852 . . . . 0.0 111.904 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -84.2 -38.15 20.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.483 -0.76 . . . . 0.0 112.036 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -70.42 -28.84 65.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.445 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 90.6 mt -83.49 -50.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 110.326 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -62.88 -26.24 68.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.749 . . . . 0.0 110.993 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.78 -15.83 33.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 111.014 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.72 -41.66 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.058 -1.026 . . . . 0.0 108.709 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.93 -15.39 59.01 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.835 -0.541 . . . . 0.0 111.662 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -60.2 -30.49 69.39 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.293 -0.879 . . . . 0.0 110.027 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.82 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.678 0.751 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.1 161.17 14.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.812 -0.555 . . . . 0.0 110.185 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -109.22 162.0 14.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.97 0.89 . . . . 0.0 111.213 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 m -50.54 -30.69 13.63 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.596 0.712 . . . . 0.0 109.777 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -52.56 -36.19 55.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.916 -0.49 . . . . 0.0 111.107 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.35 -50.01 74.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 109.92 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.412 ' CE2' HD23 ' A' ' 147' ' ' LEU . 5.6 m-85 -75.87 -40.01 55.41 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.707 -0.621 . . . . 0.0 111.254 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.51 -50.01 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.267 -0.896 . . . . 0.0 110.365 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -57.95 -32.75 68.13 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.897 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.27 8.29 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.565 -0.709 . . . . 0.0 111.867 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.446 ' CE1' ' CD1' ' A' ' 106' ' ' LEU . 95.7 m-85 -78.81 -55.85 4.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.203 -0.936 . . . . 0.0 112.105 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -48.58 -38.64 21.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.421 -0.8 . . . . 0.0 112.808 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -56.5 -38.6 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.993 -1.067 . . . . 0.0 110.222 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 95' ' ' LYS . 23.4 m-85 -67.13 -42.5 84.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.77 83.1 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PHE . 67.4 mmtt -68.57 -16.82 63.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -113.53 15.73 18.93 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.0 110.445 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.55 37.08 0.1 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 t -63.57 -33.14 74.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.626 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.35 53.59 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.121 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -132.83 153.57 51.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.044 -1.268 . . . . 0.0 110.368 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.7 m -150.06 160.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.8 p -83.69 146.27 28.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.555 -0.715 . . . . 0.0 109.654 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 m -61.76 -34.81 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.303 -0.873 . . . . 0.0 110.283 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.43 99.79 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -79.62 -41.23 27.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.705 -0.879 . . . . 0.0 109.813 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.446 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 28.9 tp -60.04 -48.6 81.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -64.38 -30.98 72.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.67 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -65.52 -48.53 72.2 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.141 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -39.95 74.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.015 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 tp -54.17 -39.51 66.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.453 -0.779 . . . . 0.0 111.024 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.8 t -73.01 -17.86 61.4 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.471 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.76 -13.94 66.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 8.52 42.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -1.121 . . . . 0.0 112.23 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.12 30.14 5.2 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -114.17 121.48 43.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.81 -0.817 . . . . 0.0 110.273 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -123.02 61.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.095 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.6 mt -91.45 148.87 22.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -110.14 143.11 40.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -38.5 -31.38 0.05 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.557 -0.715 . . . . 0.0 112.406 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.05 50.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.97 -41.97 40.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.647 . . . . 0.0 110.324 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.61 -36.33 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.608 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.037 -1.039 . . . . 0.0 108.945 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.72 -43.72 80.88 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.62 -0.675 . . . . 0.0 109.57 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.92 -53.47 55.29 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.503 0.668 . . . . 0.0 110.253 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.36 -21.13 65.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.793 -0.567 . . . . 0.0 111.032 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.37 -20.9 32.25 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 111.334 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.85 -14.2 8.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.24 126.27 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.094 -1.239 . . . . 0.0 110.102 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -92.58 102.19 14.62 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.103 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -86.47 159.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -95.68 -173.25 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.94 -0.64 9.69 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.878 -0.514 . . . . 0.0 111.913 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -106.09 -9.82 16.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.935 -1.103 . . . . 0.0 110.272 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.01 25.25 49.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -111.45 143.0 42.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.483 -1.01 . . . . 0.0 111.135 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.0 170.64 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -94.41 117.62 30.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.421 -0.799 . . . . 0.0 110.344 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 49.0 p90 -68.47 -37.2 79.96 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.645 -0.659 . . . . 0.0 111.737 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 6.8 mttt -67.04 -41.0 87.27 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.58 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -69.94 -42.54 73.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.756 -0.59 . . . . 0.0 111.428 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -70.7 -29.36 65.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.502 -0.749 . . . . 0.0 110.348 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.405 HD12 ' CE2' ' A' ' 90' ' ' PHE . 94.8 mt -85.35 -50.99 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 110.235 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.77 -26.68 68.83 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.528 -0.733 . . . . 0.0 110.85 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.25 -15.46 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.816 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 58.1 t -95.98 -42.42 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 108.695 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.412 HD23 ' CE2' ' A' ' 86' ' ' PHE . 1.7 mm? -62.06 -15.61 46.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 111.693 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -59.36 141.26 54.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.234 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.751 0.786 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.07 159.6 18.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.947 -0.47 . . . . 0.0 110.263 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -109.92 161.98 14.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.859 0.838 . . . . 0.0 111.184 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 m -50.98 -30.86 16.17 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.59 0.709 . . . . 0.0 109.73 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -36.93 41.23 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.875 -0.516 . . . . 0.0 111.189 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -60.03 -50.06 75.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.598 -0.689 . . . . 0.0 109.996 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 143' ' ' ILE . 3.6 m-85 -76.35 -39.6 53.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 111.025 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.22 -53.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.25 -0.906 . . . . 0.0 110.665 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -59.45 -33.15 70.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.608 -0.682 . . . . 0.0 110.955 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -62.49 -51.69 66.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.508 -0.745 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.55 -54.87 6.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 111.505 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -48.46 -37.29 16.92 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.485 -0.759 . . . . 0.0 112.83 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.29 -36.94 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.843 -1.16 . . . . 0.0 109.715 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.59 -46.98 65.07 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -62.28 82.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.507 -0.746 . . . . 0.0 110.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -64.13 -40.01 95.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.0 110.447 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -91.54 16.7 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.5 36.31 0.13 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.8 p -63.75 -34.6 78.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.076 -1.015 . . . . 0.0 109.37 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.81 11.28 55.4 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.131 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -132.39 153.95 50.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.044 -1.268 . . . . 0.0 110.402 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.8 m -149.98 161.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.344 -0.848 . . . . 0.0 110.09 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 p -83.85 145.77 28.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.035 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.3 p -56.94 -38.3 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.395 -0.816 . . . . 0.0 110.675 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.92 -40.76 97.3 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.6 -39.96 26.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.602 -0.94 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.89 -49.87 75.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.64 . . . . 0.0 110.025 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -64.66 -29.94 70.95 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.502 -0.749 . . . . 0.0 110.652 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.5 -47.68 69.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.424 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -39.19 93.65 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.016 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.406 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -55.59 -45.29 77.45 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.1 m -59.65 -30.42 68.73 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.571 0.7 . . . . 0.0 109.917 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.3 63.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.425 HD11 ' CE1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 6.83 47.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.322 -1.105 . . . . 0.0 112.736 -177.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.66 32.35 4.83 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 19.9 tp10 -114.16 120.25 39.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 122.034 -0.686 . . . . 0.0 109.896 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -122.06 59.5 1.0 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.203 1.001 . . . . 0.0 109.364 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.38 148.44 23.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -111.05 143.1 42.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -39.98 -28.26 0.05 Allowed 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.318 -0.864 . . . . 0.0 112.486 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.41 59.29 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.4 -29.32 59.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 110.584 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.85 -32.6 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.99 -41.93 77.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.328 -0.857 . . . . 0.0 110.454 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 125' ' ' LEU . 9.1 pt-20 -60.0 -40.06 87.93 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.139 -0.975 . . . . 0.0 109.898 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.403 ' N ' ' HG3' ' A' ' 124' ' ' GLU . 0.2 OUTLIER -70.34 -44.06 68.97 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.394 -0.816 . . . . 0.0 110.354 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 mt -60.18 -16.11 30.07 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.841 -0.537 . . . . 0.0 111.775 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -57.64 -19.24 25.06 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.276 -0.89 . . . . 0.0 111.304 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.64 25.09 9.26 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.7 124.5 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.301 -1.117 . . . . 0.0 109.549 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.03 105.85 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.474 0.654 . . . . 0.0 111.874 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 m -88.81 163.2 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -93.41 -175.05 3.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.794 . . . . 0.0 111.015 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 m -71.24 -1.35 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.899 -0.5 . . . . 0.0 111.776 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -108.26 -11.89 15.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.937 -1.102 . . . . 0.0 110.726 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.72 27.55 26.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -109.94 137.81 47.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.969 . . . . 0.0 111.108 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.68 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -69.33 110.65 4.77 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.941 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.449 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 45.6 p90 -62.84 -30.96 71.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.48 -0.763 . . . . 0.0 111.89 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.449 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 24.3 mttt -71.28 -33.41 69.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.333 -0.855 . . . . 0.0 110.466 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -72.34 -46.17 56.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.751 -0.593 . . . . 0.0 111.493 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -71.15 -29.0 64.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.467 -0.771 . . . . 0.0 111.329 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -79.28 -44.62 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.163 -0.961 . . . . 0.0 110.366 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.29 -26.25 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.126 -0.984 . . . . 0.0 109.856 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.42 -12.56 45.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.434 -0.791 . . . . 0.0 110.099 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.5 t -96.36 -41.8 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.429 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.9 tp -58.49 -28.96 65.87 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.379 0.609 . . . . 0.0 110.758 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -52.87 -40.0 63.09 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.728 -0.607 . . . . 0.0 110.844 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.161 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.586 0.708 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.13 159.8 21.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.814 -0.554 . . . . 0.0 110.059 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -107.3 158.88 16.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.838 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.7 m -51.26 -30.28 17.26 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.799 0.809 . . . . 0.0 109.329 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.17 -39.09 63.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.907 -0.496 . . . . 0.0 111.286 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -61.77 -50.03 74.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.551 -0.718 . . . . 0.0 109.918 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CD1' HD11 ' A' ' 113' ' ' LEU . 1.6 m-85 -72.82 -36.58 67.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.743 -0.598 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.36 -46.15 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.16 -0.963 . . . . 0.0 110.79 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.27 -36.48 75.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.573 -0.704 . . . . 0.0 111.549 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.75 -57.52 12.57 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 111.592 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -77.64 -53.63 7.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.278 -0.889 . . . . 0.0 112.028 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 139' ' ' TYR . 37.5 mm-40 -48.36 -38.71 19.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.175 -0.953 . . . . 0.0 113.14 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.14 -34.54 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.754 -1.216 . . . . 0.0 110.164 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -68.38 -43.33 77.57 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.3 80.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.359 -0.838 . . . . 0.0 110.901 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.26 -39.92 92.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 0.0 110.482 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -92.44 20.14 6.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.343 -0.848 . . . . 0.0 110.811 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 m 38.14 65.04 0.63 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -91.43 -33.78 15.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.17 -0.956 . . . . 0.0 109.148 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 15.12 57.48 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -131.93 153.1 50.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -1.217 . . . . 0.0 110.06 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.98 159.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.313 -0.867 . . . . 0.0 110.047 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -81.85 144.8 30.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.624 -0.672 . . . . 0.0 110.083 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.41 -38.66 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.492 -0.755 . . . . 0.0 110.702 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.1 -40.6 97.36 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.52 -40.04 26.75 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.569 -0.959 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.4 tt -58.96 -49.62 77.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.667 -0.646 . . . . 0.0 110.212 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -64.95 -29.6 70.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.705 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -67.93 -48.08 66.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.389 -0.82 . . . . 0.0 110.684 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -37.68 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.22 -0.925 . . . . 0.0 111.041 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.4 tp -55.33 -42.85 74.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.222 -0.924 . . . . 0.0 109.388 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.1 p -66.45 -20.5 66.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.45 -14.87 62.99 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -94.09 8.41 41.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.321 -1.105 . . . . 0.0 112.507 -177.318 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.08 31.31 4.77 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -113.97 120.27 40.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.985 -0.715 . . . . 0.0 109.734 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -122.07 59.33 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -0.964 . . . . 0.0 109.909 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.0 mt -91.68 148.82 21.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 p -111.06 142.28 43.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -39.61 -29.21 0.05 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.422 -0.799 . . . . 0.0 112.482 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.03 -52.89 62.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.341 -0.849 . . . . 0.0 108.852 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.78 -43.18 37.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.714 -0.616 . . . . 0.0 110.304 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.32 -34.9 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.549 -0.719 . . . . 0.0 110.405 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -64.17 -37.44 87.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.216 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.99 -46.67 88.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 110.086 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.72 -41.18 99.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.524 -0.735 . . . . 0.0 110.367 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.98 -17.13 61.72 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.826 -0.546 . . . . 0.0 111.569 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -56.57 -22.51 34.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.259 -0.9 . . . . 0.0 111.084 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.98 25.29 8.94 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.363 -1.081 . . . . 0.0 109.911 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -102.38 102.94 13.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.448 0.642 . . . . 0.0 111.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.27 158.97 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -95.92 -177.54 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.355 -0.84 . . . . 0.0 111.333 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -71.22 -2.06 14.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.832 -0.543 . . . . 0.0 111.971 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.82 -10.52 16.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.994 -1.066 . . . . 0.0 110.241 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.98 32.37 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -111.13 139.2 46.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.913 . . . . 0.0 111.14 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 5.0 mp -128.42 142.22 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.92 113.88 6.73 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.731 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.447 ' CZ ' ' NE2' ' A' ' 91' ' ' GLN . 30.9 p90 -63.95 -36.16 83.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.617 -0.677 . . . . 0.0 111.887 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.421 ' HG2' ' CE2' ' A' ' 139' ' ' TYR . 2.5 mmtt -70.01 -37.02 75.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.27 -45.37 66.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.634 -0.667 . . . . 0.0 111.702 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -71.3 -29.2 64.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.418 -0.801 . . . . 0.0 110.767 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.6 -47.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.484 -0.76 . . . . 0.0 109.611 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -60.31 -26.77 66.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.017 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.14 -12.28 44.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.414 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.2 t -95.57 -38.91 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.1 mt -56.16 -21.22 21.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.925 -0.484 . . . . 0.0 111.181 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -58.17 148.44 26.84 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.408 -0.807 . . . . 0.0 110.358 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.266 179.958 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.3 tttt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.825 0.822 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.35 159.55 17.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.941 -0.474 . . . . 0.0 110.211 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -109.96 158.89 17.76 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.788 . . . . 0.0 111.021 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -49.96 -29.99 9.54 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.533 0.682 . . . . 0.0 110.286 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -46.57 -32.47 3.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.822 -0.549 . . . . 0.0 112.144 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -62.48 -43.79 97.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.378 -0.826 . . . . 0.0 110.543 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.426 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -77.45 -40.22 44.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.489 -0.757 . . . . 0.0 110.704 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.53 -57.46 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.411 -0.806 . . . . 0.0 111.077 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -60.03 -34.35 73.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.815 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -60.42 -54.29 47.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.703 . . . . 0.0 111.645 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.416 ' CZ ' ' HG ' ' A' ' 106' ' ' LEU . 24.5 m-85 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.219 -0.926 . . . . 0.0 111.615 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -48.69 -39.68 25.41 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.369 -0.832 . . . . 0.0 112.814 -177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.5 t -60.05 -38.07 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.876 -1.14 . . . . 0.0 109.754 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -67.48 -44.89 77.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -61.36 82.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.558 -0.714 . . . . 0.0 111.04 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.714 -0.616 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -94.05 18.18 11.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.179 -0.951 . . . . 0.0 110.507 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.1 m 38.7 63.0 0.95 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.3 p -90.83 -34.77 15.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.981 . . . . 0.0 109.122 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.49 62.25 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.307 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -129.83 150.03 51.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.113 -1.227 . . . . 0.0 110.074 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.2 m -150.15 164.69 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -0.828 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 p -85.39 147.08 26.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.688 -0.633 . . . . 0.0 109.293 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.5 m -62.43 -33.17 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.295 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.94 -42.25 99.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.9 -39.91 29.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.664 -0.903 . . . . 0.0 109.624 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HG ' ' CZ ' ' A' ' 90' ' ' PHE . 9.9 tt -59.9 -49.19 78.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.827 -0.546 . . . . 0.0 109.527 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -63.9 -29.44 70.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.24 -48.41 67.85 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.391 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -40.03 95.77 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.682 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 mp -55.95 -44.29 78.28 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.0 m -60.04 -31.08 69.63 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.577 0.703 . . . . 0.0 109.754 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.14 -14.79 63.72 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -96.53 7.27 46.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -1.124 . . . . 0.0 112.557 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 31.53 5.05 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -113.52 120.17 40.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.877 -0.778 . . . . 0.0 109.952 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.5 60.3 1.01 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 0.0 109.879 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.41 148.8 22.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -110.76 142.75 42.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -39.37 -29.27 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 O-C-N 121.376 -0.827 . . . . 0.0 112.571 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.87 -53.04 61.24 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -0.855 . . . . 0.0 108.808 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -76.75 -42.83 39.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.624 -0.673 . . . . 0.0 110.169 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.25 -35.82 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.568 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.63 -38.41 87.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.184 -0.947 . . . . 0.0 109.115 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.63 -45.36 92.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.591 -0.693 . . . . 0.0 109.527 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.33 -51.47 68.7 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.587 -0.696 . . . . 0.0 110.151 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mt -59.99 -19.04 50.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.634 -0.667 . . . . 0.0 110.962 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -57.06 -24.0 50.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.501 -0.75 . . . . 0.0 110.93 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.27 25.41 8.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.0 t -106.74 120.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -1.113 . . . . 0.0 109.659 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.52 103.0 15.45 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.487 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 m -86.74 161.38 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -95.87 -171.98 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 110.946 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 p -72.08 -0.21 11.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.84 -0.537 . . . . 0.0 111.752 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.68 -11.09 15.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.944 -1.098 . . . . 0.0 110.257 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.89 24.55 52.49 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.96 141.62 44.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.392 -1.064 . . . . 0.0 110.966 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 3.4 mp -127.05 147.22 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.311 0.577 . . . . 0.0 109.657 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.23 116.29 9.5 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.227 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 140' ' ' LYS . 7.2 p90 -68.15 -34.14 75.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.653 -0.654 . . . . 0.0 111.983 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 13.8 mttt -69.97 -28.85 65.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.342 -0.849 . . . . 0.0 111.278 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -80.42 -43.22 21.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 112.254 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -70.9 -30.72 67.14 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.0 111.727 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 144' ' ' GLU . 18.2 pt -83.69 -44.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.114 -0.991 . . . . 0.0 110.579 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 143' ' ' ILE . 65.3 mt-10 -67.33 -26.53 66.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.72 -13.98 46.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.273 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 70.4 t -95.31 -37.82 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.02 -27.4 66.88 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.293 0.568 . . . . 0.0 110.933 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -51.31 133.8 28.59 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.626 -0.672 . . . . 0.0 111.018 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.275 179.906 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.695 0.759 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.44 160.69 19.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.94 -0.475 . . . . 0.0 110.464 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -109.21 160.71 15.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.81 0.814 . . . . 0.0 110.79 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.2 m -51.32 -31.08 20.42 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.698 0.761 . . . . 0.0 109.542 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -51.39 -37.43 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.854 -0.529 . . . . 0.0 111.152 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -64.64 -45.55 86.3 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.682 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.458 ' CD1' HD11 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.65 -38.39 62.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.729 -0.607 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.8 t -66.56 -47.09 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.141 -0.974 . . . . 0.0 111.041 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -60.06 -35.32 74.9 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.582 -0.699 . . . . 0.0 111.419 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.74 -52.8 62.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.456 -0.777 . . . . 0.0 111.816 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.48 -53.61 7.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 111.367 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -48.09 -36.19 12.7 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.291 -0.88 . . . . 0.0 112.854 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.25 -35.74 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 109.981 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.05 -50.97 35.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.363 -0.835 . . . . 0.0 109.276 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.67 82.39 4.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.214 -0.929 . . . . 0.0 109.663 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -61.16 -26.86 67.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.817 -0.552 . . . . 0.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.65 17.97 5.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.17 -0.956 . . . . 0.0 111.015 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.6 t 38.5 37.11 0.16 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.1 p -63.9 -34.91 79.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.082 -1.011 . . . . 0.0 109.24 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.85 59.59 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -131.77 153.38 50.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.266 . . . . 0.0 110.176 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 m -150.37 161.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.381 -0.825 . . . . 0.0 110.28 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -83.08 145.85 29.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.502 -0.749 . . . . 0.0 109.923 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.26 -39.99 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.423 -0.798 . . . . 0.0 110.741 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.67 -41.47 97.44 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -80.08 -41.87 24.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.512 -0.993 . . . . 0.0 110.539 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -60.06 -49.76 76.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.639 -0.663 . . . . 0.0 109.959 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -64.24 -31.65 72.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 110.265 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -67.45 -48.83 66.07 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -33.57 65.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.804 . . . . 0.0 110.583 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 27.7 tp -54.57 -44.32 72.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.4 m -67.41 -15.87 63.92 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.061 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.98 -14.51 64.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 HD11 ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -94.82 8.02 44.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -1.055 . . . . 0.0 112.583 -177.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 31.0 5.05 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 58.5 mm-40 -114.18 120.72 41.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.929 -0.748 . . . . 0.0 109.638 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -122.8 60.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.39 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.6 mt -89.95 148.26 23.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.3 m -110.6 141.66 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -0.903 . . . . 0.0 110.16 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -39.2 -30.83 0.06 Allowed 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.566 -0.709 . . . . 0.0 112.161 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.63 -51.75 67.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -77.28 -40.73 43.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.722 -0.611 . . . . 0.0 110.454 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.55 -35.36 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.607 -0.683 . . . . 0.0 110.466 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -64.21 -38.03 89.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -59.97 -46.86 88.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.619 -0.676 . . . . 0.0 109.521 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.3 -46.95 86.47 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.659 0.742 . . . . 0.0 109.944 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.97 -18.96 60.21 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.85 -0.531 . . . . 0.0 111.205 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.75 -21.32 27.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.218 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.43 -12.04 11.14 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.89 134.24 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.08 -1.247 . . . . 0.0 110.242 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -102.4 102.96 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.602 . . . . 0.0 111.804 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.69 157.31 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.05 -179.17 4.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.288 -0.883 . . . . 0.0 111.287 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -71.0 -2.61 15.95 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.874 -0.516 . . . . 0.0 111.854 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -107.33 -12.19 15.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.429 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.15 27.09 22.0 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -110.87 135.65 51.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.938 . . . . 0.0 111.068 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.2 mp -128.32 140.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -68.93 111.29 4.87 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.657 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 140' ' ' LYS . 18.6 p90 -64.48 -32.51 74.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.481 -0.762 . . . . 0.0 112.095 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.2 mtmp? -71.22 -35.93 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.258 -0.901 . . . . 0.0 111.067 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -70.41 -44.51 67.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.684 -0.635 . . . . 0.0 111.659 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -70.02 -29.15 66.13 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.431 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 143' ' ' ILE . 32.4 pt -80.27 -43.68 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 110.197 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.437 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.7 mt-10 -62.59 -26.84 68.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.266 -0.896 . . . . 0.0 109.929 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.1 -12.31 44.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.355 -0.841 . . . . 0.0 110.276 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.92 -39.94 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.53 -18.65 20.25 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.941 -0.474 . . . . 0.0 111.565 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -59.94 -40.09 87.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.245 -0.91 . . . . 0.0 110.22 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.294 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.8 tptt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.776 0.798 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.51 160.43 16.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.888 -0.508 . . . . 0.0 110.004 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -109.07 160.17 16.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.849 . . . . 0.0 111.001 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -51.15 -30.5 16.81 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.612 0.72 . . . . 0.0 109.54 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -52.3 -37.27 55.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.871 -0.518 . . . . 0.0 111.275 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -60.04 -51.05 71.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.56 -0.713 . . . . 0.0 109.865 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.429 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -75.62 -39.69 57.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 110.814 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.25 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.26 -0.9 . . . . 0.0 110.282 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -60.07 -36.16 76.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.651 -0.656 . . . . 0.0 110.923 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.32 -49.04 77.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.708 -0.62 . . . . 0.0 111.565 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -77.41 -56.07 4.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 111.751 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -48.16 -34.27 9.7 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.84 -34.55 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.814 -1.178 . . . . 0.0 109.657 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -72.58 -52.1 16.95 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.66 81.77 8.72 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -60.39 -21.16 61.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.688 -0.632 . . . . 0.0 111.002 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.97 18.91 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.147 -0.971 . . . . 0.0 111.044 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.5 m 38.73 37.43 0.19 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.5 p -64.24 -35.6 81.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.0 12.52 60.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -131.74 151.61 51.52 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.247 . . . . 0.0 110.155 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.1 t -149.84 162.51 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.349 -0.844 . . . . 0.0 109.97 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.9 p -84.95 148.16 26.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.517 -0.74 . . . . 0.0 109.991 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.1 t -56.23 -40.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.34 94.03 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -81.05 -42.75 20.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.238 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -49.92 75.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 110.222 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -67.04 -31.01 71.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.581 -0.699 . . . . 0.0 110.792 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.7 -47.81 65.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.67 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -40.61 92.33 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.508 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -45.07 77.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.474 -0.89 . . . . 0.0 108.675 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -59.94 -28.36 67.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.538 0.685 . . . . 0.0 109.9 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.59 63.38 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.77 6.9 47.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.295 -1.12 . . . . 0.0 112.76 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.11 31.46 5.03 Favored Glycine 0 N--CA 1.501 3.009 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -114.13 121.0 42.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.792 -0.828 . . . . 0.0 109.871 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -122.33 59.89 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.051 0.929 . . . . 0.0 109.598 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.13 148.92 22.04 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.0 p -110.77 142.21 43.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 0.0 110.024 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -39.87 -28.46 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 O-C-N 121.297 -0.877 . . . . 0.0 112.543 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.95 -52.59 63.43 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.7 -43.01 39.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 110.312 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.04 -35.53 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.497 -0.752 . . . . 0.0 110.562 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -63.21 -37.32 86.76 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.216 -0.927 . . . . 0.0 109.275 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.81 -46.03 90.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.559 -0.713 . . . . 0.0 109.578 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.19 -48.44 81.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.541 -0.724 . . . . 0.0 109.825 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.33 -21.34 66.58 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.859 -0.526 . . . . 0.0 111.05 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -57.19 -22.23 39.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.497 -0.752 . . . . 0.0 111.104 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.69 -14.32 8.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.4 t -68.37 134.11 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.044 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.91 99.1 11.2 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 111.71 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.33 156.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.51 -177.79 4.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -71.46 -0.92 11.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.773 -0.579 . . . . 0.0 111.954 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -107.5 -12.52 15.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.843 -1.161 . . . . 0.0 110.442 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.4 25.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -111.91 136.14 51.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.962 . . . . 0.0 111.086 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.98 141.38 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -69.41 106.67 3.03 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.433 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.459 ' CE1' ' CG ' ' A' ' 140' ' ' LYS . 54.4 p90 -62.51 -35.8 80.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.301 -0.874 . . . . 0.0 112.128 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.459 ' CG ' ' CE1' ' A' ' 139' ' ' TYR . 19.4 mtpp -58.44 -56.57 20.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.278 -0.889 . . . . 0.0 111.052 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -59.91 -39.1 84.27 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.786 -0.572 . . . . 0.0 111.585 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -70.05 -28.98 65.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 0.0 109.685 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.417 HG23 ' CG ' ' A' ' 86' ' ' PHE . 69.3 mt -83.27 -50.03 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.713 . . . . 0.0 109.725 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.72 -27.01 67.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.466 -0.771 . . . . 0.0 110.11 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -87.85 -12.98 43.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.861 . . . . 0.0 110.466 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.7 t -95.82 -39.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.54 -27.29 62.49 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.318 0.58 . . . . 0.0 110.679 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -53.01 140.21 25.68 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.664 -0.647 . . . . 0.0 110.801 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.267 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.776 0.798 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.91 160.59 16.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.838 -0.539 . . . . 0.0 110.198 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -109.58 159.66 16.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 111.084 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.3 m -50.89 -30.43 14.59 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.695 0.76 . . . . 0.0 109.564 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.62 -37.01 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.842 -0.536 . . . . 0.0 111.279 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.98 -50.5 73.49 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.418 ' CD1' HD12 ' A' ' 113' ' ' LEU . 2.0 m-85 -76.48 -40.57 49.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.687 -0.633 . . . . 0.0 110.944 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.8 t -60.34 -57.21 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.83 . . . . 0.0 110.958 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -54.45 -32.55 57.83 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.451 -0.781 . . . . 0.0 111.022 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -65.17 -44.77 87.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.743 -0.598 . . . . 0.0 111.89 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 14.3 m-85 -80.61 -56.88 3.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.916 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -36.56 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.01 -35.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.01 -1.056 . . . . 0.0 109.655 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -71.62 -47.41 54.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 80.6 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.444 -0.785 . . . . 0.0 110.593 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -60.52 -38.22 83.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.569 -0.707 . . . . 0.0 110.738 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.54 20.44 5.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t 37.98 36.85 0.12 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.1 p -64.17 -34.47 78.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.209 -0.932 . . . . 0.0 109.519 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.04 13.31 57.86 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -132.47 151.89 51.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.095 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.8 t -148.41 159.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.39 -0.818 . . . . 0.0 109.494 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -79.82 144.3 33.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.773 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.1 p -55.81 -38.76 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.417 -0.802 . . . . 0.0 110.542 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.69 97.29 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -81.15 -40.0 24.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.885 . . . . 0.0 110.511 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HG ' ' CE2' ' A' ' 90' ' ' PHE . 9.7 tt -59.18 -49.82 76.41 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.63 -0.668 . . . . 0.0 110.173 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -67.03 -28.87 68.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.787 . . . . 0.0 111.075 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.18 -48.51 70.46 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.372 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -40.78 98.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.06 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.95 -44.64 78.61 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.7 m -60.06 -31.44 69.99 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.502 0.668 . . . . 0.0 109.619 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.79 64.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.418 HD12 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -96.15 7.85 45.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -1.136 . . . . 0.0 112.475 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 31.78 4.91 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -113.22 119.88 39.28 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.742 -0.858 . . . . 0.0 110.28 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.77 59.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.798 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.02 148.72 22.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 m -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.04 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -40.06 -27.47 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 O-C-N 121.231 -0.918 . . . . 0.0 112.95 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.09 60.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.195 -0.941 . . . . 0.0 109.072 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.54 -41.95 44.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.97 -35.92 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 110.258 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.71 -37.11 86.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.085 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -63.71 -49.88 71.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.577 0.703 . . . . 0.0 109.978 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.1 mt -61.87 -16.64 52.0 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.826 -0.547 . . . . 0.0 110.985 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -56.8 -20.58 23.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.398 -0.814 . . . . 0.0 111.173 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 25.65 8.29 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.32 129.98 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.294 -1.121 . . . . 0.0 109.783 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 100.54 11.38 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.885 0.85 . . . . 0.0 112.418 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.47 158.88 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -95.62 -179.04 4.6 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.835 0.826 . . . . 0.0 111.423 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.4 m -70.97 -1.67 12.74 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.833 -0.542 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -107.66 -11.96 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.998 -1.064 . . . . 0.0 110.434 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.94 28.79 17.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -111.15 135.58 51.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.931 . . . . 0.0 111.153 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.35 168.55 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -98.19 112.02 24.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.448 -0.782 . . . . 0.0 110.148 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 43.9 p90 -65.92 -34.22 77.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.471 -0.768 . . . . 0.0 112.171 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 mttt -70.04 -40.02 75.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.075 -1.016 . . . . 0.0 110.946 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.19 -43.82 81.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.629 -0.669 . . . . 0.0 111.391 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -71.66 -27.87 63.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.578 -0.701 . . . . 0.0 110.993 -178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.42 HD12 ' CE1' ' A' ' 90' ' ' PHE . 96.6 mt -83.93 -51.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.812 . . . . 0.0 110.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -61.93 -26.4 68.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 111.016 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.14 -16.44 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 76.8 t -97.19 -42.88 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.14 -0.975 . . . . 0.0 109.187 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.71 -16.14 64.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.703 -0.623 . . . . 0.0 111.721 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -59.92 136.26 57.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.31 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.6 tptt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.754 0.788 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.03 161.18 13.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.829 -0.544 . . . . 0.0 110.07 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -108.56 154.48 21.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 110.94 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.3 m -50.75 -30.41 13.91 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.415 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 44.0 mt-10 -50.49 -35.87 31.15 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.687 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.89 -47.22 75.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.595 -0.691 . . . . 0.0 110.326 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CD2' HD13 ' A' ' 147' ' ' LEU . 21.3 m-85 -77.42 -39.95 45.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.656 -0.653 . . . . 0.0 112.692 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' CG2' ' HA ' ' A' ' 84' ' ' GLU . 33.4 m -68.22 -41.87 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.826 -1.171 . . . . 0.0 110.801 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -60.05 -33.7 72.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.487 -0.758 . . . . 0.0 110.187 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.75 -56.5 21.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.64 -0.663 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.408 ' CE1' ' HA ' ' A' ' 106' ' ' LEU . 56.0 m-85 -77.34 -53.14 8.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 111.048 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -49.03 -42.71 39.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.497 -0.752 . . . . 0.0 112.436 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.91 -39.26 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.861 -1.149 . . . . 0.0 109.611 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.03 -43.65 87.0 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.61 81.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -62.15 -37.38 84.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.606 -0.684 . . . . 0.0 110.868 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -89.94 17.06 7.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.9 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.3 t 37.69 37.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.6 p -63.78 -33.29 75.34 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.12 -0.988 . . . . 0.0 109.465 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.17 54.69 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.187 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -132.19 153.41 50.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -1.191 . . . . 0.0 109.9 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.6 m -148.86 159.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.283 -0.886 . . . . 0.0 110.388 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.8 p -84.75 147.66 26.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.575 . . . . 0.0 110.222 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.36 -39.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.366 -0.834 . . . . 0.0 110.238 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.42 -41.61 95.34 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.31 -39.79 28.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.579 -0.954 . . . . 0.0 110.216 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.408 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 28.7 tp -60.04 -49.0 79.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.75 -0.594 . . . . 0.0 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -66.77 -29.83 69.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 111.036 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.76 -48.85 62.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.078 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -38.57 77.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.368 -0.832 . . . . 0.0 110.667 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.3 tp -55.09 -44.2 74.65 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -61.49 -25.21 67.11 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.511 0.672 . . . . 0.0 110.081 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.39 -14.52 63.72 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.55 7.88 44.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.317 -1.108 . . . . 0.0 112.214 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.63 32.5 4.78 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -113.98 119.94 38.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.99 -0.712 . . . . 0.0 110.342 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -122.32 59.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.0 109.579 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -90.97 148.78 22.19 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 p -111.18 141.62 44.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -40.09 -27.79 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 O-C-N 121.311 -0.868 . . . . 0.0 112.84 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.1 -52.56 63.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.294 -0.878 . . . . 0.0 109.16 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.62 -42.92 40.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.99 -35.42 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.669 -0.644 . . . . 0.0 110.608 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.76 -38.09 89.81 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.294 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.01 -46.36 89.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.615 -0.678 . . . . 0.0 109.71 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -50.02 74.1 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.559 0.695 . . . . 0.0 109.884 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.41 -18.98 43.64 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.772 -0.58 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.05 -21.96 35.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.471 -0.768 . . . . 0.0 111.161 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.23 -12.91 10.36 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.3 t -68.98 130.02 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.098 -1.237 . . . . 0.0 110.169 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -99.15 103.64 15.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.437 0.637 . . . . 0.0 111.589 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -87.77 159.69 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.37 -177.05 4.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.8 p -69.58 -2.39 11.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.933 -0.479 . . . . 0.0 112.159 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -105.07 -6.26 20.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.948 -1.095 . . . . 0.0 110.225 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.83 23.23 60.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -110.41 145.91 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 110.984 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.55 170.09 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.24 116.91 29.38 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 47.8 p90 -65.47 -39.83 92.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.56 -0.712 . . . . 0.0 111.751 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.2 mttt -64.56 -40.03 94.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.529 -0.732 . . . . 0.0 110.469 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -68.17 -43.94 77.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.779 -0.575 . . . . 0.0 111.225 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -69.89 -28.67 65.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.523 -0.736 . . . . 0.0 110.357 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 42.8 mt -76.15 -46.89 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.521 -0.737 . . . . 0.0 109.133 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.6 -28.78 69.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.41 -0.806 . . . . 0.0 110.496 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -88.37 -12.0 44.59 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.861 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.0 t -95.12 -38.15 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 86' ' ' PHE . 5.1 mp -55.93 -21.11 18.8 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.167 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -57.64 140.03 52.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.35 -0.844 . . . . 0.0 110.371 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.215 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 mttt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.885 0.85 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.01 159.77 17.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.905 -0.497 . . . . 0.0 110.381 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -108.81 161.62 14.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 110.895 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -50.91 -31.35 17.31 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -50.97 -35.94 36.35 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.854 -0.529 . . . . 0.0 111.079 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -59.96 -50.61 73.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.62 -0.675 . . . . 0.0 109.834 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.423 ' CG ' HG22 ' A' ' 143' ' ' ILE . 0.7 OUTLIER -76.53 -40.08 51.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.708 -0.62 . . . . 0.0 110.79 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.09 -53.3 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.272 -0.893 . . . . 0.0 110.344 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -59.99 -34.24 73.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.681 -0.637 . . . . 0.0 110.402 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.94 -54.27 48.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 111.026 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.404 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 47.7 m-85 -77.63 -54.43 6.4 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.371 -0.83 . . . . 0.0 111.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -48.91 -39.56 26.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.503 -0.748 . . . . 0.0 112.922 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.2 -37.69 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.852 -1.155 . . . . 0.0 109.652 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -69.44 -46.46 66.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -64.34 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.0 110.641 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -60.01 -39.34 85.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.5 -0.75 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -91.61 20.7 5.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.314 -0.866 . . . . 0.0 110.899 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 p 38.36 37.95 0.2 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 p -64.06 -34.72 78.67 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.254 -0.979 . . . . 0.0 109.384 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 14.48 55.24 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -132.93 154.88 50.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.054 -1.263 . . . . 0.0 110.528 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 m -150.08 159.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.402 -0.811 . . . . 0.0 109.783 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -81.98 144.57 30.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.0 110.007 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.4 p -56.75 -38.9 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.538 -0.726 . . . . 0.0 110.772 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.82 -41.32 97.6 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.53 -39.1 28.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.547 -0.972 . . . . 0.0 110.527 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.404 ' HG ' ' CE2' ' A' ' 90' ' ' PHE . 7.5 tt -60.08 -49.95 75.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 110.108 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -63.44 -29.61 70.87 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.517 -0.74 . . . . 0.0 110.313 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.32 -47.48 67.44 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -39.71 87.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.39 -0.819 . . . . 0.0 110.574 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.84 -44.82 74.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 m -60.83 -26.54 67.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.49 0.662 . . . . 0.0 109.966 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.06 -15.21 63.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 86' ' ' PHE . 21.7 tp -95.65 8.08 44.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 112.399 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.91 33.48 4.34 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -114.25 119.81 38.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.02 -0.694 . . . . 0.0 110.174 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -122.1 59.43 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.074 0.94 . . . . 0.0 109.612 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.5 mt -90.53 148.76 22.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 p -110.83 141.59 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -39.69 -28.89 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.35 -0.844 . . . . 0.0 112.62 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.73 -51.79 66.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -76.78 -43.12 38.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.581 -0.7 . . . . 0.0 110.549 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.0 t -59.97 -34.9 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 110.592 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -64.98 -36.82 85.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.138 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.76 -47.33 86.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.15 -46.63 88.15 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.69 0.757 . . . . 0.0 109.879 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.2 -19.52 63.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.907 -0.496 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -56.74 -21.03 25.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 0.0 111.191 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.34 -11.95 11.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.36 130.48 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.091 -1.241 . . . . 0.0 110.211 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -101.82 104.17 14.92 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.409 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.9 m -87.96 161.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.22 -176.2 3.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.59 -0.92 9.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.834 -0.541 . . . . 0.0 111.901 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -107.73 -10.06 15.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.923 -1.111 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.29 25.89 38.34 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -109.72 139.98 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.573 -0.957 . . . . 0.0 110.973 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.64 140.98 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -68.88 110.77 4.55 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.813 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 43.8 p90 -62.76 -34.02 76.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.491 -0.755 . . . . 0.0 112.004 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.7 mtmt -69.31 -38.67 78.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.272 -0.893 . . . . 0.0 110.581 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.33 -45.01 70.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.744 -0.597 . . . . 0.0 111.587 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -70.56 -28.8 65.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.449 -0.782 . . . . 0.0 110.645 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.423 HG22 ' CG ' ' A' ' 86' ' ' PHE . 85.5 mt -79.28 -47.95 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.509 -0.744 . . . . 0.0 109.646 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -60.41 -26.5 66.74 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.499 -0.75 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.0 -13.29 39.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.373 -0.829 . . . . 0.0 110.656 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.0 t -96.23 -43.22 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.2 mt -59.06 -18.21 32.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.795 -0.565 . . . . 0.0 111.546 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.0 mmt-85 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.346 -0.846 . . . . 0.0 110.12 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 91.9 mttt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.749 0.785 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.06 159.92 16.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.866 -0.521 . . . . 0.0 110.108 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -110.03 160.02 16.8 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.878 0.847 . . . . 0.0 111.188 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -50.58 -30.95 14.44 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.706 0.765 . . . . 0.0 109.738 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -51.1 -36.45 40.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.752 -0.592 . . . . 0.0 111.322 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.44 -44.97 85.63 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.603 -0.686 . . . . 0.0 109.711 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.41 ' CD1' HD13 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -76.63 -41.12 47.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.734 -0.604 . . . . 0.0 111.131 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.5 t -63.7 -52.83 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 111.011 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -55.73 -32.21 63.18 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.538 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.22 -39.94 82.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.581 -0.699 . . . . 0.0 112.344 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -80.11 -58.0 3.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.043 -1.036 . . . . 0.0 110.959 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -48.52 -32.76 8.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -61.55 -31.38 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.804 -1.185 . . . . 0.0 109.716 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.35 -49.0 29.68 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 80.15 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -62.29 -34.5 76.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.518 -0.739 . . . . 0.0 110.647 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.37 18.51 8.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.233 -0.917 . . . . 0.0 110.657 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.1 m 37.83 35.27 0.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.3 p -63.95 -33.74 76.4 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.198 -0.939 . . . . 0.0 109.316 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 12.08 58.99 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -131.72 153.65 49.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -1.182 . . . . 0.0 109.933 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 m -149.98 159.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.308 -0.87 . . . . 0.0 110.018 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 144.85 31.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.09 -38.96 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.455 -0.778 . . . . 0.0 110.699 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.68 97.29 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.29 -42.25 23.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.545 -0.974 . . . . 0.0 110.574 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 tt -60.04 -49.91 75.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 109.979 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -64.45 -33.06 75.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.537 -0.727 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -66.24 -48.03 71.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -25.74 59.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.489 -0.757 . . . . 0.0 110.68 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 29.8 tp -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.8 p -66.14 -16.73 64.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.301 0.572 . . . . 0.0 110.695 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.42 65.51 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.41 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.57 7.45 45.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.416 -1.05 . . . . 0.0 112.102 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.59 32.99 4.61 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 12.4 mm-40 -114.73 120.98 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.897 -0.766 . . . . 0.0 110.851 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -122.19 59.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.088 0.947 . . . . 0.0 109.297 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.73 149.08 21.79 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -110.87 142.84 42.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -39.83 -27.8 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.814 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.72 62.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.228 -0.92 . . . . 0.0 108.932 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.7 -43.3 38.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.588 -0.695 . . . . 0.0 110.425 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.99 -35.64 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.05 -39.1 93.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.24 -0.912 . . . . 0.0 109.171 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.437 -0.789 . . . . 0.0 109.641 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.32 -48.4 81.89 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.984 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.62 -18.14 51.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.799 -0.563 . . . . 0.0 111.191 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.56 -21.47 26.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.23 25.77 8.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 65.8 t -107.67 129.84 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -1.103 . . . . 0.0 109.855 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -102.59 103.03 13.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.751 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.05 161.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -95.28 -177.08 3.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 111.281 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.7 p -70.23 -0.8 8.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.907 -0.496 . . . . 0.0 112.01 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -107.5 -9.08 16.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.94 -1.1 . . . . 0.0 110.365 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.59 28.41 29.72 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -110.48 139.27 45.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.955 . . . . 0.0 110.969 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.407 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 4.6 mp -127.63 143.37 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.3 115.23 8.33 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.037 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.421 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 10.7 p90 -67.2 -35.26 79.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.723 -0.611 . . . . 0.0 111.769 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 25.3 mttt -70.98 -39.98 72.17 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.352 -0.842 . . . . 0.0 111.032 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.15 -44.57 83.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 111.705 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -70.02 -28.0 65.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.491 -0.756 . . . . 0.0 110.42 -178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.409 HG21 ' CD2' ' A' ' 86' ' ' PHE . 96.3 mt -79.57 -48.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.382 -0.824 . . . . 0.0 110.133 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -59.99 -27.74 67.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.486 -0.759 . . . . 0.0 110.278 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.4 -16.1 31.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 110.64 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 54.1 t -97.52 -48.07 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.128 -0.983 . . . . 0.0 108.87 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -24.62 67.59 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.7 -0.625 . . . . 0.0 111.222 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -55.04 -48.05 73.94 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.486 -0.759 . . . . 0.0 110.597 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.274 -179.9 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.64 0.733 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.43 160.65 18.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.891 -0.505 . . . . 0.0 110.362 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.47 160.28 15.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.87 . . . . 0.0 110.973 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -51.18 -30.58 17.34 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.702 0.763 . . . . 0.0 109.487 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -52.46 -37.07 56.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.841 -0.537 . . . . 0.0 111.28 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -61.05 -50.06 74.85 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.573 -0.704 . . . . 0.0 109.919 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.428 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.5 m-85 -75.97 -38.87 57.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.771 -0.581 . . . . 0.0 111.264 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.17 -50.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.213 -0.929 . . . . 0.0 110.678 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -59.95 -34.17 72.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.547 -0.721 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -67.39 -44.28 79.25 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.664 -0.648 . . . . 0.0 111.736 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -78.49 -58.91 3.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.093 -1.005 . . . . 0.0 111.654 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -48.35 -28.97 3.5 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.13 -32.68 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.999 -1.063 . . . . 0.0 109.848 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -71.53 -50.87 27.07 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.33 81.35 6.66 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.377 -0.827 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -63.1 -17.16 62.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.83 16.11 7.36 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.05 -1.031 . . . . 0.0 110.945 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.4 p 39.1 35.84 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 t -63.11 -33.99 76.65 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.097 -1.002 . . . . 0.0 109.588 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.52 9.66 58.72 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.014 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -132.16 154.94 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.239 . . . . 0.0 110.382 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.8 m -151.04 160.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.371 -0.831 . . . . 0.0 109.914 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -82.04 144.86 30.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.574 -0.704 . . . . 0.0 109.956 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.07 -40.0 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.493 -0.755 . . . . 0.0 110.836 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.4 96.89 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.14 -39.84 28.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.579 -0.954 . . . . 0.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.94 -49.73 76.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.67 -0.644 . . . . 0.0 110.102 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -64.46 -30.26 71.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.697 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -67.89 -48.01 67.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.591 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -41.0 97.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.11 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.406 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 2.5 tp -55.78 -44.77 78.04 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.9 m -60.12 -30.61 69.39 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.616 0.722 . . . . 0.0 109.704 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.52 -14.65 63.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.42 7.09 47.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 112.762 -177.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.79 4.94 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 12.0 tp10 -113.75 119.97 39.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.925 -0.75 . . . . 0.0 109.992 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -121.96 59.22 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.002 0.906 . . . . 0.0 109.598 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 75.5 mt -90.85 148.58 22.4 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -111.17 141.36 44.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -39.9 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 O-C-N 121.353 -0.842 . . . . 0.0 112.726 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.0 61.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.434 -0.791 . . . . 0.0 109.0 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -76.71 -42.94 39.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.692 -0.63 . . . . 0.0 110.384 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -60.02 -35.25 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.587 -0.695 . . . . 0.0 110.466 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.01 -39.44 94.78 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.255 -0.903 . . . . 0.0 109.004 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.09 -49.38 77.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.624 -0.673 . . . . 0.0 109.537 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.19 -49.97 75.51 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.571 0.7 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.96 -17.22 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.915 -0.491 . . . . 0.0 111.333 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -57.47 -16.77 10.48 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.306 -0.871 . . . . 0.0 111.895 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.12 -11.06 11.22 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.051 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.51 133.95 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.94 -1.329 . . . . 0.0 110.854 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -103.3 102.48 12.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.393 0.616 . . . . 0.0 111.093 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 m -86.38 160.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -94.91 -176.39 3.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.473 -0.767 . . . . 0.0 111.114 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -69.95 -0.99 8.37 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.866 -0.521 . . . . 0.0 112.055 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -107.28 -7.74 16.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.949 -1.095 . . . . 0.0 110.438 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.08 27.2 38.02 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -108.62 140.07 42.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.598 -0.942 . . . . 0.0 111.125 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 4.4 mp -128.42 169.02 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -96.98 114.05 25.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.368 -0.833 . . . . 0.0 110.134 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 47.6 p90 -66.12 -35.42 80.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.558 -0.714 . . . . 0.0 111.643 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.3 mttt -69.22 -37.05 77.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.308 -0.87 . . . . 0.0 110.661 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -70.06 -44.12 69.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.602 -0.687 . . . . 0.0 111.62 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -70.36 -28.59 65.24 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.512 -0.743 . . . . 0.0 110.61 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 97.6 mt -76.46 -45.78 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.508 -0.745 . . . . 0.0 109.518 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.72 -26.74 65.88 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.262 -0.899 . . . . 0.0 109.738 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -88.97 -11.64 43.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 110.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 62.3 t -96.01 -42.08 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.2 mt -55.49 -20.35 12.54 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.895 -0.503 . . . . 0.0 111.395 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -58.91 -40.05 83.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.318 -0.864 . . . . 0.0 110.236 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.127 179.777 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.7 mttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.693 0.759 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.28 161.4 13.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.896 -0.502 . . . . 0.0 109.95 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 164.06 13.55 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.104 0.954 . . . . 0.0 111.225 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m -50.23 -30.37 11.5 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.396 0.617 . . . . 0.0 110.215 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -53.17 -36.86 61.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.719 -0.613 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.49 -50.88 71.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.53 -0.731 . . . . 0.0 109.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.428 ' CE2' HD12 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -76.44 -39.62 52.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 0.0 111.086 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.5 t -59.98 -47.82 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.166 -0.959 . . . . 0.0 109.901 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -59.42 -31.95 69.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.713 -0.617 . . . . 0.0 110.368 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.93 -59.33 5.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.732 . . . . 0.0 112.016 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -77.12 -54.3 6.7 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.0 112.342 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -47.97 -37.87 15.56 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.365 -0.834 . . . . 0.0 113.163 -176.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.1 -31.35 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.71 -1.244 . . . . 0.0 109.752 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -70.0 -45.46 67.22 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -63.25 81.27 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.458 -0.777 . . . . 0.0 110.892 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -62.81 -40.06 96.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.672 -0.643 . . . . 0.0 110.94 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -91.0 17.0 8.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -0.902 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.6 m 38.05 35.58 0.09 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.8 p -63.73 -33.99 76.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.13 -0.981 . . . . 0.0 109.428 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.78 9.97 53.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.951 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.4 mttp -132.86 154.98 49.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.068 -1.254 . . . . 0.0 110.349 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.1 m -150.16 160.08 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.028 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 p -82.72 145.64 29.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.515 -0.741 . . . . 0.0 110.077 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.6 p -56.95 -39.66 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.475 -0.766 . . . . 0.0 110.649 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.11 96.87 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -80.41 -43.3 21.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.534 -0.98 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.97 -50.02 75.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.641 -0.662 . . . . 0.0 109.951 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -63.57 -31.88 73.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -66.06 -47.87 72.9 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.088 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.19 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.904 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.428 HD12 ' CE2' ' A' ' 86' ' ' PHE . 9.9 tp -56.2 -44.68 79.71 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.9 m -60.83 -31.39 70.82 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.577 0.704 . . . . 0.0 109.529 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.15 -13.87 67.86 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 86' ' ' PHE . 29.1 tp -95.09 8.44 42.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -1.086 . . . . 0.0 112.123 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.6 4.15 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 17.8 tp10 -114.91 120.4 39.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.952 -0.734 . . . . 0.0 110.769 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -122.27 59.67 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.063 0.935 . . . . 0.0 109.208 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.2 mt -92.0 149.74 21.37 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.3 m -110.86 144.14 40.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -40.11 -27.3 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.195 -0.941 . . . . 0.0 112.973 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.61 -52.1 64.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.33 -0.856 . . . . 0.0 109.279 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.35 -46.06 29.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 0.0 110.984 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.15 -33.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.352 -0.843 . . . . 0.0 110.513 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.85 -36.85 85.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -0.928 . . . . 0.0 109.001 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.75 -48.02 81.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.39 -28.36 69.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.544 -0.722 . . . . 0.0 110.884 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.1 mt -79.67 -15.78 56.95 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.653 . . . . 0.0 112.12 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -18.74 20.94 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.259 -0.9 . . . . 0.0 111.654 -177.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.55 -11.63 11.43 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.665 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.92 129.51 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.083 -1.245 . . . . 0.0 109.936 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -106.03 105.7 15.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.346 0.593 . . . . 0.0 111.623 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 m -88.86 161.52 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -93.12 -171.89 2.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.29 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -0.96 15.02 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -108.57 -11.14 15.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 110.453 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.19 28.42 28.08 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -109.08 138.04 46.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.909 . . . . 0.0 110.999 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 4.9 mp -129.25 140.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -69.54 108.61 3.88 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.816 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CE1' ' CG ' ' A' ' 140' ' ' LYS . 50.7 p90 -60.57 -29.47 69.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.432 -0.793 . . . . 0.0 111.871 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' CG ' ' CE1' ' A' ' 139' ' ' TYR . 61.2 mttt -69.01 -39.99 78.95 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.222 -0.924 . . . . 0.0 110.598 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.87 -43.87 82.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.801 -0.562 . . . . 0.0 111.502 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -70.46 -27.72 64.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 110.256 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 23.5 mm -80.29 -50.38 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.59 -28.72 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.69 -13.72 39.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.207 -0.933 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.1 t -95.97 -38.21 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mt -57.87 -19.24 27.88 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.468 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -59.84 139.93 56.97 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.302 -0.874 . . . . 0.0 110.237 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.2 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.4 tttt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.757 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.18 161.2 17.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.96 -0.463 . . . . 0.0 110.26 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -113.25 163.17 15.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 111.007 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.8 m -51.2 -31.29 19.85 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.485 0.66 . . . . 0.0 110.211 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -53.55 -38.68 64.08 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.648 -0.658 . . . . 0.0 111.111 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.52 -45.07 84.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.68 . . . . 0.0 109.571 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.417 ' CD1' HD11 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.63 -36.6 62.91 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.819 -0.551 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.1 t -70.9 -43.14 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 110.64 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.68 -35.84 73.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.455 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.75 69.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 111.989 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -79.19 -57.73 3.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.049 . . . . 0.0 111.681 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -48.9 -37.26 19.26 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.464 -0.773 . . . . 0.0 112.826 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -58.05 -37.73 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.156 -0.965 . . . . 0.0 109.988 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -66.1 -42.03 89.81 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.481 -0.762 . . . . 0.0 111.069 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -65.75 -24.99 67.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.563 -0.711 . . . . 0.0 110.479 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -106.15 15.69 25.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.661 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.7 t 38.2 63.06 0.88 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -91.65 -33.66 14.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.76 10.9 58.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.88 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -132.27 154.49 49.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.13 -1.218 . . . . 0.0 110.071 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -150.36 160.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 p -82.35 145.95 29.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.652 -0.655 . . . . 0.0 109.974 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.1 p -56.43 -39.67 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.461 -0.775 . . . . 0.0 110.629 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.9 -40.8 97.32 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.0 -40.31 28.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.978 . . . . 0.0 110.392 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.1 tp -59.95 -49.79 76.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 109.934 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -63.87 -32.28 73.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 110.375 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -67.77 -47.51 68.97 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.192 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -30.55 63.07 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.825 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 tp -60.06 -42.04 93.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.862 . . . . 0.0 109.068 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.7 p -68.03 -18.81 64.8 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.49 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.46 -14.72 63.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.417 HD11 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -93.1 7.15 45.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.381 -1.07 . . . . 0.0 112.362 -177.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.82 4.51 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.92 120.68 40.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 122.03 -0.688 . . . . 0.0 110.131 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.1 59.64 1.0 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.137 0.97 . . . . 0.0 109.815 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.9 mt -91.05 148.91 22.06 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.4 m -110.87 142.55 42.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.908 . . . . 0.0 110.086 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -39.4 -29.73 0.05 Allowed 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.402 -0.811 . . . . 0.0 112.406 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.6 62.53 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -76.67 -41.93 43.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.63 -0.669 . . . . 0.0 110.227 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.06 -34.44 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.599 -0.688 . . . . 0.0 110.312 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.31 -36.62 84.61 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.221 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.76 -48.85 77.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.462 -0.774 . . . . 0.0 109.37 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.22 -47.14 87.45 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.615 0.721 . . . . 0.0 109.905 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.0 mt -60.33 -17.28 41.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.842 -0.536 . . . . 0.0 111.207 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -56.39 -20.36 19.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.243 -0.911 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.73 27.92 7.31 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.6 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.9 p -107.23 128.72 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.132 -1.216 . . . . 0.0 110.182 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -103.52 105.29 15.5 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.332 0.587 . . . . 0.0 111.575 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 m -89.43 161.26 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -92.26 -176.51 4.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.419 -0.801 . . . . 0.0 111.064 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 m -69.7 -1.61 9.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.798 -0.564 . . . . 0.0 111.973 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -107.71 -8.4 16.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.936 -1.102 . . . . 0.0 110.655 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.83 38.41 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -109.06 139.84 43.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.964 . . . . 0.0 110.906 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.03 168.81 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -96.54 112.84 24.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.413 -0.805 . . . . 0.0 109.719 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.468 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 42.8 p90 -62.78 -22.32 66.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 111.857 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 46.6 mtpt -83.18 -32.85 26.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.142 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.21 -46.85 66.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.662 -0.649 . . . . 0.0 111.604 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -70.02 -28.6 65.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.542 -0.724 . . . . 0.0 111.572 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 144' ' ' GLU . 36.3 pt -79.13 -42.67 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.439 ' N ' HG13 ' A' ' 143' ' ' ILE . 63.9 mt-10 -65.09 -26.46 68.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.209 -0.932 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -88.1 -12.46 44.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.0 110.646 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.11 -41.1 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' A' ' 86' ' ' PHE . 3.6 mp -59.24 -18.3 35.79 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.881 -0.512 . . . . 0.0 111.543 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -60.03 -39.98 87.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.37 -0.831 . . . . 0.0 110.224 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.213 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.753 0.787 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.39 159.45 20.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.93 -0.481 . . . . 0.0 110.354 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -107.75 160.2 15.91 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.878 0.847 . . . . 0.0 110.992 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -50.83 -30.6 14.75 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.666 0.746 . . . . 0.0 109.522 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -52.28 -37.49 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.839 -0.538 . . . . 0.0 111.209 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -61.26 -49.29 77.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE1' HD11 ' A' ' 113' ' ' LEU . 1.8 m-85 -76.02 -39.97 54.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.765 -0.584 . . . . 0.0 111.047 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.5 -51.29 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -58.49 -32.7 69.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.642 -0.661 . . . . 0.0 110.547 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.405 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -63.48 -55.35 24.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.788 -0.57 . . . . 0.0 111.725 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -78.74 -56.76 4.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.098 -1.001 . . . . 0.0 111.737 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.67 -37.84 19.57 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.561 -0.712 . . . . 0.0 112.819 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.86 -36.84 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.066 -1.021 . . . . 0.0 109.924 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -67.67 -43.41 80.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.5 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.483 -0.76 . . . . 0.0 110.761 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -61.17 -39.78 91.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 0.0 110.621 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.41 20.1 6.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.257 -0.902 . . . . 0.0 110.829 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t 38.15 36.51 0.12 Allowed 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 42.1 p -63.83 -34.66 78.43 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 12.53 58.04 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -132.42 154.68 49.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.036 -1.273 . . . . 0.0 110.475 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.07 160.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.365 -0.835 . . . . 0.0 109.896 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.1 p -80.5 144.06 32.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.2 p -57.21 -40.07 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 0.0 110.883 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.25 96.63 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -80.45 -39.24 28.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.984 . . . . 0.0 110.4 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.05 -49.97 75.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.715 -0.616 . . . . 0.0 110.121 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -63.21 -28.95 70.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.51 -47.84 68.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.366 -0.833 . . . . 0.0 110.619 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -40.75 96.12 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 115' ' ' GLU . 3.4 tp -55.85 -44.59 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -60.35 -30.1 69.33 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.557 0.694 . . . . 0.0 109.65 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.13 -14.21 64.79 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.12 7.38 46.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.299 -1.118 . . . . 0.0 112.552 -177.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.58 31.89 5.03 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -113.82 120.32 40.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.988 -0.713 . . . . 0.0 110.249 178.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -122.45 59.74 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.042 0.925 . . . . 0.0 109.498 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -90.92 148.65 22.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.4 m -111.09 141.84 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.331 -0.855 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -39.87 -28.29 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.283 -0.886 . . . . 0.0 112.685 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.43 -52.84 62.91 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.37 -0.831 . . . . 0.0 109.059 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -77.01 -42.2 39.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.628 -0.67 . . . . 0.0 110.431 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.34 -36.36 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.602 -0.686 . . . . 0.0 110.295 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -63.19 -39.92 96.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.06 -47.51 85.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.63 -0.669 . . . . 0.0 109.839 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.94 -40.03 96.4 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.614 0.721 . . . . 0.0 110.669 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 68.7 mt -67.84 -15.97 63.87 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.779 -0.575 . . . . 0.0 111.856 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -57.55 -17.02 11.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.197 -0.939 . . . . 0.0 111.877 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.65 -10.93 12.07 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.221 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.7 p -70.65 132.36 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.953 -1.321 . . . . 0.0 110.522 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.48 100.06 10.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.367 0.603 . . . . 0.0 111.363 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -83.82 159.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -95.88 -179.51 4.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.415 -0.803 . . . . 0.0 111.502 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.2 m -70.41 -1.49 10.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.849 -0.532 . . . . 0.0 112.13 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -107.83 -11.49 15.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.863 -1.148 . . . . 0.0 110.411 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.02 29.05 16.17 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -110.43 135.7 50.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.649 -0.912 . . . . 0.0 111.328 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.35 169.0 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -97.83 114.75 26.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.44 -0.787 . . . . 0.0 110.468 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 46.6 p90 -68.32 -36.22 78.96 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.511 -0.743 . . . . 0.0 111.676 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.5 mttt -68.51 -40.0 81.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.294 -0.879 . . . . 0.0 110.798 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -67.3 -43.26 82.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.694 -0.629 . . . . 0.0 111.299 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -70.74 -27.76 64.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.494 -0.753 . . . . 0.0 110.46 -178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 20.3 mm -78.5 -49.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.477 -0.764 . . . . 0.0 109.585 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -60.04 -27.51 66.99 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 0.0 110.384 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.06 -12.3 44.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 110.502 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.24 -39.14 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.24 -22.43 61.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.912 -0.492 . . . . 0.0 111.204 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -57.92 141.99 47.62 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.464 -0.772 . . . . 0.0 110.46 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.152 179.916 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.774 0.797 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.02 159.56 17.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.882 -0.511 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.51 159.55 16.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.813 0.816 . . . . 0.0 111.009 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.6 m -50.97 -30.81 16.0 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.666 0.746 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.73 -36.89 38.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.851 -0.53 . . . . 0.0 111.274 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -57.64 -54.11 50.57 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -76.59 -38.51 54.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.606 -0.684 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.9 t -57.12 -51.55 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -0.992 . . . . 0.0 110.328 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -60.07 -32.13 70.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.687 -0.633 . . . . 0.0 110.255 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.21 -56.56 20.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.643 -0.66 . . . . 0.0 111.805 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.02 -53.54 7.68 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.307 -0.871 . . . . 0.0 111.813 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -48.58 -40.24 26.63 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.424 -0.798 . . . . 0.0 112.759 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 74.7 t -59.8 -37.93 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.773 -1.205 . . . . 0.0 109.663 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -68.97 -45.97 69.29 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -62.12 82.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.431 -0.793 . . . . 0.0 110.937 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -62.57 -41.24 98.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -91.64 18.88 6.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.278 -0.889 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.1 p 38.48 37.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.3 p -63.72 -34.99 79.1 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.089 -1.007 . . . . 0.0 109.311 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.86 12.75 55.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.007 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -132.63 154.84 49.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.133 -1.216 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.2 m -150.72 160.4 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.389 -0.82 . . . . 0.0 109.855 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 p -83.21 145.55 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.96 -39.21 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.471 -0.768 . . . . 0.0 110.715 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.18 -41.04 96.48 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -80.53 -39.96 26.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.616 -0.932 . . . . 0.0 110.394 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.9 -50.01 75.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.698 -0.626 . . . . 0.0 110.145 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -64.89 -29.57 70.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 110.551 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -69.0 -47.97 64.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.437 -0.789 . . . . 0.0 110.773 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.62 88.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.321 -0.862 . . . . 0.0 110.445 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.36 -44.76 76.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.5 m -59.99 -27.87 67.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.546 0.688 . . . . 0.0 110.051 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.09 -14.62 64.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.55 8.3 42.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.33 -1.1 . . . . 0.0 112.287 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 33.01 4.52 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -114.03 119.85 38.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.982 -0.716 . . . . 0.0 110.298 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -121.98 59.28 1.0 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.198 0.999 . . . . 0.0 109.236 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.5 mt -90.11 148.7 22.85 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -111.05 143.9 41.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.252 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -40.33 -27.03 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.199 -0.938 . . . . 0.0 112.817 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.9 55.5 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 18.3 mp0 -75.15 -28.48 60.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.455 -0.778 . . . . 0.0 110.592 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.69 -33.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.819 . . . . 0.0 110.348 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -65.83 -45.12 83.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 11.2 pt-20 -56.63 -42.39 78.77 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.168 -0.958 . . . . 0.0 109.83 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.05 -47.22 81.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 0.0 109.648 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 mt -60.59 -18.04 50.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.888 -0.508 . . . . 0.0 111.07 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -56.79 -21.57 29.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.461 -0.775 . . . . 0.0 111.056 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 26.32 7.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.2 t -107.9 129.88 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -1.109 . . . . 0.0 109.671 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.96 101.87 13.09 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.437 0.637 . . . . 0.0 111.935 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.04 158.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -95.85 -177.72 4.13 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.383 -0.823 . . . . 0.0 111.286 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.09 -1.27 14.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.941 -0.474 . . . . 0.0 111.805 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -108.21 -15.02 14.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.423 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.78 29.2 12.19 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -111.03 133.7 53.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.624 -0.927 . . . . 0.0 111.167 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.8 mp -124.77 139.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -69.79 112.48 6.26 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.73 -0.606 . . . . 0.0 110.502 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.449 ' CG ' ' N ' ' A' ' 140' ' ' LYS . 32.7 p90 -69.96 -41.64 74.24 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.391 -0.818 . . . . 0.0 112.222 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 4.0 mttt -60.22 -29.87 69.02 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.605 -0.684 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -84.12 -39.48 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 111.649 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -70.01 -29.88 67.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.444 -0.785 . . . . 0.0 111.349 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.429 HG13 ' N ' ' A' ' 144' ' ' GLU . 27.8 pt -83.17 -43.43 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.429 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.9 mt-10 -68.91 -27.44 65.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.322 -0.861 . . . . 0.0 110.715 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -85.1 -15.79 42.73 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.319 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 76.6 t -95.48 -37.41 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.2 mt -61.05 -18.15 56.26 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.305 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -59.1 133.99 56.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.298 -0.876 . . . . 0.0 110.078 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.137 -179.85 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.4 mttt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.607 0.718 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.14 159.11 15.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.91 -0.494 . . . . 0.0 110.097 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -110.18 161.0 16.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 111.283 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.2 m -51.04 -30.37 15.33 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.636 0.731 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -51.01 -37.61 46.17 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.883 -0.511 . . . . 0.0 111.222 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.18 -47.24 85.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.41 ' CD2' HD13 ' A' ' 147' ' ' LEU . 1.2 m-85 -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.75 -49.99 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.368 -0.833 . . . . 0.0 110.658 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.58 -34.96 73.38 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.583 -0.698 . . . . 0.0 111.388 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.413 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.26 -56.61 18.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.605 -0.685 . . . . 0.0 112.005 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -76.7 -54.1 7.1 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.188 -0.945 . . . . 0.0 111.976 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -48.41 -37.21 16.46 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.31 -0.869 . . . . 0.0 113.045 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.94 -36.36 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 120.843 -1.16 . . . . 0.0 109.89 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.91 -42.78 89.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -62.1 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.43 -0.794 . . . . 0.0 111.249 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -61.44 -41.05 96.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.557 -0.714 . . . . 0.0 110.048 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.3 20.58 7.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.44 -0.787 . . . . 0.0 110.44 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 38.2 36.68 0.12 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 t -63.46 -33.39 75.46 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.128 -0.983 . . . . 0.0 109.566 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.17 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.31 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -131.58 152.73 50.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -1.216 . . . . 0.0 109.736 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.8 m -148.89 160.0 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.9 p -81.37 145.93 30.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 9.1 p -54.46 -39.52 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.484 -0.76 . . . . 0.0 110.658 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.04 96.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.58 -43.16 21.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.633 -0.922 . . . . 0.0 110.8 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.0 -50.07 75.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.48 -0.762 . . . . 0.0 110.057 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -63.32 -31.64 72.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.724 . . . . 0.0 110.165 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -67.73 -47.7 68.56 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.401 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -40.4 95.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 tp -55.73 -44.81 77.87 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.5 m -60.45 -29.68 69.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.33 -14.25 64.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.413 ' CD1' ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -94.74 7.33 46.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -1.087 . . . . 0.0 112.545 -177.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.77 32.11 4.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -113.87 120.16 39.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.932 -0.746 . . . . 0.0 110.204 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -121.92 59.51 0.99 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.203 1.002 . . . . 0.0 109.304 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.2 mt -92.03 148.96 21.79 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 p -110.95 143.25 41.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.261 -0.899 . . . . 0.0 109.854 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -40.08 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 O-C-N 121.213 -0.929 . . . . 0.0 112.805 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.99 61.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 108.982 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -76.69 -42.83 40.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.598 -0.689 . . . . 0.0 110.433 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.41 -35.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.73 -38.38 90.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.229 -0.919 . . . . 0.0 109.208 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.01 -47.62 85.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.614 . . . . 0.0 109.739 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.83 -49.88 75.68 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.508 0.67 . . . . 0.0 110.052 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.98 -18.72 47.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.888 -0.507 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -57.04 -21.03 28.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.447 -0.783 . . . . 0.0 111.136 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.92 9.08 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.45 132.82 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.041 -1.27 . . . . 0.0 109.982 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -102.51 102.34 12.6 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.389 0.614 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -85.4 159.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.85 -176.79 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -71.67 -1.14 12.69 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.794 -0.566 . . . . 0.0 111.834 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -107.43 -12.07 15.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.13 . . . . 0.0 110.403 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.61 27.09 28.04 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -110.89 140.1 45.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.619 -0.93 . . . . 0.0 111.245 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.407 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 5.1 mp -130.86 142.39 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.89 113.04 5.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.971 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 26.0 p90 -62.84 -33.26 74.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.642 -0.661 . . . . 0.0 111.706 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 20.5 mttt -69.97 -35.05 74.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 110.712 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -69.95 -44.11 70.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.72 -0.613 . . . . 0.0 111.518 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -74.33 -27.69 60.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.762 . . . . 0.0 111.077 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.33 -51.8 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.447 -0.783 . . . . 0.0 109.884 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -63.77 -26.43 68.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.439 -0.788 . . . . 0.0 110.791 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.34 -13.39 43.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.217 -0.927 . . . . 0.0 110.746 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.83 -38.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.41 HD13 ' CD2' ' A' ' 86' ' ' PHE . 14.3 mt -57.22 -19.9 23.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.954 -0.466 . . . . 0.0 111.406 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -57.96 129.87 43.93 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.258 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -100.75 168.52 9.61 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.95 0.881 . . . . 0.0 111.245 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.845 HG22 ' CG2' ' A' ' 87' ' ' VAL . 23.2 m -51.16 -31.19 19.09 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.45 0.643 . . . . 0.0 109.96 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -52.17 -37.92 56.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.709 -0.62 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.59 -47.11 85.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.859 ' CD2' HD11 ' A' ' 147' ' ' LEU . 2.9 m-85 -76.03 -40.0 54.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.845 ' CG2' HG22 ' A' ' 83' ' ' THR . 65.7 t -61.5 -51.84 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.244 -0.91 . . . . 0.0 110.588 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 92' ' ' VAL . 48.0 tttp -56.96 -32.55 66.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -61.28 -59.92 4.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.503 -0.748 . . . . 0.0 111.934 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.726 ' CE1' HD12 ' A' ' 106' ' ' LEU . 65.3 m-85 -76.63 -53.67 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.188 -0.945 . . . . 0.0 111.951 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -48.16 -38.52 18.25 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.26 -0.9 . . . . 0.0 112.791 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 88' ' ' LYS . 56.5 t -59.62 -34.81 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.801 -1.187 . . . . 0.0 109.602 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.14 -41.01 97.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.4 81.41 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.448 -0.782 . . . . 0.0 111.083 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.26 -41.63 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.642 -0.661 . . . . 0.0 110.425 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -91.46 16.18 10.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.333 -0.854 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 t 38.42 61.7 1.11 Allowed 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.8 p -90.5 -33.48 15.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.146 -0.971 . . . . 0.0 109.31 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.07 9.98 55.33 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.925 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.451 ' C ' HG13 ' A' ' 101' ' ' VAL . 2.1 mppt? -132.84 154.82 49.97 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.021 -1.282 . . . . 0.0 110.274 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 106' ' ' LEU . 31.3 m -150.02 159.92 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.258 -0.901 . . . . 0.0 109.964 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.1 p -81.38 144.21 31.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.8 p -56.92 -39.98 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.562 -0.711 . . . . 0.0 110.857 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -58.82 -41.58 96.13 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.59 -39.67 27.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.939 . . . . 0.0 110.453 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.726 HD12 ' CE1' ' A' ' 90' ' ' PHE . 29.0 tp -59.97 -49.88 75.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.687 -0.633 . . . . 0.0 110.168 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -65.87 -29.52 69.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.401 -0.812 . . . . 0.0 111.005 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -65.58 -48.29 72.85 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.093 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.111 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.678 HD23 ' HG2' ' A' ' 115' ' ' GLU . 4.1 tp -55.69 -44.74 77.65 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.266 -0.896 . . . . 0.0 108.702 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -60.85 -30.25 70.0 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.545 0.688 . . . . 0.0 109.622 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.59 -13.83 66.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.632 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 7.7 45.38 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.31 -1.112 . . . . 0.0 112.406 -177.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.39 31.67 5.17 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 110' ' ' LEU . 12.2 tp10 -113.25 119.93 39.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.873 -0.781 . . . . 0.0 110.281 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -122.39 59.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.955 0.883 . . . . 0.0 109.386 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.527 HD11 ' OE2' ' A' ' 115' ' ' GLU . 77.3 mt -90.99 148.62 22.28 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 m -111.01 141.89 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 34.5 t0 -40.08 -27.24 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.226 -0.921 . . . . 0.0 112.899 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -53.18 59.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.202 -0.936 . . . . 0.0 108.975 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.72 -42.68 40.37 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.531 -0.73 . . . . 0.0 110.414 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.522 HG12 HD12 ' A' ' 126' ' ' LEU . 58.9 t -60.01 -36.66 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.604 -0.685 . . . . 0.0 110.272 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -63.33 -38.37 90.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.207 -0.933 . . . . 0.0 109.069 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -62.95 -49.82 73.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.626 -0.671 . . . . 0.0 109.365 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.91 -49.43 77.74 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.576 0.703 . . . . 0.0 110.237 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.794 ' O ' HG12 ' A' ' 129' ' ' VAL . 46.6 mt -62.34 -15.99 51.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.938 -0.476 . . . . 0.0 111.257 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -57.26 -17.16 10.51 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.264 -0.897 . . . . 0.0 111.853 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.03 -10.19 14.46 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.071 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.794 HG12 ' O ' ' A' ' 126' ' ' LEU . 7.1 p -70.4 135.9 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.989 -1.301 . . . . 0.0 110.765 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -104.62 100.63 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.412 0.625 . . . . 0.0 111.267 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.7 p -84.27 158.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -95.34 -179.06 4.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -0.805 . . . . 0.0 111.36 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 m -70.72 -1.55 11.77 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.942 -0.474 . . . . 0.0 112.032 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -107.14 -11.15 15.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 0.0 110.421 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.73 26.02 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.531 ' C ' HD12 ' A' ' 137' ' ' ILE . 87.2 mt-10 -110.61 137.92 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.96 . . . . 0.0 111.14 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.7 mp -126.81 168.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.462 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.3 t70 -96.14 112.33 24.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 109.891 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.458 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 48.1 p90 -62.68 -29.12 70.41 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.729 . . . . 0.0 111.632 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 15.7 mttt -73.1 -34.63 66.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.25 -0.906 . . . . 0.0 110.615 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -70.16 -45.98 65.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.689 -0.632 . . . . 0.0 112.183 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 146' ' ' VAL . 24.1 t80 -70.68 -28.37 64.72 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 0.0 110.8 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 110' ' ' LEU . 28.1 mm -74.58 -45.98 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.48 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -60.06 -27.43 66.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.68 -12.33 42.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 142' ' ' PHE . 60.7 t -95.71 -40.68 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.859 HD11 ' CD2' ' A' ' 86' ' ' PHE . 4.4 mp . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.948 -0.47 . . . . 0.0 111.301 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.8 0.333 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -102.17 160.01 14.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.713 0.768 . . . . 0.0 110.843 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.708 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.2 m -51.13 -30.65 17.06 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.701 0.762 . . . . 0.0 109.337 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -52.24 -37.47 55.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.955 -0.466 . . . . 0.0 111.168 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -60.58 -50.04 75.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.592 -0.693 . . . . 0.0 109.856 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' A' ' 147' ' ' LEU . 1.2 m-85 -75.91 -40.06 55.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.783 -0.573 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.708 ' CG2' HG22 ' A' ' 83' ' ' THR . 83.5 t -61.92 -49.89 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.322 -0.861 . . . . 0.0 110.606 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 92' ' ' VAL . 24.0 mmtt -59.75 -34.33 72.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.566 -0.709 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 113' ' ' LEU . . . -62.06 -51.82 66.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.677 -0.64 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' HD11 ' A' ' 143' ' ' ILE . 50.9 m-85 -77.23 -54.92 5.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 111.802 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.485 ' OE1' HG12 ' A' ' 87' ' ' VAL . 57.2 mt-30 -48.04 -35.57 11.39 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.504 -0.747 . . . . 0.0 112.954 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 88' ' ' LYS . 96.2 t -60.87 -29.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.679 -1.263 . . . . 0.0 109.122 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -92.81 23.16 4.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.679 -0.638 . . . . 0.0 109.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -132.02 78.47 1.82 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 0.0 108.941 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -63.56 -45.48 90.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.765 -0.584 . . . . 0.0 111.435 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.99 17.68 5.55 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.014 -1.054 . . . . 0.0 111.389 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 t 38.27 39.82 0.3 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.597 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.8 t -63.47 -34.16 77.16 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.43 14.58 50.26 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.384 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.597 ' H ' HG23 ' A' ' 98' ' ' THR . 31.2 mttt -132.93 153.84 51.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.081 -1.246 . . . . 0.0 110.643 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 139' ' ' TYR . 30.9 m -150.29 160.02 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.6 p -84.74 147.34 26.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.0 109.711 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.871 HG13 HD13 ' A' ' 137' ' ' ILE . 21.6 m -63.35 -34.02 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.289 -0.882 . . . . 0.0 110.268 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.29 -42.49 99.79 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.49 -41.43 27.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.653 -0.91 . . . . 0.0 109.493 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 101' ' ' VAL . 5.9 tt -59.96 -49.23 78.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -63.63 -32.51 74.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.693 -0.63 . . . . 0.0 110.543 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.72 -48.91 67.72 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -36.41 74.79 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.889 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 19.9 tp -53.72 -45.02 70.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -66.27 -18.77 65.55 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.018 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.7 -14.15 65.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.533 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -95.03 8.28 43.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 112.67 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.3 31.19 5.07 Favored Glycine 0 N--CA 1.503 3.104 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 49.5 mm-40 -114.88 121.76 44.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.957 -0.731 . . . . 0.0 110.165 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -122.83 61.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 109.899 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.5 mt -91.96 148.87 21.87 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 m -110.6 144.26 39.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 109.989 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.435 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 28.0 t0 -39.43 -29.28 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.361 -0.837 . . . . 0.0 112.598 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.95 49.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.35 -0.844 . . . . 0.0 108.847 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -76.44 -39.93 52.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.616 . . . . 0.0 110.284 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 58.1 t -64.2 -35.95 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.585 -0.697 . . . . 0.0 110.653 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.0 -39.92 87.45 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.075 -1.016 . . . . 0.0 108.927 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.71 -43.89 81.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.708 -0.62 . . . . 0.0 109.397 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.17 -50.04 74.77 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.657 0.741 . . . . 0.0 109.856 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.457 HD23 HG11 ' A' ' 129' ' ' VAL . 6.9 mt -67.67 -22.15 65.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.779 -0.575 . . . . 0.0 110.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -57.4 -19.72 25.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.501 -0.749 . . . . 0.0 111.358 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.65 -14.86 5.57 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.25 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.457 HG11 HD23 ' A' ' 126' ' ' LEU . 6.1 p -66.19 128.83 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 118.897 1.348 . . . . 0.0 110.517 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.05 99.86 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.407 0.623 . . . . 0.0 111.226 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.602 HG23 HD11 ' A' ' 137' ' ' ILE . 7.6 p -84.21 157.08 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -96.68 -174.35 2.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 111.206 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.2 m -71.67 -0.7 11.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.839 -0.538 . . . . 0.0 111.853 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.95 -11.32 15.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.19 25.32 44.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.77 ' C ' HD12 ' A' ' 137' ' ' ILE . 51.7 mt-10 -111.7 139.52 47.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.555 -0.968 . . . . 0.0 110.998 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.871 HD13 HG13 ' A' ' 103' ' ' VAL . 3.2 mp -126.56 146.48 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -69.09 114.38 7.31 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.51 ' HB3' HG21 ' A' ' 101' ' ' VAL . 49.9 p90 -67.55 -38.88 84.79 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.544 -0.722 . . . . 0.0 111.548 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.8 mttt -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.0 110.102 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -70.02 -42.32 73.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 110.927 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.411 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.9 t80 -71.88 -28.13 63.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.54 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.634 HD11 ' CE1' ' A' ' 90' ' ' PHE . 92.3 mt -85.05 -52.25 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.324 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -87.63 -13.91 41.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -0.914 . . . . 0.0 110.56 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 142' ' ' PHE . 40.1 t -95.96 -38.29 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.697 HD11 ' CD2' ' A' ' 86' ' ' PHE . 22.3 mt . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.896 -0.502 . . . . 0.0 111.258 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.857 0.36 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -103.43 162.23 13.2 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 110.969 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.782 HG22 ' CG2' ' A' ' 87' ' ' VAL . 18.5 m -51.33 -30.69 19.26 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.608 0.718 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.66 -38.15 59.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.843 -0.535 . . . . 0.0 111.162 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.429 ' OD1' HD21 ' A' ' 113' ' ' LEU . 8.0 t70 -60.69 -50.18 74.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 109.871 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.657 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -74.29 -38.35 63.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.782 -0.573 . . . . 0.0 110.999 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.782 ' CG2' HG22 ' A' ' 83' ' ' THR . 97.0 t -63.99 -48.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.231 -0.918 . . . . 0.0 110.678 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 92' ' ' VAL . 39.2 ttmt -60.02 -35.75 75.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.628 -0.67 . . . . 0.0 111.019 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.613 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -59.95 -52.16 66.61 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 111.245 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -77.0 -53.3 8.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.378 -0.826 . . . . 0.0 111.249 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.518 ' OE1' HG12 ' A' ' 87' ' ' VAL . 55.6 mt-30 -48.7 -38.69 22.1 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 88' ' ' LYS . 95.8 t -59.17 -31.03 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 120.565 -1.334 . . . . 0.0 109.193 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.95 23.6 4.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -131.57 78.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.0 109.399 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -70.5 -10.46 59.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.767 -0.583 . . . . 0.0 111.355 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.22 11.65 15.21 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.125 -0.985 . . . . 0.0 110.963 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m 37.54 37.55 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 p -63.88 -34.53 78.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.424 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.07 14.91 53.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' C ' HG13 ' A' ' 101' ' ' VAL . 37.2 mttt -133.6 156.41 47.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.178 -1.19 . . . . 0.0 110.435 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.611 ' CG2' HD12 ' A' ' 106' ' ' LEU . 27.2 m -151.61 160.02 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -82.61 144.94 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.905 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.9 p -57.3 -39.92 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.746 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.01 -41.89 96.64 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.01 -42.6 23.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.528 -0.983 . . . . 0.0 110.336 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.611 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.2 tt -60.01 -49.75 76.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -64.89 -33.66 76.54 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -67.16 -49.04 66.18 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -34.84 71.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.54 -0.725 . . . . 0.0 110.523 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.718 HD11 ' OE2' ' A' ' 115' ' ' GLU . 30.8 tp -54.66 -45.28 73.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.413 -0.804 . . . . 0.0 109.116 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.0 m -63.96 -19.04 64.85 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.346 0.593 . . . . 0.0 110.789 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.31 -14.57 63.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.657 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -94.13 7.38 45.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -1.03 . . . . 0.0 112.649 -177.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.8 4.84 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.718 ' OE2' HD11 ' A' ' 110' ' ' LEU . 6.4 mm-40 -114.79 121.02 42.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.941 -0.741 . . . . 0.0 110.116 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -122.23 59.64 1.01 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.138 0.971 . . . . 0.0 109.755 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.99 148.83 22.13 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.5 m -111.06 141.63 44.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 39.5 t0 -39.63 -29.14 0.05 Allowed 'General case' 0 N--CA 1.513 2.701 0 O-C-N 121.417 -0.802 . . . . 0.0 112.487 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.84 -52.62 63.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.368 -0.833 . . . . 0.0 108.953 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -77.01 -42.61 37.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.632 -0.668 . . . . 0.0 110.295 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 126' ' ' LEU . 62.8 t -60.02 -35.21 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.52 -38.8 92.5 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 109.041 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.77 -45.5 93.64 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.692 0.758 . . . . 0.0 110.143 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.763 ' O ' HG12 ' A' ' 129' ' ' VAL . 67.1 mt -63.65 -18.45 63.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.899 -0.501 . . . . 0.0 111.304 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -56.67 -18.24 11.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.196 -0.94 . . . . 0.0 111.68 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.14 -9.62 15.29 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.944 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 126' ' ' LEU . 9.9 p -70.13 133.78 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.926 -1.338 . . . . 0.0 110.988 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -99.59 99.41 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.365 0.602 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.13 155.77 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.89 -176.9 3.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 111.18 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.04 -0.96 12.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.819 -0.55 . . . . 0.0 111.805 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -108.0 -14.02 14.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 0.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.04 28.98 16.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.56 ' C ' HD12 ' A' ' 137' ' ' ILE . 96.8 mt-10 -110.51 134.94 51.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.677 -0.896 . . . . 0.0 111.073 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.8 mp -125.28 142.63 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.66 112.41 6.12 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.247 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 41.5 p90 -68.11 -34.11 75.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.531 -0.731 . . . . 0.0 111.531 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 mttt -69.8 -32.73 71.33 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.272 -0.893 . . . . 0.0 110.426 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -73.2 -43.29 61.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.702 -0.623 . . . . 0.0 111.643 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.703 ' O ' HG23 ' A' ' 146' ' ' VAL . 30.8 t80 -70.73 -28.16 64.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.488 -0.758 . . . . 0.0 110.695 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.494 HG22 ' CD1' ' A' ' 147' ' ' LEU . 90.5 mt -75.18 -45.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.758 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.55 -26.83 65.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.91 -11.74 43.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.46 -0.775 . . . . 0.0 110.327 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 142' ' ' PHE . 65.9 t -95.97 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.617 HD21 ' CE2' ' A' ' 86' ' ' PHE . 87.2 mt . . . . . 0 N--CA 1.498 1.96 0 O-C-N 121.913 -0.492 . . . . 0.0 111.379 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -109.22 161.47 15.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.931 0.872 . . . . 0.0 111.319 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.786 ' O ' HG23 ' A' ' 87' ' ' VAL . 18.3 m -51.18 -30.32 16.6 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.663 0.744 . . . . 0.0 109.674 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.93 -37.64 32.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.717 -0.614 . . . . 0.0 111.146 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -59.12 -50.4 74.2 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.439 ' HB3' HD13 ' A' ' 143' ' ' ILE . 12.1 m-85 -76.18 -38.38 56.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 83' ' ' THR . 65.8 t -57.34 -55.39 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.177 -0.952 . . . . 0.0 110.49 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -59.99 -33.27 71.74 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.633 -0.667 . . . . 0.0 110.553 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.29 -51.88 67.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.682 -0.636 . . . . 0.0 111.429 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 33.4 m-85 -78.74 -54.94 5.57 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 0.0 111.508 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -49.19 -39.98 31.51 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.585 -0.697 . . . . 0.0 112.69 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 93' ' ' PHE . 9.7 p -58.38 -38.57 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.071 -1.018 . . . . 0.0 110.072 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 92' ' ' VAL . 2.5 t80 -69.07 -44.83 71.78 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -61.74 82.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.516 -0.74 . . . . 0.0 111.018 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -69.1 -15.35 63.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.11 12.87 20.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.2 -0.937 . . . . 0.0 110.5 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m 38.27 62.8 0.93 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -91.28 -34.18 15.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.161 -0.962 . . . . 0.0 109.359 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.66 11.67 54.88 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.463 ' C ' HG13 ' A' ' 101' ' ' VAL . 83.0 mttt -132.21 154.66 49.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.262 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 106' ' ' LEU . 30.4 m -150.77 160.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.407 -0.808 . . . . 0.0 110.182 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.7 p -85.75 147.84 26.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 110.118 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 137' ' ' ILE . 81.9 t -57.16 -40.2 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.336 -0.852 . . . . 0.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.16 -42.04 95.03 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.45 -44.17 19.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.512 -0.993 . . . . 0.0 110.4 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 HG21 ' A' ' 101' ' ' VAL . 8.2 tt -60.03 -49.96 75.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.714 -0.616 . . . . 0.0 110.001 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -64.08 -32.21 73.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -68.08 -47.83 67.21 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.516 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.33 95.45 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.144 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.604 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.98 -44.79 78.9 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 m -59.89 -30.5 69.06 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.59 0.71 . . . . 0.0 109.789 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.44 -14.62 63.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 7.3 46.6 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.301 -1.117 . . . . 0.0 112.602 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.4 4.76 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.604 ' HG2' HD23 ' A' ' 110' ' ' LEU . 21.2 tp10 -114.01 120.13 39.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.884 -0.774 . . . . 0.0 110.005 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -122.09 59.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.142 0.972 . . . . 0.0 109.518 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 92.5 mt -92.18 149.36 21.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 144.19 40.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.917 . . . . 0.0 109.663 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -40.13 -27.4 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.254 -0.904 . . . . 0.0 112.809 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.66 62.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.278 -0.889 . . . . 0.0 109.028 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.59 -42.79 41.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 110.382 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 60.3 t -59.93 -35.55 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.519 -0.738 . . . . 0.0 110.419 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -64.49 -37.74 88.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -60.05 -47.24 86.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 0.0 109.717 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.13 -50.13 74.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.631 0.729 . . . . 0.0 109.947 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.45 -19.58 56.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.893 -0.504 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -57.32 -22.01 39.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.486 -0.758 . . . . 0.0 111.203 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -113.81 -13.87 9.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.05 126.3 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.14 -1.212 . . . . 0.0 110.128 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -89.89 99.96 12.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.201 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 137' ' ' ILE . 8.1 p -83.32 155.67 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -96.6 -175.6 3.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.377 -0.827 . . . . 0.0 111.182 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -72.02 -0.85 12.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.829 -0.544 . . . . 0.0 111.863 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.23 -12.58 15.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.104 . . . . 0.0 110.351 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.92 26.69 30.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.682 ' C ' HD12 ' A' ' 137' ' ' ILE . 44.2 mt-10 -111.92 136.12 51.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.491 -1.005 . . . . 0.0 110.963 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.682 HD12 ' C ' ' A' ' 136' ' ' GLU . 3.5 mp -124.71 142.55 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 39.2 p-10 -69.74 109.07 4.19 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.378 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 49.9 p90 -65.28 -36.87 85.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.454 -0.779 . . . . 0.0 112.266 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 29.1 mttt -60.09 -31.52 70.1 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.337 -0.852 . . . . 0.0 111.904 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -84.2 -38.15 20.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.483 -0.76 . . . . 0.0 112.036 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 146' ' ' VAL . 22.7 t80 -70.42 -28.84 65.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.445 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 86' ' ' PHE . 90.6 mt -83.49 -50.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 110.326 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -62.88 -26.24 68.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.749 . . . . 0.0 110.993 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.78 -15.83 33.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 111.014 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 142' ' ' PHE . 70.5 t -96.72 -41.66 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.058 -1.026 . . . . 0.0 108.709 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.835 -0.541 . . . . 0.0 111.662 179.569 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.781 0.324 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -109.22 162.0 14.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.97 0.89 . . . . 0.0 111.213 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.685 HG22 ' CG2' ' A' ' 87' ' ' VAL . 5.5 m -50.54 -30.69 13.63 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.596 0.712 . . . . 0.0 109.777 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -52.56 -36.19 55.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.916 -0.49 . . . . 0.0 111.107 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.35 -50.01 74.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 109.92 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.594 ' CE2' HD21 ' A' ' 147' ' ' LEU . 5.6 m-85 -75.87 -40.01 55.41 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.707 -0.621 . . . . 0.0 111.254 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.685 ' CG2' HG22 ' A' ' 83' ' ' THR . 95.8 t -61.51 -50.01 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.267 -0.896 . . . . 0.0 110.365 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -57.95 -32.75 68.13 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.897 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.456 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -62.34 -58.27 8.29 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.565 -0.709 . . . . 0.0 111.867 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.876 ' CE1' HD12 ' A' ' 106' ' ' LEU . 95.7 m-85 -78.81 -55.85 4.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.203 -0.936 . . . . 0.0 112.105 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -48.58 -38.64 21.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.421 -0.8 . . . . 0.0 112.808 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -56.5 -38.6 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.993 -1.067 . . . . 0.0 110.222 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' VAL . 23.4 m-85 -67.13 -42.5 84.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.77 83.1 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PHE . 67.4 mmtt -68.57 -16.82 63.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -113.53 15.73 18.93 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.0 110.445 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.55 37.08 0.1 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.7 t -63.57 -33.14 74.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.626 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.35 53.59 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.121 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.636 ' H ' HG23 ' A' ' 98' ' ' THR . 1.8 mtpt -132.83 153.57 51.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.044 -1.268 . . . . 0.0 110.368 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.686 HG21 HD13 ' A' ' 106' ' ' LEU . 34.7 m -150.06 160.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.8 p -83.69 146.27 28.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.555 -0.715 . . . . 0.0 109.654 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.984 HG13 HD13 ' A' ' 137' ' ' ILE . 21.0 m -61.76 -34.81 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.303 -0.873 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.43 99.79 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -79.62 -41.23 27.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.705 -0.879 . . . . 0.0 109.813 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.876 HD12 ' CE1' ' A' ' 90' ' ' PHE . 28.9 tp -60.04 -48.6 81.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -64.38 -30.98 72.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.67 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.679 ' O ' HG22 ' A' ' 111' ' ' THR . 61.1 t80 -65.52 -48.53 72.2 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.141 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -39.95 74.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.015 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 tp -54.17 -39.51 66.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.453 -0.779 . . . . 0.0 111.024 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 108' ' ' TYR . 8.8 t -73.01 -17.86 61.4 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.471 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.76 -13.94 66.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 8.52 42.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -1.121 . . . . 0.0 112.23 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.12 30.14 5.2 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 111' ' ' THR . 2.1 tp10 -114.17 121.48 43.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.81 -0.817 . . . . 0.0 110.273 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -123.02 61.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.095 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.6 mt -91.45 148.87 22.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -110.14 143.11 40.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.423 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 10.6 p-10 -38.5 -31.38 0.05 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.557 -0.715 . . . . 0.0 112.406 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.05 50.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.97 -41.97 40.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.647 . . . . 0.0 110.324 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 62.7 t -61.61 -36.33 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.608 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.037 -1.039 . . . . 0.0 108.945 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.72 -43.72 80.88 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.62 -0.675 . . . . 0.0 109.57 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 125' ' ' LEU . 3.6 mm? -61.92 -53.47 55.29 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.503 0.668 . . . . 0.0 110.253 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.36 -21.13 65.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.793 -0.567 . . . . 0.0 111.032 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.37 -20.9 32.25 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 111.334 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.85 -14.2 8.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.24 126.27 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.094 -1.239 . . . . 0.0 110.102 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -92.58 102.19 14.62 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.103 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.419 ' CG2' HD11 ' A' ' 137' ' ' ILE . 7.7 p -86.47 159.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -95.68 -173.25 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.94 -0.64 9.69 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.878 -0.514 . . . . 0.0 111.913 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -106.09 -9.82 16.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.935 -1.103 . . . . 0.0 110.272 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.01 25.25 49.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.604 ' C ' HD12 ' A' ' 137' ' ' ILE . 71.9 mt-10 -111.45 143.0 42.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.483 -1.01 . . . . 0.0 111.135 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.984 HD13 HG13 ' A' ' 103' ' ' VAL . 2.6 mp -127.0 170.64 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 137' ' ' ILE . 40.1 t0 -94.41 117.62 30.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.421 -0.799 . . . . 0.0 110.344 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.586 ' HB3' HG21 ' A' ' 101' ' ' VAL . 49.0 p90 -68.47 -37.2 79.96 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.645 -0.659 . . . . 0.0 111.737 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 6.8 mttt -67.04 -41.0 87.27 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.58 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -69.94 -42.54 73.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.756 -0.59 . . . . 0.0 111.428 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.445 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.3 t80 -70.7 -29.36 65.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.502 -0.749 . . . . 0.0 110.348 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 139' ' ' TYR . 94.8 mt -85.35 -50.99 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 110.235 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.77 -26.68 68.83 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.528 -0.733 . . . . 0.0 110.85 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.25 -15.46 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.816 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 142' ' ' PHE . 58.1 t -95.98 -42.42 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 108.695 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.594 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.7 mm? . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 111.693 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.807 0.337 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -109.92 161.98 14.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.859 0.838 . . . . 0.0 111.184 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.86 HG22 ' CG2' ' A' ' 87' ' ' VAL . 28.2 m -50.98 -30.86 16.17 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.59 0.709 . . . . 0.0 109.73 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -36.93 41.23 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.875 -0.516 . . . . 0.0 111.189 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -60.03 -50.06 75.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.598 -0.689 . . . . 0.0 109.996 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.825 ' CD1' HD11 ' A' ' 143' ' ' ILE . 3.6 m-85 -76.35 -39.6 53.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 111.025 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.86 ' CG2' HG22 ' A' ' 83' ' ' THR . 68.8 t -59.22 -53.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.25 -0.906 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.612 ' O ' HG23 ' A' ' 92' ' ' VAL . 38.4 ttpt -59.45 -33.15 70.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.608 -0.682 . . . . 0.0 110.955 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.658 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -62.49 -51.69 66.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.508 -0.745 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.55 -54.87 6.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 111.505 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -48.46 -37.29 16.92 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.485 -0.759 . . . . 0.0 112.83 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 88' ' ' LYS . 76.6 t -60.29 -36.94 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.843 -1.16 . . . . 0.0 109.715 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.59 -46.98 65.07 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -62.28 82.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.507 -0.746 . . . . 0.0 110.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -64.13 -40.01 95.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.0 110.447 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -91.54 16.7 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.5 36.31 0.13 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.8 p -63.75 -34.6 78.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.076 -1.015 . . . . 0.0 109.37 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.81 11.28 55.4 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.131 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 29.2 mmtm -132.39 153.95 50.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.044 -1.268 . . . . 0.0 110.402 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 139' ' ' TYR . 35.8 m -149.98 161.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.344 -0.848 . . . . 0.0 110.09 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 p -83.85 145.77 28.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.035 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.3 p -56.94 -38.3 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.395 -0.816 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.92 -40.76 97.3 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.6 -39.96 26.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.602 -0.94 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.89 -49.87 75.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.64 . . . . 0.0 110.025 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -64.66 -29.94 70.95 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.502 -0.749 . . . . 0.0 110.652 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.5 -47.68 69.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.424 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -39.19 93.65 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.016 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -55.59 -45.29 77.45 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.1 m -59.65 -30.42 68.73 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.571 0.7 . . . . 0.0 109.917 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.3 63.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 6.83 47.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.322 -1.105 . . . . 0.0 112.736 -177.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.66 32.35 4.83 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.566 ' HG2' HD23 ' A' ' 110' ' ' LEU . 19.9 tp10 -114.16 120.25 39.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 122.034 -0.686 . . . . 0.0 109.896 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -122.06 59.5 1.0 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.203 1.001 . . . . 0.0 109.364 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.38 148.44 23.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -111.05 143.1 42.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -39.98 -28.26 0.05 Allowed 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.318 -0.864 . . . . 0.0 112.486 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.41 59.29 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 45.4 mt-10 -75.4 -29.32 59.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 110.584 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.85 -32.6 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.99 -41.93 77.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.328 -0.857 . . . . 0.0 110.454 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 125' ' ' LEU . 9.1 pt-20 -60.0 -40.06 87.93 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.139 -0.975 . . . . 0.0 109.898 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -70.34 -44.06 68.97 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.394 -0.816 . . . . 0.0 110.354 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 129' ' ' VAL . 26.7 mt -60.18 -16.11 30.07 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.841 -0.537 . . . . 0.0 111.775 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -57.64 -19.24 25.06 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.276 -0.89 . . . . 0.0 111.304 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.64 25.09 9.26 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.438 HG21 HD23 ' A' ' 126' ' ' LEU . 58.6 t -106.7 124.5 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.301 -1.117 . . . . 0.0 109.549 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.03 105.85 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.474 0.654 . . . . 0.0 111.874 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.637 HG12 ' CG1' ' A' ' 137' ' ' ILE . 26.3 m -88.81 163.2 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -93.41 -175.05 3.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.794 . . . . 0.0 111.015 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 m -71.24 -1.35 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.899 -0.5 . . . . 0.0 111.776 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -108.26 -11.89 15.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.937 -1.102 . . . . 0.0 110.726 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.72 27.55 26.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.586 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.6 mt-10 -109.94 137.81 47.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.969 . . . . 0.0 111.108 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.637 ' CG1' HG12 ' A' ' 131' ' ' VAL . 5.1 mp -129.68 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -69.33 110.65 4.77 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.941 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' HB3' HG21 ' A' ' 101' ' ' VAL . 45.6 p90 -62.84 -30.96 71.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.48 -0.763 . . . . 0.0 111.89 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 24.3 mttt -71.28 -33.41 69.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.333 -0.855 . . . . 0.0 110.466 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -72.34 -46.17 56.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.751 -0.593 . . . . 0.0 111.493 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.2 t80 -71.15 -29.0 64.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.467 -0.771 . . . . 0.0 111.329 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.825 HD11 ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -79.28 -44.62 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.163 -0.961 . . . . 0.0 110.366 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.45 ' N ' HG23 ' A' ' 143' ' ' ILE . 94.0 mt-10 -62.29 -26.25 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.126 -0.984 . . . . 0.0 109.856 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.42 -12.56 45.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.434 -0.791 . . . . 0.0 110.099 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 142' ' ' PHE . 59.5 t -96.36 -41.8 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.429 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.9 tp . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.379 0.609 . . . . 0.0 110.758 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -107.3 158.88 16.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.838 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.7 m -51.26 -30.28 17.26 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.799 0.809 . . . . 0.0 109.329 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.17 -39.09 63.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.907 -0.496 . . . . 0.0 111.286 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.45 ' OD1' HD21 ' A' ' 113' ' ' LEU . 7.7 t0 -61.77 -50.03 74.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.551 -0.718 . . . . 0.0 109.918 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.735 ' CE2' HD21 ' A' ' 147' ' ' LEU . 1.6 m-85 -72.82 -36.58 67.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.743 -0.598 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 83' ' ' THR . 77.7 t -67.36 -46.15 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.16 -0.963 . . . . 0.0 110.79 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.598 ' O ' HG13 ' A' ' 92' ' ' VAL . 71.0 mmtt -59.27 -36.48 75.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.573 -0.704 . . . . 0.0 111.549 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 113' ' ' LEU . . . -59.75 -57.52 12.57 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 111.592 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -77.64 -53.63 7.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.278 -0.889 . . . . 0.0 112.028 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -48.36 -38.71 19.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.175 -0.953 . . . . 0.0 113.14 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 88' ' ' LYS . 29.7 m -59.14 -34.54 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.754 -1.216 . . . . 0.0 110.164 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -68.38 -43.33 77.57 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.3 80.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.359 -0.838 . . . . 0.0 110.901 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.26 -39.92 92.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 0.0 110.482 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -92.44 20.14 6.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.343 -0.848 . . . . 0.0 110.811 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 m 38.14 65.04 0.63 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -91.43 -33.78 15.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.17 -0.956 . . . . 0.0 109.148 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 15.12 57.48 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' C ' HG13 ' A' ' 101' ' ' VAL . 24.4 mmtp -131.93 153.1 50.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -1.217 . . . . 0.0 110.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 100' ' ' LYS . 35.9 m -148.98 159.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.313 -0.867 . . . . 0.0 110.047 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -81.85 144.8 30.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.624 -0.672 . . . . 0.0 110.083 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.7 p -56.41 -38.66 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.492 -0.755 . . . . 0.0 110.702 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.444 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -60.1 -40.6 97.36 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.52 -40.04 26.75 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.569 -0.959 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 106' ' ' LEU . 10.4 tt -58.96 -49.62 77.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.667 -0.646 . . . . 0.0 110.212 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -64.95 -29.6 70.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.705 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -67.93 -48.08 66.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.389 -0.82 . . . . 0.0 110.684 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -37.68 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.22 -0.925 . . . . 0.0 111.041 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.68 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.4 tp -55.33 -42.85 74.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.222 -0.924 . . . . 0.0 109.388 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' GLU . 1.1 p -66.45 -20.5 66.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.45 -14.87 62.99 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.488 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -94.09 8.41 41.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.321 -1.105 . . . . 0.0 112.507 -177.318 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.08 31.31 4.77 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.68 ' HG2' HD23 ' A' ' 110' ' ' LEU . 3.2 tp10 -113.97 120.27 40.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.985 -0.715 . . . . 0.0 109.734 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -122.07 59.33 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -0.964 . . . . 0.0 109.909 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.0 mt -91.68 148.82 21.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 p -111.06 142.28 43.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -39.61 -29.21 0.05 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.422 -0.799 . . . . 0.0 112.482 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.03 -52.89 62.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.341 -0.849 . . . . 0.0 108.852 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.78 -43.18 37.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.714 -0.616 . . . . 0.0 110.304 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.32 -34.9 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.549 -0.719 . . . . 0.0 110.405 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -64.17 -37.44 87.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.216 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.99 -46.67 88.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 110.086 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 125' ' ' LEU . 10.9 mp -62.72 -41.18 99.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.524 -0.735 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 26.4 mt -62.98 -17.13 61.72 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.826 -0.546 . . . . 0.0 111.569 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -56.57 -22.51 34.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.259 -0.9 . . . . 0.0 111.084 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.98 25.29 8.94 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 66.2 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.363 -1.081 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -102.38 102.94 13.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.448 0.642 . . . . 0.0 111.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.27 158.97 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -95.92 -177.54 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.355 -0.84 . . . . 0.0 111.333 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -71.22 -2.06 14.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.832 -0.543 . . . . 0.0 111.971 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.82 -10.52 16.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.994 -1.066 . . . . 0.0 110.241 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.98 32.37 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.57 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.6 mt-10 -111.13 139.2 46.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.913 . . . . 0.0 111.14 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.0 mp -128.42 142.22 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.92 113.88 6.73 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.731 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.491 ' O ' HD12 ' A' ' 143' ' ' ILE . 30.9 p90 -63.95 -36.16 83.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.617 -0.677 . . . . 0.0 111.887 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.5 mmtt -70.01 -37.02 75.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.27 -45.37 66.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.634 -0.667 . . . . 0.0 111.702 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.647 ' O ' HG23 ' A' ' 146' ' ' VAL . 24.7 t80 -71.3 -29.2 64.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.418 -0.801 . . . . 0.0 110.767 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 139' ' ' TYR . 96.8 mt -79.6 -47.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.484 -0.76 . . . . 0.0 109.611 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -60.31 -26.77 66.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.017 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.14 -12.28 44.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.414 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 142' ' ' PHE . 55.2 t -95.57 -38.91 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.735 HD21 ' CE2' ' A' ' 86' ' ' PHE . 72.1 mt . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.925 -0.484 . . . . 0.0 111.181 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.8 0.333 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -109.96 158.89 17.76 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.788 . . . . 0.0 111.021 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -49.96 -29.99 9.54 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.533 0.682 . . . . 0.0 110.286 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -46.57 -32.47 3.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.822 -0.549 . . . . 0.0 112.144 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -62.48 -43.79 97.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.378 -0.826 . . . . 0.0 110.543 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.543 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -77.45 -40.22 44.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.489 -0.757 . . . . 0.0 110.704 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.53 -57.46 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.411 -0.806 . . . . 0.0 111.077 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 92' ' ' VAL . 50.5 tttt -60.03 -34.35 73.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.815 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.586 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -60.42 -54.29 47.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.703 . . . . 0.0 111.645 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.427 ' CZ ' ' HG ' ' A' ' 106' ' ' LEU . 24.5 m-85 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.219 -0.926 . . . . 0.0 111.615 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -48.69 -39.68 25.41 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.369 -0.832 . . . . 0.0 112.814 -177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 88' ' ' LYS . 71.5 t -60.05 -38.07 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.876 -1.14 . . . . 0.0 109.754 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -67.48 -44.89 77.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -61.36 82.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.558 -0.714 . . . . 0.0 111.04 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.714 -0.616 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -94.05 18.18 11.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.179 -0.951 . . . . 0.0 110.507 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.1 m 38.7 63.0 0.95 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.3 p -90.83 -34.77 15.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.981 . . . . 0.0 109.122 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.49 62.25 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.307 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 2.6 mppt? -129.83 150.03 51.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.113 -1.227 . . . . 0.0 110.074 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.456 ' CG2' HD12 ' A' ' 106' ' ' LEU . 35.2 m -150.15 164.69 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -0.828 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 p -85.39 147.08 26.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.688 -0.633 . . . . 0.0 109.293 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 137' ' ' ILE . 35.5 m -62.43 -33.17 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.94 -42.25 99.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.9 -39.91 29.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.664 -0.903 . . . . 0.0 109.624 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 106' ' ' LEU . 9.9 tt -59.9 -49.19 78.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.827 -0.546 . . . . 0.0 109.527 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -63.9 -29.44 70.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.24 -48.41 67.85 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.391 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -40.03 95.77 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.682 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 115' ' ' GLU . 1.5 mp -55.95 -44.29 78.28 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.0 m -60.04 -31.08 69.63 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.577 0.703 . . . . 0.0 109.754 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.14 -14.79 63.72 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -96.53 7.27 46.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -1.124 . . . . 0.0 112.557 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 31.53 5.05 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.551 ' HG2' HD23 ' A' ' 110' ' ' LEU . 18.2 tp10 -113.52 120.17 40.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.877 -0.778 . . . . 0.0 109.952 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.5 60.3 1.01 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 0.0 109.879 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 85.7 mt -91.41 148.8 22.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -110.76 142.75 42.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 28.6 t0 -39.37 -29.27 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 O-C-N 121.376 -0.827 . . . . 0.0 112.571 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.87 -53.04 61.24 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -0.855 . . . . 0.0 108.808 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -76.75 -42.83 39.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.624 -0.673 . . . . 0.0 110.169 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 62.6 t -60.25 -35.82 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.568 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.63 -38.41 87.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.184 -0.947 . . . . 0.0 109.115 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.63 -45.36 92.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.591 -0.693 . . . . 0.0 109.527 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.33 -51.47 68.7 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.587 -0.696 . . . . 0.0 110.151 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.411 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 8.5 mt -59.99 -19.04 50.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.634 -0.667 . . . . 0.0 110.962 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -57.06 -24.0 50.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.501 -0.75 . . . . 0.0 110.93 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.27 25.41 8.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 62.0 t -106.74 120.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -1.113 . . . . 0.0 109.659 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.52 103.0 15.45 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.487 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.71 HG12 ' CG1' ' A' ' 137' ' ' ILE . 23.6 m -86.74 161.38 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -95.87 -171.98 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 110.946 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 p -72.08 -0.21 11.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.84 -0.537 . . . . 0.0 111.752 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.68 -11.09 15.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.944 -1.098 . . . . 0.0 110.257 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.89 24.55 52.49 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.777 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.4 mt-10 -110.96 141.62 44.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.392 -1.064 . . . . 0.0 110.966 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 1.062 HD13 HG13 ' A' ' 103' ' ' VAL . 3.4 mp -127.05 147.22 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.311 0.577 . . . . 0.0 109.657 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.23 116.29 9.5 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.227 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.48 ' CZ ' ' HG3' ' A' ' 140' ' ' LYS . 7.2 p90 -68.15 -34.14 75.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.653 -0.654 . . . . 0.0 111.983 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 13.8 mttt -69.97 -28.85 65.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.342 -0.849 . . . . 0.0 111.278 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -80.42 -43.22 21.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 112.254 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.6 t80 -70.9 -30.72 67.14 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.0 111.727 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 86' ' ' PHE . 18.2 pt -83.69 -44.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.114 -0.991 . . . . 0.0 110.579 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.424 ' N ' HG13 ' A' ' 143' ' ' ILE . 65.3 mt-10 -67.33 -26.53 66.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.72 -13.98 46.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.273 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 142' ' ' PHE . 70.4 t -95.31 -37.82 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.293 0.568 . . . . 0.0 110.933 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.824 0.345 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -109.21 160.71 15.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.81 0.814 . . . . 0.0 110.79 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 87' ' ' VAL . 16.2 m -51.32 -31.08 20.42 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.698 0.761 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -51.39 -37.43 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.854 -0.529 . . . . 0.0 111.152 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.473 ' OD1' HD21 ' A' ' 113' ' ' LEU . 13.4 t0 -64.64 -45.55 86.3 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.682 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.658 ' HE2' HD21 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -74.65 -38.39 62.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.729 -0.607 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.639 ' CG2' HG22 ' A' ' 83' ' ' THR . 64.8 t -66.56 -47.09 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.141 -0.974 . . . . 0.0 111.041 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 92' ' ' VAL . 24.1 tptt -60.06 -35.32 74.9 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.582 -0.699 . . . . 0.0 111.419 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.74 -52.8 62.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.456 -0.777 . . . . 0.0 111.816 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.48 -53.61 7.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 111.367 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.417 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 35.3 mt-30 -48.09 -36.19 12.7 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.291 -0.88 . . . . 0.0 112.854 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 88' ' ' LYS . 85.5 t -62.25 -35.74 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 109.981 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.05 -50.97 35.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.363 -0.835 . . . . 0.0 109.276 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 91' ' ' GLN . 2.6 p30 -77.67 82.39 4.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.214 -0.929 . . . . 0.0 109.663 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -61.16 -26.86 67.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.817 -0.552 . . . . 0.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.65 17.97 5.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.17 -0.956 . . . . 0.0 111.015 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.6 t 38.5 37.11 0.16 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.1 p -63.9 -34.91 79.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.082 -1.011 . . . . 0.0 109.24 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.85 59.59 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' C ' HG13 ' A' ' 101' ' ' VAL . 48.0 mttm -131.77 153.38 50.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.266 . . . . 0.0 110.176 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.619 ' CG2' HD12 ' A' ' 106' ' ' LEU . 34.0 m -150.37 161.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.381 -0.825 . . . . 0.0 110.28 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -83.08 145.85 29.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.502 -0.749 . . . . 0.0 109.923 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.1 p -57.26 -39.99 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.423 -0.798 . . . . 0.0 110.741 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.67 -41.47 97.44 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -80.08 -41.87 24.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.512 -0.993 . . . . 0.0 110.539 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.619 HD12 ' CG2' ' A' ' 101' ' ' VAL . 9.8 tt -60.06 -49.76 76.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.639 -0.663 . . . . 0.0 109.959 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -64.24 -31.65 72.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 110.265 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -67.45 -48.83 66.07 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -33.57 65.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.804 . . . . 0.0 110.583 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 27.7 tp -54.57 -44.32 72.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' GLU . 25.4 m -67.41 -15.87 63.92 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.061 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.98 -14.51 64.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.499 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -94.82 8.02 44.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -1.055 . . . . 0.0 112.583 -177.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 31.0 5.05 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 58.5 mm-40 -114.18 120.72 41.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.929 -0.748 . . . . 0.0 109.638 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -122.8 60.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.39 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 72.6 mt -89.95 148.26 23.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.3 m -110.6 141.66 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -0.903 . . . . 0.0 110.16 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 26.2 t0 -39.2 -30.83 0.06 Allowed 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.566 -0.709 . . . . 0.0 112.161 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.63 -51.75 67.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -77.28 -40.73 43.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.722 -0.611 . . . . 0.0 110.454 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 62.2 t -62.55 -35.36 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.607 -0.683 . . . . 0.0 110.466 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -64.21 -38.03 89.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -59.97 -46.86 88.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.619 -0.676 . . . . 0.0 109.521 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.3 -46.95 86.47 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.659 0.742 . . . . 0.0 109.944 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.97 -18.96 60.21 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.85 -0.531 . . . . 0.0 111.205 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.75 -21.32 27.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.218 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.43 -12.04 11.14 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.89 134.24 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.08 -1.247 . . . . 0.0 110.242 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -102.4 102.96 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.602 . . . . 0.0 111.804 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.427 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.4 p -85.69 157.31 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.05 -179.17 4.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.288 -0.883 . . . . 0.0 111.287 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -71.0 -2.61 15.95 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.874 -0.516 . . . . 0.0 111.854 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -107.33 -12.19 15.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.429 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.15 27.09 22.0 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' HD12 ' A' ' 137' ' ' ILE . 64.3 mt-10 -110.87 135.65 51.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.938 . . . . 0.0 111.068 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.556 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.2 mp -128.32 140.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -68.93 111.29 4.87 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.657 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 143' ' ' ILE . 18.6 p90 -64.48 -32.51 74.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.481 -0.762 . . . . 0.0 112.095 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.2 mtmp? -71.22 -35.93 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.258 -0.901 . . . . 0.0 111.067 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -70.41 -44.51 67.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.684 -0.635 . . . . 0.0 111.659 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 146' ' ' VAL . 29.2 t80 -70.02 -29.15 66.13 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.431 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 139' ' ' TYR . 32.4 pt -80.27 -43.68 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 110.197 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.461 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.7 mt-10 -62.59 -26.84 68.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.266 -0.896 . . . . 0.0 109.929 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.1 -12.31 44.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.355 -0.841 . . . . 0.0 110.276 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 142' ' ' PHE . 54.5 t -95.92 -39.94 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.658 HD21 ' HE2' ' A' ' 86' ' ' PHE . 52.7 mt . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.941 -0.474 . . . . 0.0 111.565 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -109.07 160.17 16.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.849 . . . . 0.0 111.001 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.88 HG22 ' CG2' ' A' ' 87' ' ' VAL . 23.8 m -51.15 -30.5 16.81 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.612 0.72 . . . . 0.0 109.54 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -52.3 -37.27 55.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.871 -0.518 . . . . 0.0 111.275 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -60.04 -51.05 71.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.56 -0.713 . . . . 0.0 109.865 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -75.62 -39.69 57.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 110.814 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.88 ' CG2' HG22 ' A' ' 83' ' ' THR . 99.8 t -61.25 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.26 -0.9 . . . . 0.0 110.282 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 92' ' ' VAL . 37.8 mmtt -60.07 -36.16 76.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.651 -0.656 . . . . 0.0 110.923 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.491 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -62.32 -49.04 77.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.708 -0.62 . . . . 0.0 111.565 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.703 ' CE2' HD12 ' A' ' 106' ' ' LEU . 19.0 m-85 -77.41 -56.07 4.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 111.751 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.539 ' OE1' HG12 ' A' ' 87' ' ' VAL . 66.5 mt-30 -48.16 -34.27 9.7 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 88' ' ' LYS . 81.8 t -61.84 -34.55 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.814 -1.178 . . . . 0.0 109.657 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -72.58 -52.1 16.95 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.66 81.77 8.72 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -60.39 -21.16 61.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.688 -0.632 . . . . 0.0 111.002 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.97 18.91 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.147 -0.971 . . . . 0.0 111.044 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.5 m 38.73 37.43 0.19 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.5 p -64.24 -35.6 81.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.0 12.52 60.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.442 ' C ' HG23 ' A' ' 101' ' ' VAL . 89.2 mttt -131.74 151.61 51.52 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.247 . . . . 0.0 110.155 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 100' ' ' LYS . 48.1 t -149.84 162.51 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.349 -0.844 . . . . 0.0 109.97 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 101' ' ' VAL . 8.9 p -84.95 148.16 26.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.517 -0.74 . . . . 0.0 109.991 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.775 ' CG2' HD13 ' A' ' 137' ' ' ILE . 98.1 t -56.23 -40.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.34 94.03 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -81.05 -42.75 20.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.238 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.703 HD12 ' CE2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -60.08 -49.92 75.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 110.222 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -67.04 -31.01 71.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.581 -0.699 . . . . 0.0 110.792 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.7 -47.81 65.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.67 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -40.61 92.33 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.508 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -45.07 77.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.474 -0.89 . . . . 0.0 108.675 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -59.94 -28.36 67.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.538 0.685 . . . . 0.0 109.9 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.59 63.38 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.77 6.9 47.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.295 -1.12 . . . . 0.0 112.76 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.11 31.46 5.03 Favored Glycine 0 N--CA 1.501 3.009 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -114.13 121.0 42.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.792 -0.828 . . . . 0.0 109.871 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -122.33 59.89 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.051 0.929 . . . . 0.0 109.598 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.13 148.92 22.04 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.0 p -110.77 142.21 43.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 0.0 110.024 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.41 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 35.8 t0 -39.87 -28.46 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 O-C-N 121.297 -0.877 . . . . 0.0 112.543 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.95 -52.59 63.43 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.7 -43.01 39.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 110.312 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 59.3 t -60.04 -35.53 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.497 -0.752 . . . . 0.0 110.562 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -63.21 -37.32 86.76 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.216 -0.927 . . . . 0.0 109.275 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.81 -46.03 90.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.559 -0.713 . . . . 0.0 109.578 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 129' ' ' VAL . 11.0 mp -61.19 -48.44 81.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.541 -0.724 . . . . 0.0 109.825 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.33 -21.34 66.58 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.859 -0.526 . . . . 0.0 111.05 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -57.19 -22.23 39.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.497 -0.752 . . . . 0.0 111.104 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.69 -14.32 8.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 125' ' ' LEU . 72.4 t -68.37 134.11 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.044 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.91 99.1 11.2 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 111.71 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 137' ' ' ILE . 7.4 p -82.33 156.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.51 -177.79 4.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -71.46 -0.92 11.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.773 -0.579 . . . . 0.0 111.954 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -107.5 -12.52 15.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.843 -1.161 . . . . 0.0 110.442 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.4 25.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 137' ' ' ILE . 46.2 mt-10 -111.91 136.14 51.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.962 . . . . 0.0 111.086 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.775 HD13 ' CG2' ' A' ' 103' ' ' VAL . 4.0 mp -126.98 141.38 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -69.41 106.67 3.03 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.433 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.487 ' O ' HD12 ' A' ' 143' ' ' ILE . 54.4 p90 -62.51 -35.8 80.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.301 -0.874 . . . . 0.0 112.128 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.459 ' CG ' ' CE1' ' A' ' 139' ' ' TYR . 19.4 mtpp -58.44 -56.57 20.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.278 -0.889 . . . . 0.0 111.052 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -59.91 -39.1 84.27 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.786 -0.572 . . . . 0.0 111.585 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 146' ' ' VAL . 18.4 t80 -70.05 -28.98 65.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 0.0 109.685 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 139' ' ' TYR . 69.3 mt -83.27 -50.03 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.713 . . . . 0.0 109.725 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.72 -27.01 67.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.466 -0.771 . . . . 0.0 110.11 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -87.85 -12.98 43.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.861 . . . . 0.0 110.466 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 142' ' ' PHE . 41.7 t -95.82 -39.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.318 0.58 . . . . 0.0 110.679 178.563 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.752 0.311 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -109.58 159.66 16.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 111.084 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.78 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.3 m -50.89 -30.43 14.59 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.695 0.76 . . . . 0.0 109.564 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.62 -37.01 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.842 -0.536 . . . . 0.0 111.279 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.98 -50.5 73.49 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.0 m-85 -76.48 -40.57 49.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.687 -0.633 . . . . 0.0 110.944 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.78 ' CG2' HG22 ' A' ' 83' ' ' THR . 71.8 t -60.34 -57.21 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.83 . . . . 0.0 110.958 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 91' ' ' GLN . 57.3 tptt -54.45 -32.55 57.83 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.451 -0.781 . . . . 0.0 111.022 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.575 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -65.17 -44.77 87.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.743 -0.598 . . . . 0.0 111.89 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 143' ' ' ILE . 14.3 m-85 -80.61 -56.88 3.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.916 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.427 ' CG ' ' HA ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -48.59 -36.56 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.3 p -60.01 -35.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.01 -1.056 . . . . 0.0 109.655 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -71.62 -47.41 54.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 80.6 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.444 -0.785 . . . . 0.0 110.593 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -60.52 -38.22 83.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.569 -0.707 . . . . 0.0 110.738 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.54 20.44 5.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t 37.98 36.85 0.12 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.1 p -64.17 -34.47 78.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.209 -0.932 . . . . 0.0 109.519 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.04 13.31 57.86 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' C ' HG23 ' A' ' 101' ' ' VAL . 48.8 mttm -132.47 151.89 51.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.095 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 100' ' ' LYS . 58.8 t -148.41 159.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.39 -0.818 . . . . 0.0 109.494 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -79.82 144.3 33.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.773 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.1 p -55.81 -38.76 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.417 -0.802 . . . . 0.0 110.542 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.446 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.98 -40.69 97.29 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -81.15 -40.0 24.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.885 . . . . 0.0 110.511 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 106' ' ' LEU . 9.7 tt -59.18 -49.82 76.41 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.63 -0.668 . . . . 0.0 110.173 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -67.03 -28.87 68.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.787 . . . . 0.0 111.075 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.18 -48.51 70.46 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.372 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -40.78 98.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.06 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.68 HD23 ' HG3' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.95 -44.64 78.61 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.7 m -60.06 -31.44 69.99 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.502 0.668 . . . . 0.0 109.619 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.79 64.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.575 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -96.15 7.85 45.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -1.136 . . . . 0.0 112.475 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 31.78 4.91 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.721 ' OE2' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -113.22 119.88 39.28 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.742 -0.858 . . . . 0.0 110.28 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.77 59.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.798 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.721 HD12 ' OE2' ' A' ' 115' ' ' GLU . 90.6 mt -90.02 148.72 22.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 m -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.04 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 11.6 t70 -40.06 -27.47 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 O-C-N 121.231 -0.918 . . . . 0.0 112.95 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.09 60.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.195 -0.941 . . . . 0.0 109.072 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.54 -41.95 44.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.485 HG12 HD12 ' A' ' 126' ' ' LEU . 62.6 t -59.97 -35.92 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 110.258 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.71 -37.11 86.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.085 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -63.71 -49.88 71.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.577 0.703 . . . . 0.0 109.978 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 122' ' ' VAL . 34.1 mt -61.87 -16.64 52.0 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.826 -0.547 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -56.8 -20.58 23.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.398 -0.814 . . . . 0.0 111.173 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 25.65 8.29 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 62.6 t -107.32 129.98 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.294 -1.121 . . . . 0.0 109.783 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 100.54 11.38 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.885 0.85 . . . . 0.0 112.418 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.3 p -83.47 158.88 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -95.62 -179.04 4.6 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.835 0.826 . . . . 0.0 111.423 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.4 m -70.97 -1.67 12.74 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.833 -0.542 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -107.66 -11.96 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.998 -1.064 . . . . 0.0 110.434 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.94 28.79 17.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.487 ' C ' HD12 ' A' ' 137' ' ' ILE . 67.8 mt-10 -111.15 135.58 51.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.931 . . . . 0.0 111.153 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.5 mp -125.35 168.55 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 137' ' ' ILE . 19.7 t0 -98.19 112.02 24.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.448 -0.782 . . . . 0.0 110.148 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.487 ' HA ' HD11 ' A' ' 106' ' ' LEU . 43.9 p90 -65.92 -34.22 77.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.471 -0.768 . . . . 0.0 112.171 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.456 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 mttt -70.04 -40.02 75.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.075 -1.016 . . . . 0.0 110.946 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.19 -43.82 81.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.629 -0.669 . . . . 0.0 111.391 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.5 t80 -71.66 -27.87 63.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.578 -0.701 . . . . 0.0 110.993 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.6 HD11 ' CE1' ' A' ' 90' ' ' PHE . 96.6 mt -83.93 -51.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.812 . . . . 0.0 110.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -61.93 -26.4 68.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 111.016 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.14 -16.44 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 142' ' ' PHE . 76.8 t -97.19 -42.88 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.14 -0.975 . . . . 0.0 109.187 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.465 HD11 ' HE2' ' A' ' 86' ' ' PHE . 4.0 mm? . . . . . 0 N--CA 1.498 1.933 0 O-C-N 121.703 -0.623 . . . . 0.0 111.721 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -108.56 154.48 21.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 110.94 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.641 HG22 ' CG1' ' A' ' 87' ' ' VAL . 5.3 m -50.75 -30.41 13.91 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 44.0 mt-10 -50.49 -35.87 31.15 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.687 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.89 -47.22 75.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.595 -0.691 . . . . 0.0 110.326 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 147' ' ' LEU . 21.3 m-85 -77.42 -39.95 45.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.656 -0.653 . . . . 0.0 112.692 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.641 ' CG1' HG22 ' A' ' 83' ' ' THR . 33.4 m -68.22 -41.87 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.826 -1.171 . . . . 0.0 110.801 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 92' ' ' VAL . 34.2 mttt -60.05 -33.7 72.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.487 -0.758 . . . . 0.0 110.187 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' A' ' 113' ' ' LEU . . . -58.75 -56.5 21.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.64 -0.663 . . . . 0.0 111.067 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' HD12 ' A' ' 106' ' ' LEU . 56.0 m-85 -77.34 -53.14 8.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 111.048 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -49.03 -42.71 39.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.497 -0.752 . . . . 0.0 112.436 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 88' ' ' LYS . 76.1 t -58.91 -39.26 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.861 -1.149 . . . . 0.0 109.611 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.03 -43.65 87.0 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.61 81.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -62.15 -37.38 84.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.606 -0.684 . . . . 0.0 110.868 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -89.94 17.06 7.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.9 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.3 t 37.69 37.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.6 p -63.78 -33.29 75.34 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.12 -0.988 . . . . 0.0 109.465 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.17 54.69 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.187 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' C ' HG13 ' A' ' 101' ' ' VAL . 81.3 mttt -132.19 153.41 50.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -1.191 . . . . 0.0 109.9 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.476 HG21 HD13 ' A' ' 106' ' ' LEU . 35.6 m -148.86 159.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.283 -0.886 . . . . 0.0 110.388 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.8 p -84.75 147.66 26.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.575 . . . . 0.0 110.222 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.639 ' CG2' HD13 ' A' ' 137' ' ' ILE . 86.4 t -57.36 -39.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.366 -0.834 . . . . 0.0 110.238 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.42 -41.61 95.34 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.31 -39.79 28.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.579 -0.954 . . . . 0.0 110.216 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.689 HD12 ' CE1' ' A' ' 90' ' ' PHE . 28.7 tp -60.04 -49.0 79.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.75 -0.594 . . . . 0.0 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -66.77 -29.83 69.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 111.036 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.76 -48.85 62.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.078 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -38.57 77.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.368 -0.832 . . . . 0.0 110.667 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.585 HD23 ' HG2' ' A' ' 115' ' ' GLU . 6.3 tp -55.09 -44.2 74.65 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -61.49 -25.21 67.11 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.511 0.672 . . . . 0.0 110.081 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.39 -14.52 63.72 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.724 ' CD2' ' HB2' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -94.55 7.88 44.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.317 -1.108 . . . . 0.0 112.214 -177.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.63 32.5 4.78 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.585 ' HG2' HD23 ' A' ' 110' ' ' LEU . 3.5 tp10 -113.98 119.94 38.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.99 -0.712 . . . . 0.0 110.342 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -122.32 59.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.0 109.579 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 90.3 mt -90.97 148.78 22.19 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 p -111.18 141.62 44.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -40.09 -27.79 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 O-C-N 121.311 -0.868 . . . . 0.0 112.84 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.468 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . . . -62.1 -52.56 63.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.294 -0.878 . . . . 0.0 109.16 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.468 ' OE1' ' HB3' ' A' ' 120' ' ' ALA . 1.3 mp0 -76.62 -42.92 40.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 58.5 t -59.99 -35.42 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.669 -0.644 . . . . 0.0 110.608 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.76 -38.09 89.81 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.294 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.01 -46.36 89.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.615 -0.678 . . . . 0.0 109.71 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -50.02 74.1 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.559 0.695 . . . . 0.0 109.884 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.41 -18.98 43.64 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.772 -0.58 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.05 -21.96 35.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.471 -0.768 . . . . 0.0 111.161 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.23 -12.91 10.36 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.3 t -68.98 130.02 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.098 -1.237 . . . . 0.0 110.169 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -99.15 103.64 15.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.437 0.637 . . . . 0.0 111.589 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -87.77 159.69 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.37 -177.05 4.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.8 p -69.58 -2.39 11.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.933 -0.479 . . . . 0.0 112.159 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -105.07 -6.26 20.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.948 -1.095 . . . . 0.0 110.225 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.83 23.23 60.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.451 ' C ' HD12 ' A' ' 137' ' ' ILE . 48.4 mt-10 -110.41 145.91 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 110.984 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.639 HD13 ' CG2' ' A' ' 103' ' ' VAL . 3.5 mp -131.55 170.09 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.6 t70 -95.24 116.91 29.38 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.62 ' O ' HD12 ' A' ' 143' ' ' ILE . 47.8 p90 -65.47 -39.83 92.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.56 -0.712 . . . . 0.0 111.751 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.2 mttt -64.56 -40.03 94.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.529 -0.732 . . . . 0.0 110.469 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -68.17 -43.94 77.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.779 -0.575 . . . . 0.0 111.225 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.607 ' O ' HG23 ' A' ' 146' ' ' VAL . 16.9 t80 -69.89 -28.67 65.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.523 -0.736 . . . . 0.0 110.357 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 139' ' ' TYR . 42.8 mt -76.15 -46.89 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.521 -0.737 . . . . 0.0 109.133 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.6 -28.78 69.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.41 -0.806 . . . . 0.0 110.496 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -88.37 -12.0 44.59 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.861 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 142' ' ' PHE . 53.0 t -95.12 -38.15 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 143' ' ' ILE . 5.1 mp . . . . . 0 N--CA 1.497 1.877 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.167 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.919 0.39 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -108.81 161.62 14.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 110.895 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 87' ' ' VAL . 4.0 m -50.91 -31.35 17.31 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -50.97 -35.94 36.35 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.854 -0.529 . . . . 0.0 111.079 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.653 ' OD1' HD11 ' A' ' 113' ' ' LEU . 44.8 t0 -59.96 -50.61 73.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.62 -0.675 . . . . 0.0 109.834 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.651 ' CE1' HD23 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -76.53 -40.08 51.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.708 -0.62 . . . . 0.0 110.79 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 83' ' ' THR . 97.7 t -59.09 -53.3 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.272 -0.893 . . . . 0.0 110.344 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 92' ' ' VAL . 29.0 tttt -59.99 -34.24 73.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.681 -0.637 . . . . 0.0 110.402 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.94 -54.27 48.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 111.026 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE1' HD11 ' A' ' 143' ' ' ILE . 47.7 m-85 -77.63 -54.43 6.4 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.371 -0.83 . . . . 0.0 111.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -48.91 -39.56 26.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.503 -0.748 . . . . 0.0 112.922 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 88' ' ' LYS . 73.8 t -59.2 -37.69 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.852 -1.155 . . . . 0.0 109.652 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -69.44 -46.46 66.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -64.34 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.0 110.641 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -60.01 -39.34 85.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.5 -0.75 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -91.61 20.7 5.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.314 -0.866 . . . . 0.0 110.899 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 p 38.36 37.95 0.2 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 p -64.06 -34.72 78.67 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.254 -0.979 . . . . 0.0 109.384 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 14.48 55.24 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 59.4 mttt -132.93 154.88 50.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.054 -1.263 . . . . 0.0 110.528 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.454 HG13 ' C ' ' A' ' 100' ' ' LYS . 34.0 m -150.08 159.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.402 -0.811 . . . . 0.0 109.783 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -81.98 144.57 30.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.0 110.007 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.4 p -56.75 -38.9 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.538 -0.726 . . . . 0.0 110.772 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.44 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.82 -41.32 97.6 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.53 -39.1 28.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.547 -0.972 . . . . 0.0 110.527 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.451 HD12 ' CG2' ' A' ' 101' ' ' VAL . 7.5 tt -60.08 -49.95 75.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 110.108 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -63.44 -29.61 70.87 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.517 -0.74 . . . . 0.0 110.313 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.32 -47.48 67.44 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -39.71 87.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.39 -0.819 . . . . 0.0 110.574 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.665 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -54.84 -44.82 74.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 m -60.83 -26.54 67.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.49 0.662 . . . . 0.0 109.966 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.06 -15.21 63.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.653 HD11 ' OD1' ' A' ' 85' ' ' ASP . 21.7 tp -95.65 8.08 44.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 112.399 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.91 33.48 4.34 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.665 ' HG2' HD23 ' A' ' 110' ' ' LEU . 4.6 tp10 -114.25 119.81 38.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.02 -0.694 . . . . 0.0 110.174 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -122.1 59.43 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.074 0.94 . . . . 0.0 109.612 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.53 HD11 ' OE2' ' A' ' 115' ' ' GLU . 61.5 mt -90.53 148.76 22.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 p -110.83 141.59 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -39.69 -28.89 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.35 -0.844 . . . . 0.0 112.62 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.73 -51.79 66.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -76.78 -43.12 38.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.581 -0.7 . . . . 0.0 110.549 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.0 t -59.97 -34.9 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 110.592 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -64.98 -36.82 85.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.138 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.76 -47.33 86.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.478 ' HA ' HD13 ' A' ' 125' ' ' LEU . 4.3 mm? -62.15 -46.63 88.15 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.69 0.757 . . . . 0.0 109.879 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.2 -19.52 63.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.907 -0.496 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -56.74 -21.03 25.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 0.0 111.191 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.34 -11.95 11.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.36 130.48 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.091 -1.241 . . . . 0.0 110.211 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -101.82 104.17 14.92 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.409 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.541 HG12 ' CG1' ' A' ' 137' ' ' ILE . 19.9 m -87.96 161.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.22 -176.2 3.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.59 -0.92 9.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.834 -0.541 . . . . 0.0 111.901 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -107.73 -10.06 15.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.923 -1.111 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.29 25.89 38.34 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.612 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.1 mt-10 -109.72 139.98 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.573 -0.957 . . . . 0.0 110.973 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.0 mp -130.64 140.98 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -68.88 110.77 4.55 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.813 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 43.8 p90 -62.76 -34.02 76.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.491 -0.755 . . . . 0.0 112.004 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.7 mtmt -69.31 -38.67 78.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.272 -0.893 . . . . 0.0 110.581 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.33 -45.01 70.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.744 -0.597 . . . . 0.0 111.587 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.613 ' O ' HG23 ' A' ' 146' ' ' VAL . 22.0 t80 -70.56 -28.8 65.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.449 -0.782 . . . . 0.0 110.645 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.548 HD13 ' CD1' ' A' ' 86' ' ' PHE . 85.5 mt -79.28 -47.95 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.509 -0.744 . . . . 0.0 109.646 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -60.41 -26.5 66.74 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.499 -0.75 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.0 -13.29 39.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.373 -0.829 . . . . 0.0 110.656 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 142' ' ' PHE . 59.0 t -96.23 -43.22 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 143' ' ' ILE . 70.2 mt . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.795 -0.565 . . . . 0.0 111.546 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -110.03 160.02 16.8 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.878 0.847 . . . . 0.0 111.188 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.711 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.4 m -50.58 -30.95 14.44 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.706 0.765 . . . . 0.0 109.738 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -51.1 -36.45 40.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.752 -0.592 . . . . 0.0 111.322 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.44 -44.97 85.63 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.603 -0.686 . . . . 0.0 109.711 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.672 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -76.63 -41.12 47.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.734 -0.604 . . . . 0.0 111.131 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.711 ' CG2' HG22 ' A' ' 83' ' ' THR . 67.5 t -63.7 -52.83 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 111.011 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.674 ' O ' HG13 ' A' ' 92' ' ' VAL . 61.3 tttt -55.73 -32.21 63.18 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.538 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HB3' HD11 ' A' ' 113' ' ' LEU . . . -68.22 -39.94 82.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.581 -0.699 . . . . 0.0 112.344 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 143' ' ' ILE . 26.6 m-85 -80.11 -58.0 3.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.043 -1.036 . . . . 0.0 110.959 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.613 ' OE1' HG12 ' A' ' 87' ' ' VAL . 20.0 pt20 -48.52 -32.76 8.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 88' ' ' LYS . 29.0 m -61.55 -31.38 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.804 -1.185 . . . . 0.0 109.716 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.35 -49.0 29.68 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 80.15 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -62.29 -34.5 76.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.518 -0.739 . . . . 0.0 110.647 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.37 18.51 8.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.233 -0.917 . . . . 0.0 110.657 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.1 m 37.83 35.27 0.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.3 p -63.95 -33.74 76.4 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.198 -0.939 . . . . 0.0 109.316 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 12.08 58.99 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' C ' HG13 ' A' ' 101' ' ' VAL . 21.6 mmtt -131.72 153.65 49.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -1.182 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.522 ' CG2' HD12 ' A' ' 106' ' ' LEU . 31.9 m -149.98 159.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.308 -0.87 . . . . 0.0 110.018 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 144.85 31.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.7 p -56.09 -38.96 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.455 -0.778 . . . . 0.0 110.699 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.99 -40.68 97.29 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.29 -42.25 23.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.545 -0.974 . . . . 0.0 110.574 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.522 HD12 ' CG2' ' A' ' 101' ' ' VAL . 9.8 tt -60.04 -49.91 75.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 109.979 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -64.45 -33.06 75.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.537 -0.727 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -66.24 -48.03 71.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -25.74 59.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.489 -0.757 . . . . 0.0 110.68 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 29.8 tp -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.8 p -66.14 -16.73 64.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.301 0.572 . . . . 0.0 110.695 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.42 65.51 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.57 7.45 45.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.416 -1.05 . . . . 0.0 112.102 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.59 32.99 4.61 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 12.4 mm-40 -114.73 120.98 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.897 -0.766 . . . . 0.0 110.851 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -122.19 59.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.088 0.947 . . . . 0.0 109.297 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.73 149.08 21.79 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -110.87 142.84 42.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -39.83 -27.8 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.814 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.72 62.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.228 -0.92 . . . . 0.0 108.932 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.7 -43.3 38.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.588 -0.695 . . . . 0.0 110.425 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.99 -35.64 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.05 -39.1 93.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.24 -0.912 . . . . 0.0 109.171 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.437 -0.789 . . . . 0.0 109.641 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.32 -48.4 81.89 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.984 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 35.1 mt -60.62 -18.14 51.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.799 -0.563 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.56 -21.47 26.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.23 25.77 8.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 65.8 t -107.67 129.84 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -1.103 . . . . 0.0 109.855 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -102.59 103.03 13.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.751 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.64 HG12 ' CG1' ' A' ' 137' ' ' ILE . 20.1 m -86.05 161.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -95.28 -177.08 3.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 111.281 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.7 p -70.23 -0.8 8.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.907 -0.496 . . . . 0.0 112.01 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -107.5 -9.08 16.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.94 -1.1 . . . . 0.0 110.365 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.59 28.41 29.72 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.617 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.9 mt-10 -110.48 139.27 45.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.955 . . . . 0.0 110.969 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.64 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.6 mp -127.63 143.37 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.3 115.23 8.33 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.037 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.488 ' O ' HD12 ' A' ' 143' ' ' ILE . 10.7 p90 -67.2 -35.26 79.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.723 -0.611 . . . . 0.0 111.769 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 25.3 mttt -70.98 -39.98 72.17 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.352 -0.842 . . . . 0.0 111.032 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.15 -44.57 83.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 111.705 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 146' ' ' VAL . 23.1 t80 -70.02 -28.0 65.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.491 -0.756 . . . . 0.0 110.42 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 139' ' ' TYR . 96.3 mt -79.57 -48.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.382 -0.824 . . . . 0.0 110.133 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -59.99 -27.74 67.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.486 -0.759 . . . . 0.0 110.278 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.4 -16.1 31.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 110.64 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 142' ' ' PHE . 54.1 t -97.52 -48.07 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.128 -0.983 . . . . 0.0 108.87 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.7 -0.625 . . . . 0.0 111.222 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.47 160.28 15.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.87 . . . . 0.0 110.973 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.742 HG22 ' CG2' ' A' ' 87' ' ' VAL . 7.4 m -51.18 -30.58 17.34 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.702 0.763 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -52.46 -37.07 56.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.841 -0.537 . . . . 0.0 111.28 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -61.05 -50.06 74.85 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.573 -0.704 . . . . 0.0 109.919 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.663 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.5 m-85 -75.97 -38.87 57.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.771 -0.581 . . . . 0.0 111.264 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.742 ' CG2' HG22 ' A' ' 83' ' ' THR . 76.4 t -64.17 -50.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.213 -0.929 . . . . 0.0 110.678 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -59.95 -34.17 72.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.547 -0.721 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.592 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -67.39 -44.28 79.25 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.664 -0.648 . . . . 0.0 111.736 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.524 ' CE2' HD11 ' A' ' 143' ' ' ILE . 8.9 m-85 -78.49 -58.91 3.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.093 -1.005 . . . . 0.0 111.654 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -48.35 -28.97 3.5 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -62.13 -32.68 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.999 -1.063 . . . . 0.0 109.848 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -71.53 -50.87 27.07 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.33 81.35 6.66 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.377 -0.827 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -63.1 -17.16 62.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.83 16.11 7.36 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.05 -1.031 . . . . 0.0 110.945 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.4 p 39.1 35.84 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 100' ' ' LYS . 3.4 t -63.11 -33.99 76.65 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.097 -1.002 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.52 9.66 58.72 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.014 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.637 ' H ' HG23 ' A' ' 98' ' ' THR . 1.5 mptt -132.16 154.94 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.239 . . . . 0.0 110.382 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 106' ' ' LEU . 28.8 m -151.04 160.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.371 -0.831 . . . . 0.0 109.914 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -82.04 144.86 30.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.574 -0.704 . . . . 0.0 109.956 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 11.5 p -57.07 -40.0 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.493 -0.755 . . . . 0.0 110.836 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.33 -41.4 96.89 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.14 -39.84 28.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.579 -0.954 . . . . 0.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 101' ' ' VAL . 5.8 tt -59.94 -49.73 76.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.67 -0.644 . . . . 0.0 110.102 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -64.46 -30.26 71.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.697 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -67.89 -48.01 67.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.591 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -41.0 97.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.11 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.623 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.5 tp -55.78 -44.77 78.04 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.9 m -60.12 -30.61 69.39 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.616 0.722 . . . . 0.0 109.704 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.52 -14.65 63.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.663 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.42 7.09 47.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 112.762 -177.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.79 4.94 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.623 ' HG2' HD23 ' A' ' 110' ' ' LEU . 12.0 tp10 -113.75 119.97 39.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.925 -0.75 . . . . 0.0 109.992 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -121.96 59.22 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.002 0.906 . . . . 0.0 109.598 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 75.5 mt -90.85 148.58 22.4 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -111.17 141.36 44.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -39.9 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 O-C-N 121.353 -0.842 . . . . 0.0 112.726 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.0 61.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.434 -0.791 . . . . 0.0 109.0 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -76.71 -42.94 39.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.692 -0.63 . . . . 0.0 110.384 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 126' ' ' LEU . 57.5 t -60.02 -35.25 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.587 -0.695 . . . . 0.0 110.466 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.01 -39.44 94.78 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.255 -0.903 . . . . 0.0 109.004 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.09 -49.38 77.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.624 -0.673 . . . . 0.0 109.537 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.19 -49.97 75.51 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.571 0.7 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.745 ' O ' HG12 ' A' ' 129' ' ' VAL . 63.2 mt -61.96 -17.22 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.915 -0.491 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -57.47 -16.77 10.48 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.306 -0.871 . . . . 0.0 111.895 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.12 -11.06 11.22 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.051 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 126' ' ' LEU . 8.8 p -69.51 133.95 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.94 -1.329 . . . . 0.0 110.854 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -103.3 102.48 12.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.393 0.616 . . . . 0.0 111.093 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.691 HG12 ' CG1' ' A' ' 137' ' ' ILE . 21.5 m -86.38 160.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -94.91 -176.39 3.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.473 -0.767 . . . . 0.0 111.114 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -69.95 -0.99 8.37 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.866 -0.521 . . . . 0.0 112.055 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -107.28 -7.74 16.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.949 -1.095 . . . . 0.0 110.438 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.08 27.2 38.02 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.649 ' C ' HD12 ' A' ' 137' ' ' ILE . 88.4 mt-10 -108.62 140.07 42.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.598 -0.942 . . . . 0.0 111.125 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.691 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.4 mp -128.42 169.02 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 137' ' ' ILE . 47.0 t0 -96.98 114.05 25.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.368 -0.833 . . . . 0.0 110.134 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.488 ' HA ' HD11 ' A' ' 106' ' ' LEU . 47.6 p90 -66.12 -35.42 80.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.558 -0.714 . . . . 0.0 111.643 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.3 mttt -69.22 -37.05 77.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.308 -0.87 . . . . 0.0 110.661 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -70.06 -44.12 69.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.602 -0.687 . . . . 0.0 111.62 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 146' ' ' VAL . 25.3 t80 -70.36 -28.59 65.24 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.512 -0.743 . . . . 0.0 110.61 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.524 HD11 ' CE2' ' A' ' 90' ' ' PHE . 97.6 mt -76.46 -45.78 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.508 -0.745 . . . . 0.0 109.518 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.72 -26.74 65.88 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.262 -0.899 . . . . 0.0 109.738 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -88.97 -11.64 43.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 110.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 142' ' ' PHE . 62.3 t -96.01 -42.08 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 143' ' ' ILE . 15.2 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.895 -0.503 . . . . 0.0 111.395 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 164.06 13.55 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.104 0.954 . . . . 0.0 111.225 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.724 HG22 ' CG2' ' A' ' 87' ' ' VAL . 3.5 m -50.23 -30.37 11.5 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.396 0.617 . . . . 0.0 110.215 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -53.17 -36.86 61.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.719 -0.613 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.49 -50.88 71.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.53 -0.731 . . . . 0.0 109.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.805 ' CD2' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -76.44 -39.62 52.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 0.0 111.086 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.724 ' CG2' HG22 ' A' ' 83' ' ' THR . 97.5 t -59.98 -47.82 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.166 -0.959 . . . . 0.0 109.901 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 92' ' ' VAL . 16.1 tttp -59.42 -31.95 69.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.713 -0.617 . . . . 0.0 110.368 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' CB ' HD13 ' A' ' 113' ' ' LEU . . . -61.93 -59.33 5.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.732 . . . . 0.0 112.016 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -77.12 -54.3 6.7 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.0 112.342 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.461 ' NE2' HG13 ' A' ' 87' ' ' VAL . 35.9 mt-30 -47.97 -37.87 15.56 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.365 -0.834 . . . . 0.0 113.163 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 88' ' ' LYS . 27.7 m -60.1 -31.35 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.71 -1.244 . . . . 0.0 109.752 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -70.0 -45.46 67.22 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -63.25 81.27 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.458 -0.777 . . . . 0.0 110.892 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -62.81 -40.06 96.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.672 -0.643 . . . . 0.0 110.94 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -91.0 17.0 8.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -0.902 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.6 m 38.05 35.58 0.09 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.8 p -63.73 -33.99 76.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.13 -0.981 . . . . 0.0 109.428 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.78 9.97 53.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.951 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 23.4 mttp -132.86 154.98 49.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.068 -1.254 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.563 ' CG2' HD12 ' A' ' 106' ' ' LEU . 35.1 m -150.16 160.08 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.028 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 p -82.72 145.64 29.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.515 -0.741 . . . . 0.0 110.077 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.6 p -56.95 -39.66 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.475 -0.766 . . . . 0.0 110.649 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.41 -41.11 96.87 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -80.41 -43.3 21.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.534 -0.98 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.563 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.1 tt -59.97 -50.02 75.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.641 -0.662 . . . . 0.0 109.951 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -63.57 -31.88 73.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -66.06 -47.87 72.9 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.088 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.19 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.904 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 ' HG2' ' A' ' 115' ' ' GLU . 9.9 tp -56.2 -44.68 79.71 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.9 m -60.83 -31.39 70.82 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.577 0.704 . . . . 0.0 109.529 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.15 -13.87 67.86 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 86' ' ' PHE . 29.1 tp -95.09 8.44 42.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -1.086 . . . . 0.0 112.123 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.6 4.15 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.547 ' OE2' HD11 ' A' ' 117' ' ' LEU . 17.8 tp10 -114.91 120.4 39.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.952 -0.734 . . . . 0.0 110.769 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -122.27 59.67 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.063 0.935 . . . . 0.0 109.208 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.547 HD11 ' OE2' ' A' ' 115' ' ' GLU . 88.2 mt -92.0 149.74 21.37 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.3 m -110.86 144.14 40.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -40.11 -27.3 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.195 -0.941 . . . . 0.0 112.973 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.61 -52.1 64.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.33 -0.856 . . . . 0.0 109.279 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.35 -46.06 29.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 0.0 110.984 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 48.1 t -58.15 -33.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.352 -0.843 . . . . 0.0 110.513 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.85 -36.85 85.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -0.928 . . . . 0.0 109.001 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.75 -48.02 81.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 125' ' ' LEU . 11.0 mp -63.39 -28.36 69.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.544 -0.722 . . . . 0.0 110.884 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.1 mt -79.67 -15.78 56.95 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.653 . . . . 0.0 112.12 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -18.74 20.94 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.259 -0.9 . . . . 0.0 111.654 -177.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.55 -11.63 11.43 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.665 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.92 129.51 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.083 -1.245 . . . . 0.0 109.936 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -106.03 105.7 15.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.346 0.593 . . . . 0.0 111.623 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.697 HG12 ' CG1' ' A' ' 137' ' ' ILE . 19.7 m -88.86 161.52 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -93.12 -171.89 2.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.29 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -0.96 15.02 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -108.57 -11.14 15.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 110.453 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.19 28.42 28.08 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.61 ' C ' HD12 ' A' ' 137' ' ' ILE . 48.8 mt-10 -109.08 138.04 46.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.909 . . . . 0.0 110.999 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.697 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.9 mp -129.25 140.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -69.54 108.61 3.88 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.816 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE1' ' HG3' ' A' ' 140' ' ' LYS . 50.7 p90 -60.57 -29.47 69.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.432 -0.793 . . . . 0.0 111.871 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 139' ' ' TYR . 61.2 mttt -69.01 -39.99 78.95 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.222 -0.924 . . . . 0.0 110.598 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.87 -43.87 82.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.801 -0.562 . . . . 0.0 111.502 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.6 t80 -70.46 -27.72 64.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 110.256 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.805 HD12 ' CD2' ' A' ' 86' ' ' PHE . 23.5 mm -80.29 -50.38 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.59 -28.72 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.69 -13.72 39.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.207 -0.933 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 142' ' ' PHE . 43.1 t -95.97 -38.21 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 143' ' ' ILE . 3.3 mt . . . . . 0 N--CA 1.496 1.852 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.468 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.745 0.307 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -113.25 163.17 15.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 111.007 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.8 m -51.2 -31.29 19.85 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.485 0.66 . . . . 0.0 110.211 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -53.55 -38.68 64.08 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.648 -0.658 . . . . 0.0 111.111 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.52 -45.07 84.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.68 . . . . 0.0 109.571 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.582 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.63 -36.6 62.91 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.819 -0.551 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 83' ' ' THR . 84.1 t -70.9 -43.14 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 110.64 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.68 -35.84 73.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.455 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.446 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -64.92 -49.75 69.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 111.989 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -79.19 -57.73 3.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.049 . . . . 0.0 111.681 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -48.9 -37.26 19.26 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.464 -0.773 . . . . 0.0 112.826 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -58.05 -37.73 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.156 -0.965 . . . . 0.0 109.988 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' N ' HG13 ' A' ' 92' ' ' VAL . 59.4 t80 -66.1 -42.03 89.81 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.481 -0.762 . . . . 0.0 111.069 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -65.75 -24.99 67.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.563 -0.711 . . . . 0.0 110.479 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -106.15 15.69 25.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.661 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.7 t 38.2 63.06 0.88 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -91.65 -33.66 14.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.76 10.9 58.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.88 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' C ' HG13 ' A' ' 101' ' ' VAL . 43.2 mttp -132.27 154.49 49.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.13 -1.218 . . . . 0.0 110.071 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 106' ' ' LEU . 30.9 m -150.36 160.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 p -82.35 145.95 29.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.652 -0.655 . . . . 0.0 109.974 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.1 p -56.43 -39.67 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.461 -0.775 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.463 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.9 -40.8 97.32 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.0 -40.31 28.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.978 . . . . 0.0 110.392 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 101' ' ' VAL . 13.1 tp -59.95 -49.79 76.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 109.934 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -63.87 -32.28 73.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 110.375 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -67.77 -47.51 68.97 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.192 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -30.55 63.07 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.825 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 tp -60.06 -42.04 93.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.862 . . . . 0.0 109.068 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.7 p -68.03 -18.81 64.8 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.49 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.46 -14.72 63.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -93.1 7.15 45.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.381 -1.07 . . . . 0.0 112.362 -177.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.82 4.51 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.92 120.68 40.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 122.03 -0.688 . . . . 0.0 110.131 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.1 59.64 1.0 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.137 0.97 . . . . 0.0 109.815 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 79.9 mt -91.05 148.91 22.06 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.4 m -110.87 142.55 42.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.908 . . . . 0.0 110.086 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 32.7 t0 -39.4 -29.73 0.05 Allowed 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.402 -0.811 . . . . 0.0 112.406 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.6 62.53 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -76.67 -41.93 43.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.63 -0.669 . . . . 0.0 110.227 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 82.7 t -60.06 -34.44 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.599 -0.688 . . . . 0.0 110.312 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.31 -36.62 84.61 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.221 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.76 -48.85 77.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.462 -0.774 . . . . 0.0 109.37 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 125' ' ' LEU . 3.5 mm? -61.22 -47.14 87.45 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.615 0.721 . . . . 0.0 109.905 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.9 ' O ' HG12 ' A' ' 129' ' ' VAL . 33.0 mt -60.33 -17.28 41.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.842 -0.536 . . . . 0.0 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -56.39 -20.36 19.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.243 -0.911 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.73 27.92 7.31 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.6 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 126' ' ' LEU . 10.9 p -107.23 128.72 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.132 -1.216 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -103.52 105.29 15.5 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.332 0.587 . . . . 0.0 111.575 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.683 HG12 ' CG1' ' A' ' 137' ' ' ILE . 21.2 m -89.43 161.26 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -92.26 -176.51 4.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.419 -0.801 . . . . 0.0 111.064 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 m -69.7 -1.61 9.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.798 -0.564 . . . . 0.0 111.973 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -107.71 -8.4 16.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.936 -1.102 . . . . 0.0 110.655 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.83 38.41 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 137' ' ' ILE . 66.0 mt-10 -109.06 139.84 43.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.964 . . . . 0.0 110.906 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.683 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.9 mp -130.03 168.81 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.47 ' N ' HG22 ' A' ' 137' ' ' ILE . 42.0 t0 -96.54 112.84 24.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.413 -0.805 . . . . 0.0 109.719 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 143' ' ' ILE . 42.8 p90 -62.78 -22.32 66.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 111.857 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 46.6 mtpt -83.18 -32.85 26.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.142 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.21 -46.85 66.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.662 -0.649 . . . . 0.0 111.604 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.623 ' O ' HG23 ' A' ' 146' ' ' VAL . 38.4 t80 -70.02 -28.6 65.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.542 -0.724 . . . . 0.0 111.572 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 139' ' ' TYR . 36.3 pt -79.13 -42.67 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.463 ' N ' HG13 ' A' ' 143' ' ' ILE . 63.9 mt-10 -65.09 -26.46 68.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.209 -0.932 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -88.1 -12.46 44.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.0 110.646 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 142' ' ' PHE . 88.2 t -96.11 -41.1 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.881 -0.512 . . . . 0.0 111.543 179.191 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.842 0.353 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -107.75 160.2 15.91 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.878 0.847 . . . . 0.0 110.992 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.731 ' O ' HG23 ' A' ' 87' ' ' VAL . 4.4 m -50.83 -30.6 14.75 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.666 0.746 . . . . 0.0 109.522 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -52.28 -37.49 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.839 -0.538 . . . . 0.0 111.209 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -61.26 -49.29 77.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -76.02 -39.97 54.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.765 -0.584 . . . . 0.0 111.047 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 83' ' ' THR . 76.3 t -60.5 -51.29 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -58.49 -32.7 69.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.642 -0.661 . . . . 0.0 110.547 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.657 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -63.48 -55.35 24.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.788 -0.57 . . . . 0.0 111.725 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.505 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 47.6 m-85 -78.74 -56.76 4.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.098 -1.001 . . . . 0.0 111.737 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.67 -37.84 19.57 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.561 -0.712 . . . . 0.0 112.819 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -57.86 -36.84 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.066 -1.021 . . . . 0.0 109.924 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.4 ' N ' HG13 ' A' ' 92' ' ' VAL . 53.5 t80 -67.67 -43.41 80.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.5 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.483 -0.76 . . . . 0.0 110.761 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -61.17 -39.78 91.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 0.0 110.621 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.41 20.1 6.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.257 -0.902 . . . . 0.0 110.829 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t 38.15 36.51 0.12 Allowed 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 42.1 p -63.83 -34.66 78.43 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 12.53 58.04 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.456 ' C ' HG13 ' A' ' 101' ' ' VAL . 84.1 mttt -132.42 154.68 49.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.036 -1.273 . . . . 0.0 110.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 106' ' ' LEU . 26.8 m -151.07 160.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.365 -0.835 . . . . 0.0 109.896 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.1 p -80.5 144.06 32.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.567 ' HB ' HD13 ' A' ' 137' ' ' ILE . 10.2 p -57.21 -40.07 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 0.0 110.883 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.21 -41.25 96.63 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -80.45 -39.24 28.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.984 . . . . 0.0 110.4 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.562 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.2 tt -60.05 -49.97 75.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.715 -0.616 . . . . 0.0 110.121 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -63.21 -28.95 70.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.51 -47.84 68.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.366 -0.833 . . . . 0.0 110.619 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -40.75 96.12 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 143' ' ' ILE . 3.4 tp -55.85 -44.59 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -60.35 -30.1 69.33 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.557 0.694 . . . . 0.0 109.65 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.13 -14.21 64.79 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.657 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -95.12 7.38 46.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.299 -1.118 . . . . 0.0 112.552 -177.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.58 31.89 5.03 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.62 ' OE2' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -113.82 120.32 40.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.988 -0.713 . . . . 0.0 110.249 178.465 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -122.45 59.74 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.042 0.925 . . . . 0.0 109.498 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.541 HD12 ' CD ' ' A' ' 115' ' ' GLU . 89.9 mt -90.92 148.65 22.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.4 m -111.09 141.84 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.331 -0.855 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -39.87 -28.29 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.283 -0.886 . . . . 0.0 112.685 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.43 -52.84 62.91 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.37 -0.831 . . . . 0.0 109.059 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -77.01 -42.2 39.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.628 -0.67 . . . . 0.0 110.431 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.34 -36.36 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.602 -0.686 . . . . 0.0 110.295 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -63.19 -39.92 96.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.06 -47.51 85.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.63 -0.669 . . . . 0.0 109.839 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.94 -40.03 96.4 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.614 0.721 . . . . 0.0 110.669 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.698 ' O ' HG12 ' A' ' 129' ' ' VAL . 68.7 mt -67.84 -15.97 63.87 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.779 -0.575 . . . . 0.0 111.856 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -57.55 -17.02 11.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.197 -0.939 . . . . 0.0 111.877 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.65 -10.93 12.07 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.221 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 126' ' ' LEU . 8.7 p -70.65 132.36 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.953 -1.321 . . . . 0.0 110.522 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.48 100.06 10.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.367 0.603 . . . . 0.0 111.363 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.423 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.8 p -83.82 159.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -95.88 -179.51 4.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.415 -0.803 . . . . 0.0 111.502 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.2 m -70.41 -1.49 10.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.849 -0.532 . . . . 0.0 112.13 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -107.83 -11.49 15.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.863 -1.148 . . . . 0.0 110.411 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.02 29.05 16.17 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.437 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.7 mt-10 -110.43 135.7 50.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.649 -0.912 . . . . 0.0 111.328 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.567 HD13 ' HB ' ' A' ' 103' ' ' VAL . 4.0 mp -126.35 169.0 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.456 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.7 t70 -97.83 114.75 26.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.44 -0.787 . . . . 0.0 110.468 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.56 ' HB3' HG21 ' A' ' 101' ' ' VAL . 46.6 p90 -68.32 -36.22 78.96 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.511 -0.743 . . . . 0.0 111.676 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.5 mttt -68.51 -40.0 81.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.294 -0.879 . . . . 0.0 110.798 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -67.3 -43.26 82.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.694 -0.629 . . . . 0.0 111.299 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.605 ' O ' HG23 ' A' ' 146' ' ' VAL . 20.2 t80 -70.74 -27.76 64.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.494 -0.753 . . . . 0.0 110.46 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.698 HD11 HD11 ' A' ' 110' ' ' LEU . 20.3 mm -78.5 -49.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.477 -0.764 . . . . 0.0 109.585 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -60.04 -27.51 66.99 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 0.0 110.384 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.06 -12.3 44.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 110.502 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 142' ' ' PHE . 56.1 t -96.24 -39.14 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.544 HD12 HG22 ' A' ' 143' ' ' ILE . 13.4 mt . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.912 -0.492 . . . . 0.0 111.204 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.51 159.55 16.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.813 0.816 . . . . 0.0 111.009 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 87' ' ' VAL . 5.6 m -50.97 -30.81 16.0 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.666 0.746 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.73 -36.89 38.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.851 -0.53 . . . . 0.0 111.274 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -57.64 -54.11 50.57 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.645 ' HB3' HD12 ' A' ' 143' ' ' ILE . 5.8 m-85 -76.59 -38.51 54.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.606 -0.684 . . . . 0.0 111.141 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 83' ' ' THR . 98.9 t -57.12 -51.55 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -0.992 . . . . 0.0 110.328 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 92' ' ' VAL . 29.4 tttm -60.07 -32.13 70.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.687 -0.633 . . . . 0.0 110.255 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -60.21 -56.56 20.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.643 -0.66 . . . . 0.0 111.805 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.02 -53.54 7.68 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.307 -0.871 . . . . 0.0 111.813 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -48.58 -40.24 26.63 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.424 -0.798 . . . . 0.0 112.759 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 88' ' ' LYS . 74.7 t -59.8 -37.93 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.773 -1.205 . . . . 0.0 109.663 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -68.97 -45.97 69.29 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -62.12 82.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.431 -0.793 . . . . 0.0 110.937 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -62.57 -41.24 98.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -91.64 18.88 6.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.278 -0.889 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.1 p 38.48 37.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.3 p -63.72 -34.99 79.1 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.089 -1.007 . . . . 0.0 109.311 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.86 12.75 55.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.007 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' C ' HG13 ' A' ' 101' ' ' VAL . 27.7 mmtp -132.63 154.84 49.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.133 -1.216 . . . . 0.0 110.501 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 100' ' ' LYS . 32.2 m -150.72 160.4 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.389 -0.82 . . . . 0.0 109.855 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 p -83.21 145.55 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.5 p -56.96 -39.21 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.471 -0.768 . . . . 0.0 110.715 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.18 -41.04 96.48 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -80.53 -39.96 26.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.616 -0.932 . . . . 0.0 110.394 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.9 -50.01 75.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.698 -0.626 . . . . 0.0 110.145 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -64.89 -29.57 70.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 110.551 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -69.0 -47.97 64.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.437 -0.789 . . . . 0.0 110.773 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.62 88.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.321 -0.862 . . . . 0.0 110.445 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.729 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.6 tp -55.36 -44.76 76.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.5 m -59.99 -27.87 67.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.546 0.688 . . . . 0.0 110.051 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.09 -14.62 64.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.55 8.3 42.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.33 -1.1 . . . . 0.0 112.287 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 33.01 4.52 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.729 ' HG2' HD23 ' A' ' 110' ' ' LEU . 6.0 tp10 -114.03 119.85 38.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.982 -0.716 . . . . 0.0 110.298 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -121.98 59.28 1.0 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.198 0.999 . . . . 0.0 109.236 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.5 mt -90.11 148.7 22.85 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -111.05 143.9 41.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.252 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -40.33 -27.03 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.199 -0.938 . . . . 0.0 112.817 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.9 55.5 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 18.3 mp0 -75.15 -28.48 60.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.455 -0.778 . . . . 0.0 110.592 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.69 -33.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.819 . . . . 0.0 110.348 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -65.83 -45.12 83.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 11.2 pt-20 -56.63 -42.39 78.77 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.168 -0.958 . . . . 0.0 109.83 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.417 ' N ' ' HG3' ' A' ' 124' ' ' GLU . 91.8 mt -64.05 -47.22 81.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 0.0 109.648 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 41.1 mt -60.59 -18.04 50.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.888 -0.508 . . . . 0.0 111.07 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -56.79 -21.57 29.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.461 -0.775 . . . . 0.0 111.056 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 26.32 7.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 66.2 t -107.9 129.88 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -1.109 . . . . 0.0 109.671 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.96 101.87 13.09 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.437 0.637 . . . . 0.0 111.935 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 131' ' ' VAL . 8.8 p -84.04 158.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -95.85 -177.72 4.13 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.383 -0.823 . . . . 0.0 111.286 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.09 -1.27 14.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.941 -0.474 . . . . 0.0 111.805 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -108.21 -15.02 14.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.423 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.78 29.2 12.19 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.524 ' C ' HD12 ' A' ' 137' ' ' ILE . 96.1 mt-10 -111.03 133.7 53.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.624 -0.927 . . . . 0.0 111.167 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.8 mp -124.77 139.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -69.79 112.48 6.26 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.73 -0.606 . . . . 0.0 110.502 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.449 ' CG ' ' N ' ' A' ' 140' ' ' LYS . 32.7 p90 -69.96 -41.64 74.24 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.391 -0.818 . . . . 0.0 112.222 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 4.0 mttt -60.22 -29.87 69.02 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.605 -0.684 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -84.12 -39.48 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 111.649 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 146' ' ' VAL . 23.1 t80 -70.01 -29.88 67.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.444 -0.785 . . . . 0.0 111.349 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.645 HD12 ' HB3' ' A' ' 86' ' ' PHE . 27.8 pt -83.17 -43.43 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.451 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.9 mt-10 -68.91 -27.44 65.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.322 -0.861 . . . . 0.0 110.715 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -85.1 -15.79 42.73 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.319 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 142' ' ' PHE . 76.6 t -95.48 -37.41 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 86' ' ' PHE . 26.2 mt . . . . . 0 N--CA 1.497 1.889 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.305 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -110.18 161.0 16.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 111.283 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.694 HG22 ' CG2' ' A' ' 87' ' ' VAL . 24.2 m -51.04 -30.37 15.33 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.636 0.731 . . . . 0.0 109.689 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -51.01 -37.61 46.17 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.883 -0.511 . . . . 0.0 111.222 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.18 -47.24 85.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.694 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.2 m-85 -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.694 ' CG2' HG22 ' A' ' 83' ' ' THR . 71.6 t -60.75 -49.99 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.368 -0.833 . . . . 0.0 110.658 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 92' ' ' VAL . 97.3 mttt -59.58 -34.96 73.38 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.583 -0.698 . . . . 0.0 111.388 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -61.26 -56.61 18.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.605 -0.685 . . . . 0.0 112.005 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.77 ' CE1' HD12 ' A' ' 106' ' ' LEU . 57.0 m-85 -76.7 -54.1 7.1 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.188 -0.945 . . . . 0.0 111.976 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -48.41 -37.21 16.46 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.31 -0.869 . . . . 0.0 113.045 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 88' ' ' LYS . 77.9 t -59.94 -36.36 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 120.843 -1.16 . . . . 0.0 109.89 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.91 -42.78 89.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -62.1 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.43 -0.794 . . . . 0.0 111.249 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -61.44 -41.05 96.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.557 -0.714 . . . . 0.0 110.048 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.3 20.58 7.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.44 -0.787 . . . . 0.0 110.44 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 38.2 36.68 0.12 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.2 t -63.46 -33.39 75.46 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.128 -0.983 . . . . 0.0 109.566 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.17 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.31 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.605 ' H ' HG23 ' A' ' 98' ' ' THR . 1.4 mppt? -131.58 152.73 50.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -1.216 . . . . 0.0 109.736 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 106' ' ' LEU . 35.8 m -148.89 160.0 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.9 p -81.37 145.93 30.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.1 p -54.46 -39.52 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.484 -0.76 . . . . 0.0 110.658 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.94 -40.04 96.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.58 -43.16 21.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.633 -0.922 . . . . 0.0 110.8 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.77 HD12 ' CE1' ' A' ' 90' ' ' PHE . 25.0 tp -60.0 -50.07 75.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.48 -0.762 . . . . 0.0 110.057 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -63.32 -31.64 72.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.724 . . . . 0.0 110.165 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -67.73 -47.7 68.56 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.401 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -40.4 95.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.589 HD23 ' HG2' ' A' ' 115' ' ' GLU . 5.4 tp -55.73 -44.81 77.87 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.5 m -60.45 -29.68 69.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.33 -14.25 64.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.74 7.33 46.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -1.087 . . . . 0.0 112.545 -177.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.77 32.11 4.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' HD23 ' A' ' 110' ' ' LEU . 17.5 tp10 -113.87 120.16 39.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.932 -0.746 . . . . 0.0 110.204 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -121.92 59.51 0.99 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.203 1.002 . . . . 0.0 109.304 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.541 HD11 ' OE2' ' A' ' 115' ' ' GLU . 90.2 mt -92.03 148.96 21.79 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 p -110.95 143.25 41.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.261 -0.899 . . . . 0.0 109.854 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -40.08 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 O-C-N 121.213 -0.929 . . . . 0.0 112.805 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.99 61.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 108.982 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -76.69 -42.83 40.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.598 -0.689 . . . . 0.0 110.433 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.41 -35.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.73 -38.38 90.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.229 -0.919 . . . . 0.0 109.208 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.01 -47.62 85.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.614 . . . . 0.0 109.739 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.83 -49.88 75.68 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.508 0.67 . . . . 0.0 110.052 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.98 -18.72 47.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.888 -0.507 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -57.04 -21.03 28.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.447 -0.783 . . . . 0.0 111.136 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.92 9.08 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.45 132.82 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.041 -1.27 . . . . 0.0 109.982 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -102.51 102.34 12.6 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.389 0.614 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -85.4 159.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.85 -176.79 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -71.67 -1.14 12.69 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.794 -0.566 . . . . 0.0 111.834 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -107.43 -12.07 15.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.13 . . . . 0.0 110.403 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.61 27.09 28.04 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.2 mt-10 -110.89 140.1 45.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.619 -0.93 . . . . 0.0 111.245 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.1 mp -130.86 142.39 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.89 113.04 5.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.971 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 26.0 p90 -62.84 -33.26 74.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.642 -0.661 . . . . 0.0 111.706 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 20.5 mttt -69.97 -35.05 74.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 110.712 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -69.95 -44.11 70.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.72 -0.613 . . . . 0.0 111.518 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.468 ' O ' HG23 ' A' ' 146' ' ' VAL . 12.7 t80 -74.33 -27.69 60.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.762 . . . . 0.0 111.077 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.33 -51.8 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.447 -0.783 . . . . 0.0 109.884 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -63.77 -26.43 68.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.439 -0.788 . . . . 0.0 110.791 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.34 -13.39 43.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.217 -0.927 . . . . 0.0 110.746 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 142' ' ' PHE . 46.2 t -95.83 -38.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' A' ' 86' ' ' PHE . 14.3 mt . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.954 -0.466 . . . . 0.0 111.406 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.8 pttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.611 0.72 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.45 148.93 24.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.797 -0.564 . . . . 0.0 110.445 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -100.75 168.52 9.61 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.95 0.881 . . . . 0.0 111.245 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.845 HG22 ' CG2' ' A' ' 87' ' ' VAL . 23.2 m -51.16 -31.19 19.09 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.45 0.643 . . . . 0.0 109.96 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -52.17 -37.92 56.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.709 -0.62 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.59 -47.11 85.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.859 ' CD2' HD11 ' A' ' 147' ' ' LEU . 2.9 m-85 -76.03 -40.0 54.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.845 ' CG2' HG22 ' A' ' 83' ' ' THR . 65.7 t -61.5 -51.84 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.244 -0.91 . . . . 0.0 110.588 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 92' ' ' VAL . 48.0 tttp -56.96 -32.55 66.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -61.28 -59.92 4.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.503 -0.748 . . . . 0.0 111.934 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.726 ' CE1' HD12 ' A' ' 106' ' ' LEU . 65.3 m-85 -76.63 -53.67 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.188 -0.945 . . . . 0.0 111.951 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -48.16 -38.52 18.25 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.26 -0.9 . . . . 0.0 112.791 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 88' ' ' LYS . 56.5 t -59.62 -34.81 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.801 -1.187 . . . . 0.0 109.602 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.14 -41.01 97.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.4 81.41 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.448 -0.782 . . . . 0.0 111.083 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.26 -41.63 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.642 -0.661 . . . . 0.0 110.425 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -91.46 16.18 10.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.333 -0.854 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 t 38.42 61.7 1.11 Allowed 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.8 p -90.5 -33.48 15.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.146 -0.971 . . . . 0.0 109.31 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.07 9.98 55.33 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.925 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.451 ' C ' HG13 ' A' ' 101' ' ' VAL . 2.1 mppt? -132.84 154.82 49.97 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.021 -1.282 . . . . 0.0 110.274 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 106' ' ' LEU . 31.3 m -150.02 159.92 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.258 -0.901 . . . . 0.0 109.964 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.1 p -81.38 144.21 31.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.8 p -56.92 -39.98 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.562 -0.711 . . . . 0.0 110.857 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -58.82 -41.58 96.13 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.59 -39.67 27.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.939 . . . . 0.0 110.453 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.726 HD12 ' CE1' ' A' ' 90' ' ' PHE . 29.0 tp -59.97 -49.88 75.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.687 -0.633 . . . . 0.0 110.168 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -65.87 -29.52 69.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.401 -0.812 . . . . 0.0 111.005 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -65.58 -48.29 72.85 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.093 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.111 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.678 HD23 ' HG2' ' A' ' 115' ' ' GLU . 4.1 tp -55.69 -44.74 77.65 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.266 -0.896 . . . . 0.0 108.702 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -60.85 -30.25 70.0 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.545 0.688 . . . . 0.0 109.622 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.59 -13.83 66.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.632 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 7.7 45.38 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.31 -1.112 . . . . 0.0 112.406 -177.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.39 31.67 5.17 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 110' ' ' LEU . 12.2 tp10 -113.25 119.93 39.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.873 -0.781 . . . . 0.0 110.281 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -122.39 59.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.955 0.883 . . . . 0.0 109.386 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.527 HD11 ' OE2' ' A' ' 115' ' ' GLU . 77.3 mt -90.99 148.62 22.28 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 m -111.01 141.89 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 34.5 t0 -40.08 -27.24 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.226 -0.921 . . . . 0.0 112.899 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -53.18 59.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.202 -0.936 . . . . 0.0 108.975 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.72 -42.68 40.37 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.531 -0.73 . . . . 0.0 110.414 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.522 HG12 HD12 ' A' ' 126' ' ' LEU . 58.9 t -60.01 -36.66 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.604 -0.685 . . . . 0.0 110.272 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -63.33 -38.37 90.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.207 -0.933 . . . . 0.0 109.069 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -62.95 -49.82 73.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.626 -0.671 . . . . 0.0 109.365 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.91 -49.43 77.74 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.576 0.703 . . . . 0.0 110.237 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.794 ' O ' HG12 ' A' ' 129' ' ' VAL . 46.6 mt -62.34 -15.99 51.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.938 -0.476 . . . . 0.0 111.257 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -57.26 -17.16 10.51 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.264 -0.897 . . . . 0.0 111.853 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.03 -10.19 14.46 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.071 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.794 HG12 ' O ' ' A' ' 126' ' ' LEU . 7.1 p -70.4 135.9 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.989 -1.301 . . . . 0.0 110.765 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -104.62 100.63 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.412 0.625 . . . . 0.0 111.267 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.7 p -84.27 158.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -95.34 -179.06 4.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -0.805 . . . . 0.0 111.36 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 m -70.72 -1.55 11.77 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.942 -0.474 . . . . 0.0 112.032 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -107.14 -11.15 15.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 0.0 110.421 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.73 26.02 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.531 ' C ' HD12 ' A' ' 137' ' ' ILE . 87.2 mt-10 -110.61 137.92 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.96 . . . . 0.0 111.14 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.7 mp -126.81 168.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.462 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.3 t70 -96.14 112.33 24.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 109.891 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.458 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 48.1 p90 -62.68 -29.12 70.41 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.729 . . . . 0.0 111.632 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 15.7 mttt -73.1 -34.63 66.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.25 -0.906 . . . . 0.0 110.615 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -70.16 -45.98 65.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.689 -0.632 . . . . 0.0 112.183 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 146' ' ' VAL . 24.1 t80 -70.68 -28.37 64.72 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 0.0 110.8 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 110' ' ' LEU . 28.1 mm -74.58 -45.98 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.48 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -60.06 -27.43 66.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.68 -12.33 42.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 142' ' ' PHE . 60.7 t -95.71 -40.68 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.859 HD11 ' CD2' ' A' ' 86' ' ' PHE . 4.4 mp -55.49 -20.88 14.12 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.948 -0.47 . . . . 0.0 111.301 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -59.14 -40.02 84.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.381 -0.824 . . . . 0.0 110.364 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.195 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.6 tttm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.682 0.753 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.17 155.11 23.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.946 -0.471 . . . . 0.0 110.255 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -102.17 160.01 14.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.713 0.768 . . . . 0.0 110.843 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.708 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.2 m -51.13 -30.65 17.06 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.701 0.762 . . . . 0.0 109.337 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -52.24 -37.47 55.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.955 -0.466 . . . . 0.0 111.168 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -60.58 -50.04 75.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.592 -0.693 . . . . 0.0 109.856 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' A' ' 147' ' ' LEU . 1.2 m-85 -75.91 -40.06 55.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.783 -0.573 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.708 ' CG2' HG22 ' A' ' 83' ' ' THR . 83.5 t -61.92 -49.89 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.322 -0.861 . . . . 0.0 110.606 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 92' ' ' VAL . 24.0 mmtt -59.75 -34.33 72.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.566 -0.709 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 113' ' ' LEU . . . -62.06 -51.82 66.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.677 -0.64 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' HD11 ' A' ' 143' ' ' ILE . 50.9 m-85 -77.23 -54.92 5.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 111.802 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.485 ' OE1' HG12 ' A' ' 87' ' ' VAL . 57.2 mt-30 -48.04 -35.57 11.39 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.504 -0.747 . . . . 0.0 112.954 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 88' ' ' LYS . 96.2 t -60.87 -29.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.679 -1.263 . . . . 0.0 109.122 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -92.81 23.16 4.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.679 -0.638 . . . . 0.0 109.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -132.02 78.47 1.82 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 0.0 108.941 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -63.56 -45.48 90.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.765 -0.584 . . . . 0.0 111.435 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.99 17.68 5.55 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.014 -1.054 . . . . 0.0 111.389 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 t 38.27 39.82 0.3 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.597 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.8 t -63.47 -34.16 77.16 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.43 14.58 50.26 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.384 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.597 ' H ' HG23 ' A' ' 98' ' ' THR . 31.2 mttt -132.93 153.84 51.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.081 -1.246 . . . . 0.0 110.643 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 139' ' ' TYR . 30.9 m -150.29 160.02 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.6 p -84.74 147.34 26.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.0 109.711 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.871 HG13 HD13 ' A' ' 137' ' ' ILE . 21.6 m -63.35 -34.02 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.289 -0.882 . . . . 0.0 110.268 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.29 -42.49 99.79 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.49 -41.43 27.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.653 -0.91 . . . . 0.0 109.493 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 101' ' ' VAL . 5.9 tt -59.96 -49.23 78.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -63.63 -32.51 74.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.693 -0.63 . . . . 0.0 110.543 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.72 -48.91 67.72 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -36.41 74.79 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.889 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 19.9 tp -53.72 -45.02 70.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -66.27 -18.77 65.55 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.018 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.7 -14.15 65.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.533 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -95.03 8.28 43.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 112.67 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.3 31.19 5.07 Favored Glycine 0 N--CA 1.503 3.104 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 49.5 mm-40 -114.88 121.76 44.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.957 -0.731 . . . . 0.0 110.165 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -122.83 61.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 109.899 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.5 mt -91.96 148.87 21.87 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 m -110.6 144.26 39.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 109.989 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 28.0 t0 -39.43 -29.28 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.361 -0.837 . . . . 0.0 112.598 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.95 49.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.35 -0.844 . . . . 0.0 108.847 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -76.44 -39.93 52.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.616 . . . . 0.0 110.284 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 58.1 t -64.2 -35.95 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.585 -0.697 . . . . 0.0 110.653 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.0 -39.92 87.45 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.075 -1.016 . . . . 0.0 108.927 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.71 -43.89 81.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.708 -0.62 . . . . 0.0 109.397 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.17 -50.04 74.77 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.657 0.741 . . . . 0.0 109.856 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.457 HD23 HG11 ' A' ' 129' ' ' VAL . 6.9 mt -67.67 -22.15 65.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.779 -0.575 . . . . 0.0 110.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -57.4 -19.72 25.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.501 -0.749 . . . . 0.0 111.358 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.65 -14.86 5.57 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.25 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.457 HG11 HD23 ' A' ' 126' ' ' LEU . 6.1 p -66.19 128.83 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 118.897 1.348 . . . . 0.0 110.517 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.05 99.86 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.407 0.623 . . . . 0.0 111.226 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.602 HG23 HD11 ' A' ' 137' ' ' ILE . 7.6 p -84.21 157.08 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -96.68 -174.35 2.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 111.206 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.2 m -71.67 -0.7 11.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.839 -0.538 . . . . 0.0 111.853 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.95 -11.32 15.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.19 25.32 44.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.77 ' C ' HD12 ' A' ' 137' ' ' ILE . 51.7 mt-10 -111.7 139.52 47.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.555 -0.968 . . . . 0.0 110.998 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.871 HD13 HG13 ' A' ' 103' ' ' VAL . 3.2 mp -126.56 146.48 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -69.09 114.38 7.31 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.51 ' HB3' HG21 ' A' ' 101' ' ' VAL . 49.9 p90 -67.55 -38.88 84.79 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.544 -0.722 . . . . 0.0 111.548 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.8 mttt -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.0 110.102 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -70.02 -42.32 73.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 110.927 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.411 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.9 t80 -71.88 -28.13 63.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.54 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.634 HD11 ' CE1' ' A' ' 90' ' ' PHE . 92.3 mt -85.05 -52.25 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.324 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -87.63 -13.91 41.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -0.914 . . . . 0.0 110.56 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 142' ' ' PHE . 40.1 t -95.96 -38.29 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.697 HD11 ' CD2' ' A' ' 86' ' ' PHE . 22.3 mt -59.71 -19.82 52.38 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.896 -0.502 . . . . 0.0 111.258 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -58.18 137.8 56.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.34 -0.85 . . . . 0.0 110.272 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.202 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.652 0.739 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.46 154.59 26.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 122.018 -0.426 . . . . 0.0 110.252 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -103.43 162.23 13.2 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 110.969 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.782 HG22 ' CG2' ' A' ' 87' ' ' VAL . 18.5 m -51.33 -30.69 19.26 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.608 0.718 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.66 -38.15 59.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.843 -0.535 . . . . 0.0 111.162 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.429 ' OD1' HD21 ' A' ' 113' ' ' LEU . 8.0 t70 -60.69 -50.18 74.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 109.871 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.657 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -74.29 -38.35 63.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.782 -0.573 . . . . 0.0 110.999 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.782 ' CG2' HG22 ' A' ' 83' ' ' THR . 97.0 t -63.99 -48.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.231 -0.918 . . . . 0.0 110.678 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 92' ' ' VAL . 39.2 ttmt -60.02 -35.75 75.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.628 -0.67 . . . . 0.0 111.019 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.613 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -59.95 -52.16 66.61 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 111.245 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -77.0 -53.3 8.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.378 -0.826 . . . . 0.0 111.249 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.518 ' OE1' HG12 ' A' ' 87' ' ' VAL . 55.6 mt-30 -48.7 -38.69 22.1 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 88' ' ' LYS . 95.8 t -59.17 -31.03 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 120.565 -1.334 . . . . 0.0 109.193 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.95 23.6 4.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -131.57 78.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.0 109.399 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -70.5 -10.46 59.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.767 -0.583 . . . . 0.0 111.355 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.22 11.65 15.21 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.125 -0.985 . . . . 0.0 110.963 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m 37.54 37.55 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 p -63.88 -34.53 78.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.424 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.07 14.91 53.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' C ' HG13 ' A' ' 101' ' ' VAL . 37.2 mttt -133.6 156.41 47.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.178 -1.19 . . . . 0.0 110.435 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.611 ' CG2' HD12 ' A' ' 106' ' ' LEU . 27.2 m -151.61 160.02 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -82.61 144.94 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.905 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.9 p -57.3 -39.92 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.746 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.01 -41.89 96.64 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.01 -42.6 23.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.528 -0.983 . . . . 0.0 110.336 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.611 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.2 tt -60.01 -49.75 76.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -64.89 -33.66 76.54 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -67.16 -49.04 66.18 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -34.84 71.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.54 -0.725 . . . . 0.0 110.523 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.718 HD11 ' OE2' ' A' ' 115' ' ' GLU . 30.8 tp -54.66 -45.28 73.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.413 -0.804 . . . . 0.0 109.116 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.0 m -63.96 -19.04 64.85 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.346 0.593 . . . . 0.0 110.789 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.31 -14.57 63.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.657 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -94.13 7.38 45.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -1.03 . . . . 0.0 112.649 -177.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.8 4.84 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.718 ' OE2' HD11 ' A' ' 110' ' ' LEU . 6.4 mm-40 -114.79 121.02 42.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.941 -0.741 . . . . 0.0 110.116 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -122.23 59.64 1.01 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.138 0.971 . . . . 0.0 109.755 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.99 148.83 22.13 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.5 m -111.06 141.63 44.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 39.5 t0 -39.63 -29.14 0.05 Allowed 'General case' 0 N--CA 1.513 2.701 0 O-C-N 121.417 -0.802 . . . . 0.0 112.487 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.84 -52.62 63.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.368 -0.833 . . . . 0.0 108.953 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -77.01 -42.61 37.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.632 -0.668 . . . . 0.0 110.295 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 126' ' ' LEU . 62.8 t -60.02 -35.21 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.52 -38.8 92.5 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 109.041 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.77 -45.5 93.64 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.692 0.758 . . . . 0.0 110.143 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.763 ' O ' HG12 ' A' ' 129' ' ' VAL . 67.1 mt -63.65 -18.45 63.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.899 -0.501 . . . . 0.0 111.304 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -56.67 -18.24 11.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.196 -0.94 . . . . 0.0 111.68 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.14 -9.62 15.29 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.944 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 126' ' ' LEU . 9.9 p -70.13 133.78 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.926 -1.338 . . . . 0.0 110.988 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -99.59 99.41 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.365 0.602 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.13 155.77 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.89 -176.9 3.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 111.18 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.04 -0.96 12.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.819 -0.55 . . . . 0.0 111.805 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -108.0 -14.02 14.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 0.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.04 28.98 16.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.56 ' C ' HD12 ' A' ' 137' ' ' ILE . 96.8 mt-10 -110.51 134.94 51.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.677 -0.896 . . . . 0.0 111.073 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.8 mp -125.28 142.63 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.66 112.41 6.12 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.247 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 41.5 p90 -68.11 -34.11 75.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.531 -0.731 . . . . 0.0 111.531 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 mttt -69.8 -32.73 71.33 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.272 -0.893 . . . . 0.0 110.426 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -73.2 -43.29 61.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.702 -0.623 . . . . 0.0 111.643 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.703 ' O ' HG23 ' A' ' 146' ' ' VAL . 30.8 t80 -70.73 -28.16 64.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.488 -0.758 . . . . 0.0 110.695 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.494 HG22 ' CD1' ' A' ' 147' ' ' LEU . 90.5 mt -75.18 -45.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.758 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.55 -26.83 65.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.91 -11.74 43.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.46 -0.775 . . . . 0.0 110.327 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 142' ' ' PHE . 65.9 t -95.97 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.617 HD21 ' CE2' ' A' ' 86' ' ' PHE . 87.2 mt -54.47 -21.33 9.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.913 -0.492 . . . . 0.0 111.379 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 -58.62 -39.96 81.98 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.212 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.6 mttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.722 0.772 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.65 156.0 21.61 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.984 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -109.22 161.47 15.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.931 0.872 . . . . 0.0 111.319 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.786 ' O ' HG23 ' A' ' 87' ' ' VAL . 18.3 m -51.18 -30.32 16.6 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.663 0.744 . . . . 0.0 109.674 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.93 -37.64 32.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.717 -0.614 . . . . 0.0 111.146 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -59.12 -50.4 74.2 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.439 ' HB3' HD13 ' A' ' 143' ' ' ILE . 12.1 m-85 -76.18 -38.38 56.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 83' ' ' THR . 65.8 t -57.34 -55.39 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.177 -0.952 . . . . 0.0 110.49 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -59.99 -33.27 71.74 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.633 -0.667 . . . . 0.0 110.553 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.29 -51.88 67.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.682 -0.636 . . . . 0.0 111.429 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 33.4 m-85 -78.74 -54.94 5.57 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 0.0 111.508 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -49.19 -39.98 31.51 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.585 -0.697 . . . . 0.0 112.69 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 93' ' ' PHE . 9.7 p -58.38 -38.57 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.071 -1.018 . . . . 0.0 110.072 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 92' ' ' VAL . 2.5 t80 -69.07 -44.83 71.78 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -61.74 82.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.516 -0.74 . . . . 0.0 111.018 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -69.1 -15.35 63.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.11 12.87 20.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.2 -0.937 . . . . 0.0 110.5 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m 38.27 62.8 0.93 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -91.28 -34.18 15.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.161 -0.962 . . . . 0.0 109.359 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.66 11.67 54.88 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.463 ' C ' HG13 ' A' ' 101' ' ' VAL . 83.0 mttt -132.21 154.66 49.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.262 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 106' ' ' LEU . 30.4 m -150.77 160.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.407 -0.808 . . . . 0.0 110.182 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.7 p -85.75 147.84 26.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 110.118 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 137' ' ' ILE . 81.9 t -57.16 -40.2 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.336 -0.852 . . . . 0.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.16 -42.04 95.03 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.45 -44.17 19.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.512 -0.993 . . . . 0.0 110.4 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 HG21 ' A' ' 101' ' ' VAL . 8.2 tt -60.03 -49.96 75.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.714 -0.616 . . . . 0.0 110.001 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -64.08 -32.21 73.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -68.08 -47.83 67.21 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.516 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.33 95.45 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.144 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.604 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.98 -44.79 78.9 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 m -59.89 -30.5 69.06 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.59 0.71 . . . . 0.0 109.789 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.44 -14.62 63.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 7.3 46.6 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.301 -1.117 . . . . 0.0 112.602 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.4 4.76 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.604 ' HG2' HD23 ' A' ' 110' ' ' LEU . 21.2 tp10 -114.01 120.13 39.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.884 -0.774 . . . . 0.0 110.005 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -122.09 59.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.142 0.972 . . . . 0.0 109.518 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 92.5 mt -92.18 149.36 21.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 144.19 40.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.917 . . . . 0.0 109.663 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -40.13 -27.4 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.254 -0.904 . . . . 0.0 112.809 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.66 62.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.278 -0.889 . . . . 0.0 109.028 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.59 -42.79 41.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 110.382 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 60.3 t -59.93 -35.55 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.519 -0.738 . . . . 0.0 110.419 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -64.49 -37.74 88.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -60.05 -47.24 86.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 0.0 109.717 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.13 -50.13 74.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.631 0.729 . . . . 0.0 109.947 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.45 -19.58 56.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.893 -0.504 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -57.32 -22.01 39.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.486 -0.758 . . . . 0.0 111.203 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -113.81 -13.87 9.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.05 126.3 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.14 -1.212 . . . . 0.0 110.128 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -89.89 99.96 12.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.201 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 137' ' ' ILE . 8.1 p -83.32 155.67 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -96.6 -175.6 3.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.377 -0.827 . . . . 0.0 111.182 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -72.02 -0.85 12.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.829 -0.544 . . . . 0.0 111.863 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.23 -12.58 15.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.104 . . . . 0.0 110.351 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.92 26.69 30.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.682 ' C ' HD12 ' A' ' 137' ' ' ILE . 44.2 mt-10 -111.92 136.12 51.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.491 -1.005 . . . . 0.0 110.963 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.682 HD12 ' C ' ' A' ' 136' ' ' GLU . 3.5 mp -124.71 142.55 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 39.2 p-10 -69.74 109.07 4.19 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.378 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 49.9 p90 -65.28 -36.87 85.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.454 -0.779 . . . . 0.0 112.266 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 29.1 mttt -60.09 -31.52 70.1 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.337 -0.852 . . . . 0.0 111.904 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -84.2 -38.15 20.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.483 -0.76 . . . . 0.0 112.036 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 146' ' ' VAL . 22.7 t80 -70.42 -28.84 65.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.445 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 86' ' ' PHE . 90.6 mt -83.49 -50.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 110.326 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -62.88 -26.24 68.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.749 . . . . 0.0 110.993 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.78 -15.83 33.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 111.014 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 142' ' ' PHE . 70.5 t -96.72 -41.66 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.058 -1.026 . . . . 0.0 108.709 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.93 -15.39 59.01 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.835 -0.541 . . . . 0.0 111.662 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -60.2 -30.49 69.39 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.293 -0.879 . . . . 0.0 110.027 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.82 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.678 0.751 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.1 161.17 14.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.812 -0.555 . . . . 0.0 110.185 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -109.22 162.0 14.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.97 0.89 . . . . 0.0 111.213 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.685 HG22 ' CG2' ' A' ' 87' ' ' VAL . 5.5 m -50.54 -30.69 13.63 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.596 0.712 . . . . 0.0 109.777 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -52.56 -36.19 55.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.916 -0.49 . . . . 0.0 111.107 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.35 -50.01 74.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 109.92 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.594 ' CE2' HD21 ' A' ' 147' ' ' LEU . 5.6 m-85 -75.87 -40.01 55.41 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.707 -0.621 . . . . 0.0 111.254 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.685 ' CG2' HG22 ' A' ' 83' ' ' THR . 95.8 t -61.51 -50.01 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.267 -0.896 . . . . 0.0 110.365 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -57.95 -32.75 68.13 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.897 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -62.34 -58.27 8.29 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.565 -0.709 . . . . 0.0 111.867 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.876 ' CE1' HD12 ' A' ' 106' ' ' LEU . 95.7 m-85 -78.81 -55.85 4.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.203 -0.936 . . . . 0.0 112.105 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -48.58 -38.64 21.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.421 -0.8 . . . . 0.0 112.808 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -56.5 -38.6 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.993 -1.067 . . . . 0.0 110.222 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' VAL . 23.4 m-85 -67.13 -42.5 84.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.77 83.1 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PHE . 67.4 mmtt -68.57 -16.82 63.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -113.53 15.73 18.93 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.0 110.445 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.55 37.08 0.1 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.7 t -63.57 -33.14 74.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.626 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.35 53.59 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.121 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.636 ' H ' HG23 ' A' ' 98' ' ' THR . 1.8 mtpt -132.83 153.57 51.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.044 -1.268 . . . . 0.0 110.368 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.686 HG21 HD13 ' A' ' 106' ' ' LEU . 34.7 m -150.06 160.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.8 p -83.69 146.27 28.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.555 -0.715 . . . . 0.0 109.654 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.984 HG13 HD13 ' A' ' 137' ' ' ILE . 21.0 m -61.76 -34.81 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.303 -0.873 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.43 99.79 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -79.62 -41.23 27.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.705 -0.879 . . . . 0.0 109.813 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.876 HD12 ' CE1' ' A' ' 90' ' ' PHE . 28.9 tp -60.04 -48.6 81.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -64.38 -30.98 72.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.67 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.679 ' O ' HG22 ' A' ' 111' ' ' THR . 61.1 t80 -65.52 -48.53 72.2 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.141 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -39.95 74.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.015 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 tp -54.17 -39.51 66.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.453 -0.779 . . . . 0.0 111.024 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 108' ' ' TYR . 8.8 t -73.01 -17.86 61.4 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.471 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.76 -13.94 66.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 8.52 42.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -1.121 . . . . 0.0 112.23 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.12 30.14 5.2 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 111' ' ' THR . 2.1 tp10 -114.17 121.48 43.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.81 -0.817 . . . . 0.0 110.273 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -123.02 61.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.095 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.6 mt -91.45 148.87 22.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -110.14 143.11 40.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.423 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 10.6 p-10 -38.5 -31.38 0.05 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.557 -0.715 . . . . 0.0 112.406 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.05 50.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.97 -41.97 40.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.647 . . . . 0.0 110.324 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 62.7 t -61.61 -36.33 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.608 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.037 -1.039 . . . . 0.0 108.945 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.72 -43.72 80.88 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.62 -0.675 . . . . 0.0 109.57 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 125' ' ' LEU . 3.6 mm? -61.92 -53.47 55.29 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.503 0.668 . . . . 0.0 110.253 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.36 -21.13 65.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.793 -0.567 . . . . 0.0 111.032 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.37 -20.9 32.25 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 111.334 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.85 -14.2 8.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.24 126.27 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.094 -1.239 . . . . 0.0 110.102 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -92.58 102.19 14.62 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.103 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.419 ' CG2' HD11 ' A' ' 137' ' ' ILE . 7.7 p -86.47 159.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -95.68 -173.25 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.94 -0.64 9.69 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.878 -0.514 . . . . 0.0 111.913 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -106.09 -9.82 16.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.935 -1.103 . . . . 0.0 110.272 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.01 25.25 49.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.604 ' C ' HD12 ' A' ' 137' ' ' ILE . 71.9 mt-10 -111.45 143.0 42.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.483 -1.01 . . . . 0.0 111.135 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.984 HD13 HG13 ' A' ' 103' ' ' VAL . 2.6 mp -127.0 170.64 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 137' ' ' ILE . 40.1 t0 -94.41 117.62 30.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.421 -0.799 . . . . 0.0 110.344 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.586 ' HB3' HG21 ' A' ' 101' ' ' VAL . 49.0 p90 -68.47 -37.2 79.96 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.645 -0.659 . . . . 0.0 111.737 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 6.8 mttt -67.04 -41.0 87.27 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.58 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -69.94 -42.54 73.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.756 -0.59 . . . . 0.0 111.428 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.445 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.3 t80 -70.7 -29.36 65.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.502 -0.749 . . . . 0.0 110.348 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 139' ' ' TYR . 94.8 mt -85.35 -50.99 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 110.235 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.77 -26.68 68.83 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.528 -0.733 . . . . 0.0 110.85 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.25 -15.46 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.816 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 142' ' ' PHE . 58.1 t -95.98 -42.42 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 108.695 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.594 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.7 mm? -62.06 -15.61 46.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 111.693 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -59.36 141.26 54.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.234 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.751 0.786 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.07 159.6 18.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.947 -0.47 . . . . 0.0 110.263 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -109.92 161.98 14.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.859 0.838 . . . . 0.0 111.184 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.86 HG22 ' CG2' ' A' ' 87' ' ' VAL . 28.2 m -50.98 -30.86 16.17 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.59 0.709 . . . . 0.0 109.73 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -36.93 41.23 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.875 -0.516 . . . . 0.0 111.189 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -60.03 -50.06 75.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.598 -0.689 . . . . 0.0 109.996 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.825 ' CD1' HD11 ' A' ' 143' ' ' ILE . 3.6 m-85 -76.35 -39.6 53.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 111.025 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.86 ' CG2' HG22 ' A' ' 83' ' ' THR . 68.8 t -59.22 -53.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.25 -0.906 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.612 ' O ' HG23 ' A' ' 92' ' ' VAL . 38.4 ttpt -59.45 -33.15 70.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.608 -0.682 . . . . 0.0 110.955 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.658 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -62.49 -51.69 66.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.508 -0.745 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.55 -54.87 6.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 111.505 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -48.46 -37.29 16.92 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.485 -0.759 . . . . 0.0 112.83 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 88' ' ' LYS . 76.6 t -60.29 -36.94 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.843 -1.16 . . . . 0.0 109.715 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.59 -46.98 65.07 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -62.28 82.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.507 -0.746 . . . . 0.0 110.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -64.13 -40.01 95.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.0 110.447 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -91.54 16.7 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.5 36.31 0.13 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.8 p -63.75 -34.6 78.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.076 -1.015 . . . . 0.0 109.37 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.81 11.28 55.4 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.131 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 29.2 mmtm -132.39 153.95 50.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.044 -1.268 . . . . 0.0 110.402 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 139' ' ' TYR . 35.8 m -149.98 161.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.344 -0.848 . . . . 0.0 110.09 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 p -83.85 145.77 28.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.035 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.3 p -56.94 -38.3 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.395 -0.816 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.92 -40.76 97.3 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.6 -39.96 26.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.602 -0.94 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.89 -49.87 75.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.64 . . . . 0.0 110.025 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -64.66 -29.94 70.95 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.502 -0.749 . . . . 0.0 110.652 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.5 -47.68 69.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.424 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -39.19 93.65 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.016 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -55.59 -45.29 77.45 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.1 m -59.65 -30.42 68.73 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.571 0.7 . . . . 0.0 109.917 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.3 63.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 6.83 47.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.322 -1.105 . . . . 0.0 112.736 -177.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.66 32.35 4.83 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.566 ' HG2' HD23 ' A' ' 110' ' ' LEU . 19.9 tp10 -114.16 120.25 39.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 122.034 -0.686 . . . . 0.0 109.896 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -122.06 59.5 1.0 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.203 1.001 . . . . 0.0 109.364 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.38 148.44 23.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -111.05 143.1 42.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -39.98 -28.26 0.05 Allowed 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.318 -0.864 . . . . 0.0 112.486 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.41 59.29 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 45.4 mt-10 -75.4 -29.32 59.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 110.584 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.85 -32.6 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.99 -41.93 77.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.328 -0.857 . . . . 0.0 110.454 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 125' ' ' LEU . 9.1 pt-20 -60.0 -40.06 87.93 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.139 -0.975 . . . . 0.0 109.898 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -70.34 -44.06 68.97 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.394 -0.816 . . . . 0.0 110.354 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 129' ' ' VAL . 26.7 mt -60.18 -16.11 30.07 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.841 -0.537 . . . . 0.0 111.775 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -57.64 -19.24 25.06 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.276 -0.89 . . . . 0.0 111.304 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.64 25.09 9.26 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.438 HG21 HD23 ' A' ' 126' ' ' LEU . 58.6 t -106.7 124.5 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.301 -1.117 . . . . 0.0 109.549 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.03 105.85 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.474 0.654 . . . . 0.0 111.874 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.637 HG12 ' CG1' ' A' ' 137' ' ' ILE . 26.3 m -88.81 163.2 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -93.41 -175.05 3.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.794 . . . . 0.0 111.015 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 m -71.24 -1.35 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.899 -0.5 . . . . 0.0 111.776 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -108.26 -11.89 15.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.937 -1.102 . . . . 0.0 110.726 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.72 27.55 26.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.586 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.6 mt-10 -109.94 137.81 47.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.969 . . . . 0.0 111.108 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.637 ' CG1' HG12 ' A' ' 131' ' ' VAL . 5.1 mp -129.68 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -69.33 110.65 4.77 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.941 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' HB3' HG21 ' A' ' 101' ' ' VAL . 45.6 p90 -62.84 -30.96 71.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.48 -0.763 . . . . 0.0 111.89 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 24.3 mttt -71.28 -33.41 69.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.333 -0.855 . . . . 0.0 110.466 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -72.34 -46.17 56.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.751 -0.593 . . . . 0.0 111.493 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.2 t80 -71.15 -29.0 64.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.467 -0.771 . . . . 0.0 111.329 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.825 HD11 ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -79.28 -44.62 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.163 -0.961 . . . . 0.0 110.366 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.45 ' N ' HG23 ' A' ' 143' ' ' ILE . 94.0 mt-10 -62.29 -26.25 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.126 -0.984 . . . . 0.0 109.856 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.42 -12.56 45.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.434 -0.791 . . . . 0.0 110.099 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 142' ' ' PHE . 59.5 t -96.36 -41.8 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.429 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.9 tp -58.49 -28.96 65.87 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.379 0.609 . . . . 0.0 110.758 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -52.87 -40.0 63.09 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.728 -0.607 . . . . 0.0 110.844 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.161 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.586 0.708 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.13 159.8 21.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.814 -0.554 . . . . 0.0 110.059 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -107.3 158.88 16.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.838 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.7 m -51.26 -30.28 17.26 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.799 0.809 . . . . 0.0 109.329 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.17 -39.09 63.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.907 -0.496 . . . . 0.0 111.286 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.45 ' OD1' HD21 ' A' ' 113' ' ' LEU . 7.7 t0 -61.77 -50.03 74.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.551 -0.718 . . . . 0.0 109.918 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.735 ' CE2' HD21 ' A' ' 147' ' ' LEU . 1.6 m-85 -72.82 -36.58 67.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.743 -0.598 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 83' ' ' THR . 77.7 t -67.36 -46.15 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.16 -0.963 . . . . 0.0 110.79 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.598 ' O ' HG13 ' A' ' 92' ' ' VAL . 71.0 mmtt -59.27 -36.48 75.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.573 -0.704 . . . . 0.0 111.549 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 113' ' ' LEU . . . -59.75 -57.52 12.57 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 111.592 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -77.64 -53.63 7.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.278 -0.889 . . . . 0.0 112.028 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -48.36 -38.71 19.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.175 -0.953 . . . . 0.0 113.14 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 88' ' ' LYS . 29.7 m -59.14 -34.54 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.754 -1.216 . . . . 0.0 110.164 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -68.38 -43.33 77.57 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.3 80.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.359 -0.838 . . . . 0.0 110.901 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.26 -39.92 92.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 0.0 110.482 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -92.44 20.14 6.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.343 -0.848 . . . . 0.0 110.811 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 m 38.14 65.04 0.63 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -91.43 -33.78 15.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.17 -0.956 . . . . 0.0 109.148 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 15.12 57.48 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' C ' HG13 ' A' ' 101' ' ' VAL . 24.4 mmtp -131.93 153.1 50.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -1.217 . . . . 0.0 110.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 100' ' ' LYS . 35.9 m -148.98 159.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.313 -0.867 . . . . 0.0 110.047 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -81.85 144.8 30.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.624 -0.672 . . . . 0.0 110.083 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.7 p -56.41 -38.66 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.492 -0.755 . . . . 0.0 110.702 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.444 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -60.1 -40.6 97.36 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.52 -40.04 26.75 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.569 -0.959 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 106' ' ' LEU . 10.4 tt -58.96 -49.62 77.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.667 -0.646 . . . . 0.0 110.212 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -64.95 -29.6 70.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.705 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -67.93 -48.08 66.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.389 -0.82 . . . . 0.0 110.684 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -37.68 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.22 -0.925 . . . . 0.0 111.041 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.68 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.4 tp -55.33 -42.85 74.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.222 -0.924 . . . . 0.0 109.388 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' GLU . 1.1 p -66.45 -20.5 66.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.45 -14.87 62.99 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.488 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -94.09 8.41 41.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.321 -1.105 . . . . 0.0 112.507 -177.318 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.08 31.31 4.77 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.68 ' HG2' HD23 ' A' ' 110' ' ' LEU . 3.2 tp10 -113.97 120.27 40.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.985 -0.715 . . . . 0.0 109.734 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -122.07 59.33 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -0.964 . . . . 0.0 109.909 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.0 mt -91.68 148.82 21.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 p -111.06 142.28 43.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -39.61 -29.21 0.05 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.422 -0.799 . . . . 0.0 112.482 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.03 -52.89 62.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.341 -0.849 . . . . 0.0 108.852 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.78 -43.18 37.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.714 -0.616 . . . . 0.0 110.304 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.32 -34.9 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.549 -0.719 . . . . 0.0 110.405 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -64.17 -37.44 87.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.216 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.99 -46.67 88.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 110.086 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 125' ' ' LEU . 10.9 mp -62.72 -41.18 99.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.524 -0.735 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 26.4 mt -62.98 -17.13 61.72 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.826 -0.546 . . . . 0.0 111.569 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -56.57 -22.51 34.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.259 -0.9 . . . . 0.0 111.084 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.98 25.29 8.94 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 66.2 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.363 -1.081 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -102.38 102.94 13.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.448 0.642 . . . . 0.0 111.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.27 158.97 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -95.92 -177.54 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.355 -0.84 . . . . 0.0 111.333 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -71.22 -2.06 14.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.832 -0.543 . . . . 0.0 111.971 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.82 -10.52 16.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.994 -1.066 . . . . 0.0 110.241 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.98 32.37 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.57 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.6 mt-10 -111.13 139.2 46.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.913 . . . . 0.0 111.14 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.0 mp -128.42 142.22 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.92 113.88 6.73 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.731 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.491 ' O ' HD12 ' A' ' 143' ' ' ILE . 30.9 p90 -63.95 -36.16 83.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.617 -0.677 . . . . 0.0 111.887 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.5 mmtt -70.01 -37.02 75.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.27 -45.37 66.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.634 -0.667 . . . . 0.0 111.702 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.647 ' O ' HG23 ' A' ' 146' ' ' VAL . 24.7 t80 -71.3 -29.2 64.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.418 -0.801 . . . . 0.0 110.767 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 139' ' ' TYR . 96.8 mt -79.6 -47.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.484 -0.76 . . . . 0.0 109.611 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -60.31 -26.77 66.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.017 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.14 -12.28 44.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.414 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 142' ' ' PHE . 55.2 t -95.57 -38.91 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.735 HD21 ' CE2' ' A' ' 86' ' ' PHE . 72.1 mt -56.16 -21.22 21.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.925 -0.484 . . . . 0.0 111.181 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -58.17 148.44 26.84 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.408 -0.807 . . . . 0.0 110.358 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.266 179.958 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.3 tttt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.825 0.822 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.35 159.55 17.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.941 -0.474 . . . . 0.0 110.211 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -109.96 158.89 17.76 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.788 . . . . 0.0 111.021 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -49.96 -29.99 9.54 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.533 0.682 . . . . 0.0 110.286 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -46.57 -32.47 3.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.822 -0.549 . . . . 0.0 112.144 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -62.48 -43.79 97.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.378 -0.826 . . . . 0.0 110.543 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.543 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -77.45 -40.22 44.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.489 -0.757 . . . . 0.0 110.704 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.53 -57.46 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.411 -0.806 . . . . 0.0 111.077 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 92' ' ' VAL . 50.5 tttt -60.03 -34.35 73.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.815 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.586 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -60.42 -54.29 47.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.703 . . . . 0.0 111.645 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.427 ' CZ ' ' HG ' ' A' ' 106' ' ' LEU . 24.5 m-85 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.219 -0.926 . . . . 0.0 111.615 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -48.69 -39.68 25.41 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.369 -0.832 . . . . 0.0 112.814 -177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 88' ' ' LYS . 71.5 t -60.05 -38.07 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.876 -1.14 . . . . 0.0 109.754 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -67.48 -44.89 77.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -61.36 82.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.558 -0.714 . . . . 0.0 111.04 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.714 -0.616 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -94.05 18.18 11.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.179 -0.951 . . . . 0.0 110.507 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.1 m 38.7 63.0 0.95 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.3 p -90.83 -34.77 15.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.981 . . . . 0.0 109.122 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.49 62.25 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.307 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 2.6 mppt? -129.83 150.03 51.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.113 -1.227 . . . . 0.0 110.074 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.456 ' CG2' HD12 ' A' ' 106' ' ' LEU . 35.2 m -150.15 164.69 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -0.828 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 p -85.39 147.08 26.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.688 -0.633 . . . . 0.0 109.293 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 137' ' ' ILE . 35.5 m -62.43 -33.17 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.94 -42.25 99.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.9 -39.91 29.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.664 -0.903 . . . . 0.0 109.624 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 106' ' ' LEU . 9.9 tt -59.9 -49.19 78.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.827 -0.546 . . . . 0.0 109.527 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -63.9 -29.44 70.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.24 -48.41 67.85 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.391 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -40.03 95.77 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.682 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 115' ' ' GLU . 1.5 mp -55.95 -44.29 78.28 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.0 m -60.04 -31.08 69.63 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.577 0.703 . . . . 0.0 109.754 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.14 -14.79 63.72 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -96.53 7.27 46.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -1.124 . . . . 0.0 112.557 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 31.53 5.05 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.551 ' HG2' HD23 ' A' ' 110' ' ' LEU . 18.2 tp10 -113.52 120.17 40.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.877 -0.778 . . . . 0.0 109.952 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.5 60.3 1.01 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 0.0 109.879 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 85.7 mt -91.41 148.8 22.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -110.76 142.75 42.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 28.6 t0 -39.37 -29.27 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 O-C-N 121.376 -0.827 . . . . 0.0 112.571 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.87 -53.04 61.24 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -0.855 . . . . 0.0 108.808 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -76.75 -42.83 39.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.624 -0.673 . . . . 0.0 110.169 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 62.6 t -60.25 -35.82 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.568 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.63 -38.41 87.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.184 -0.947 . . . . 0.0 109.115 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.63 -45.36 92.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.591 -0.693 . . . . 0.0 109.527 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.33 -51.47 68.7 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.587 -0.696 . . . . 0.0 110.151 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.411 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 8.5 mt -59.99 -19.04 50.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.634 -0.667 . . . . 0.0 110.962 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -57.06 -24.0 50.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.501 -0.75 . . . . 0.0 110.93 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.27 25.41 8.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 62.0 t -106.74 120.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -1.113 . . . . 0.0 109.659 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.52 103.0 15.45 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.487 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.71 HG12 ' CG1' ' A' ' 137' ' ' ILE . 23.6 m -86.74 161.38 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -95.87 -171.98 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 110.946 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 p -72.08 -0.21 11.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.84 -0.537 . . . . 0.0 111.752 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.68 -11.09 15.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.944 -1.098 . . . . 0.0 110.257 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.89 24.55 52.49 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.777 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.4 mt-10 -110.96 141.62 44.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.392 -1.064 . . . . 0.0 110.966 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 1.062 HD13 HG13 ' A' ' 103' ' ' VAL . 3.4 mp -127.05 147.22 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.311 0.577 . . . . 0.0 109.657 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.23 116.29 9.5 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.227 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.48 ' CZ ' ' HG3' ' A' ' 140' ' ' LYS . 7.2 p90 -68.15 -34.14 75.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.653 -0.654 . . . . 0.0 111.983 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 13.8 mttt -69.97 -28.85 65.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.342 -0.849 . . . . 0.0 111.278 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -80.42 -43.22 21.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 112.254 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.6 t80 -70.9 -30.72 67.14 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.0 111.727 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 86' ' ' PHE . 18.2 pt -83.69 -44.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.114 -0.991 . . . . 0.0 110.579 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.424 ' N ' HG13 ' A' ' 143' ' ' ILE . 65.3 mt-10 -67.33 -26.53 66.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.72 -13.98 46.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.273 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 142' ' ' PHE . 70.4 t -95.31 -37.82 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.02 -27.4 66.88 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.293 0.568 . . . . 0.0 110.933 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -51.31 133.8 28.59 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.626 -0.672 . . . . 0.0 111.018 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.275 179.906 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.695 0.759 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.44 160.69 19.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.94 -0.475 . . . . 0.0 110.464 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -109.21 160.71 15.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.81 0.814 . . . . 0.0 110.79 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 87' ' ' VAL . 16.2 m -51.32 -31.08 20.42 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.698 0.761 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -51.39 -37.43 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.854 -0.529 . . . . 0.0 111.152 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.473 ' OD1' HD21 ' A' ' 113' ' ' LEU . 13.4 t0 -64.64 -45.55 86.3 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.682 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.658 ' HE2' HD21 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -74.65 -38.39 62.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.729 -0.607 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.639 ' CG2' HG22 ' A' ' 83' ' ' THR . 64.8 t -66.56 -47.09 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.141 -0.974 . . . . 0.0 111.041 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 92' ' ' VAL . 24.1 tptt -60.06 -35.32 74.9 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.582 -0.699 . . . . 0.0 111.419 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.74 -52.8 62.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.456 -0.777 . . . . 0.0 111.816 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.48 -53.61 7.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 111.367 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.417 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 35.3 mt-30 -48.09 -36.19 12.7 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.291 -0.88 . . . . 0.0 112.854 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 88' ' ' LYS . 85.5 t -62.25 -35.74 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 109.981 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.05 -50.97 35.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.363 -0.835 . . . . 0.0 109.276 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 91' ' ' GLN . 2.6 p30 -77.67 82.39 4.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.214 -0.929 . . . . 0.0 109.663 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -61.16 -26.86 67.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.817 -0.552 . . . . 0.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.65 17.97 5.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.17 -0.956 . . . . 0.0 111.015 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.6 t 38.5 37.11 0.16 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.1 p -63.9 -34.91 79.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.082 -1.011 . . . . 0.0 109.24 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.85 59.59 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' C ' HG13 ' A' ' 101' ' ' VAL . 48.0 mttm -131.77 153.38 50.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.266 . . . . 0.0 110.176 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.619 ' CG2' HD12 ' A' ' 106' ' ' LEU . 34.0 m -150.37 161.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.381 -0.825 . . . . 0.0 110.28 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -83.08 145.85 29.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.502 -0.749 . . . . 0.0 109.923 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.1 p -57.26 -39.99 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.423 -0.798 . . . . 0.0 110.741 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.67 -41.47 97.44 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -80.08 -41.87 24.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.512 -0.993 . . . . 0.0 110.539 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.619 HD12 ' CG2' ' A' ' 101' ' ' VAL . 9.8 tt -60.06 -49.76 76.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.639 -0.663 . . . . 0.0 109.959 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -64.24 -31.65 72.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 110.265 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -67.45 -48.83 66.07 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -33.57 65.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.804 . . . . 0.0 110.583 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 27.7 tp -54.57 -44.32 72.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' GLU . 25.4 m -67.41 -15.87 63.92 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.061 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.98 -14.51 64.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.499 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -94.82 8.02 44.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -1.055 . . . . 0.0 112.583 -177.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 31.0 5.05 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 58.5 mm-40 -114.18 120.72 41.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.929 -0.748 . . . . 0.0 109.638 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -122.8 60.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.39 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 72.6 mt -89.95 148.26 23.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.3 m -110.6 141.66 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -0.903 . . . . 0.0 110.16 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 26.2 t0 -39.2 -30.83 0.06 Allowed 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.566 -0.709 . . . . 0.0 112.161 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.63 -51.75 67.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -77.28 -40.73 43.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.722 -0.611 . . . . 0.0 110.454 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 62.2 t -62.55 -35.36 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.607 -0.683 . . . . 0.0 110.466 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -64.21 -38.03 89.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -59.97 -46.86 88.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.619 -0.676 . . . . 0.0 109.521 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.3 -46.95 86.47 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.659 0.742 . . . . 0.0 109.944 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.97 -18.96 60.21 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.85 -0.531 . . . . 0.0 111.205 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.75 -21.32 27.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.218 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.43 -12.04 11.14 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.89 134.24 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.08 -1.247 . . . . 0.0 110.242 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -102.4 102.96 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.602 . . . . 0.0 111.804 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.427 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.4 p -85.69 157.31 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.05 -179.17 4.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.288 -0.883 . . . . 0.0 111.287 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -71.0 -2.61 15.95 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.874 -0.516 . . . . 0.0 111.854 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -107.33 -12.19 15.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.429 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.15 27.09 22.0 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' HD12 ' A' ' 137' ' ' ILE . 64.3 mt-10 -110.87 135.65 51.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.938 . . . . 0.0 111.068 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.556 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.2 mp -128.32 140.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -68.93 111.29 4.87 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.657 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 143' ' ' ILE . 18.6 p90 -64.48 -32.51 74.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.481 -0.762 . . . . 0.0 112.095 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.2 mtmp? -71.22 -35.93 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.258 -0.901 . . . . 0.0 111.067 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -70.41 -44.51 67.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.684 -0.635 . . . . 0.0 111.659 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 146' ' ' VAL . 29.2 t80 -70.02 -29.15 66.13 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.431 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 139' ' ' TYR . 32.4 pt -80.27 -43.68 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 110.197 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.461 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.7 mt-10 -62.59 -26.84 68.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.266 -0.896 . . . . 0.0 109.929 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.1 -12.31 44.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.355 -0.841 . . . . 0.0 110.276 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 142' ' ' PHE . 54.5 t -95.92 -39.94 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.658 HD21 ' HE2' ' A' ' 86' ' ' PHE . 52.7 mt -57.53 -18.65 20.25 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.941 -0.474 . . . . 0.0 111.565 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -59.94 -40.09 87.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.245 -0.91 . . . . 0.0 110.22 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.294 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.8 tptt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.776 0.798 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.51 160.43 16.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.888 -0.508 . . . . 0.0 110.004 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -109.07 160.17 16.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.849 . . . . 0.0 111.001 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.88 HG22 ' CG2' ' A' ' 87' ' ' VAL . 23.8 m -51.15 -30.5 16.81 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.612 0.72 . . . . 0.0 109.54 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -52.3 -37.27 55.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.871 -0.518 . . . . 0.0 111.275 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -60.04 -51.05 71.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.56 -0.713 . . . . 0.0 109.865 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -75.62 -39.69 57.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 110.814 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.88 ' CG2' HG22 ' A' ' 83' ' ' THR . 99.8 t -61.25 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.26 -0.9 . . . . 0.0 110.282 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 92' ' ' VAL . 37.8 mmtt -60.07 -36.16 76.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.651 -0.656 . . . . 0.0 110.923 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.491 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -62.32 -49.04 77.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.708 -0.62 . . . . 0.0 111.565 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.703 ' CE2' HD12 ' A' ' 106' ' ' LEU . 19.0 m-85 -77.41 -56.07 4.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 111.751 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.539 ' OE1' HG12 ' A' ' 87' ' ' VAL . 66.5 mt-30 -48.16 -34.27 9.7 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 88' ' ' LYS . 81.8 t -61.84 -34.55 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.814 -1.178 . . . . 0.0 109.657 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -72.58 -52.1 16.95 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.66 81.77 8.72 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -60.39 -21.16 61.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.688 -0.632 . . . . 0.0 111.002 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.97 18.91 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.147 -0.971 . . . . 0.0 111.044 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.5 m 38.73 37.43 0.19 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.5 p -64.24 -35.6 81.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.0 12.52 60.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.442 ' C ' HG23 ' A' ' 101' ' ' VAL . 89.2 mttt -131.74 151.61 51.52 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.247 . . . . 0.0 110.155 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 100' ' ' LYS . 48.1 t -149.84 162.51 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.349 -0.844 . . . . 0.0 109.97 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 101' ' ' VAL . 8.9 p -84.95 148.16 26.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.517 -0.74 . . . . 0.0 109.991 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.775 ' CG2' HD13 ' A' ' 137' ' ' ILE . 98.1 t -56.23 -40.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.34 94.03 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -81.05 -42.75 20.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.238 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.703 HD12 ' CE2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -60.08 -49.92 75.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 110.222 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -67.04 -31.01 71.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.581 -0.699 . . . . 0.0 110.792 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.7 -47.81 65.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.67 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -40.61 92.33 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.508 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -45.07 77.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.474 -0.89 . . . . 0.0 108.675 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -59.94 -28.36 67.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.538 0.685 . . . . 0.0 109.9 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.59 63.38 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.77 6.9 47.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.295 -1.12 . . . . 0.0 112.76 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.11 31.46 5.03 Favored Glycine 0 N--CA 1.501 3.009 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -114.13 121.0 42.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.792 -0.828 . . . . 0.0 109.871 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -122.33 59.89 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.051 0.929 . . . . 0.0 109.598 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.13 148.92 22.04 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.0 p -110.77 142.21 43.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 0.0 110.024 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.41 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 35.8 t0 -39.87 -28.46 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 O-C-N 121.297 -0.877 . . . . 0.0 112.543 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.95 -52.59 63.43 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.7 -43.01 39.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 110.312 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 59.3 t -60.04 -35.53 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.497 -0.752 . . . . 0.0 110.562 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -63.21 -37.32 86.76 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.216 -0.927 . . . . 0.0 109.275 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.81 -46.03 90.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.559 -0.713 . . . . 0.0 109.578 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 129' ' ' VAL . 11.0 mp -61.19 -48.44 81.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.541 -0.724 . . . . 0.0 109.825 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.33 -21.34 66.58 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.859 -0.526 . . . . 0.0 111.05 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -57.19 -22.23 39.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.497 -0.752 . . . . 0.0 111.104 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.69 -14.32 8.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 125' ' ' LEU . 72.4 t -68.37 134.11 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.044 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.91 99.1 11.2 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 111.71 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 137' ' ' ILE . 7.4 p -82.33 156.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.51 -177.79 4.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -71.46 -0.92 11.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.773 -0.579 . . . . 0.0 111.954 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -107.5 -12.52 15.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.843 -1.161 . . . . 0.0 110.442 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.4 25.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 137' ' ' ILE . 46.2 mt-10 -111.91 136.14 51.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.962 . . . . 0.0 111.086 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.775 HD13 ' CG2' ' A' ' 103' ' ' VAL . 4.0 mp -126.98 141.38 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -69.41 106.67 3.03 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.433 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.487 ' O ' HD12 ' A' ' 143' ' ' ILE . 54.4 p90 -62.51 -35.8 80.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.301 -0.874 . . . . 0.0 112.128 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.459 ' CG ' ' CE1' ' A' ' 139' ' ' TYR . 19.4 mtpp -58.44 -56.57 20.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.278 -0.889 . . . . 0.0 111.052 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -59.91 -39.1 84.27 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.786 -0.572 . . . . 0.0 111.585 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 146' ' ' VAL . 18.4 t80 -70.05 -28.98 65.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 0.0 109.685 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 139' ' ' TYR . 69.3 mt -83.27 -50.03 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.713 . . . . 0.0 109.725 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.72 -27.01 67.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.466 -0.771 . . . . 0.0 110.11 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -87.85 -12.98 43.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.861 . . . . 0.0 110.466 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 142' ' ' PHE . 41.7 t -95.82 -39.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.54 -27.29 62.49 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.318 0.58 . . . . 0.0 110.679 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -53.01 140.21 25.68 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.664 -0.647 . . . . 0.0 110.801 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.267 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.776 0.798 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.91 160.59 16.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.838 -0.539 . . . . 0.0 110.198 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -109.58 159.66 16.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 111.084 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.78 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.3 m -50.89 -30.43 14.59 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.695 0.76 . . . . 0.0 109.564 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.62 -37.01 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.842 -0.536 . . . . 0.0 111.279 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.98 -50.5 73.49 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.0 m-85 -76.48 -40.57 49.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.687 -0.633 . . . . 0.0 110.944 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.78 ' CG2' HG22 ' A' ' 83' ' ' THR . 71.8 t -60.34 -57.21 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.83 . . . . 0.0 110.958 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 91' ' ' GLN . 57.3 tptt -54.45 -32.55 57.83 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.451 -0.781 . . . . 0.0 111.022 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.575 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -65.17 -44.77 87.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.743 -0.598 . . . . 0.0 111.89 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 143' ' ' ILE . 14.3 m-85 -80.61 -56.88 3.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.916 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' CG ' ' HA ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -48.59 -36.56 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.3 p -60.01 -35.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.01 -1.056 . . . . 0.0 109.655 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -71.62 -47.41 54.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 80.6 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.444 -0.785 . . . . 0.0 110.593 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -60.52 -38.22 83.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.569 -0.707 . . . . 0.0 110.738 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.54 20.44 5.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t 37.98 36.85 0.12 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.1 p -64.17 -34.47 78.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.209 -0.932 . . . . 0.0 109.519 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.04 13.31 57.86 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' C ' HG23 ' A' ' 101' ' ' VAL . 48.8 mttm -132.47 151.89 51.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.095 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 100' ' ' LYS . 58.8 t -148.41 159.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.39 -0.818 . . . . 0.0 109.494 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -79.82 144.3 33.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.773 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.1 p -55.81 -38.76 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.417 -0.802 . . . . 0.0 110.542 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.446 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.98 -40.69 97.29 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -81.15 -40.0 24.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.885 . . . . 0.0 110.511 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 106' ' ' LEU . 9.7 tt -59.18 -49.82 76.41 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.63 -0.668 . . . . 0.0 110.173 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -67.03 -28.87 68.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.787 . . . . 0.0 111.075 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.18 -48.51 70.46 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.372 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -40.78 98.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.06 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.68 HD23 ' HG3' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.95 -44.64 78.61 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.7 m -60.06 -31.44 69.99 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.502 0.668 . . . . 0.0 109.619 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.79 64.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.575 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -96.15 7.85 45.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -1.136 . . . . 0.0 112.475 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 31.78 4.91 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.721 ' OE2' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -113.22 119.88 39.28 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.742 -0.858 . . . . 0.0 110.28 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.77 59.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.798 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.721 HD12 ' OE2' ' A' ' 115' ' ' GLU . 90.6 mt -90.02 148.72 22.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 m -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.04 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 11.6 t70 -40.06 -27.47 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 O-C-N 121.231 -0.918 . . . . 0.0 112.95 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.09 60.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.195 -0.941 . . . . 0.0 109.072 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.54 -41.95 44.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.485 HG12 HD12 ' A' ' 126' ' ' LEU . 62.6 t -59.97 -35.92 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 110.258 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.71 -37.11 86.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.085 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -63.71 -49.88 71.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.577 0.703 . . . . 0.0 109.978 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 122' ' ' VAL . 34.1 mt -61.87 -16.64 52.0 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.826 -0.547 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -56.8 -20.58 23.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.398 -0.814 . . . . 0.0 111.173 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 25.65 8.29 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 62.6 t -107.32 129.98 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.294 -1.121 . . . . 0.0 109.783 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 100.54 11.38 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.885 0.85 . . . . 0.0 112.418 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.3 p -83.47 158.88 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -95.62 -179.04 4.6 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.835 0.826 . . . . 0.0 111.423 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.4 m -70.97 -1.67 12.74 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.833 -0.542 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -107.66 -11.96 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.998 -1.064 . . . . 0.0 110.434 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.94 28.79 17.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.487 ' C ' HD12 ' A' ' 137' ' ' ILE . 67.8 mt-10 -111.15 135.58 51.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.931 . . . . 0.0 111.153 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.5 mp -125.35 168.55 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 137' ' ' ILE . 19.7 t0 -98.19 112.02 24.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.448 -0.782 . . . . 0.0 110.148 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.487 ' HA ' HD11 ' A' ' 106' ' ' LEU . 43.9 p90 -65.92 -34.22 77.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.471 -0.768 . . . . 0.0 112.171 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 mttt -70.04 -40.02 75.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.075 -1.016 . . . . 0.0 110.946 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.19 -43.82 81.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.629 -0.669 . . . . 0.0 111.391 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.5 t80 -71.66 -27.87 63.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.578 -0.701 . . . . 0.0 110.993 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.6 HD11 ' CE1' ' A' ' 90' ' ' PHE . 96.6 mt -83.93 -51.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.812 . . . . 0.0 110.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -61.93 -26.4 68.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 111.016 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.14 -16.44 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 142' ' ' PHE . 76.8 t -97.19 -42.88 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.14 -0.975 . . . . 0.0 109.187 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.465 HD11 ' HE2' ' A' ' 86' ' ' PHE . 4.0 mm? -66.71 -16.14 64.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.703 -0.623 . . . . 0.0 111.721 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -59.92 136.26 57.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.31 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.6 tptt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.754 0.788 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.03 161.18 13.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.829 -0.544 . . . . 0.0 110.07 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -108.56 154.48 21.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 110.94 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.641 HG22 ' CG1' ' A' ' 87' ' ' VAL . 5.3 m -50.75 -30.41 13.91 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 44.0 mt-10 -50.49 -35.87 31.15 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.687 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.89 -47.22 75.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.595 -0.691 . . . . 0.0 110.326 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 147' ' ' LEU . 21.3 m-85 -77.42 -39.95 45.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.656 -0.653 . . . . 0.0 112.692 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.641 ' CG1' HG22 ' A' ' 83' ' ' THR . 33.4 m -68.22 -41.87 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.826 -1.171 . . . . 0.0 110.801 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 92' ' ' VAL . 34.2 mttt -60.05 -33.7 72.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.487 -0.758 . . . . 0.0 110.187 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' A' ' 113' ' ' LEU . . . -58.75 -56.5 21.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.64 -0.663 . . . . 0.0 111.067 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' HD12 ' A' ' 106' ' ' LEU . 56.0 m-85 -77.34 -53.14 8.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 111.048 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -49.03 -42.71 39.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.497 -0.752 . . . . 0.0 112.436 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 88' ' ' LYS . 76.1 t -58.91 -39.26 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.861 -1.149 . . . . 0.0 109.611 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.03 -43.65 87.0 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.61 81.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -62.15 -37.38 84.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.606 -0.684 . . . . 0.0 110.868 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -89.94 17.06 7.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.9 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.3 t 37.69 37.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.6 p -63.78 -33.29 75.34 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.12 -0.988 . . . . 0.0 109.465 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.17 54.69 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.187 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' C ' HG13 ' A' ' 101' ' ' VAL . 81.3 mttt -132.19 153.41 50.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -1.191 . . . . 0.0 109.9 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.476 HG21 HD13 ' A' ' 106' ' ' LEU . 35.6 m -148.86 159.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.283 -0.886 . . . . 0.0 110.388 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.8 p -84.75 147.66 26.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.575 . . . . 0.0 110.222 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.639 ' CG2' HD13 ' A' ' 137' ' ' ILE . 86.4 t -57.36 -39.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.366 -0.834 . . . . 0.0 110.238 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.42 -41.61 95.34 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.31 -39.79 28.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.579 -0.954 . . . . 0.0 110.216 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.689 HD12 ' CE1' ' A' ' 90' ' ' PHE . 28.7 tp -60.04 -49.0 79.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.75 -0.594 . . . . 0.0 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -66.77 -29.83 69.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 111.036 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.76 -48.85 62.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.078 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -38.57 77.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.368 -0.832 . . . . 0.0 110.667 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.585 HD23 ' HG2' ' A' ' 115' ' ' GLU . 6.3 tp -55.09 -44.2 74.65 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -61.49 -25.21 67.11 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.511 0.672 . . . . 0.0 110.081 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.39 -14.52 63.72 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.724 ' CD2' ' HB2' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -94.55 7.88 44.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.317 -1.108 . . . . 0.0 112.214 -177.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.63 32.5 4.78 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.585 ' HG2' HD23 ' A' ' 110' ' ' LEU . 3.5 tp10 -113.98 119.94 38.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.99 -0.712 . . . . 0.0 110.342 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -122.32 59.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.0 109.579 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 90.3 mt -90.97 148.78 22.19 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 p -111.18 141.62 44.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -40.09 -27.79 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 O-C-N 121.311 -0.868 . . . . 0.0 112.84 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.468 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . . . -62.1 -52.56 63.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.294 -0.878 . . . . 0.0 109.16 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.468 ' OE1' ' HB3' ' A' ' 120' ' ' ALA . 1.3 mp0 -76.62 -42.92 40.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 58.5 t -59.99 -35.42 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.669 -0.644 . . . . 0.0 110.608 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.76 -38.09 89.81 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.294 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.01 -46.36 89.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.615 -0.678 . . . . 0.0 109.71 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -50.02 74.1 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.559 0.695 . . . . 0.0 109.884 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.41 -18.98 43.64 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.772 -0.58 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.05 -21.96 35.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.471 -0.768 . . . . 0.0 111.161 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.23 -12.91 10.36 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.3 t -68.98 130.02 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.098 -1.237 . . . . 0.0 110.169 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -99.15 103.64 15.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.437 0.637 . . . . 0.0 111.589 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -87.77 159.69 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.37 -177.05 4.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.8 p -69.58 -2.39 11.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.933 -0.479 . . . . 0.0 112.159 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -105.07 -6.26 20.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.948 -1.095 . . . . 0.0 110.225 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.83 23.23 60.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.451 ' C ' HD12 ' A' ' 137' ' ' ILE . 48.4 mt-10 -110.41 145.91 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 110.984 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.639 HD13 ' CG2' ' A' ' 103' ' ' VAL . 3.5 mp -131.55 170.09 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.6 t70 -95.24 116.91 29.38 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.62 ' O ' HD12 ' A' ' 143' ' ' ILE . 47.8 p90 -65.47 -39.83 92.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.56 -0.712 . . . . 0.0 111.751 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.2 mttt -64.56 -40.03 94.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.529 -0.732 . . . . 0.0 110.469 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -68.17 -43.94 77.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.779 -0.575 . . . . 0.0 111.225 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.607 ' O ' HG23 ' A' ' 146' ' ' VAL . 16.9 t80 -69.89 -28.67 65.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.523 -0.736 . . . . 0.0 110.357 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 139' ' ' TYR . 42.8 mt -76.15 -46.89 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.521 -0.737 . . . . 0.0 109.133 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.6 -28.78 69.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.41 -0.806 . . . . 0.0 110.496 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -88.37 -12.0 44.59 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.861 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 142' ' ' PHE . 53.0 t -95.12 -38.15 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 143' ' ' ILE . 5.1 mp -55.93 -21.11 18.8 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.167 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -57.64 140.03 52.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.35 -0.844 . . . . 0.0 110.371 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.215 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 mttt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.885 0.85 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.01 159.77 17.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.905 -0.497 . . . . 0.0 110.381 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -108.81 161.62 14.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 110.895 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 87' ' ' VAL . 4.0 m -50.91 -31.35 17.31 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -50.97 -35.94 36.35 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.854 -0.529 . . . . 0.0 111.079 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.653 ' OD1' HD11 ' A' ' 113' ' ' LEU . 44.8 t0 -59.96 -50.61 73.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.62 -0.675 . . . . 0.0 109.834 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.651 ' CE1' HD23 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -76.53 -40.08 51.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.708 -0.62 . . . . 0.0 110.79 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 83' ' ' THR . 97.7 t -59.09 -53.3 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.272 -0.893 . . . . 0.0 110.344 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 92' ' ' VAL . 29.0 tttt -59.99 -34.24 73.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.681 -0.637 . . . . 0.0 110.402 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.94 -54.27 48.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 111.026 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE1' HD11 ' A' ' 143' ' ' ILE . 47.7 m-85 -77.63 -54.43 6.4 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.371 -0.83 . . . . 0.0 111.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -48.91 -39.56 26.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.503 -0.748 . . . . 0.0 112.922 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 88' ' ' LYS . 73.8 t -59.2 -37.69 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.852 -1.155 . . . . 0.0 109.652 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -69.44 -46.46 66.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -64.34 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.0 110.641 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -60.01 -39.34 85.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.5 -0.75 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -91.61 20.7 5.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.314 -0.866 . . . . 0.0 110.899 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 p 38.36 37.95 0.2 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 p -64.06 -34.72 78.67 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.254 -0.979 . . . . 0.0 109.384 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 14.48 55.24 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 59.4 mttt -132.93 154.88 50.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.054 -1.263 . . . . 0.0 110.528 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.454 HG13 ' C ' ' A' ' 100' ' ' LYS . 34.0 m -150.08 159.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.402 -0.811 . . . . 0.0 109.783 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -81.98 144.57 30.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.0 110.007 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.4 p -56.75 -38.9 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.538 -0.726 . . . . 0.0 110.772 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.44 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.82 -41.32 97.6 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.53 -39.1 28.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.547 -0.972 . . . . 0.0 110.527 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.451 HD12 ' CG2' ' A' ' 101' ' ' VAL . 7.5 tt -60.08 -49.95 75.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 110.108 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -63.44 -29.61 70.87 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.517 -0.74 . . . . 0.0 110.313 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.32 -47.48 67.44 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -39.71 87.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.39 -0.819 . . . . 0.0 110.574 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.665 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -54.84 -44.82 74.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 m -60.83 -26.54 67.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.49 0.662 . . . . 0.0 109.966 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.06 -15.21 63.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.653 HD11 ' OD1' ' A' ' 85' ' ' ASP . 21.7 tp -95.65 8.08 44.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 112.399 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.91 33.48 4.34 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.665 ' HG2' HD23 ' A' ' 110' ' ' LEU . 4.6 tp10 -114.25 119.81 38.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.02 -0.694 . . . . 0.0 110.174 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -122.1 59.43 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.074 0.94 . . . . 0.0 109.612 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.53 HD11 ' OE2' ' A' ' 115' ' ' GLU . 61.5 mt -90.53 148.76 22.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 p -110.83 141.59 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -39.69 -28.89 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.35 -0.844 . . . . 0.0 112.62 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.73 -51.79 66.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -76.78 -43.12 38.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.581 -0.7 . . . . 0.0 110.549 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.0 t -59.97 -34.9 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 110.592 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -64.98 -36.82 85.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.138 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.76 -47.33 86.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.478 ' HA ' HD13 ' A' ' 125' ' ' LEU . 4.3 mm? -62.15 -46.63 88.15 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.69 0.757 . . . . 0.0 109.879 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.2 -19.52 63.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.907 -0.496 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -56.74 -21.03 25.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 0.0 111.191 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.34 -11.95 11.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.36 130.48 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.091 -1.241 . . . . 0.0 110.211 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -101.82 104.17 14.92 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.409 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.541 HG12 ' CG1' ' A' ' 137' ' ' ILE . 19.9 m -87.96 161.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.22 -176.2 3.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.59 -0.92 9.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.834 -0.541 . . . . 0.0 111.901 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -107.73 -10.06 15.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.923 -1.111 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.29 25.89 38.34 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.612 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.1 mt-10 -109.72 139.98 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.573 -0.957 . . . . 0.0 110.973 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.0 mp -130.64 140.98 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -68.88 110.77 4.55 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.813 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 43.8 p90 -62.76 -34.02 76.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.491 -0.755 . . . . 0.0 112.004 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.7 mtmt -69.31 -38.67 78.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.272 -0.893 . . . . 0.0 110.581 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.33 -45.01 70.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.744 -0.597 . . . . 0.0 111.587 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.613 ' O ' HG23 ' A' ' 146' ' ' VAL . 22.0 t80 -70.56 -28.8 65.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.449 -0.782 . . . . 0.0 110.645 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.548 HD13 ' CD1' ' A' ' 86' ' ' PHE . 85.5 mt -79.28 -47.95 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.509 -0.744 . . . . 0.0 109.646 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -60.41 -26.5 66.74 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.499 -0.75 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.0 -13.29 39.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.373 -0.829 . . . . 0.0 110.656 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 142' ' ' PHE . 59.0 t -96.23 -43.22 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 143' ' ' ILE . 70.2 mt -59.06 -18.21 32.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.795 -0.565 . . . . 0.0 111.546 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.0 mmt-85 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.346 -0.846 . . . . 0.0 110.12 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 91.9 mttt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.749 0.785 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.06 159.92 16.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.866 -0.521 . . . . 0.0 110.108 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -110.03 160.02 16.8 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.878 0.847 . . . . 0.0 111.188 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.711 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.4 m -50.58 -30.95 14.44 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.706 0.765 . . . . 0.0 109.738 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -51.1 -36.45 40.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.752 -0.592 . . . . 0.0 111.322 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.44 -44.97 85.63 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.603 -0.686 . . . . 0.0 109.711 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.672 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -76.63 -41.12 47.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.734 -0.604 . . . . 0.0 111.131 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.711 ' CG2' HG22 ' A' ' 83' ' ' THR . 67.5 t -63.7 -52.83 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 111.011 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.674 ' O ' HG13 ' A' ' 92' ' ' VAL . 61.3 tttt -55.73 -32.21 63.18 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.538 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HB3' HD11 ' A' ' 113' ' ' LEU . . . -68.22 -39.94 82.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.581 -0.699 . . . . 0.0 112.344 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 143' ' ' ILE . 26.6 m-85 -80.11 -58.0 3.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.043 -1.036 . . . . 0.0 110.959 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.613 ' OE1' HG12 ' A' ' 87' ' ' VAL . 20.0 pt20 -48.52 -32.76 8.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 88' ' ' LYS . 29.0 m -61.55 -31.38 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.804 -1.185 . . . . 0.0 109.716 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.35 -49.0 29.68 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 80.15 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -62.29 -34.5 76.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.518 -0.739 . . . . 0.0 110.647 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.37 18.51 8.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.233 -0.917 . . . . 0.0 110.657 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.1 m 37.83 35.27 0.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.3 p -63.95 -33.74 76.4 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.198 -0.939 . . . . 0.0 109.316 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 12.08 58.99 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' C ' HG13 ' A' ' 101' ' ' VAL . 21.6 mmtt -131.72 153.65 49.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -1.182 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.522 ' CG2' HD12 ' A' ' 106' ' ' LEU . 31.9 m -149.98 159.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.308 -0.87 . . . . 0.0 110.018 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 144.85 31.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.7 p -56.09 -38.96 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.455 -0.778 . . . . 0.0 110.699 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.99 -40.68 97.29 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.29 -42.25 23.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.545 -0.974 . . . . 0.0 110.574 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.522 HD12 ' CG2' ' A' ' 101' ' ' VAL . 9.8 tt -60.04 -49.91 75.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 109.979 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -64.45 -33.06 75.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.537 -0.727 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -66.24 -48.03 71.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -25.74 59.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.489 -0.757 . . . . 0.0 110.68 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 29.8 tp -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.8 p -66.14 -16.73 64.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.301 0.572 . . . . 0.0 110.695 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.42 65.51 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.57 7.45 45.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.416 -1.05 . . . . 0.0 112.102 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.59 32.99 4.61 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 12.4 mm-40 -114.73 120.98 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.897 -0.766 . . . . 0.0 110.851 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -122.19 59.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.088 0.947 . . . . 0.0 109.297 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.73 149.08 21.79 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -110.87 142.84 42.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -39.83 -27.8 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.814 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.72 62.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.228 -0.92 . . . . 0.0 108.932 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.7 -43.3 38.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.588 -0.695 . . . . 0.0 110.425 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.99 -35.64 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.05 -39.1 93.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.24 -0.912 . . . . 0.0 109.171 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.437 -0.789 . . . . 0.0 109.641 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.32 -48.4 81.89 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.984 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 35.1 mt -60.62 -18.14 51.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.799 -0.563 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.56 -21.47 26.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.23 25.77 8.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 65.8 t -107.67 129.84 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -1.103 . . . . 0.0 109.855 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -102.59 103.03 13.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.751 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.64 HG12 ' CG1' ' A' ' 137' ' ' ILE . 20.1 m -86.05 161.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -95.28 -177.08 3.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 111.281 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.7 p -70.23 -0.8 8.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.907 -0.496 . . . . 0.0 112.01 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -107.5 -9.08 16.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.94 -1.1 . . . . 0.0 110.365 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.59 28.41 29.72 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.617 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.9 mt-10 -110.48 139.27 45.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.955 . . . . 0.0 110.969 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.64 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.6 mp -127.63 143.37 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.3 115.23 8.33 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.037 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.488 ' O ' HD12 ' A' ' 143' ' ' ILE . 10.7 p90 -67.2 -35.26 79.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.723 -0.611 . . . . 0.0 111.769 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 25.3 mttt -70.98 -39.98 72.17 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.352 -0.842 . . . . 0.0 111.032 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.15 -44.57 83.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 111.705 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 146' ' ' VAL . 23.1 t80 -70.02 -28.0 65.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.491 -0.756 . . . . 0.0 110.42 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 139' ' ' TYR . 96.3 mt -79.57 -48.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.382 -0.824 . . . . 0.0 110.133 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -59.99 -27.74 67.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.486 -0.759 . . . . 0.0 110.278 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.4 -16.1 31.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 110.64 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 142' ' ' PHE . 54.1 t -97.52 -48.07 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.128 -0.983 . . . . 0.0 108.87 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -24.62 67.59 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.7 -0.625 . . . . 0.0 111.222 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -55.04 -48.05 73.94 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.486 -0.759 . . . . 0.0 110.597 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.274 -179.9 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.64 0.733 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.43 160.65 18.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.891 -0.505 . . . . 0.0 110.362 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.47 160.28 15.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.87 . . . . 0.0 110.973 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.742 HG22 ' CG2' ' A' ' 87' ' ' VAL . 7.4 m -51.18 -30.58 17.34 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.702 0.763 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -52.46 -37.07 56.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.841 -0.537 . . . . 0.0 111.28 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -61.05 -50.06 74.85 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.573 -0.704 . . . . 0.0 109.919 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.663 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.5 m-85 -75.97 -38.87 57.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.771 -0.581 . . . . 0.0 111.264 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.742 ' CG2' HG22 ' A' ' 83' ' ' THR . 76.4 t -64.17 -50.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.213 -0.929 . . . . 0.0 110.678 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -59.95 -34.17 72.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.547 -0.721 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.592 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -67.39 -44.28 79.25 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.664 -0.648 . . . . 0.0 111.736 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.524 ' CE2' HD11 ' A' ' 143' ' ' ILE . 8.9 m-85 -78.49 -58.91 3.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.093 -1.005 . . . . 0.0 111.654 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -48.35 -28.97 3.5 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -62.13 -32.68 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.999 -1.063 . . . . 0.0 109.848 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -71.53 -50.87 27.07 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.33 81.35 6.66 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.377 -0.827 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -63.1 -17.16 62.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.83 16.11 7.36 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.05 -1.031 . . . . 0.0 110.945 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.4 p 39.1 35.84 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 100' ' ' LYS . 3.4 t -63.11 -33.99 76.65 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.097 -1.002 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.52 9.66 58.72 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.014 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.637 ' H ' HG23 ' A' ' 98' ' ' THR . 1.5 mptt -132.16 154.94 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.239 . . . . 0.0 110.382 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 106' ' ' LEU . 28.8 m -151.04 160.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.371 -0.831 . . . . 0.0 109.914 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -82.04 144.86 30.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.574 -0.704 . . . . 0.0 109.956 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 11.5 p -57.07 -40.0 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.493 -0.755 . . . . 0.0 110.836 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.33 -41.4 96.89 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.14 -39.84 28.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.579 -0.954 . . . . 0.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 101' ' ' VAL . 5.8 tt -59.94 -49.73 76.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.67 -0.644 . . . . 0.0 110.102 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -64.46 -30.26 71.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.697 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -67.89 -48.01 67.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.591 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -41.0 97.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.11 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.623 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.5 tp -55.78 -44.77 78.04 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.9 m -60.12 -30.61 69.39 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.616 0.722 . . . . 0.0 109.704 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.52 -14.65 63.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.663 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.42 7.09 47.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 112.762 -177.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.79 4.94 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.623 ' HG2' HD23 ' A' ' 110' ' ' LEU . 12.0 tp10 -113.75 119.97 39.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.925 -0.75 . . . . 0.0 109.992 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -121.96 59.22 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.002 0.906 . . . . 0.0 109.598 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 75.5 mt -90.85 148.58 22.4 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -111.17 141.36 44.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -39.9 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 O-C-N 121.353 -0.842 . . . . 0.0 112.726 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.0 61.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.434 -0.791 . . . . 0.0 109.0 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -76.71 -42.94 39.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.692 -0.63 . . . . 0.0 110.384 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 126' ' ' LEU . 57.5 t -60.02 -35.25 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.587 -0.695 . . . . 0.0 110.466 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.01 -39.44 94.78 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.255 -0.903 . . . . 0.0 109.004 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.09 -49.38 77.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.624 -0.673 . . . . 0.0 109.537 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.19 -49.97 75.51 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.571 0.7 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.745 ' O ' HG12 ' A' ' 129' ' ' VAL . 63.2 mt -61.96 -17.22 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.915 -0.491 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -57.47 -16.77 10.48 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.306 -0.871 . . . . 0.0 111.895 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.12 -11.06 11.22 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.051 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 126' ' ' LEU . 8.8 p -69.51 133.95 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.94 -1.329 . . . . 0.0 110.854 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -103.3 102.48 12.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.393 0.616 . . . . 0.0 111.093 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.691 HG12 ' CG1' ' A' ' 137' ' ' ILE . 21.5 m -86.38 160.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -94.91 -176.39 3.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.473 -0.767 . . . . 0.0 111.114 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -69.95 -0.99 8.37 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.866 -0.521 . . . . 0.0 112.055 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -107.28 -7.74 16.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.949 -1.095 . . . . 0.0 110.438 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.08 27.2 38.02 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.649 ' C ' HD12 ' A' ' 137' ' ' ILE . 88.4 mt-10 -108.62 140.07 42.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.598 -0.942 . . . . 0.0 111.125 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.691 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.4 mp -128.42 169.02 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 137' ' ' ILE . 47.0 t0 -96.98 114.05 25.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.368 -0.833 . . . . 0.0 110.134 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.488 ' HA ' HD11 ' A' ' 106' ' ' LEU . 47.6 p90 -66.12 -35.42 80.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.558 -0.714 . . . . 0.0 111.643 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.3 mttt -69.22 -37.05 77.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.308 -0.87 . . . . 0.0 110.661 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -70.06 -44.12 69.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.602 -0.687 . . . . 0.0 111.62 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 146' ' ' VAL . 25.3 t80 -70.36 -28.59 65.24 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.512 -0.743 . . . . 0.0 110.61 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.524 HD11 ' CE2' ' A' ' 90' ' ' PHE . 97.6 mt -76.46 -45.78 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.508 -0.745 . . . . 0.0 109.518 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.72 -26.74 65.88 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.262 -0.899 . . . . 0.0 109.738 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -88.97 -11.64 43.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 110.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 142' ' ' PHE . 62.3 t -96.01 -42.08 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 143' ' ' ILE . 15.2 mt -55.49 -20.35 12.54 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.895 -0.503 . . . . 0.0 111.395 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -58.91 -40.05 83.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.318 -0.864 . . . . 0.0 110.236 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.127 179.777 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.7 mttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.693 0.759 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.28 161.4 13.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.896 -0.502 . . . . 0.0 109.95 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 164.06 13.55 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.104 0.954 . . . . 0.0 111.225 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.724 HG22 ' CG2' ' A' ' 87' ' ' VAL . 3.5 m -50.23 -30.37 11.5 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.396 0.617 . . . . 0.0 110.215 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -53.17 -36.86 61.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.719 -0.613 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.49 -50.88 71.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.53 -0.731 . . . . 0.0 109.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.805 ' CD2' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -76.44 -39.62 52.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 0.0 111.086 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.724 ' CG2' HG22 ' A' ' 83' ' ' THR . 97.5 t -59.98 -47.82 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.166 -0.959 . . . . 0.0 109.901 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 92' ' ' VAL . 16.1 tttp -59.42 -31.95 69.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.713 -0.617 . . . . 0.0 110.368 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' CB ' HD13 ' A' ' 113' ' ' LEU . . . -61.93 -59.33 5.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.732 . . . . 0.0 112.016 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -77.12 -54.3 6.7 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.0 112.342 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.461 ' NE2' HG13 ' A' ' 87' ' ' VAL . 35.9 mt-30 -47.97 -37.87 15.56 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.365 -0.834 . . . . 0.0 113.163 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 88' ' ' LYS . 27.7 m -60.1 -31.35 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.71 -1.244 . . . . 0.0 109.752 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -70.0 -45.46 67.22 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -63.25 81.27 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.458 -0.777 . . . . 0.0 110.892 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -62.81 -40.06 96.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.672 -0.643 . . . . 0.0 110.94 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -91.0 17.0 8.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -0.902 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.6 m 38.05 35.58 0.09 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.8 p -63.73 -33.99 76.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.13 -0.981 . . . . 0.0 109.428 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.78 9.97 53.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.951 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 23.4 mttp -132.86 154.98 49.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.068 -1.254 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.563 ' CG2' HD12 ' A' ' 106' ' ' LEU . 35.1 m -150.16 160.08 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.028 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 p -82.72 145.64 29.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.515 -0.741 . . . . 0.0 110.077 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.6 p -56.95 -39.66 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.475 -0.766 . . . . 0.0 110.649 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.41 -41.11 96.87 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -80.41 -43.3 21.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.534 -0.98 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.563 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.1 tt -59.97 -50.02 75.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.641 -0.662 . . . . 0.0 109.951 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -63.57 -31.88 73.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -66.06 -47.87 72.9 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.088 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.19 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.904 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 ' HG2' ' A' ' 115' ' ' GLU . 9.9 tp -56.2 -44.68 79.71 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.9 m -60.83 -31.39 70.82 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.577 0.704 . . . . 0.0 109.529 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.15 -13.87 67.86 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 86' ' ' PHE . 29.1 tp -95.09 8.44 42.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -1.086 . . . . 0.0 112.123 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.6 4.15 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.547 ' OE2' HD11 ' A' ' 117' ' ' LEU . 17.8 tp10 -114.91 120.4 39.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.952 -0.734 . . . . 0.0 110.769 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -122.27 59.67 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.063 0.935 . . . . 0.0 109.208 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.547 HD11 ' OE2' ' A' ' 115' ' ' GLU . 88.2 mt -92.0 149.74 21.37 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.3 m -110.86 144.14 40.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -40.11 -27.3 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.195 -0.941 . . . . 0.0 112.973 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.61 -52.1 64.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.33 -0.856 . . . . 0.0 109.279 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.35 -46.06 29.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 0.0 110.984 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 48.1 t -58.15 -33.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.352 -0.843 . . . . 0.0 110.513 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.85 -36.85 85.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -0.928 . . . . 0.0 109.001 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.75 -48.02 81.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 125' ' ' LEU . 11.0 mp -63.39 -28.36 69.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.544 -0.722 . . . . 0.0 110.884 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.1 mt -79.67 -15.78 56.95 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.653 . . . . 0.0 112.12 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -18.74 20.94 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.259 -0.9 . . . . 0.0 111.654 -177.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.55 -11.63 11.43 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.665 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.92 129.51 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.083 -1.245 . . . . 0.0 109.936 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -106.03 105.7 15.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.346 0.593 . . . . 0.0 111.623 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.697 HG12 ' CG1' ' A' ' 137' ' ' ILE . 19.7 m -88.86 161.52 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -93.12 -171.89 2.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.29 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -0.96 15.02 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -108.57 -11.14 15.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 110.453 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.19 28.42 28.08 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.61 ' C ' HD12 ' A' ' 137' ' ' ILE . 48.8 mt-10 -109.08 138.04 46.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.909 . . . . 0.0 110.999 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.697 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.9 mp -129.25 140.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -69.54 108.61 3.88 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.816 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE1' ' HG3' ' A' ' 140' ' ' LYS . 50.7 p90 -60.57 -29.47 69.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.432 -0.793 . . . . 0.0 111.871 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 139' ' ' TYR . 61.2 mttt -69.01 -39.99 78.95 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.222 -0.924 . . . . 0.0 110.598 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.87 -43.87 82.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.801 -0.562 . . . . 0.0 111.502 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.6 t80 -70.46 -27.72 64.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 110.256 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.805 HD12 ' CD2' ' A' ' 86' ' ' PHE . 23.5 mm -80.29 -50.38 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.59 -28.72 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.69 -13.72 39.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.207 -0.933 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 142' ' ' PHE . 43.1 t -95.97 -38.21 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 143' ' ' ILE . 3.3 mt -57.87 -19.24 27.88 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.468 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -59.84 139.93 56.97 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.302 -0.874 . . . . 0.0 110.237 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.2 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.4 tttt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.757 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.18 161.2 17.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.96 -0.463 . . . . 0.0 110.26 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -113.25 163.17 15.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 111.007 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.8 m -51.2 -31.29 19.85 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.485 0.66 . . . . 0.0 110.211 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -53.55 -38.68 64.08 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.648 -0.658 . . . . 0.0 111.111 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.52 -45.07 84.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.68 . . . . 0.0 109.571 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.582 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.63 -36.6 62.91 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.819 -0.551 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 83' ' ' THR . 84.1 t -70.9 -43.14 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 110.64 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.68 -35.84 73.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.455 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.446 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -64.92 -49.75 69.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 111.989 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -79.19 -57.73 3.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.049 . . . . 0.0 111.681 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -48.9 -37.26 19.26 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.464 -0.773 . . . . 0.0 112.826 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -58.05 -37.73 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.156 -0.965 . . . . 0.0 109.988 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' N ' HG13 ' A' ' 92' ' ' VAL . 59.4 t80 -66.1 -42.03 89.81 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.481 -0.762 . . . . 0.0 111.069 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -65.75 -24.99 67.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.563 -0.711 . . . . 0.0 110.479 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -106.15 15.69 25.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.661 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.7 t 38.2 63.06 0.88 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -91.65 -33.66 14.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.76 10.9 58.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.88 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' C ' HG13 ' A' ' 101' ' ' VAL . 43.2 mttp -132.27 154.49 49.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.13 -1.218 . . . . 0.0 110.071 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 106' ' ' LEU . 30.9 m -150.36 160.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 p -82.35 145.95 29.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.652 -0.655 . . . . 0.0 109.974 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.1 p -56.43 -39.67 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.461 -0.775 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.463 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.9 -40.8 97.32 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.0 -40.31 28.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.978 . . . . 0.0 110.392 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 101' ' ' VAL . 13.1 tp -59.95 -49.79 76.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 109.934 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -63.87 -32.28 73.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 110.375 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -67.77 -47.51 68.97 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.192 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -30.55 63.07 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.825 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 tp -60.06 -42.04 93.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.862 . . . . 0.0 109.068 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.7 p -68.03 -18.81 64.8 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.49 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.46 -14.72 63.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -93.1 7.15 45.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.381 -1.07 . . . . 0.0 112.362 -177.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.82 4.51 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.92 120.68 40.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 122.03 -0.688 . . . . 0.0 110.131 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.1 59.64 1.0 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.137 0.97 . . . . 0.0 109.815 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 79.9 mt -91.05 148.91 22.06 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.4 m -110.87 142.55 42.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.908 . . . . 0.0 110.086 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 32.7 t0 -39.4 -29.73 0.05 Allowed 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.402 -0.811 . . . . 0.0 112.406 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.6 62.53 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -76.67 -41.93 43.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.63 -0.669 . . . . 0.0 110.227 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 82.7 t -60.06 -34.44 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.599 -0.688 . . . . 0.0 110.312 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.31 -36.62 84.61 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.221 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.76 -48.85 77.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.462 -0.774 . . . . 0.0 109.37 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 125' ' ' LEU . 3.5 mm? -61.22 -47.14 87.45 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.615 0.721 . . . . 0.0 109.905 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.9 ' O ' HG12 ' A' ' 129' ' ' VAL . 33.0 mt -60.33 -17.28 41.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.842 -0.536 . . . . 0.0 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -56.39 -20.36 19.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.243 -0.911 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.73 27.92 7.31 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.6 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 126' ' ' LEU . 10.9 p -107.23 128.72 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.132 -1.216 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -103.52 105.29 15.5 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.332 0.587 . . . . 0.0 111.575 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.683 HG12 ' CG1' ' A' ' 137' ' ' ILE . 21.2 m -89.43 161.26 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -92.26 -176.51 4.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.419 -0.801 . . . . 0.0 111.064 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 m -69.7 -1.61 9.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.798 -0.564 . . . . 0.0 111.973 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -107.71 -8.4 16.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.936 -1.102 . . . . 0.0 110.655 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.83 38.41 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 137' ' ' ILE . 66.0 mt-10 -109.06 139.84 43.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.964 . . . . 0.0 110.906 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.683 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.9 mp -130.03 168.81 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.47 ' N ' HG22 ' A' ' 137' ' ' ILE . 42.0 t0 -96.54 112.84 24.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.413 -0.805 . . . . 0.0 109.719 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 143' ' ' ILE . 42.8 p90 -62.78 -22.32 66.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 111.857 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 46.6 mtpt -83.18 -32.85 26.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.142 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.21 -46.85 66.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.662 -0.649 . . . . 0.0 111.604 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.623 ' O ' HG23 ' A' ' 146' ' ' VAL . 38.4 t80 -70.02 -28.6 65.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.542 -0.724 . . . . 0.0 111.572 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 139' ' ' TYR . 36.3 pt -79.13 -42.67 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.463 ' N ' HG13 ' A' ' 143' ' ' ILE . 63.9 mt-10 -65.09 -26.46 68.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.209 -0.932 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -88.1 -12.46 44.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.0 110.646 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 142' ' ' PHE . 88.2 t -96.11 -41.1 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mp -59.24 -18.3 35.79 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.881 -0.512 . . . . 0.0 111.543 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -60.03 -39.98 87.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.37 -0.831 . . . . 0.0 110.224 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.213 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.753 0.787 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.39 159.45 20.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.93 -0.481 . . . . 0.0 110.354 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -107.75 160.2 15.91 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.878 0.847 . . . . 0.0 110.992 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.731 ' O ' HG23 ' A' ' 87' ' ' VAL . 4.4 m -50.83 -30.6 14.75 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.666 0.746 . . . . 0.0 109.522 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -52.28 -37.49 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.839 -0.538 . . . . 0.0 111.209 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -61.26 -49.29 77.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -76.02 -39.97 54.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.765 -0.584 . . . . 0.0 111.047 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 83' ' ' THR . 76.3 t -60.5 -51.29 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -58.49 -32.7 69.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.642 -0.661 . . . . 0.0 110.547 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.657 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -63.48 -55.35 24.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.788 -0.57 . . . . 0.0 111.725 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.505 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 47.6 m-85 -78.74 -56.76 4.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.098 -1.001 . . . . 0.0 111.737 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.67 -37.84 19.57 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.561 -0.712 . . . . 0.0 112.819 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -57.86 -36.84 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.066 -1.021 . . . . 0.0 109.924 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.4 ' N ' HG13 ' A' ' 92' ' ' VAL . 53.5 t80 -67.67 -43.41 80.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.5 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.483 -0.76 . . . . 0.0 110.761 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -61.17 -39.78 91.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 0.0 110.621 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.41 20.1 6.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.257 -0.902 . . . . 0.0 110.829 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t 38.15 36.51 0.12 Allowed 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 42.1 p -63.83 -34.66 78.43 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 12.53 58.04 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.456 ' C ' HG13 ' A' ' 101' ' ' VAL . 84.1 mttt -132.42 154.68 49.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.036 -1.273 . . . . 0.0 110.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 106' ' ' LEU . 26.8 m -151.07 160.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.365 -0.835 . . . . 0.0 109.896 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.1 p -80.5 144.06 32.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.567 ' HB ' HD13 ' A' ' 137' ' ' ILE . 10.2 p -57.21 -40.07 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 0.0 110.883 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.21 -41.25 96.63 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -80.45 -39.24 28.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.984 . . . . 0.0 110.4 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.562 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.2 tt -60.05 -49.97 75.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.715 -0.616 . . . . 0.0 110.121 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -63.21 -28.95 70.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.51 -47.84 68.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.366 -0.833 . . . . 0.0 110.619 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -40.75 96.12 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 143' ' ' ILE . 3.4 tp -55.85 -44.59 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -60.35 -30.1 69.33 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.557 0.694 . . . . 0.0 109.65 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.13 -14.21 64.79 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.657 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -95.12 7.38 46.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.299 -1.118 . . . . 0.0 112.552 -177.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.58 31.89 5.03 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.62 ' OE2' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -113.82 120.32 40.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.988 -0.713 . . . . 0.0 110.249 178.465 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -122.45 59.74 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.042 0.925 . . . . 0.0 109.498 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.541 HD12 ' CD ' ' A' ' 115' ' ' GLU . 89.9 mt -90.92 148.65 22.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.4 m -111.09 141.84 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.331 -0.855 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -39.87 -28.29 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.283 -0.886 . . . . 0.0 112.685 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.43 -52.84 62.91 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.37 -0.831 . . . . 0.0 109.059 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -77.01 -42.2 39.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.628 -0.67 . . . . 0.0 110.431 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.34 -36.36 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.602 -0.686 . . . . 0.0 110.295 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -63.19 -39.92 96.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.06 -47.51 85.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.63 -0.669 . . . . 0.0 109.839 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.94 -40.03 96.4 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.614 0.721 . . . . 0.0 110.669 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.698 ' O ' HG12 ' A' ' 129' ' ' VAL . 68.7 mt -67.84 -15.97 63.87 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.779 -0.575 . . . . 0.0 111.856 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -57.55 -17.02 11.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.197 -0.939 . . . . 0.0 111.877 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.65 -10.93 12.07 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.221 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 126' ' ' LEU . 8.7 p -70.65 132.36 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.953 -1.321 . . . . 0.0 110.522 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.48 100.06 10.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.367 0.603 . . . . 0.0 111.363 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.423 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.8 p -83.82 159.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -95.88 -179.51 4.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.415 -0.803 . . . . 0.0 111.502 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.2 m -70.41 -1.49 10.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.849 -0.532 . . . . 0.0 112.13 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -107.83 -11.49 15.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.863 -1.148 . . . . 0.0 110.411 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.02 29.05 16.17 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.437 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.7 mt-10 -110.43 135.7 50.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.649 -0.912 . . . . 0.0 111.328 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.567 HD13 ' HB ' ' A' ' 103' ' ' VAL . 4.0 mp -126.35 169.0 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.456 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.7 t70 -97.83 114.75 26.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.44 -0.787 . . . . 0.0 110.468 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.56 ' HB3' HG21 ' A' ' 101' ' ' VAL . 46.6 p90 -68.32 -36.22 78.96 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.511 -0.743 . . . . 0.0 111.676 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.5 mttt -68.51 -40.0 81.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.294 -0.879 . . . . 0.0 110.798 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -67.3 -43.26 82.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.694 -0.629 . . . . 0.0 111.299 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.605 ' O ' HG23 ' A' ' 146' ' ' VAL . 20.2 t80 -70.74 -27.76 64.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.494 -0.753 . . . . 0.0 110.46 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.698 HD11 HD11 ' A' ' 110' ' ' LEU . 20.3 mm -78.5 -49.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.477 -0.764 . . . . 0.0 109.585 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -60.04 -27.51 66.99 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 0.0 110.384 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.06 -12.3 44.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 110.502 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 142' ' ' PHE . 56.1 t -96.24 -39.14 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.544 HD12 HG22 ' A' ' 143' ' ' ILE . 13.4 mt -59.24 -22.43 61.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.912 -0.492 . . . . 0.0 111.204 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -57.92 141.99 47.62 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.464 -0.772 . . . . 0.0 110.46 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.152 179.916 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.774 0.797 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.02 159.56 17.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.882 -0.511 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.51 159.55 16.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.813 0.816 . . . . 0.0 111.009 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 87' ' ' VAL . 5.6 m -50.97 -30.81 16.0 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.666 0.746 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.73 -36.89 38.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.851 -0.53 . . . . 0.0 111.274 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -57.64 -54.11 50.57 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.645 ' HB3' HD12 ' A' ' 143' ' ' ILE . 5.8 m-85 -76.59 -38.51 54.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.606 -0.684 . . . . 0.0 111.141 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 83' ' ' THR . 98.9 t -57.12 -51.55 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -0.992 . . . . 0.0 110.328 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 92' ' ' VAL . 29.4 tttm -60.07 -32.13 70.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.687 -0.633 . . . . 0.0 110.255 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -60.21 -56.56 20.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.643 -0.66 . . . . 0.0 111.805 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.02 -53.54 7.68 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.307 -0.871 . . . . 0.0 111.813 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -48.58 -40.24 26.63 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.424 -0.798 . . . . 0.0 112.759 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 88' ' ' LYS . 74.7 t -59.8 -37.93 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.773 -1.205 . . . . 0.0 109.663 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -68.97 -45.97 69.29 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -62.12 82.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.431 -0.793 . . . . 0.0 110.937 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -62.57 -41.24 98.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -91.64 18.88 6.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.278 -0.889 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.1 p 38.48 37.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.3 p -63.72 -34.99 79.1 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.089 -1.007 . . . . 0.0 109.311 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.86 12.75 55.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.007 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' C ' HG13 ' A' ' 101' ' ' VAL . 27.7 mmtp -132.63 154.84 49.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.133 -1.216 . . . . 0.0 110.501 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 100' ' ' LYS . 32.2 m -150.72 160.4 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.389 -0.82 . . . . 0.0 109.855 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 p -83.21 145.55 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.5 p -56.96 -39.21 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.471 -0.768 . . . . 0.0 110.715 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.18 -41.04 96.48 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -80.53 -39.96 26.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.616 -0.932 . . . . 0.0 110.394 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.9 -50.01 75.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.698 -0.626 . . . . 0.0 110.145 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -64.89 -29.57 70.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 110.551 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -69.0 -47.97 64.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.437 -0.789 . . . . 0.0 110.773 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.62 88.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.321 -0.862 . . . . 0.0 110.445 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.729 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.6 tp -55.36 -44.76 76.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.5 m -59.99 -27.87 67.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.546 0.688 . . . . 0.0 110.051 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.09 -14.62 64.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.55 8.3 42.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.33 -1.1 . . . . 0.0 112.287 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 33.01 4.52 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.729 ' HG2' HD23 ' A' ' 110' ' ' LEU . 6.0 tp10 -114.03 119.85 38.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.982 -0.716 . . . . 0.0 110.298 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -121.98 59.28 1.0 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.198 0.999 . . . . 0.0 109.236 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.5 mt -90.11 148.7 22.85 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -111.05 143.9 41.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.252 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -40.33 -27.03 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.199 -0.938 . . . . 0.0 112.817 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.9 55.5 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 18.3 mp0 -75.15 -28.48 60.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.455 -0.778 . . . . 0.0 110.592 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.69 -33.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.819 . . . . 0.0 110.348 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -65.83 -45.12 83.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 11.2 pt-20 -56.63 -42.39 78.77 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.168 -0.958 . . . . 0.0 109.83 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.417 ' N ' ' HG3' ' A' ' 124' ' ' GLU . 91.8 mt -64.05 -47.22 81.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 0.0 109.648 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 41.1 mt -60.59 -18.04 50.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.888 -0.508 . . . . 0.0 111.07 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -56.79 -21.57 29.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.461 -0.775 . . . . 0.0 111.056 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 26.32 7.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 66.2 t -107.9 129.88 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -1.109 . . . . 0.0 109.671 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.96 101.87 13.09 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.437 0.637 . . . . 0.0 111.935 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 131' ' ' VAL . 8.8 p -84.04 158.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -95.85 -177.72 4.13 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.383 -0.823 . . . . 0.0 111.286 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.09 -1.27 14.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.941 -0.474 . . . . 0.0 111.805 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -108.21 -15.02 14.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.423 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.78 29.2 12.19 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.524 ' C ' HD12 ' A' ' 137' ' ' ILE . 96.1 mt-10 -111.03 133.7 53.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.624 -0.927 . . . . 0.0 111.167 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.8 mp -124.77 139.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -69.79 112.48 6.26 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.73 -0.606 . . . . 0.0 110.502 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.449 ' CG ' ' N ' ' A' ' 140' ' ' LYS . 32.7 p90 -69.96 -41.64 74.24 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.391 -0.818 . . . . 0.0 112.222 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 4.0 mttt -60.22 -29.87 69.02 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.605 -0.684 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -84.12 -39.48 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 111.649 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 146' ' ' VAL . 23.1 t80 -70.01 -29.88 67.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.444 -0.785 . . . . 0.0 111.349 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.645 HD12 ' HB3' ' A' ' 86' ' ' PHE . 27.8 pt -83.17 -43.43 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.451 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.9 mt-10 -68.91 -27.44 65.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.322 -0.861 . . . . 0.0 110.715 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -85.1 -15.79 42.73 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.319 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 142' ' ' PHE . 76.6 t -95.48 -37.41 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 86' ' ' PHE . 26.2 mt -61.05 -18.15 56.26 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.305 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -59.1 133.99 56.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.298 -0.876 . . . . 0.0 110.078 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.137 -179.85 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.4 mttt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.607 0.718 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.14 159.11 15.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.91 -0.494 . . . . 0.0 110.097 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -110.18 161.0 16.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 111.283 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.694 HG22 ' CG2' ' A' ' 87' ' ' VAL . 24.2 m -51.04 -30.37 15.33 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.636 0.731 . . . . 0.0 109.689 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -51.01 -37.61 46.17 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.883 -0.511 . . . . 0.0 111.222 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.18 -47.24 85.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.694 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.2 m-85 -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.694 ' CG2' HG22 ' A' ' 83' ' ' THR . 71.6 t -60.75 -49.99 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.368 -0.833 . . . . 0.0 110.658 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 92' ' ' VAL . 97.3 mttt -59.58 -34.96 73.38 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.583 -0.698 . . . . 0.0 111.388 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -61.26 -56.61 18.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.605 -0.685 . . . . 0.0 112.005 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.77 ' CE1' HD12 ' A' ' 106' ' ' LEU . 57.0 m-85 -76.7 -54.1 7.1 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.188 -0.945 . . . . 0.0 111.976 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -48.41 -37.21 16.46 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.31 -0.869 . . . . 0.0 113.045 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 88' ' ' LYS . 77.9 t -59.94 -36.36 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 120.843 -1.16 . . . . 0.0 109.89 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.91 -42.78 89.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -62.1 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.43 -0.794 . . . . 0.0 111.249 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -61.44 -41.05 96.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.557 -0.714 . . . . 0.0 110.048 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.3 20.58 7.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.44 -0.787 . . . . 0.0 110.44 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 38.2 36.68 0.12 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.2 t -63.46 -33.39 75.46 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.128 -0.983 . . . . 0.0 109.566 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.17 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.31 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.605 ' H ' HG23 ' A' ' 98' ' ' THR . 1.4 mppt? -131.58 152.73 50.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -1.216 . . . . 0.0 109.736 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 106' ' ' LEU . 35.8 m -148.89 160.0 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.9 p -81.37 145.93 30.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.1 p -54.46 -39.52 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.484 -0.76 . . . . 0.0 110.658 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.94 -40.04 96.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.58 -43.16 21.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.633 -0.922 . . . . 0.0 110.8 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.77 HD12 ' CE1' ' A' ' 90' ' ' PHE . 25.0 tp -60.0 -50.07 75.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.48 -0.762 . . . . 0.0 110.057 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -63.32 -31.64 72.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.724 . . . . 0.0 110.165 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -67.73 -47.7 68.56 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.401 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -40.4 95.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.589 HD23 ' HG2' ' A' ' 115' ' ' GLU . 5.4 tp -55.73 -44.81 77.87 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.5 m -60.45 -29.68 69.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.33 -14.25 64.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.74 7.33 46.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -1.087 . . . . 0.0 112.545 -177.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.77 32.11 4.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' HD23 ' A' ' 110' ' ' LEU . 17.5 tp10 -113.87 120.16 39.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.932 -0.746 . . . . 0.0 110.204 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -121.92 59.51 0.99 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.203 1.002 . . . . 0.0 109.304 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.541 HD11 ' OE2' ' A' ' 115' ' ' GLU . 90.2 mt -92.03 148.96 21.79 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 p -110.95 143.25 41.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.261 -0.899 . . . . 0.0 109.854 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -40.08 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 O-C-N 121.213 -0.929 . . . . 0.0 112.805 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.99 61.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 108.982 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -76.69 -42.83 40.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.598 -0.689 . . . . 0.0 110.433 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.41 -35.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.73 -38.38 90.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.229 -0.919 . . . . 0.0 109.208 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.01 -47.62 85.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.614 . . . . 0.0 109.739 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.83 -49.88 75.68 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.508 0.67 . . . . 0.0 110.052 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.98 -18.72 47.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.888 -0.507 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -57.04 -21.03 28.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.447 -0.783 . . . . 0.0 111.136 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.92 9.08 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.45 132.82 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.041 -1.27 . . . . 0.0 109.982 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -102.51 102.34 12.6 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.389 0.614 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -85.4 159.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.85 -176.79 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -71.67 -1.14 12.69 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.794 -0.566 . . . . 0.0 111.834 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -107.43 -12.07 15.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.13 . . . . 0.0 110.403 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.61 27.09 28.04 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.2 mt-10 -110.89 140.1 45.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.619 -0.93 . . . . 0.0 111.245 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.1 mp -130.86 142.39 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.89 113.04 5.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.971 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 26.0 p90 -62.84 -33.26 74.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.642 -0.661 . . . . 0.0 111.706 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 20.5 mttt -69.97 -35.05 74.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 110.712 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -69.95 -44.11 70.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.72 -0.613 . . . . 0.0 111.518 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.468 ' O ' HG23 ' A' ' 146' ' ' VAL . 12.7 t80 -74.33 -27.69 60.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.762 . . . . 0.0 111.077 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.33 -51.8 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.447 -0.783 . . . . 0.0 109.884 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -63.77 -26.43 68.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.439 -0.788 . . . . 0.0 110.791 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.34 -13.39 43.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.217 -0.927 . . . . 0.0 110.746 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 142' ' ' PHE . 46.2 t -95.83 -38.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' A' ' 86' ' ' PHE . 14.3 mt -57.22 -19.9 23.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.954 -0.466 . . . . 0.0 111.406 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -57.96 129.87 43.93 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.258 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -100.75 168.52 9.61 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.95 0.881 . . . . 0.0 111.245 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.845 HG22 ' CG2' ' A' ' 87' ' ' VAL . 23.2 m -51.16 -31.19 19.09 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.45 0.643 . . . . 0.0 109.96 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -52.17 -37.92 56.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.709 -0.62 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.59 -47.11 85.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.859 ' CD2' HD11 ' A' ' 147' ' ' LEU . 2.9 m-85 -76.03 -40.0 54.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.845 ' CG2' HG22 ' A' ' 83' ' ' THR . 65.7 t -61.5 -51.84 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.244 -0.91 . . . . 0.0 110.588 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 92' ' ' VAL . 48.0 tttp -56.96 -32.55 66.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -61.28 -59.92 4.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.503 -0.748 . . . . 0.0 111.934 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.726 ' CE1' HD12 ' A' ' 106' ' ' LEU . 65.3 m-85 -76.63 -53.67 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.188 -0.945 . . . . 0.0 111.951 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -48.16 -38.52 18.25 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.26 -0.9 . . . . 0.0 112.791 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 88' ' ' LYS . 56.5 t -59.62 -34.81 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.801 -1.187 . . . . 0.0 109.602 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.14 -41.01 97.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.4 81.41 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.448 -0.782 . . . . 0.0 111.083 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.26 -41.63 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.642 -0.661 . . . . 0.0 110.425 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -91.46 16.18 10.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.333 -0.854 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 t 38.42 61.7 1.11 Allowed 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.8 p -90.5 -33.48 15.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.146 -0.971 . . . . 0.0 109.31 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.07 9.98 55.33 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.925 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.451 ' C ' HG13 ' A' ' 101' ' ' VAL . 2.1 mppt? -132.84 154.82 49.97 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.021 -1.282 . . . . 0.0 110.274 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 106' ' ' LEU . 31.3 m -150.02 159.92 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.258 -0.901 . . . . 0.0 109.964 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.1 p -81.38 144.21 31.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.8 p -56.92 -39.98 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.562 -0.711 . . . . 0.0 110.857 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -58.82 -41.58 96.13 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.59 -39.67 27.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.939 . . . . 0.0 110.453 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.726 HD12 ' CE1' ' A' ' 90' ' ' PHE . 29.0 tp -59.97 -49.88 75.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.687 -0.633 . . . . 0.0 110.168 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -65.87 -29.52 69.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.401 -0.812 . . . . 0.0 111.005 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -65.58 -48.29 72.85 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.093 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.111 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.678 HD23 ' HG2' ' A' ' 115' ' ' GLU . 4.1 tp -55.69 -44.74 77.65 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.266 -0.896 . . . . 0.0 108.702 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -60.85 -30.25 70.0 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.545 0.688 . . . . 0.0 109.622 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.59 -13.83 66.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.632 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 7.7 45.38 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.31 -1.112 . . . . 0.0 112.406 -177.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.39 31.67 5.17 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 110' ' ' LEU . 12.2 tp10 -113.25 119.93 39.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.873 -0.781 . . . . 0.0 110.281 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -122.39 59.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.955 0.883 . . . . 0.0 109.386 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.527 HD11 ' OE2' ' A' ' 115' ' ' GLU . 77.3 mt -90.99 148.62 22.28 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 m -111.01 141.89 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 34.5 t0 -40.08 -27.24 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.226 -0.921 . . . . 0.0 112.899 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -53.18 59.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.202 -0.936 . . . . 0.0 108.975 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.72 -42.68 40.37 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.531 -0.73 . . . . 0.0 110.414 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.522 HG12 HD12 ' A' ' 126' ' ' LEU . 58.9 t -60.01 -36.66 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.604 -0.685 . . . . 0.0 110.272 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -63.33 -38.37 90.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.207 -0.933 . . . . 0.0 109.069 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -62.95 -49.82 73.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.626 -0.671 . . . . 0.0 109.365 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.91 -49.43 77.74 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.576 0.703 . . . . 0.0 110.237 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.794 ' O ' HG12 ' A' ' 129' ' ' VAL . 46.6 mt -62.34 -15.99 51.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.938 -0.476 . . . . 0.0 111.257 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -57.26 -17.16 10.51 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.264 -0.897 . . . . 0.0 111.853 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.03 -10.19 14.46 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.071 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.794 HG12 ' O ' ' A' ' 126' ' ' LEU . 7.1 p -70.4 135.9 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.989 -1.301 . . . . 0.0 110.765 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -104.62 100.63 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.412 0.625 . . . . 0.0 111.267 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.7 p -84.27 158.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -95.34 -179.06 4.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -0.805 . . . . 0.0 111.36 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 m -70.72 -1.55 11.77 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.942 -0.474 . . . . 0.0 112.032 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -107.14 -11.15 15.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 0.0 110.421 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.73 26.02 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.531 ' C ' HD12 ' A' ' 137' ' ' ILE . 87.2 mt-10 -110.61 137.92 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.96 . . . . 0.0 111.14 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.7 mp -126.81 168.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.462 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.3 t70 -96.14 112.33 24.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 109.891 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.458 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 48.1 p90 -62.68 -29.12 70.41 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.729 . . . . 0.0 111.632 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 15.7 mttt -73.1 -34.63 66.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.25 -0.906 . . . . 0.0 110.615 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -70.16 -45.98 65.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.689 -0.632 . . . . 0.0 112.183 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 146' ' ' VAL . 24.1 t80 -70.68 -28.37 64.72 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 0.0 110.8 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 110' ' ' LEU . 28.1 mm -74.58 -45.98 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.48 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -60.06 -27.43 66.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.68 -12.33 42.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 142' ' ' PHE . 60.7 t -95.71 -40.68 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.859 HD11 ' CD2' ' A' ' 86' ' ' PHE . 4.4 mp . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.948 -0.47 . . . . 0.0 111.301 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.8 0.333 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -102.17 160.01 14.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.713 0.768 . . . . 0.0 110.843 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.708 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.2 m -51.13 -30.65 17.06 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.701 0.762 . . . . 0.0 109.337 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -52.24 -37.47 55.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.955 -0.466 . . . . 0.0 111.168 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -60.58 -50.04 75.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.592 -0.693 . . . . 0.0 109.856 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' A' ' 147' ' ' LEU . 1.2 m-85 -75.91 -40.06 55.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.783 -0.573 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.708 ' CG2' HG22 ' A' ' 83' ' ' THR . 83.5 t -61.92 -49.89 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.322 -0.861 . . . . 0.0 110.606 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 92' ' ' VAL . 24.0 mmtt -59.75 -34.33 72.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.566 -0.709 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 113' ' ' LEU . . . -62.06 -51.82 66.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.677 -0.64 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' HD11 ' A' ' 143' ' ' ILE . 50.9 m-85 -77.23 -54.92 5.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 111.802 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.485 ' OE1' HG12 ' A' ' 87' ' ' VAL . 57.2 mt-30 -48.04 -35.57 11.39 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.504 -0.747 . . . . 0.0 112.954 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 88' ' ' LYS . 96.2 t -60.87 -29.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.679 -1.263 . . . . 0.0 109.122 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -92.81 23.16 4.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.679 -0.638 . . . . 0.0 109.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -132.02 78.47 1.82 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 0.0 108.941 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -63.56 -45.48 90.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.765 -0.584 . . . . 0.0 111.435 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.99 17.68 5.55 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.014 -1.054 . . . . 0.0 111.389 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 t 38.27 39.82 0.3 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.597 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.8 t -63.47 -34.16 77.16 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.43 14.58 50.26 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.384 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.597 ' H ' HG23 ' A' ' 98' ' ' THR . 31.2 mttt -132.93 153.84 51.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.081 -1.246 . . . . 0.0 110.643 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 139' ' ' TYR . 30.9 m -150.29 160.02 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.6 p -84.74 147.34 26.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.0 109.711 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.871 HG13 HD13 ' A' ' 137' ' ' ILE . 21.6 m -63.35 -34.02 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.289 -0.882 . . . . 0.0 110.268 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.29 -42.49 99.79 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.49 -41.43 27.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.653 -0.91 . . . . 0.0 109.493 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 101' ' ' VAL . 5.9 tt -59.96 -49.23 78.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -63.63 -32.51 74.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.693 -0.63 . . . . 0.0 110.543 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.72 -48.91 67.72 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -36.41 74.79 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.889 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 19.9 tp -53.72 -45.02 70.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -66.27 -18.77 65.55 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.018 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.7 -14.15 65.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.533 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -95.03 8.28 43.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 112.67 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.3 31.19 5.07 Favored Glycine 0 N--CA 1.503 3.104 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 49.5 mm-40 -114.88 121.76 44.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.957 -0.731 . . . . 0.0 110.165 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -122.83 61.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 109.899 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.5 mt -91.96 148.87 21.87 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 m -110.6 144.26 39.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 109.989 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.435 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 28.0 t0 -39.43 -29.28 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.361 -0.837 . . . . 0.0 112.598 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.95 49.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.35 -0.844 . . . . 0.0 108.847 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -76.44 -39.93 52.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.616 . . . . 0.0 110.284 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 58.1 t -64.2 -35.95 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.585 -0.697 . . . . 0.0 110.653 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.0 -39.92 87.45 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.075 -1.016 . . . . 0.0 108.927 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.71 -43.89 81.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.708 -0.62 . . . . 0.0 109.397 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.17 -50.04 74.77 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.657 0.741 . . . . 0.0 109.856 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.457 HD23 HG11 ' A' ' 129' ' ' VAL . 6.9 mt -67.67 -22.15 65.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.779 -0.575 . . . . 0.0 110.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -57.4 -19.72 25.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.501 -0.749 . . . . 0.0 111.358 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.65 -14.86 5.57 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.25 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.457 HG11 HD23 ' A' ' 126' ' ' LEU . 6.1 p -66.19 128.83 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 118.897 1.348 . . . . 0.0 110.517 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.05 99.86 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.407 0.623 . . . . 0.0 111.226 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.602 HG23 HD11 ' A' ' 137' ' ' ILE . 7.6 p -84.21 157.08 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -96.68 -174.35 2.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 111.206 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.2 m -71.67 -0.7 11.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.839 -0.538 . . . . 0.0 111.853 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -106.95 -11.32 15.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.19 25.32 44.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.77 ' C ' HD12 ' A' ' 137' ' ' ILE . 51.7 mt-10 -111.7 139.52 47.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.555 -0.968 . . . . 0.0 110.998 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.871 HD13 HG13 ' A' ' 103' ' ' VAL . 3.2 mp -126.56 146.48 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -69.09 114.38 7.31 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.51 ' HB3' HG21 ' A' ' 101' ' ' VAL . 49.9 p90 -67.55 -38.88 84.79 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.544 -0.722 . . . . 0.0 111.548 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.8 mttt -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.0 110.102 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -70.02 -42.32 73.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 110.927 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.411 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.9 t80 -71.88 -28.13 63.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.54 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.634 HD11 ' CE1' ' A' ' 90' ' ' PHE . 92.3 mt -85.05 -52.25 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.324 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -87.63 -13.91 41.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -0.914 . . . . 0.0 110.56 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 142' ' ' PHE . 40.1 t -95.96 -38.29 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.697 HD11 ' CD2' ' A' ' 86' ' ' PHE . 22.3 mt . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.896 -0.502 . . . . 0.0 111.258 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.857 0.36 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -103.43 162.23 13.2 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 110.969 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.782 HG22 ' CG2' ' A' ' 87' ' ' VAL . 18.5 m -51.33 -30.69 19.26 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.608 0.718 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.66 -38.15 59.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.843 -0.535 . . . . 0.0 111.162 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.429 ' OD1' HD21 ' A' ' 113' ' ' LEU . 8.0 t70 -60.69 -50.18 74.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 109.871 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.657 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -74.29 -38.35 63.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.782 -0.573 . . . . 0.0 110.999 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.782 ' CG2' HG22 ' A' ' 83' ' ' THR . 97.0 t -63.99 -48.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.231 -0.918 . . . . 0.0 110.678 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 92' ' ' VAL . 39.2 ttmt -60.02 -35.75 75.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.628 -0.67 . . . . 0.0 111.019 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.613 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -59.95 -52.16 66.61 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 111.245 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -77.0 -53.3 8.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.378 -0.826 . . . . 0.0 111.249 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.518 ' OE1' HG12 ' A' ' 87' ' ' VAL . 55.6 mt-30 -48.7 -38.69 22.1 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 88' ' ' LYS . 95.8 t -59.17 -31.03 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 120.565 -1.334 . . . . 0.0 109.193 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.95 23.6 4.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -131.57 78.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.0 109.399 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -70.5 -10.46 59.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.767 -0.583 . . . . 0.0 111.355 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.22 11.65 15.21 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.125 -0.985 . . . . 0.0 110.963 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m 37.54 37.55 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 p -63.88 -34.53 78.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.424 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.07 14.91 53.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' C ' HG13 ' A' ' 101' ' ' VAL . 37.2 mttt -133.6 156.41 47.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.178 -1.19 . . . . 0.0 110.435 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.611 ' CG2' HD12 ' A' ' 106' ' ' LEU . 27.2 m -151.61 160.02 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -82.61 144.94 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.905 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.9 p -57.3 -39.92 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.746 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.01 -41.89 96.64 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.01 -42.6 23.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.528 -0.983 . . . . 0.0 110.336 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.611 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.2 tt -60.01 -49.75 76.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -64.89 -33.66 76.54 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -67.16 -49.04 66.18 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -34.84 71.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.54 -0.725 . . . . 0.0 110.523 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.718 HD11 ' OE2' ' A' ' 115' ' ' GLU . 30.8 tp -54.66 -45.28 73.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.413 -0.804 . . . . 0.0 109.116 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.0 m -63.96 -19.04 64.85 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.346 0.593 . . . . 0.0 110.789 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.31 -14.57 63.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.657 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -94.13 7.38 45.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -1.03 . . . . 0.0 112.649 -177.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.8 4.84 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.718 ' OE2' HD11 ' A' ' 110' ' ' LEU . 6.4 mm-40 -114.79 121.02 42.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.941 -0.741 . . . . 0.0 110.116 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -122.23 59.64 1.01 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.138 0.971 . . . . 0.0 109.755 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.99 148.83 22.13 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.5 m -111.06 141.63 44.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 39.5 t0 -39.63 -29.14 0.05 Allowed 'General case' 0 N--CA 1.513 2.701 0 O-C-N 121.417 -0.802 . . . . 0.0 112.487 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.84 -52.62 63.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.368 -0.833 . . . . 0.0 108.953 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -77.01 -42.61 37.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.632 -0.668 . . . . 0.0 110.295 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 126' ' ' LEU . 62.8 t -60.02 -35.21 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.52 -38.8 92.5 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 109.041 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.77 -45.5 93.64 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.692 0.758 . . . . 0.0 110.143 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.763 ' O ' HG12 ' A' ' 129' ' ' VAL . 67.1 mt -63.65 -18.45 63.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.899 -0.501 . . . . 0.0 111.304 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -56.67 -18.24 11.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.196 -0.94 . . . . 0.0 111.68 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.14 -9.62 15.29 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.944 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 126' ' ' LEU . 9.9 p -70.13 133.78 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.926 -1.338 . . . . 0.0 110.988 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -99.59 99.41 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.365 0.602 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.13 155.77 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.89 -176.9 3.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 111.18 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.04 -0.96 12.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.819 -0.55 . . . . 0.0 111.805 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -108.0 -14.02 14.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 0.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.04 28.98 16.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.56 ' C ' HD12 ' A' ' 137' ' ' ILE . 96.8 mt-10 -110.51 134.94 51.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.677 -0.896 . . . . 0.0 111.073 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.8 mp -125.28 142.63 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.66 112.41 6.12 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.247 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 41.5 p90 -68.11 -34.11 75.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.531 -0.731 . . . . 0.0 111.531 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 mttt -69.8 -32.73 71.33 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.272 -0.893 . . . . 0.0 110.426 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -73.2 -43.29 61.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.702 -0.623 . . . . 0.0 111.643 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.703 ' O ' HG23 ' A' ' 146' ' ' VAL . 30.8 t80 -70.73 -28.16 64.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.488 -0.758 . . . . 0.0 110.695 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.494 HG22 ' CD1' ' A' ' 147' ' ' LEU . 90.5 mt -75.18 -45.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.758 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.55 -26.83 65.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.91 -11.74 43.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.46 -0.775 . . . . 0.0 110.327 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 142' ' ' PHE . 65.9 t -95.97 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.617 HD21 ' CE2' ' A' ' 86' ' ' PHE . 87.2 mt . . . . . 0 N--CA 1.498 1.96 0 O-C-N 121.913 -0.492 . . . . 0.0 111.379 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -109.22 161.47 15.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.931 0.872 . . . . 0.0 111.319 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.786 ' O ' HG23 ' A' ' 87' ' ' VAL . 18.3 m -51.18 -30.32 16.6 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.663 0.744 . . . . 0.0 109.674 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.93 -37.64 32.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.717 -0.614 . . . . 0.0 111.146 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -59.12 -50.4 74.2 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.439 ' HB3' HD13 ' A' ' 143' ' ' ILE . 12.1 m-85 -76.18 -38.38 56.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 83' ' ' THR . 65.8 t -57.34 -55.39 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.177 -0.952 . . . . 0.0 110.49 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -59.99 -33.27 71.74 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.633 -0.667 . . . . 0.0 110.553 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.29 -51.88 67.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.682 -0.636 . . . . 0.0 111.429 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 33.4 m-85 -78.74 -54.94 5.57 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 0.0 111.508 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -49.19 -39.98 31.51 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.585 -0.697 . . . . 0.0 112.69 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 93' ' ' PHE . 9.7 p -58.38 -38.57 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.071 -1.018 . . . . 0.0 110.072 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 92' ' ' VAL . 2.5 t80 -69.07 -44.83 71.78 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -61.74 82.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.516 -0.74 . . . . 0.0 111.018 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -69.1 -15.35 63.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.11 12.87 20.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.2 -0.937 . . . . 0.0 110.5 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m 38.27 62.8 0.93 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -91.28 -34.18 15.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.161 -0.962 . . . . 0.0 109.359 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.66 11.67 54.88 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.463 ' C ' HG13 ' A' ' 101' ' ' VAL . 83.0 mttt -132.21 154.66 49.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.262 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 106' ' ' LEU . 30.4 m -150.77 160.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.407 -0.808 . . . . 0.0 110.182 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.7 p -85.75 147.84 26.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 110.118 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 137' ' ' ILE . 81.9 t -57.16 -40.2 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.336 -0.852 . . . . 0.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.16 -42.04 95.03 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.45 -44.17 19.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.512 -0.993 . . . . 0.0 110.4 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 HG21 ' A' ' 101' ' ' VAL . 8.2 tt -60.03 -49.96 75.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.714 -0.616 . . . . 0.0 110.001 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -64.08 -32.21 73.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -68.08 -47.83 67.21 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.516 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.33 95.45 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.144 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.604 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.98 -44.79 78.9 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 m -59.89 -30.5 69.06 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.59 0.71 . . . . 0.0 109.789 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.44 -14.62 63.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 7.3 46.6 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.301 -1.117 . . . . 0.0 112.602 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.4 4.76 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.604 ' HG2' HD23 ' A' ' 110' ' ' LEU . 21.2 tp10 -114.01 120.13 39.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.884 -0.774 . . . . 0.0 110.005 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -122.09 59.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.142 0.972 . . . . 0.0 109.518 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 92.5 mt -92.18 149.36 21.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 144.19 40.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.917 . . . . 0.0 109.663 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -40.13 -27.4 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.254 -0.904 . . . . 0.0 112.809 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.66 62.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.278 -0.889 . . . . 0.0 109.028 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.59 -42.79 41.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 110.382 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 60.3 t -59.93 -35.55 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.519 -0.738 . . . . 0.0 110.419 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -64.49 -37.74 88.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -60.05 -47.24 86.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 0.0 109.717 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.13 -50.13 74.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.631 0.729 . . . . 0.0 109.947 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.45 -19.58 56.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.893 -0.504 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -57.32 -22.01 39.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.486 -0.758 . . . . 0.0 111.203 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -113.81 -13.87 9.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.05 126.3 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.14 -1.212 . . . . 0.0 110.128 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -89.89 99.96 12.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.201 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 137' ' ' ILE . 8.1 p -83.32 155.67 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -96.6 -175.6 3.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.377 -0.827 . . . . 0.0 111.182 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -72.02 -0.85 12.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.829 -0.544 . . . . 0.0 111.863 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.23 -12.58 15.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.104 . . . . 0.0 110.351 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.92 26.69 30.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.682 ' C ' HD12 ' A' ' 137' ' ' ILE . 44.2 mt-10 -111.92 136.12 51.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.491 -1.005 . . . . 0.0 110.963 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.682 HD12 ' C ' ' A' ' 136' ' ' GLU . 3.5 mp -124.71 142.55 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 39.2 p-10 -69.74 109.07 4.19 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.378 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 49.9 p90 -65.28 -36.87 85.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.454 -0.779 . . . . 0.0 112.266 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 29.1 mttt -60.09 -31.52 70.1 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.337 -0.852 . . . . 0.0 111.904 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -84.2 -38.15 20.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.483 -0.76 . . . . 0.0 112.036 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 146' ' ' VAL . 22.7 t80 -70.42 -28.84 65.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.445 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 86' ' ' PHE . 90.6 mt -83.49 -50.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 110.326 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -62.88 -26.24 68.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.749 . . . . 0.0 110.993 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.78 -15.83 33.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 111.014 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 142' ' ' PHE . 70.5 t -96.72 -41.66 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.058 -1.026 . . . . 0.0 108.709 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.498 1.927 0 O-C-N 121.835 -0.541 . . . . 0.0 111.662 179.569 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.781 0.324 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -109.22 162.0 14.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.97 0.89 . . . . 0.0 111.213 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.685 HG22 ' CG2' ' A' ' 87' ' ' VAL . 5.5 m -50.54 -30.69 13.63 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.596 0.712 . . . . 0.0 109.777 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -52.56 -36.19 55.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.916 -0.49 . . . . 0.0 111.107 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.35 -50.01 74.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 109.92 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.594 ' CE2' HD21 ' A' ' 147' ' ' LEU . 5.6 m-85 -75.87 -40.01 55.41 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.707 -0.621 . . . . 0.0 111.254 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.685 ' CG2' HG22 ' A' ' 83' ' ' THR . 95.8 t -61.51 -50.01 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.267 -0.896 . . . . 0.0 110.365 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -57.95 -32.75 68.13 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.897 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.456 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -62.34 -58.27 8.29 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.565 -0.709 . . . . 0.0 111.867 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.876 ' CE1' HD12 ' A' ' 106' ' ' LEU . 95.7 m-85 -78.81 -55.85 4.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.203 -0.936 . . . . 0.0 112.105 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -48.58 -38.64 21.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.421 -0.8 . . . . 0.0 112.808 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -56.5 -38.6 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.993 -1.067 . . . . 0.0 110.222 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' VAL . 23.4 m-85 -67.13 -42.5 84.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.77 83.1 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PHE . 67.4 mmtt -68.57 -16.82 63.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -113.53 15.73 18.93 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.0 110.445 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.55 37.08 0.1 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.7 t -63.57 -33.14 74.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.626 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.35 53.59 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.121 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.636 ' H ' HG23 ' A' ' 98' ' ' THR . 1.8 mtpt -132.83 153.57 51.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.044 -1.268 . . . . 0.0 110.368 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.686 HG21 HD13 ' A' ' 106' ' ' LEU . 34.7 m -150.06 160.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.8 p -83.69 146.27 28.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.555 -0.715 . . . . 0.0 109.654 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.984 HG13 HD13 ' A' ' 137' ' ' ILE . 21.0 m -61.76 -34.81 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.303 -0.873 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.43 99.79 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -79.62 -41.23 27.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.705 -0.879 . . . . 0.0 109.813 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.876 HD12 ' CE1' ' A' ' 90' ' ' PHE . 28.9 tp -60.04 -48.6 81.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -64.38 -30.98 72.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.67 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.679 ' O ' HG22 ' A' ' 111' ' ' THR . 61.1 t80 -65.52 -48.53 72.2 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.141 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -39.95 74.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.015 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 tp -54.17 -39.51 66.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.453 -0.779 . . . . 0.0 111.024 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 108' ' ' TYR . 8.8 t -73.01 -17.86 61.4 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.471 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.76 -13.94 66.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 8.52 42.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -1.121 . . . . 0.0 112.23 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.12 30.14 5.2 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 111' ' ' THR . 2.1 tp10 -114.17 121.48 43.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.81 -0.817 . . . . 0.0 110.273 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -123.02 61.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.095 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.6 mt -91.45 148.87 22.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -110.14 143.11 40.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.423 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 10.6 p-10 -38.5 -31.38 0.05 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.557 -0.715 . . . . 0.0 112.406 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.05 50.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.97 -41.97 40.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.647 . . . . 0.0 110.324 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 62.7 t -61.61 -36.33 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.608 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.037 -1.039 . . . . 0.0 108.945 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.72 -43.72 80.88 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.62 -0.675 . . . . 0.0 109.57 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 125' ' ' LEU . 3.6 mm? -61.92 -53.47 55.29 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.503 0.668 . . . . 0.0 110.253 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.36 -21.13 65.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.793 -0.567 . . . . 0.0 111.032 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.37 -20.9 32.25 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 111.334 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.85 -14.2 8.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.24 126.27 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.094 -1.239 . . . . 0.0 110.102 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -92.58 102.19 14.62 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.103 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.419 ' CG2' HD11 ' A' ' 137' ' ' ILE . 7.7 p -86.47 159.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -95.68 -173.25 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.94 -0.64 9.69 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.878 -0.514 . . . . 0.0 111.913 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -106.09 -9.82 16.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.935 -1.103 . . . . 0.0 110.272 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.01 25.25 49.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.604 ' C ' HD12 ' A' ' 137' ' ' ILE . 71.9 mt-10 -111.45 143.0 42.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.483 -1.01 . . . . 0.0 111.135 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.984 HD13 HG13 ' A' ' 103' ' ' VAL . 2.6 mp -127.0 170.64 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 137' ' ' ILE . 40.1 t0 -94.41 117.62 30.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.421 -0.799 . . . . 0.0 110.344 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.586 ' HB3' HG21 ' A' ' 101' ' ' VAL . 49.0 p90 -68.47 -37.2 79.96 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.645 -0.659 . . . . 0.0 111.737 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 6.8 mttt -67.04 -41.0 87.27 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.58 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -69.94 -42.54 73.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.756 -0.59 . . . . 0.0 111.428 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.445 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.3 t80 -70.7 -29.36 65.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.502 -0.749 . . . . 0.0 110.348 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 139' ' ' TYR . 94.8 mt -85.35 -50.99 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 110.235 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.77 -26.68 68.83 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.528 -0.733 . . . . 0.0 110.85 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.25 -15.46 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.816 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 142' ' ' PHE . 58.1 t -95.98 -42.42 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 108.695 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.594 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.7 mm? . . . . . 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 111.693 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.807 0.337 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -109.92 161.98 14.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.859 0.838 . . . . 0.0 111.184 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.86 HG22 ' CG2' ' A' ' 87' ' ' VAL . 28.2 m -50.98 -30.86 16.17 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.59 0.709 . . . . 0.0 109.73 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -36.93 41.23 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.875 -0.516 . . . . 0.0 111.189 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -60.03 -50.06 75.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.598 -0.689 . . . . 0.0 109.996 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.825 ' CD1' HD11 ' A' ' 143' ' ' ILE . 3.6 m-85 -76.35 -39.6 53.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 111.025 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.86 ' CG2' HG22 ' A' ' 83' ' ' THR . 68.8 t -59.22 -53.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.25 -0.906 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.612 ' O ' HG23 ' A' ' 92' ' ' VAL . 38.4 ttpt -59.45 -33.15 70.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.608 -0.682 . . . . 0.0 110.955 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.658 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -62.49 -51.69 66.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.508 -0.745 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.55 -54.87 6.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 111.505 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -48.46 -37.29 16.92 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.485 -0.759 . . . . 0.0 112.83 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 88' ' ' LYS . 76.6 t -60.29 -36.94 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.843 -1.16 . . . . 0.0 109.715 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.59 -46.98 65.07 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -62.28 82.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.507 -0.746 . . . . 0.0 110.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -64.13 -40.01 95.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.0 110.447 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -91.54 16.7 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.5 36.31 0.13 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.8 p -63.75 -34.6 78.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.076 -1.015 . . . . 0.0 109.37 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.81 11.28 55.4 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.131 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 29.2 mmtm -132.39 153.95 50.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.044 -1.268 . . . . 0.0 110.402 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 139' ' ' TYR . 35.8 m -149.98 161.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.344 -0.848 . . . . 0.0 110.09 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 p -83.85 145.77 28.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.035 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.3 p -56.94 -38.3 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.395 -0.816 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.92 -40.76 97.3 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.6 -39.96 26.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.602 -0.94 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.89 -49.87 75.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.64 . . . . 0.0 110.025 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -64.66 -29.94 70.95 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.502 -0.749 . . . . 0.0 110.652 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.5 -47.68 69.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.424 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -39.19 93.65 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.016 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -55.59 -45.29 77.45 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.1 m -59.65 -30.42 68.73 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.571 0.7 . . . . 0.0 109.917 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.3 63.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 6.83 47.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.322 -1.105 . . . . 0.0 112.736 -177.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.66 32.35 4.83 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.566 ' HG2' HD23 ' A' ' 110' ' ' LEU . 19.9 tp10 -114.16 120.25 39.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 122.034 -0.686 . . . . 0.0 109.896 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -122.06 59.5 1.0 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.203 1.001 . . . . 0.0 109.364 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.38 148.44 23.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -111.05 143.1 42.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -39.98 -28.26 0.05 Allowed 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.318 -0.864 . . . . 0.0 112.486 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.41 59.29 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 45.4 mt-10 -75.4 -29.32 59.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 110.584 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.85 -32.6 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.99 -41.93 77.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.328 -0.857 . . . . 0.0 110.454 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 125' ' ' LEU . 9.1 pt-20 -60.0 -40.06 87.93 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.139 -0.975 . . . . 0.0 109.898 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -70.34 -44.06 68.97 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.394 -0.816 . . . . 0.0 110.354 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 129' ' ' VAL . 26.7 mt -60.18 -16.11 30.07 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.841 -0.537 . . . . 0.0 111.775 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -57.64 -19.24 25.06 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.276 -0.89 . . . . 0.0 111.304 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.64 25.09 9.26 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.438 HG21 HD23 ' A' ' 126' ' ' LEU . 58.6 t -106.7 124.5 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.301 -1.117 . . . . 0.0 109.549 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.03 105.85 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.474 0.654 . . . . 0.0 111.874 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.637 HG12 ' CG1' ' A' ' 137' ' ' ILE . 26.3 m -88.81 163.2 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -93.41 -175.05 3.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.794 . . . . 0.0 111.015 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 m -71.24 -1.35 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.899 -0.5 . . . . 0.0 111.776 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -108.26 -11.89 15.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.937 -1.102 . . . . 0.0 110.726 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.72 27.55 26.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.586 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.6 mt-10 -109.94 137.81 47.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.969 . . . . 0.0 111.108 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.637 ' CG1' HG12 ' A' ' 131' ' ' VAL . 5.1 mp -129.68 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -69.33 110.65 4.77 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.941 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.464 ' HB3' HG21 ' A' ' 101' ' ' VAL . 45.6 p90 -62.84 -30.96 71.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.48 -0.763 . . . . 0.0 111.89 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 24.3 mttt -71.28 -33.41 69.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.333 -0.855 . . . . 0.0 110.466 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -72.34 -46.17 56.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.751 -0.593 . . . . 0.0 111.493 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.2 t80 -71.15 -29.0 64.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.467 -0.771 . . . . 0.0 111.329 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.825 HD11 ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -79.28 -44.62 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.163 -0.961 . . . . 0.0 110.366 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.45 ' N ' HG23 ' A' ' 143' ' ' ILE . 94.0 mt-10 -62.29 -26.25 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.126 -0.984 . . . . 0.0 109.856 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.42 -12.56 45.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.434 -0.791 . . . . 0.0 110.099 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 142' ' ' PHE . 59.5 t -96.36 -41.8 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.429 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.9 tp . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.379 0.609 . . . . 0.0 110.758 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -107.3 158.88 16.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.838 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.7 m -51.26 -30.28 17.26 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.799 0.809 . . . . 0.0 109.329 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.17 -39.09 63.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.907 -0.496 . . . . 0.0 111.286 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.45 ' OD1' HD21 ' A' ' 113' ' ' LEU . 7.7 t0 -61.77 -50.03 74.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.551 -0.718 . . . . 0.0 109.918 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.735 ' CE2' HD21 ' A' ' 147' ' ' LEU . 1.6 m-85 -72.82 -36.58 67.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.743 -0.598 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 83' ' ' THR . 77.7 t -67.36 -46.15 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.16 -0.963 . . . . 0.0 110.79 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.598 ' O ' HG13 ' A' ' 92' ' ' VAL . 71.0 mmtt -59.27 -36.48 75.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.573 -0.704 . . . . 0.0 111.549 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 113' ' ' LEU . . . -59.75 -57.52 12.57 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 111.592 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -77.64 -53.63 7.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.278 -0.889 . . . . 0.0 112.028 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 139' ' ' TYR . 37.5 mm-40 -48.36 -38.71 19.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.175 -0.953 . . . . 0.0 113.14 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 88' ' ' LYS . 29.7 m -59.14 -34.54 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.754 -1.216 . . . . 0.0 110.164 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -68.38 -43.33 77.57 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.3 80.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.359 -0.838 . . . . 0.0 110.901 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.26 -39.92 92.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 0.0 110.482 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -92.44 20.14 6.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.343 -0.848 . . . . 0.0 110.811 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 m 38.14 65.04 0.63 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -91.43 -33.78 15.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.17 -0.956 . . . . 0.0 109.148 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 15.12 57.48 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' C ' HG13 ' A' ' 101' ' ' VAL . 24.4 mmtp -131.93 153.1 50.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -1.217 . . . . 0.0 110.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 100' ' ' LYS . 35.9 m -148.98 159.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.313 -0.867 . . . . 0.0 110.047 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -81.85 144.8 30.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.624 -0.672 . . . . 0.0 110.083 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.7 p -56.41 -38.66 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.492 -0.755 . . . . 0.0 110.702 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.444 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -60.1 -40.6 97.36 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.52 -40.04 26.75 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.569 -0.959 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 106' ' ' LEU . 10.4 tt -58.96 -49.62 77.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.667 -0.646 . . . . 0.0 110.212 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -64.95 -29.6 70.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.705 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -67.93 -48.08 66.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.389 -0.82 . . . . 0.0 110.684 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -37.68 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.22 -0.925 . . . . 0.0 111.041 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.68 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.4 tp -55.33 -42.85 74.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.222 -0.924 . . . . 0.0 109.388 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' GLU . 1.1 p -66.45 -20.5 66.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.45 -14.87 62.99 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.488 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -94.09 8.41 41.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.321 -1.105 . . . . 0.0 112.507 -177.318 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.08 31.31 4.77 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.68 ' HG2' HD23 ' A' ' 110' ' ' LEU . 3.2 tp10 -113.97 120.27 40.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.985 -0.715 . . . . 0.0 109.734 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -122.07 59.33 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -0.964 . . . . 0.0 109.909 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.0 mt -91.68 148.82 21.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 p -111.06 142.28 43.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -39.61 -29.21 0.05 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.422 -0.799 . . . . 0.0 112.482 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.03 -52.89 62.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.341 -0.849 . . . . 0.0 108.852 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.78 -43.18 37.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.714 -0.616 . . . . 0.0 110.304 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.32 -34.9 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.549 -0.719 . . . . 0.0 110.405 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -64.17 -37.44 87.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.216 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.99 -46.67 88.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 110.086 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 125' ' ' LEU . 10.9 mp -62.72 -41.18 99.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.524 -0.735 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 26.4 mt -62.98 -17.13 61.72 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.826 -0.546 . . . . 0.0 111.569 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -56.57 -22.51 34.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.259 -0.9 . . . . 0.0 111.084 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.98 25.29 8.94 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 66.2 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.363 -1.081 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -102.38 102.94 13.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.448 0.642 . . . . 0.0 111.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.27 158.97 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -95.92 -177.54 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.355 -0.84 . . . . 0.0 111.333 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -71.22 -2.06 14.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.832 -0.543 . . . . 0.0 111.971 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.82 -10.52 16.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.994 -1.066 . . . . 0.0 110.241 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.98 32.37 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.57 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.6 mt-10 -111.13 139.2 46.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.913 . . . . 0.0 111.14 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.0 mp -128.42 142.22 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.92 113.88 6.73 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.731 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.491 ' O ' HD12 ' A' ' 143' ' ' ILE . 30.9 p90 -63.95 -36.16 83.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.617 -0.677 . . . . 0.0 111.887 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.5 mmtt -70.01 -37.02 75.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.27 -45.37 66.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.634 -0.667 . . . . 0.0 111.702 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.647 ' O ' HG23 ' A' ' 146' ' ' VAL . 24.7 t80 -71.3 -29.2 64.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.418 -0.801 . . . . 0.0 110.767 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 139' ' ' TYR . 96.8 mt -79.6 -47.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.484 -0.76 . . . . 0.0 109.611 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -60.31 -26.77 66.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.017 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.14 -12.28 44.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.414 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 142' ' ' PHE . 55.2 t -95.57 -38.91 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.735 HD21 ' CE2' ' A' ' 86' ' ' PHE . 72.1 mt . . . . . 0 N--CA 1.497 1.893 0 O-C-N 121.925 -0.484 . . . . 0.0 111.181 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.8 0.333 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -109.96 158.89 17.76 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.788 . . . . 0.0 111.021 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -49.96 -29.99 9.54 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.533 0.682 . . . . 0.0 110.286 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -46.57 -32.47 3.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.822 -0.549 . . . . 0.0 112.144 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -62.48 -43.79 97.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.378 -0.826 . . . . 0.0 110.543 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.543 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -77.45 -40.22 44.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.489 -0.757 . . . . 0.0 110.704 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.53 -57.46 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.411 -0.806 . . . . 0.0 111.077 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 92' ' ' VAL . 50.5 tttt -60.03 -34.35 73.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.815 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.586 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -60.42 -54.29 47.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.703 . . . . 0.0 111.645 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.427 ' CZ ' ' HG ' ' A' ' 106' ' ' LEU . 24.5 m-85 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.219 -0.926 . . . . 0.0 111.615 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -48.69 -39.68 25.41 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.369 -0.832 . . . . 0.0 112.814 -177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 88' ' ' LYS . 71.5 t -60.05 -38.07 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.876 -1.14 . . . . 0.0 109.754 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -67.48 -44.89 77.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -61.36 82.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.558 -0.714 . . . . 0.0 111.04 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.714 -0.616 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -94.05 18.18 11.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.179 -0.951 . . . . 0.0 110.507 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.1 m 38.7 63.0 0.95 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.3 p -90.83 -34.77 15.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.981 . . . . 0.0 109.122 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.49 62.25 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.307 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 2.6 mppt? -129.83 150.03 51.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.113 -1.227 . . . . 0.0 110.074 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.456 ' CG2' HD12 ' A' ' 106' ' ' LEU . 35.2 m -150.15 164.69 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -0.828 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 p -85.39 147.08 26.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.688 -0.633 . . . . 0.0 109.293 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 137' ' ' ILE . 35.5 m -62.43 -33.17 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.94 -42.25 99.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.9 -39.91 29.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.664 -0.903 . . . . 0.0 109.624 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 106' ' ' LEU . 9.9 tt -59.9 -49.19 78.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.827 -0.546 . . . . 0.0 109.527 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -63.9 -29.44 70.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.24 -48.41 67.85 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.391 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -40.03 95.77 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.682 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 115' ' ' GLU . 1.5 mp -55.95 -44.29 78.28 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.0 m -60.04 -31.08 69.63 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.577 0.703 . . . . 0.0 109.754 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.14 -14.79 63.72 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -96.53 7.27 46.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -1.124 . . . . 0.0 112.557 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 31.53 5.05 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.551 ' HG2' HD23 ' A' ' 110' ' ' LEU . 18.2 tp10 -113.52 120.17 40.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.877 -0.778 . . . . 0.0 109.952 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.5 60.3 1.01 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 0.0 109.879 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 85.7 mt -91.41 148.8 22.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -110.76 142.75 42.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 28.6 t0 -39.37 -29.27 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 O-C-N 121.376 -0.827 . . . . 0.0 112.571 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.87 -53.04 61.24 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -0.855 . . . . 0.0 108.808 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -76.75 -42.83 39.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.624 -0.673 . . . . 0.0 110.169 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 62.6 t -60.25 -35.82 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.568 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.63 -38.41 87.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.184 -0.947 . . . . 0.0 109.115 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.63 -45.36 92.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.591 -0.693 . . . . 0.0 109.527 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.33 -51.47 68.7 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.587 -0.696 . . . . 0.0 110.151 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.411 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 8.5 mt -59.99 -19.04 50.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.634 -0.667 . . . . 0.0 110.962 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -57.06 -24.0 50.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.501 -0.75 . . . . 0.0 110.93 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.27 25.41 8.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 62.0 t -106.74 120.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -1.113 . . . . 0.0 109.659 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.52 103.0 15.45 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.487 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.71 HG12 ' CG1' ' A' ' 137' ' ' ILE . 23.6 m -86.74 161.38 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -95.87 -171.98 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 110.946 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 p -72.08 -0.21 11.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.84 -0.537 . . . . 0.0 111.752 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.68 -11.09 15.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.944 -1.098 . . . . 0.0 110.257 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.89 24.55 52.49 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.777 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.4 mt-10 -110.96 141.62 44.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.392 -1.064 . . . . 0.0 110.966 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 1.062 HD13 HG13 ' A' ' 103' ' ' VAL . 3.4 mp -127.05 147.22 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.311 0.577 . . . . 0.0 109.657 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.23 116.29 9.5 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.227 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.48 ' CZ ' ' HG3' ' A' ' 140' ' ' LYS . 7.2 p90 -68.15 -34.14 75.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.653 -0.654 . . . . 0.0 111.983 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 13.8 mttt -69.97 -28.85 65.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.342 -0.849 . . . . 0.0 111.278 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -80.42 -43.22 21.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 112.254 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.6 t80 -70.9 -30.72 67.14 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.0 111.727 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 86' ' ' PHE . 18.2 pt -83.69 -44.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.114 -0.991 . . . . 0.0 110.579 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.424 ' N ' HG13 ' A' ' 143' ' ' ILE . 65.3 mt-10 -67.33 -26.53 66.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.72 -13.98 46.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.273 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 142' ' ' PHE . 70.4 t -95.31 -37.82 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.293 0.568 . . . . 0.0 110.933 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.824 0.345 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -109.21 160.71 15.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.81 0.814 . . . . 0.0 110.79 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 87' ' ' VAL . 16.2 m -51.32 -31.08 20.42 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.698 0.761 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -51.39 -37.43 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.854 -0.529 . . . . 0.0 111.152 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.473 ' OD1' HD21 ' A' ' 113' ' ' LEU . 13.4 t0 -64.64 -45.55 86.3 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.682 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.658 ' HE2' HD21 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -74.65 -38.39 62.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.729 -0.607 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.639 ' CG2' HG22 ' A' ' 83' ' ' THR . 64.8 t -66.56 -47.09 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.141 -0.974 . . . . 0.0 111.041 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 92' ' ' VAL . 24.1 tptt -60.06 -35.32 74.9 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.582 -0.699 . . . . 0.0 111.419 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.74 -52.8 62.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.456 -0.777 . . . . 0.0 111.816 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.48 -53.61 7.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 111.367 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.417 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 35.3 mt-30 -48.09 -36.19 12.7 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.291 -0.88 . . . . 0.0 112.854 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 88' ' ' LYS . 85.5 t -62.25 -35.74 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 109.981 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.05 -50.97 35.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.363 -0.835 . . . . 0.0 109.276 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 91' ' ' GLN . 2.6 p30 -77.67 82.39 4.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.214 -0.929 . . . . 0.0 109.663 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -61.16 -26.86 67.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.817 -0.552 . . . . 0.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.65 17.97 5.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.17 -0.956 . . . . 0.0 111.015 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.6 t 38.5 37.11 0.16 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.1 p -63.9 -34.91 79.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.082 -1.011 . . . . 0.0 109.24 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.85 59.59 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' C ' HG13 ' A' ' 101' ' ' VAL . 48.0 mttm -131.77 153.38 50.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.266 . . . . 0.0 110.176 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.619 ' CG2' HD12 ' A' ' 106' ' ' LEU . 34.0 m -150.37 161.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.381 -0.825 . . . . 0.0 110.28 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -83.08 145.85 29.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.502 -0.749 . . . . 0.0 109.923 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.1 p -57.26 -39.99 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.423 -0.798 . . . . 0.0 110.741 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.67 -41.47 97.44 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -80.08 -41.87 24.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.512 -0.993 . . . . 0.0 110.539 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.619 HD12 ' CG2' ' A' ' 101' ' ' VAL . 9.8 tt -60.06 -49.76 76.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.639 -0.663 . . . . 0.0 109.959 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -64.24 -31.65 72.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 110.265 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -67.45 -48.83 66.07 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -33.57 65.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.804 . . . . 0.0 110.583 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 27.7 tp -54.57 -44.32 72.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' GLU . 25.4 m -67.41 -15.87 63.92 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.061 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.98 -14.51 64.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.499 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -94.82 8.02 44.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -1.055 . . . . 0.0 112.583 -177.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 31.0 5.05 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 58.5 mm-40 -114.18 120.72 41.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.929 -0.748 . . . . 0.0 109.638 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -122.8 60.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.39 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 72.6 mt -89.95 148.26 23.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.3 m -110.6 141.66 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -0.903 . . . . 0.0 110.16 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 26.2 t0 -39.2 -30.83 0.06 Allowed 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.566 -0.709 . . . . 0.0 112.161 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.63 -51.75 67.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -77.28 -40.73 43.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.722 -0.611 . . . . 0.0 110.454 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 62.2 t -62.55 -35.36 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.607 -0.683 . . . . 0.0 110.466 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -64.21 -38.03 89.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -59.97 -46.86 88.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.619 -0.676 . . . . 0.0 109.521 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.3 -46.95 86.47 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.659 0.742 . . . . 0.0 109.944 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.97 -18.96 60.21 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.85 -0.531 . . . . 0.0 111.205 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.75 -21.32 27.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.218 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.43 -12.04 11.14 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.89 134.24 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.08 -1.247 . . . . 0.0 110.242 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -102.4 102.96 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.602 . . . . 0.0 111.804 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.427 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.4 p -85.69 157.31 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.05 -179.17 4.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.288 -0.883 . . . . 0.0 111.287 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -71.0 -2.61 15.95 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.874 -0.516 . . . . 0.0 111.854 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -107.33 -12.19 15.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.429 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.15 27.09 22.0 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' HD12 ' A' ' 137' ' ' ILE . 64.3 mt-10 -110.87 135.65 51.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.938 . . . . 0.0 111.068 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.556 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.2 mp -128.32 140.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -68.93 111.29 4.87 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.657 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 143' ' ' ILE . 18.6 p90 -64.48 -32.51 74.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.481 -0.762 . . . . 0.0 112.095 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.2 mtmp? -71.22 -35.93 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.258 -0.901 . . . . 0.0 111.067 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -70.41 -44.51 67.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.684 -0.635 . . . . 0.0 111.659 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 146' ' ' VAL . 29.2 t80 -70.02 -29.15 66.13 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.431 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 139' ' ' TYR . 32.4 pt -80.27 -43.68 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 110.197 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.461 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.7 mt-10 -62.59 -26.84 68.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.266 -0.896 . . . . 0.0 109.929 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.1 -12.31 44.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.355 -0.841 . . . . 0.0 110.276 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 142' ' ' PHE . 54.5 t -95.92 -39.94 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.658 HD21 ' HE2' ' A' ' 86' ' ' PHE . 52.7 mt . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.941 -0.474 . . . . 0.0 111.565 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -109.07 160.17 16.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.849 . . . . 0.0 111.001 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.88 HG22 ' CG2' ' A' ' 87' ' ' VAL . 23.8 m -51.15 -30.5 16.81 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.612 0.72 . . . . 0.0 109.54 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -52.3 -37.27 55.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.871 -0.518 . . . . 0.0 111.275 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -60.04 -51.05 71.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.56 -0.713 . . . . 0.0 109.865 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -75.62 -39.69 57.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 110.814 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.88 ' CG2' HG22 ' A' ' 83' ' ' THR . 99.8 t -61.25 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.26 -0.9 . . . . 0.0 110.282 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 92' ' ' VAL . 37.8 mmtt -60.07 -36.16 76.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.651 -0.656 . . . . 0.0 110.923 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.491 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -62.32 -49.04 77.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.708 -0.62 . . . . 0.0 111.565 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.703 ' CE2' HD12 ' A' ' 106' ' ' LEU . 19.0 m-85 -77.41 -56.07 4.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 111.751 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.539 ' OE1' HG12 ' A' ' 87' ' ' VAL . 66.5 mt-30 -48.16 -34.27 9.7 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 88' ' ' LYS . 81.8 t -61.84 -34.55 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.814 -1.178 . . . . 0.0 109.657 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -72.58 -52.1 16.95 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.66 81.77 8.72 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -60.39 -21.16 61.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.688 -0.632 . . . . 0.0 111.002 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.97 18.91 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.147 -0.971 . . . . 0.0 111.044 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.5 m 38.73 37.43 0.19 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.5 p -64.24 -35.6 81.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.0 12.52 60.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.442 ' C ' HG23 ' A' ' 101' ' ' VAL . 89.2 mttt -131.74 151.61 51.52 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.247 . . . . 0.0 110.155 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 100' ' ' LYS . 48.1 t -149.84 162.51 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.349 -0.844 . . . . 0.0 109.97 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 101' ' ' VAL . 8.9 p -84.95 148.16 26.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.517 -0.74 . . . . 0.0 109.991 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.775 ' CG2' HD13 ' A' ' 137' ' ' ILE . 98.1 t -56.23 -40.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.34 94.03 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -81.05 -42.75 20.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.238 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.703 HD12 ' CE2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -60.08 -49.92 75.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 110.222 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -67.04 -31.01 71.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.581 -0.699 . . . . 0.0 110.792 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.7 -47.81 65.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.67 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -40.61 92.33 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.508 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -45.07 77.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.474 -0.89 . . . . 0.0 108.675 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -59.94 -28.36 67.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.538 0.685 . . . . 0.0 109.9 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.59 63.38 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.77 6.9 47.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.295 -1.12 . . . . 0.0 112.76 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.11 31.46 5.03 Favored Glycine 0 N--CA 1.501 3.009 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -114.13 121.0 42.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.792 -0.828 . . . . 0.0 109.871 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -122.33 59.89 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.051 0.929 . . . . 0.0 109.598 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.13 148.92 22.04 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.0 p -110.77 142.21 43.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 0.0 110.024 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.41 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 35.8 t0 -39.87 -28.46 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 O-C-N 121.297 -0.877 . . . . 0.0 112.543 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.95 -52.59 63.43 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.7 -43.01 39.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 110.312 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 59.3 t -60.04 -35.53 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.497 -0.752 . . . . 0.0 110.562 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -63.21 -37.32 86.76 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.216 -0.927 . . . . 0.0 109.275 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.81 -46.03 90.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.559 -0.713 . . . . 0.0 109.578 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 129' ' ' VAL . 11.0 mp -61.19 -48.44 81.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.541 -0.724 . . . . 0.0 109.825 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.33 -21.34 66.58 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.859 -0.526 . . . . 0.0 111.05 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -57.19 -22.23 39.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.497 -0.752 . . . . 0.0 111.104 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.69 -14.32 8.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 125' ' ' LEU . 72.4 t -68.37 134.11 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.044 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.91 99.1 11.2 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 111.71 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 137' ' ' ILE . 7.4 p -82.33 156.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.51 -177.79 4.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -71.46 -0.92 11.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.773 -0.579 . . . . 0.0 111.954 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -107.5 -12.52 15.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.843 -1.161 . . . . 0.0 110.442 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.4 25.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 137' ' ' ILE . 46.2 mt-10 -111.91 136.14 51.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.962 . . . . 0.0 111.086 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.775 HD13 ' CG2' ' A' ' 103' ' ' VAL . 4.0 mp -126.98 141.38 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -69.41 106.67 3.03 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.433 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.487 ' O ' HD12 ' A' ' 143' ' ' ILE . 54.4 p90 -62.51 -35.8 80.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.301 -0.874 . . . . 0.0 112.128 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.459 ' CG ' ' CE1' ' A' ' 139' ' ' TYR . 19.4 mtpp -58.44 -56.57 20.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.278 -0.889 . . . . 0.0 111.052 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -59.91 -39.1 84.27 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.786 -0.572 . . . . 0.0 111.585 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 146' ' ' VAL . 18.4 t80 -70.05 -28.98 65.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 0.0 109.685 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 139' ' ' TYR . 69.3 mt -83.27 -50.03 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.713 . . . . 0.0 109.725 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.72 -27.01 67.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.466 -0.771 . . . . 0.0 110.11 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -87.85 -12.98 43.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.861 . . . . 0.0 110.466 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 142' ' ' PHE . 41.7 t -95.82 -39.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.318 0.58 . . . . 0.0 110.679 178.563 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.752 0.311 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -109.58 159.66 16.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 111.084 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.78 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.3 m -50.89 -30.43 14.59 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.695 0.76 . . . . 0.0 109.564 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.62 -37.01 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.842 -0.536 . . . . 0.0 111.279 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.98 -50.5 73.49 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.0 m-85 -76.48 -40.57 49.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.687 -0.633 . . . . 0.0 110.944 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.78 ' CG2' HG22 ' A' ' 83' ' ' THR . 71.8 t -60.34 -57.21 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.83 . . . . 0.0 110.958 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 91' ' ' GLN . 57.3 tptt -54.45 -32.55 57.83 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.451 -0.781 . . . . 0.0 111.022 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.575 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -65.17 -44.77 87.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.743 -0.598 . . . . 0.0 111.89 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 143' ' ' ILE . 14.3 m-85 -80.61 -56.88 3.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.916 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.427 ' CG ' ' HA ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -48.59 -36.56 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.3 p -60.01 -35.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.01 -1.056 . . . . 0.0 109.655 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -71.62 -47.41 54.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 80.6 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.444 -0.785 . . . . 0.0 110.593 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -60.52 -38.22 83.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.569 -0.707 . . . . 0.0 110.738 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.54 20.44 5.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t 37.98 36.85 0.12 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.1 p -64.17 -34.47 78.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.209 -0.932 . . . . 0.0 109.519 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.04 13.31 57.86 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' C ' HG23 ' A' ' 101' ' ' VAL . 48.8 mttm -132.47 151.89 51.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.095 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 100' ' ' LYS . 58.8 t -148.41 159.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.39 -0.818 . . . . 0.0 109.494 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -79.82 144.3 33.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.773 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.1 p -55.81 -38.76 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.417 -0.802 . . . . 0.0 110.542 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.446 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.98 -40.69 97.29 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -81.15 -40.0 24.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.885 . . . . 0.0 110.511 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 106' ' ' LEU . 9.7 tt -59.18 -49.82 76.41 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.63 -0.668 . . . . 0.0 110.173 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -67.03 -28.87 68.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.787 . . . . 0.0 111.075 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.18 -48.51 70.46 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.372 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -40.78 98.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.06 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.68 HD23 ' HG3' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.95 -44.64 78.61 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.7 m -60.06 -31.44 69.99 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.502 0.668 . . . . 0.0 109.619 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.79 64.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.575 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -96.15 7.85 45.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -1.136 . . . . 0.0 112.475 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 31.78 4.91 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.721 ' OE2' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -113.22 119.88 39.28 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.742 -0.858 . . . . 0.0 110.28 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.77 59.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.798 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.721 HD12 ' OE2' ' A' ' 115' ' ' GLU . 90.6 mt -90.02 148.72 22.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 m -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.04 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 11.6 t70 -40.06 -27.47 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 O-C-N 121.231 -0.918 . . . . 0.0 112.95 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.09 60.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.195 -0.941 . . . . 0.0 109.072 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.54 -41.95 44.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.485 HG12 HD12 ' A' ' 126' ' ' LEU . 62.6 t -59.97 -35.92 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 110.258 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.71 -37.11 86.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.085 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -63.71 -49.88 71.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.577 0.703 . . . . 0.0 109.978 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 122' ' ' VAL . 34.1 mt -61.87 -16.64 52.0 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.826 -0.547 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -56.8 -20.58 23.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.398 -0.814 . . . . 0.0 111.173 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 25.65 8.29 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 62.6 t -107.32 129.98 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.294 -1.121 . . . . 0.0 109.783 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 100.54 11.38 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.885 0.85 . . . . 0.0 112.418 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.3 p -83.47 158.88 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -95.62 -179.04 4.6 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.835 0.826 . . . . 0.0 111.423 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.4 m -70.97 -1.67 12.74 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.833 -0.542 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -107.66 -11.96 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.998 -1.064 . . . . 0.0 110.434 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.94 28.79 17.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.487 ' C ' HD12 ' A' ' 137' ' ' ILE . 67.8 mt-10 -111.15 135.58 51.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.931 . . . . 0.0 111.153 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.5 mp -125.35 168.55 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 137' ' ' ILE . 19.7 t0 -98.19 112.02 24.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.448 -0.782 . . . . 0.0 110.148 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.487 ' HA ' HD11 ' A' ' 106' ' ' LEU . 43.9 p90 -65.92 -34.22 77.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.471 -0.768 . . . . 0.0 112.171 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.456 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 mttt -70.04 -40.02 75.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.075 -1.016 . . . . 0.0 110.946 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.19 -43.82 81.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.629 -0.669 . . . . 0.0 111.391 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.5 t80 -71.66 -27.87 63.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.578 -0.701 . . . . 0.0 110.993 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.6 HD11 ' CE1' ' A' ' 90' ' ' PHE . 96.6 mt -83.93 -51.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.812 . . . . 0.0 110.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -61.93 -26.4 68.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 111.016 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.14 -16.44 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 142' ' ' PHE . 76.8 t -97.19 -42.88 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.14 -0.975 . . . . 0.0 109.187 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.465 HD11 ' HE2' ' A' ' 86' ' ' PHE . 4.0 mm? . . . . . 0 N--CA 1.498 1.933 0 O-C-N 121.703 -0.623 . . . . 0.0 111.721 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -108.56 154.48 21.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 110.94 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.641 HG22 ' CG1' ' A' ' 87' ' ' VAL . 5.3 m -50.75 -30.41 13.91 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 44.0 mt-10 -50.49 -35.87 31.15 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.687 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.89 -47.22 75.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.595 -0.691 . . . . 0.0 110.326 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 147' ' ' LEU . 21.3 m-85 -77.42 -39.95 45.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.656 -0.653 . . . . 0.0 112.692 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.641 ' CG1' HG22 ' A' ' 83' ' ' THR . 33.4 m -68.22 -41.87 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.826 -1.171 . . . . 0.0 110.801 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 92' ' ' VAL . 34.2 mttt -60.05 -33.7 72.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.487 -0.758 . . . . 0.0 110.187 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' A' ' 113' ' ' LEU . . . -58.75 -56.5 21.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.64 -0.663 . . . . 0.0 111.067 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' HD12 ' A' ' 106' ' ' LEU . 56.0 m-85 -77.34 -53.14 8.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 111.048 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -49.03 -42.71 39.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.497 -0.752 . . . . 0.0 112.436 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 88' ' ' LYS . 76.1 t -58.91 -39.26 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.861 -1.149 . . . . 0.0 109.611 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.03 -43.65 87.0 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.61 81.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -62.15 -37.38 84.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.606 -0.684 . . . . 0.0 110.868 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -89.94 17.06 7.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.9 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.3 t 37.69 37.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.6 p -63.78 -33.29 75.34 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.12 -0.988 . . . . 0.0 109.465 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.17 54.69 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.187 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.447 ' C ' HG13 ' A' ' 101' ' ' VAL . 81.3 mttt -132.19 153.41 50.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -1.191 . . . . 0.0 109.9 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.476 HG21 HD13 ' A' ' 106' ' ' LEU . 35.6 m -148.86 159.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.283 -0.886 . . . . 0.0 110.388 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.8 p -84.75 147.66 26.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.575 . . . . 0.0 110.222 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.639 ' CG2' HD13 ' A' ' 137' ' ' ILE . 86.4 t -57.36 -39.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.366 -0.834 . . . . 0.0 110.238 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.42 -41.61 95.34 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.31 -39.79 28.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.579 -0.954 . . . . 0.0 110.216 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.689 HD12 ' CE1' ' A' ' 90' ' ' PHE . 28.7 tp -60.04 -49.0 79.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.75 -0.594 . . . . 0.0 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -66.77 -29.83 69.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 111.036 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.76 -48.85 62.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.078 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -38.57 77.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.368 -0.832 . . . . 0.0 110.667 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.585 HD23 ' HG2' ' A' ' 115' ' ' GLU . 6.3 tp -55.09 -44.2 74.65 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -61.49 -25.21 67.11 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.511 0.672 . . . . 0.0 110.081 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.39 -14.52 63.72 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.724 ' CD2' ' HB2' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -94.55 7.88 44.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.317 -1.108 . . . . 0.0 112.214 -177.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.63 32.5 4.78 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.585 ' HG2' HD23 ' A' ' 110' ' ' LEU . 3.5 tp10 -113.98 119.94 38.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.99 -0.712 . . . . 0.0 110.342 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -122.32 59.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.0 109.579 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 90.3 mt -90.97 148.78 22.19 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 p -111.18 141.62 44.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -40.09 -27.79 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 O-C-N 121.311 -0.868 . . . . 0.0 112.84 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.468 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . . . -62.1 -52.56 63.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.294 -0.878 . . . . 0.0 109.16 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.468 ' OE1' ' HB3' ' A' ' 120' ' ' ALA . 1.3 mp0 -76.62 -42.92 40.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 58.5 t -59.99 -35.42 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.669 -0.644 . . . . 0.0 110.608 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.76 -38.09 89.81 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.294 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.01 -46.36 89.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.615 -0.678 . . . . 0.0 109.71 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -50.02 74.1 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.559 0.695 . . . . 0.0 109.884 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.41 -18.98 43.64 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.772 -0.58 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.05 -21.96 35.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.471 -0.768 . . . . 0.0 111.161 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.23 -12.91 10.36 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.3 t -68.98 130.02 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.098 -1.237 . . . . 0.0 110.169 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -99.15 103.64 15.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.437 0.637 . . . . 0.0 111.589 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -87.77 159.69 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.37 -177.05 4.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.8 p -69.58 -2.39 11.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.933 -0.479 . . . . 0.0 112.159 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -105.07 -6.26 20.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.948 -1.095 . . . . 0.0 110.225 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.83 23.23 60.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.451 ' C ' HD12 ' A' ' 137' ' ' ILE . 48.4 mt-10 -110.41 145.91 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 110.984 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.639 HD13 ' CG2' ' A' ' 103' ' ' VAL . 3.5 mp -131.55 170.09 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.6 t70 -95.24 116.91 29.38 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.62 ' O ' HD12 ' A' ' 143' ' ' ILE . 47.8 p90 -65.47 -39.83 92.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.56 -0.712 . . . . 0.0 111.751 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.2 mttt -64.56 -40.03 94.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.529 -0.732 . . . . 0.0 110.469 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -68.17 -43.94 77.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.779 -0.575 . . . . 0.0 111.225 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.607 ' O ' HG23 ' A' ' 146' ' ' VAL . 16.9 t80 -69.89 -28.67 65.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.523 -0.736 . . . . 0.0 110.357 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 139' ' ' TYR . 42.8 mt -76.15 -46.89 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.521 -0.737 . . . . 0.0 109.133 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.6 -28.78 69.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.41 -0.806 . . . . 0.0 110.496 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -88.37 -12.0 44.59 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.861 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 142' ' ' PHE . 53.0 t -95.12 -38.15 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 143' ' ' ILE . 5.1 mp . . . . . 0 N--CA 1.497 1.877 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.167 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.919 0.39 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -108.81 161.62 14.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 110.895 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 87' ' ' VAL . 4.0 m -50.91 -31.35 17.31 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -50.97 -35.94 36.35 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.854 -0.529 . . . . 0.0 111.079 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.653 ' OD1' HD11 ' A' ' 113' ' ' LEU . 44.8 t0 -59.96 -50.61 73.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.62 -0.675 . . . . 0.0 109.834 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.651 ' CE1' HD23 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -76.53 -40.08 51.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.708 -0.62 . . . . 0.0 110.79 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 83' ' ' THR . 97.7 t -59.09 -53.3 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.272 -0.893 . . . . 0.0 110.344 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 92' ' ' VAL . 29.0 tttt -59.99 -34.24 73.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.681 -0.637 . . . . 0.0 110.402 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.94 -54.27 48.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 111.026 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE1' HD11 ' A' ' 143' ' ' ILE . 47.7 m-85 -77.63 -54.43 6.4 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.371 -0.83 . . . . 0.0 111.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -48.91 -39.56 26.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.503 -0.748 . . . . 0.0 112.922 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 88' ' ' LYS . 73.8 t -59.2 -37.69 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.852 -1.155 . . . . 0.0 109.652 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -69.44 -46.46 66.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -64.34 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.0 110.641 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -60.01 -39.34 85.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.5 -0.75 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -91.61 20.7 5.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.314 -0.866 . . . . 0.0 110.899 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 p 38.36 37.95 0.2 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 p -64.06 -34.72 78.67 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.254 -0.979 . . . . 0.0 109.384 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 14.48 55.24 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 59.4 mttt -132.93 154.88 50.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.054 -1.263 . . . . 0.0 110.528 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.454 HG13 ' C ' ' A' ' 100' ' ' LYS . 34.0 m -150.08 159.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.402 -0.811 . . . . 0.0 109.783 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -81.98 144.57 30.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.0 110.007 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.4 p -56.75 -38.9 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.538 -0.726 . . . . 0.0 110.772 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.44 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.82 -41.32 97.6 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.53 -39.1 28.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.547 -0.972 . . . . 0.0 110.527 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.451 HD12 ' CG2' ' A' ' 101' ' ' VAL . 7.5 tt -60.08 -49.95 75.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 110.108 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -63.44 -29.61 70.87 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.517 -0.74 . . . . 0.0 110.313 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.32 -47.48 67.44 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -39.71 87.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.39 -0.819 . . . . 0.0 110.574 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.665 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -54.84 -44.82 74.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 m -60.83 -26.54 67.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.49 0.662 . . . . 0.0 109.966 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.06 -15.21 63.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.653 HD11 ' OD1' ' A' ' 85' ' ' ASP . 21.7 tp -95.65 8.08 44.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 112.399 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.91 33.48 4.34 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.665 ' HG2' HD23 ' A' ' 110' ' ' LEU . 4.6 tp10 -114.25 119.81 38.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.02 -0.694 . . . . 0.0 110.174 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -122.1 59.43 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.074 0.94 . . . . 0.0 109.612 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.53 HD11 ' OE2' ' A' ' 115' ' ' GLU . 61.5 mt -90.53 148.76 22.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 p -110.83 141.59 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -39.69 -28.89 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.35 -0.844 . . . . 0.0 112.62 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.73 -51.79 66.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -76.78 -43.12 38.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.581 -0.7 . . . . 0.0 110.549 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.0 t -59.97 -34.9 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 110.592 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -64.98 -36.82 85.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.138 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.76 -47.33 86.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.478 ' HA ' HD13 ' A' ' 125' ' ' LEU . 4.3 mm? -62.15 -46.63 88.15 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.69 0.757 . . . . 0.0 109.879 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.2 -19.52 63.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.907 -0.496 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -56.74 -21.03 25.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 0.0 111.191 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.34 -11.95 11.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.36 130.48 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.091 -1.241 . . . . 0.0 110.211 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -101.82 104.17 14.92 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.409 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.541 HG12 ' CG1' ' A' ' 137' ' ' ILE . 19.9 m -87.96 161.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.22 -176.2 3.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.59 -0.92 9.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.834 -0.541 . . . . 0.0 111.901 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -107.73 -10.06 15.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.923 -1.111 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.29 25.89 38.34 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.612 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.1 mt-10 -109.72 139.98 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.573 -0.957 . . . . 0.0 110.973 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.0 mp -130.64 140.98 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -68.88 110.77 4.55 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.813 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 43.8 p90 -62.76 -34.02 76.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.491 -0.755 . . . . 0.0 112.004 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.7 mtmt -69.31 -38.67 78.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.272 -0.893 . . . . 0.0 110.581 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.33 -45.01 70.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.744 -0.597 . . . . 0.0 111.587 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.613 ' O ' HG23 ' A' ' 146' ' ' VAL . 22.0 t80 -70.56 -28.8 65.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.449 -0.782 . . . . 0.0 110.645 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.548 HD13 ' CD1' ' A' ' 86' ' ' PHE . 85.5 mt -79.28 -47.95 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.509 -0.744 . . . . 0.0 109.646 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -60.41 -26.5 66.74 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.499 -0.75 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.0 -13.29 39.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.373 -0.829 . . . . 0.0 110.656 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 142' ' ' PHE . 59.0 t -96.23 -43.22 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 143' ' ' ILE . 70.2 mt . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.795 -0.565 . . . . 0.0 111.546 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -110.03 160.02 16.8 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.878 0.847 . . . . 0.0 111.188 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.711 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.4 m -50.58 -30.95 14.44 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.706 0.765 . . . . 0.0 109.738 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -51.1 -36.45 40.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.752 -0.592 . . . . 0.0 111.322 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.44 -44.97 85.63 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.603 -0.686 . . . . 0.0 109.711 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.672 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -76.63 -41.12 47.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.734 -0.604 . . . . 0.0 111.131 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.711 ' CG2' HG22 ' A' ' 83' ' ' THR . 67.5 t -63.7 -52.83 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 111.011 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.674 ' O ' HG13 ' A' ' 92' ' ' VAL . 61.3 tttt -55.73 -32.21 63.18 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.538 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HB3' HD11 ' A' ' 113' ' ' LEU . . . -68.22 -39.94 82.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.581 -0.699 . . . . 0.0 112.344 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 143' ' ' ILE . 26.6 m-85 -80.11 -58.0 3.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.043 -1.036 . . . . 0.0 110.959 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.613 ' OE1' HG12 ' A' ' 87' ' ' VAL . 20.0 pt20 -48.52 -32.76 8.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 88' ' ' LYS . 29.0 m -61.55 -31.38 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.804 -1.185 . . . . 0.0 109.716 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.35 -49.0 29.68 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 80.15 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -62.29 -34.5 76.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.518 -0.739 . . . . 0.0 110.647 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.37 18.51 8.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.233 -0.917 . . . . 0.0 110.657 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.1 m 37.83 35.27 0.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.3 p -63.95 -33.74 76.4 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.198 -0.939 . . . . 0.0 109.316 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 12.08 58.99 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' C ' HG13 ' A' ' 101' ' ' VAL . 21.6 mmtt -131.72 153.65 49.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -1.182 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.522 ' CG2' HD12 ' A' ' 106' ' ' LEU . 31.9 m -149.98 159.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.308 -0.87 . . . . 0.0 110.018 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 144.85 31.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.7 p -56.09 -38.96 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.455 -0.778 . . . . 0.0 110.699 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.99 -40.68 97.29 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.29 -42.25 23.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.545 -0.974 . . . . 0.0 110.574 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.522 HD12 ' CG2' ' A' ' 101' ' ' VAL . 9.8 tt -60.04 -49.91 75.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 109.979 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -64.45 -33.06 75.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.537 -0.727 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -66.24 -48.03 71.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -25.74 59.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.489 -0.757 . . . . 0.0 110.68 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 29.8 tp -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.8 p -66.14 -16.73 64.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.301 0.572 . . . . 0.0 110.695 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.42 65.51 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.57 7.45 45.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.416 -1.05 . . . . 0.0 112.102 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.59 32.99 4.61 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 12.4 mm-40 -114.73 120.98 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.897 -0.766 . . . . 0.0 110.851 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -122.19 59.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.088 0.947 . . . . 0.0 109.297 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.73 149.08 21.79 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -110.87 142.84 42.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -39.83 -27.8 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.814 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.72 62.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.228 -0.92 . . . . 0.0 108.932 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.7 -43.3 38.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.588 -0.695 . . . . 0.0 110.425 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.99 -35.64 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.05 -39.1 93.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.24 -0.912 . . . . 0.0 109.171 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.437 -0.789 . . . . 0.0 109.641 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.32 -48.4 81.89 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.984 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 35.1 mt -60.62 -18.14 51.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.799 -0.563 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.56 -21.47 26.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.23 25.77 8.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 65.8 t -107.67 129.84 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -1.103 . . . . 0.0 109.855 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -102.59 103.03 13.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.751 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.64 HG12 ' CG1' ' A' ' 137' ' ' ILE . 20.1 m -86.05 161.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -95.28 -177.08 3.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 111.281 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.7 p -70.23 -0.8 8.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.907 -0.496 . . . . 0.0 112.01 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -107.5 -9.08 16.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.94 -1.1 . . . . 0.0 110.365 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.59 28.41 29.72 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.617 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.9 mt-10 -110.48 139.27 45.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.955 . . . . 0.0 110.969 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.64 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.6 mp -127.63 143.37 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.3 115.23 8.33 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.037 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.488 ' O ' HD12 ' A' ' 143' ' ' ILE . 10.7 p90 -67.2 -35.26 79.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.723 -0.611 . . . . 0.0 111.769 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 25.3 mttt -70.98 -39.98 72.17 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.352 -0.842 . . . . 0.0 111.032 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.15 -44.57 83.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 111.705 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 146' ' ' VAL . 23.1 t80 -70.02 -28.0 65.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.491 -0.756 . . . . 0.0 110.42 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 139' ' ' TYR . 96.3 mt -79.57 -48.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.382 -0.824 . . . . 0.0 110.133 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -59.99 -27.74 67.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.486 -0.759 . . . . 0.0 110.278 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.4 -16.1 31.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 110.64 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 142' ' ' PHE . 54.1 t -97.52 -48.07 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.128 -0.983 . . . . 0.0 108.87 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.7 -0.625 . . . . 0.0 111.222 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.47 160.28 15.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.87 . . . . 0.0 110.973 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.742 HG22 ' CG2' ' A' ' 87' ' ' VAL . 7.4 m -51.18 -30.58 17.34 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.702 0.763 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -52.46 -37.07 56.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.841 -0.537 . . . . 0.0 111.28 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -61.05 -50.06 74.85 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.573 -0.704 . . . . 0.0 109.919 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.663 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.5 m-85 -75.97 -38.87 57.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.771 -0.581 . . . . 0.0 111.264 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.742 ' CG2' HG22 ' A' ' 83' ' ' THR . 76.4 t -64.17 -50.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.213 -0.929 . . . . 0.0 110.678 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -59.95 -34.17 72.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.547 -0.721 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.592 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -67.39 -44.28 79.25 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.664 -0.648 . . . . 0.0 111.736 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.524 ' CE2' HD11 ' A' ' 143' ' ' ILE . 8.9 m-85 -78.49 -58.91 3.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.093 -1.005 . . . . 0.0 111.654 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -48.35 -28.97 3.5 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -62.13 -32.68 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.999 -1.063 . . . . 0.0 109.848 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -71.53 -50.87 27.07 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.33 81.35 6.66 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.377 -0.827 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -63.1 -17.16 62.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.83 16.11 7.36 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.05 -1.031 . . . . 0.0 110.945 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.4 p 39.1 35.84 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 100' ' ' LYS . 3.4 t -63.11 -33.99 76.65 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.097 -1.002 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.52 9.66 58.72 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.014 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.637 ' H ' HG23 ' A' ' 98' ' ' THR . 1.5 mptt -132.16 154.94 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.239 . . . . 0.0 110.382 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 106' ' ' LEU . 28.8 m -151.04 160.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.371 -0.831 . . . . 0.0 109.914 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -82.04 144.86 30.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.574 -0.704 . . . . 0.0 109.956 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 11.5 p -57.07 -40.0 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.493 -0.755 . . . . 0.0 110.836 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.33 -41.4 96.89 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.14 -39.84 28.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.579 -0.954 . . . . 0.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 101' ' ' VAL . 5.8 tt -59.94 -49.73 76.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.67 -0.644 . . . . 0.0 110.102 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -64.46 -30.26 71.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.697 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -67.89 -48.01 67.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.591 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -41.0 97.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.11 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.623 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.5 tp -55.78 -44.77 78.04 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.9 m -60.12 -30.61 69.39 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.616 0.722 . . . . 0.0 109.704 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.52 -14.65 63.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.663 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.42 7.09 47.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 112.762 -177.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.79 4.94 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.623 ' HG2' HD23 ' A' ' 110' ' ' LEU . 12.0 tp10 -113.75 119.97 39.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.925 -0.75 . . . . 0.0 109.992 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -121.96 59.22 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.002 0.906 . . . . 0.0 109.598 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 75.5 mt -90.85 148.58 22.4 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -111.17 141.36 44.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -39.9 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 O-C-N 121.353 -0.842 . . . . 0.0 112.726 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.0 61.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.434 -0.791 . . . . 0.0 109.0 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -76.71 -42.94 39.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.692 -0.63 . . . . 0.0 110.384 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 126' ' ' LEU . 57.5 t -60.02 -35.25 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.587 -0.695 . . . . 0.0 110.466 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.01 -39.44 94.78 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.255 -0.903 . . . . 0.0 109.004 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.09 -49.38 77.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.624 -0.673 . . . . 0.0 109.537 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.19 -49.97 75.51 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.571 0.7 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.745 ' O ' HG12 ' A' ' 129' ' ' VAL . 63.2 mt -61.96 -17.22 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.915 -0.491 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -57.47 -16.77 10.48 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.306 -0.871 . . . . 0.0 111.895 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.12 -11.06 11.22 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.051 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 126' ' ' LEU . 8.8 p -69.51 133.95 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.94 -1.329 . . . . 0.0 110.854 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -103.3 102.48 12.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.393 0.616 . . . . 0.0 111.093 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.691 HG12 ' CG1' ' A' ' 137' ' ' ILE . 21.5 m -86.38 160.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -94.91 -176.39 3.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.473 -0.767 . . . . 0.0 111.114 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -69.95 -0.99 8.37 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.866 -0.521 . . . . 0.0 112.055 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -107.28 -7.74 16.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.949 -1.095 . . . . 0.0 110.438 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.08 27.2 38.02 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.649 ' C ' HD12 ' A' ' 137' ' ' ILE . 88.4 mt-10 -108.62 140.07 42.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.598 -0.942 . . . . 0.0 111.125 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.691 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.4 mp -128.42 169.02 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 137' ' ' ILE . 47.0 t0 -96.98 114.05 25.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.368 -0.833 . . . . 0.0 110.134 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.488 ' HA ' HD11 ' A' ' 106' ' ' LEU . 47.6 p90 -66.12 -35.42 80.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.558 -0.714 . . . . 0.0 111.643 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.3 mttt -69.22 -37.05 77.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.308 -0.87 . . . . 0.0 110.661 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -70.06 -44.12 69.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.602 -0.687 . . . . 0.0 111.62 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 146' ' ' VAL . 25.3 t80 -70.36 -28.59 65.24 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.512 -0.743 . . . . 0.0 110.61 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.524 HD11 ' CE2' ' A' ' 90' ' ' PHE . 97.6 mt -76.46 -45.78 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.508 -0.745 . . . . 0.0 109.518 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.72 -26.74 65.88 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.262 -0.899 . . . . 0.0 109.738 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -88.97 -11.64 43.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 110.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 142' ' ' PHE . 62.3 t -96.01 -42.08 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 143' ' ' ILE . 15.2 mt . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.895 -0.503 . . . . 0.0 111.395 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 164.06 13.55 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.104 0.954 . . . . 0.0 111.225 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.724 HG22 ' CG2' ' A' ' 87' ' ' VAL . 3.5 m -50.23 -30.37 11.5 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.396 0.617 . . . . 0.0 110.215 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -53.17 -36.86 61.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.719 -0.613 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.49 -50.88 71.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.53 -0.731 . . . . 0.0 109.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.805 ' CD2' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -76.44 -39.62 52.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 0.0 111.086 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.724 ' CG2' HG22 ' A' ' 83' ' ' THR . 97.5 t -59.98 -47.82 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.166 -0.959 . . . . 0.0 109.901 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 92' ' ' VAL . 16.1 tttp -59.42 -31.95 69.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.713 -0.617 . . . . 0.0 110.368 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' CB ' HD13 ' A' ' 113' ' ' LEU . . . -61.93 -59.33 5.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.732 . . . . 0.0 112.016 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -77.12 -54.3 6.7 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.0 112.342 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.461 ' NE2' HG13 ' A' ' 87' ' ' VAL . 35.9 mt-30 -47.97 -37.87 15.56 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.365 -0.834 . . . . 0.0 113.163 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 88' ' ' LYS . 27.7 m -60.1 -31.35 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.71 -1.244 . . . . 0.0 109.752 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -70.0 -45.46 67.22 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -63.25 81.27 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.458 -0.777 . . . . 0.0 110.892 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -62.81 -40.06 96.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.672 -0.643 . . . . 0.0 110.94 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -91.0 17.0 8.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -0.902 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.6 m 38.05 35.58 0.09 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.8 p -63.73 -33.99 76.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.13 -0.981 . . . . 0.0 109.428 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.78 9.97 53.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.951 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 23.4 mttp -132.86 154.98 49.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.068 -1.254 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.563 ' CG2' HD12 ' A' ' 106' ' ' LEU . 35.1 m -150.16 160.08 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.028 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 p -82.72 145.64 29.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.515 -0.741 . . . . 0.0 110.077 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.6 p -56.95 -39.66 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.475 -0.766 . . . . 0.0 110.649 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.41 -41.11 96.87 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -80.41 -43.3 21.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.534 -0.98 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.563 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.1 tt -59.97 -50.02 75.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.641 -0.662 . . . . 0.0 109.951 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -63.57 -31.88 73.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -66.06 -47.87 72.9 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.088 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.19 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.904 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 ' HG2' ' A' ' 115' ' ' GLU . 9.9 tp -56.2 -44.68 79.71 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.9 m -60.83 -31.39 70.82 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.577 0.704 . . . . 0.0 109.529 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.15 -13.87 67.86 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 86' ' ' PHE . 29.1 tp -95.09 8.44 42.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -1.086 . . . . 0.0 112.123 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.6 4.15 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.547 ' OE2' HD11 ' A' ' 117' ' ' LEU . 17.8 tp10 -114.91 120.4 39.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.952 -0.734 . . . . 0.0 110.769 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -122.27 59.67 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.063 0.935 . . . . 0.0 109.208 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.547 HD11 ' OE2' ' A' ' 115' ' ' GLU . 88.2 mt -92.0 149.74 21.37 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.3 m -110.86 144.14 40.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -40.11 -27.3 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.195 -0.941 . . . . 0.0 112.973 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.61 -52.1 64.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.33 -0.856 . . . . 0.0 109.279 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.35 -46.06 29.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 0.0 110.984 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 48.1 t -58.15 -33.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.352 -0.843 . . . . 0.0 110.513 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.85 -36.85 85.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -0.928 . . . . 0.0 109.001 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.75 -48.02 81.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 125' ' ' LEU . 11.0 mp -63.39 -28.36 69.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.544 -0.722 . . . . 0.0 110.884 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.1 mt -79.67 -15.78 56.95 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.653 . . . . 0.0 112.12 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -18.74 20.94 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.259 -0.9 . . . . 0.0 111.654 -177.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.55 -11.63 11.43 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.665 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.92 129.51 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.083 -1.245 . . . . 0.0 109.936 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -106.03 105.7 15.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.346 0.593 . . . . 0.0 111.623 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.697 HG12 ' CG1' ' A' ' 137' ' ' ILE . 19.7 m -88.86 161.52 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -93.12 -171.89 2.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.29 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -0.96 15.02 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -108.57 -11.14 15.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 110.453 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.19 28.42 28.08 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.61 ' C ' HD12 ' A' ' 137' ' ' ILE . 48.8 mt-10 -109.08 138.04 46.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.909 . . . . 0.0 110.999 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.697 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.9 mp -129.25 140.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -69.54 108.61 3.88 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.816 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE1' ' HG3' ' A' ' 140' ' ' LYS . 50.7 p90 -60.57 -29.47 69.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.432 -0.793 . . . . 0.0 111.871 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 139' ' ' TYR . 61.2 mttt -69.01 -39.99 78.95 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.222 -0.924 . . . . 0.0 110.598 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.87 -43.87 82.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.801 -0.562 . . . . 0.0 111.502 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.6 t80 -70.46 -27.72 64.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 110.256 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.805 HD12 ' CD2' ' A' ' 86' ' ' PHE . 23.5 mm -80.29 -50.38 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.59 -28.72 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.69 -13.72 39.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.207 -0.933 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 142' ' ' PHE . 43.1 t -95.97 -38.21 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 143' ' ' ILE . 3.3 mt . . . . . 0 N--CA 1.496 1.852 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.468 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.745 0.307 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -113.25 163.17 15.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 111.007 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.8 m -51.2 -31.29 19.85 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.485 0.66 . . . . 0.0 110.211 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -53.55 -38.68 64.08 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.648 -0.658 . . . . 0.0 111.111 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.52 -45.07 84.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.68 . . . . 0.0 109.571 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.582 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.63 -36.6 62.91 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.819 -0.551 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 83' ' ' THR . 84.1 t -70.9 -43.14 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 110.64 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.68 -35.84 73.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.455 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.446 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -64.92 -49.75 69.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 111.989 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -79.19 -57.73 3.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.049 . . . . 0.0 111.681 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -48.9 -37.26 19.26 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.464 -0.773 . . . . 0.0 112.826 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -58.05 -37.73 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.156 -0.965 . . . . 0.0 109.988 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' N ' HG13 ' A' ' 92' ' ' VAL . 59.4 t80 -66.1 -42.03 89.81 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.481 -0.762 . . . . 0.0 111.069 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -65.75 -24.99 67.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.563 -0.711 . . . . 0.0 110.479 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -106.15 15.69 25.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.661 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.7 t 38.2 63.06 0.88 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -91.65 -33.66 14.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.76 10.9 58.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.88 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' C ' HG13 ' A' ' 101' ' ' VAL . 43.2 mttp -132.27 154.49 49.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.13 -1.218 . . . . 0.0 110.071 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 106' ' ' LEU . 30.9 m -150.36 160.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 p -82.35 145.95 29.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.652 -0.655 . . . . 0.0 109.974 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.1 p -56.43 -39.67 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.461 -0.775 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.463 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.9 -40.8 97.32 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.0 -40.31 28.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.978 . . . . 0.0 110.392 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 101' ' ' VAL . 13.1 tp -59.95 -49.79 76.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 109.934 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -63.87 -32.28 73.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 110.375 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -67.77 -47.51 68.97 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.192 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -30.55 63.07 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.825 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 tp -60.06 -42.04 93.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.862 . . . . 0.0 109.068 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.7 p -68.03 -18.81 64.8 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.49 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.46 -14.72 63.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -93.1 7.15 45.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.381 -1.07 . . . . 0.0 112.362 -177.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.82 4.51 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.92 120.68 40.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 122.03 -0.688 . . . . 0.0 110.131 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.1 59.64 1.0 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.137 0.97 . . . . 0.0 109.815 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 79.9 mt -91.05 148.91 22.06 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.4 m -110.87 142.55 42.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.908 . . . . 0.0 110.086 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 32.7 t0 -39.4 -29.73 0.05 Allowed 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.402 -0.811 . . . . 0.0 112.406 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.6 62.53 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -76.67 -41.93 43.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.63 -0.669 . . . . 0.0 110.227 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 82.7 t -60.06 -34.44 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.599 -0.688 . . . . 0.0 110.312 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.31 -36.62 84.61 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.221 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.76 -48.85 77.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.462 -0.774 . . . . 0.0 109.37 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 125' ' ' LEU . 3.5 mm? -61.22 -47.14 87.45 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.615 0.721 . . . . 0.0 109.905 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.9 ' O ' HG12 ' A' ' 129' ' ' VAL . 33.0 mt -60.33 -17.28 41.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.842 -0.536 . . . . 0.0 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -56.39 -20.36 19.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.243 -0.911 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.73 27.92 7.31 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.6 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 126' ' ' LEU . 10.9 p -107.23 128.72 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.132 -1.216 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -103.52 105.29 15.5 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.332 0.587 . . . . 0.0 111.575 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.683 HG12 ' CG1' ' A' ' 137' ' ' ILE . 21.2 m -89.43 161.26 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -92.26 -176.51 4.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.419 -0.801 . . . . 0.0 111.064 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 m -69.7 -1.61 9.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.798 -0.564 . . . . 0.0 111.973 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -107.71 -8.4 16.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.936 -1.102 . . . . 0.0 110.655 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.83 38.41 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 137' ' ' ILE . 66.0 mt-10 -109.06 139.84 43.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.964 . . . . 0.0 110.906 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.683 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.9 mp -130.03 168.81 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.47 ' N ' HG22 ' A' ' 137' ' ' ILE . 42.0 t0 -96.54 112.84 24.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.413 -0.805 . . . . 0.0 109.719 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 143' ' ' ILE . 42.8 p90 -62.78 -22.32 66.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 111.857 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 46.6 mtpt -83.18 -32.85 26.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.142 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.21 -46.85 66.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.662 -0.649 . . . . 0.0 111.604 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.623 ' O ' HG23 ' A' ' 146' ' ' VAL . 38.4 t80 -70.02 -28.6 65.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.542 -0.724 . . . . 0.0 111.572 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 139' ' ' TYR . 36.3 pt -79.13 -42.67 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.463 ' N ' HG13 ' A' ' 143' ' ' ILE . 63.9 mt-10 -65.09 -26.46 68.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.209 -0.932 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -88.1 -12.46 44.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.0 110.646 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 142' ' ' PHE . 88.2 t -96.11 -41.1 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.881 -0.512 . . . . 0.0 111.543 179.191 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.842 0.353 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -107.75 160.2 15.91 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.878 0.847 . . . . 0.0 110.992 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.731 ' O ' HG23 ' A' ' 87' ' ' VAL . 4.4 m -50.83 -30.6 14.75 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.666 0.746 . . . . 0.0 109.522 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -52.28 -37.49 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.839 -0.538 . . . . 0.0 111.209 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -61.26 -49.29 77.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -76.02 -39.97 54.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.765 -0.584 . . . . 0.0 111.047 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 83' ' ' THR . 76.3 t -60.5 -51.29 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -58.49 -32.7 69.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.642 -0.661 . . . . 0.0 110.547 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.657 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -63.48 -55.35 24.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.788 -0.57 . . . . 0.0 111.725 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.505 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 47.6 m-85 -78.74 -56.76 4.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.098 -1.001 . . . . 0.0 111.737 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.67 -37.84 19.57 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.561 -0.712 . . . . 0.0 112.819 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -57.86 -36.84 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.066 -1.021 . . . . 0.0 109.924 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.4 ' N ' HG13 ' A' ' 92' ' ' VAL . 53.5 t80 -67.67 -43.41 80.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.5 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.483 -0.76 . . . . 0.0 110.761 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -61.17 -39.78 91.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 0.0 110.621 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.41 20.1 6.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.257 -0.902 . . . . 0.0 110.829 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t 38.15 36.51 0.12 Allowed 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 42.1 p -63.83 -34.66 78.43 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 12.53 58.04 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.456 ' C ' HG13 ' A' ' 101' ' ' VAL . 84.1 mttt -132.42 154.68 49.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.036 -1.273 . . . . 0.0 110.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 106' ' ' LEU . 26.8 m -151.07 160.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.365 -0.835 . . . . 0.0 109.896 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.1 p -80.5 144.06 32.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.567 ' HB ' HD13 ' A' ' 137' ' ' ILE . 10.2 p -57.21 -40.07 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 0.0 110.883 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.21 -41.25 96.63 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -80.45 -39.24 28.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.984 . . . . 0.0 110.4 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.562 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.2 tt -60.05 -49.97 75.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.715 -0.616 . . . . 0.0 110.121 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -63.21 -28.95 70.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.51 -47.84 68.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.366 -0.833 . . . . 0.0 110.619 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -40.75 96.12 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 143' ' ' ILE . 3.4 tp -55.85 -44.59 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -60.35 -30.1 69.33 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.557 0.694 . . . . 0.0 109.65 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.13 -14.21 64.79 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.657 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -95.12 7.38 46.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.299 -1.118 . . . . 0.0 112.552 -177.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.58 31.89 5.03 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.62 ' OE2' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -113.82 120.32 40.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.988 -0.713 . . . . 0.0 110.249 178.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -122.45 59.74 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.042 0.925 . . . . 0.0 109.498 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.541 HD12 ' CD ' ' A' ' 115' ' ' GLU . 89.9 mt -90.92 148.65 22.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.4 m -111.09 141.84 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.331 -0.855 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -39.87 -28.29 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.283 -0.886 . . . . 0.0 112.685 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.43 -52.84 62.91 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.37 -0.831 . . . . 0.0 109.059 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -77.01 -42.2 39.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.628 -0.67 . . . . 0.0 110.431 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.34 -36.36 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.602 -0.686 . . . . 0.0 110.295 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -63.19 -39.92 96.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.06 -47.51 85.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.63 -0.669 . . . . 0.0 109.839 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.94 -40.03 96.4 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.614 0.721 . . . . 0.0 110.669 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.698 ' O ' HG12 ' A' ' 129' ' ' VAL . 68.7 mt -67.84 -15.97 63.87 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.779 -0.575 . . . . 0.0 111.856 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -57.55 -17.02 11.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.197 -0.939 . . . . 0.0 111.877 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.65 -10.93 12.07 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.221 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 126' ' ' LEU . 8.7 p -70.65 132.36 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.953 -1.321 . . . . 0.0 110.522 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.48 100.06 10.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.367 0.603 . . . . 0.0 111.363 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.423 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.8 p -83.82 159.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -95.88 -179.51 4.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.415 -0.803 . . . . 0.0 111.502 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.2 m -70.41 -1.49 10.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.849 -0.532 . . . . 0.0 112.13 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -107.83 -11.49 15.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.863 -1.148 . . . . 0.0 110.411 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.02 29.05 16.17 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.437 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.7 mt-10 -110.43 135.7 50.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.649 -0.912 . . . . 0.0 111.328 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.567 HD13 ' HB ' ' A' ' 103' ' ' VAL . 4.0 mp -126.35 169.0 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.456 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.7 t70 -97.83 114.75 26.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.44 -0.787 . . . . 0.0 110.468 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.56 ' HB3' HG21 ' A' ' 101' ' ' VAL . 46.6 p90 -68.32 -36.22 78.96 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.511 -0.743 . . . . 0.0 111.676 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.5 mttt -68.51 -40.0 81.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.294 -0.879 . . . . 0.0 110.798 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -67.3 -43.26 82.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.694 -0.629 . . . . 0.0 111.299 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.605 ' O ' HG23 ' A' ' 146' ' ' VAL . 20.2 t80 -70.74 -27.76 64.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.494 -0.753 . . . . 0.0 110.46 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.698 HD11 HD11 ' A' ' 110' ' ' LEU . 20.3 mm -78.5 -49.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.477 -0.764 . . . . 0.0 109.585 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -60.04 -27.51 66.99 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 0.0 110.384 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.06 -12.3 44.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 110.502 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 142' ' ' PHE . 56.1 t -96.24 -39.14 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.544 HD12 HG22 ' A' ' 143' ' ' ILE . 13.4 mt . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.912 -0.492 . . . . 0.0 111.204 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.51 159.55 16.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.813 0.816 . . . . 0.0 111.009 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 87' ' ' VAL . 5.6 m -50.97 -30.81 16.0 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.666 0.746 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.73 -36.89 38.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.851 -0.53 . . . . 0.0 111.274 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -57.64 -54.11 50.57 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.645 ' HB3' HD12 ' A' ' 143' ' ' ILE . 5.8 m-85 -76.59 -38.51 54.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.606 -0.684 . . . . 0.0 111.141 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 83' ' ' THR . 98.9 t -57.12 -51.55 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -0.992 . . . . 0.0 110.328 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 92' ' ' VAL . 29.4 tttm -60.07 -32.13 70.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.687 -0.633 . . . . 0.0 110.255 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -60.21 -56.56 20.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.643 -0.66 . . . . 0.0 111.805 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.02 -53.54 7.68 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.307 -0.871 . . . . 0.0 111.813 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -48.58 -40.24 26.63 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.424 -0.798 . . . . 0.0 112.759 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 88' ' ' LYS . 74.7 t -59.8 -37.93 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.773 -1.205 . . . . 0.0 109.663 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -68.97 -45.97 69.29 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -62.12 82.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.431 -0.793 . . . . 0.0 110.937 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -62.57 -41.24 98.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -91.64 18.88 6.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.278 -0.889 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.1 p 38.48 37.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.3 p -63.72 -34.99 79.1 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.089 -1.007 . . . . 0.0 109.311 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.86 12.75 55.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.007 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' C ' HG13 ' A' ' 101' ' ' VAL . 27.7 mmtp -132.63 154.84 49.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.133 -1.216 . . . . 0.0 110.501 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 100' ' ' LYS . 32.2 m -150.72 160.4 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.389 -0.82 . . . . 0.0 109.855 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 p -83.21 145.55 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.5 p -56.96 -39.21 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.471 -0.768 . . . . 0.0 110.715 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.18 -41.04 96.48 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -80.53 -39.96 26.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.616 -0.932 . . . . 0.0 110.394 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.9 -50.01 75.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.698 -0.626 . . . . 0.0 110.145 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -64.89 -29.57 70.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 110.551 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -69.0 -47.97 64.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.437 -0.789 . . . . 0.0 110.773 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.62 88.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.321 -0.862 . . . . 0.0 110.445 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.729 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.6 tp -55.36 -44.76 76.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.5 m -59.99 -27.87 67.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.546 0.688 . . . . 0.0 110.051 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.09 -14.62 64.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.55 8.3 42.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.33 -1.1 . . . . 0.0 112.287 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 33.01 4.52 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.729 ' HG2' HD23 ' A' ' 110' ' ' LEU . 6.0 tp10 -114.03 119.85 38.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.982 -0.716 . . . . 0.0 110.298 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -121.98 59.28 1.0 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.198 0.999 . . . . 0.0 109.236 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.5 mt -90.11 148.7 22.85 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -111.05 143.9 41.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.252 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -40.33 -27.03 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.199 -0.938 . . . . 0.0 112.817 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.9 55.5 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 18.3 mp0 -75.15 -28.48 60.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.455 -0.778 . . . . 0.0 110.592 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.69 -33.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.819 . . . . 0.0 110.348 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -65.83 -45.12 83.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 11.2 pt-20 -56.63 -42.39 78.77 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.168 -0.958 . . . . 0.0 109.83 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.417 ' N ' ' HG3' ' A' ' 124' ' ' GLU . 91.8 mt -64.05 -47.22 81.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 0.0 109.648 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 41.1 mt -60.59 -18.04 50.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.888 -0.508 . . . . 0.0 111.07 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -56.79 -21.57 29.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.461 -0.775 . . . . 0.0 111.056 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 26.32 7.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 66.2 t -107.9 129.88 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -1.109 . . . . 0.0 109.671 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.96 101.87 13.09 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.437 0.637 . . . . 0.0 111.935 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 131' ' ' VAL . 8.8 p -84.04 158.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -95.85 -177.72 4.13 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.383 -0.823 . . . . 0.0 111.286 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.09 -1.27 14.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.941 -0.474 . . . . 0.0 111.805 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -108.21 -15.02 14.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.423 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.78 29.2 12.19 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.524 ' C ' HD12 ' A' ' 137' ' ' ILE . 96.1 mt-10 -111.03 133.7 53.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.624 -0.927 . . . . 0.0 111.167 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.8 mp -124.77 139.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -69.79 112.48 6.26 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.73 -0.606 . . . . 0.0 110.502 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.449 ' CG ' ' N ' ' A' ' 140' ' ' LYS . 32.7 p90 -69.96 -41.64 74.24 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.391 -0.818 . . . . 0.0 112.222 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 4.0 mttt -60.22 -29.87 69.02 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.605 -0.684 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -84.12 -39.48 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 111.649 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 146' ' ' VAL . 23.1 t80 -70.01 -29.88 67.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.444 -0.785 . . . . 0.0 111.349 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.645 HD12 ' HB3' ' A' ' 86' ' ' PHE . 27.8 pt -83.17 -43.43 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.451 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.9 mt-10 -68.91 -27.44 65.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.322 -0.861 . . . . 0.0 110.715 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -85.1 -15.79 42.73 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.319 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 142' ' ' PHE . 76.6 t -95.48 -37.41 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 86' ' ' PHE . 26.2 mt . . . . . 0 N--CA 1.497 1.889 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.305 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -110.18 161.0 16.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 111.283 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.694 HG22 ' CG2' ' A' ' 87' ' ' VAL . 24.2 m -51.04 -30.37 15.33 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.636 0.731 . . . . 0.0 109.689 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -51.01 -37.61 46.17 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.883 -0.511 . . . . 0.0 111.222 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.18 -47.24 85.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.694 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.2 m-85 -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.694 ' CG2' HG22 ' A' ' 83' ' ' THR . 71.6 t -60.75 -49.99 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.368 -0.833 . . . . 0.0 110.658 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 92' ' ' VAL . 97.3 mttt -59.58 -34.96 73.38 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.583 -0.698 . . . . 0.0 111.388 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -61.26 -56.61 18.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.605 -0.685 . . . . 0.0 112.005 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.77 ' CE1' HD12 ' A' ' 106' ' ' LEU . 57.0 m-85 -76.7 -54.1 7.1 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.188 -0.945 . . . . 0.0 111.976 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -48.41 -37.21 16.46 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.31 -0.869 . . . . 0.0 113.045 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 88' ' ' LYS . 77.9 t -59.94 -36.36 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 120.843 -1.16 . . . . 0.0 109.89 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.91 -42.78 89.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -62.1 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.43 -0.794 . . . . 0.0 111.249 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -61.44 -41.05 96.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.557 -0.714 . . . . 0.0 110.048 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.3 20.58 7.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.44 -0.787 . . . . 0.0 110.44 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 38.2 36.68 0.12 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.2 t -63.46 -33.39 75.46 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.128 -0.983 . . . . 0.0 109.566 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.17 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.31 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.605 ' H ' HG23 ' A' ' 98' ' ' THR . 1.4 mppt? -131.58 152.73 50.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -1.216 . . . . 0.0 109.736 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 106' ' ' LEU . 35.8 m -148.89 160.0 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.9 p -81.37 145.93 30.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.1 p -54.46 -39.52 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.484 -0.76 . . . . 0.0 110.658 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.94 -40.04 96.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.58 -43.16 21.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.633 -0.922 . . . . 0.0 110.8 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.77 HD12 ' CE1' ' A' ' 90' ' ' PHE . 25.0 tp -60.0 -50.07 75.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.48 -0.762 . . . . 0.0 110.057 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -63.32 -31.64 72.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.724 . . . . 0.0 110.165 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -67.73 -47.7 68.56 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.401 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -40.4 95.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.589 HD23 ' HG2' ' A' ' 115' ' ' GLU . 5.4 tp -55.73 -44.81 77.87 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.5 m -60.45 -29.68 69.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.33 -14.25 64.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.74 7.33 46.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -1.087 . . . . 0.0 112.545 -177.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.77 32.11 4.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' HD23 ' A' ' 110' ' ' LEU . 17.5 tp10 -113.87 120.16 39.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.932 -0.746 . . . . 0.0 110.204 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -121.92 59.51 0.99 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.203 1.002 . . . . 0.0 109.304 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.541 HD11 ' OE2' ' A' ' 115' ' ' GLU . 90.2 mt -92.03 148.96 21.79 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 p -110.95 143.25 41.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.261 -0.899 . . . . 0.0 109.854 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -40.08 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 O-C-N 121.213 -0.929 . . . . 0.0 112.805 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.99 61.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 108.982 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -76.69 -42.83 40.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.598 -0.689 . . . . 0.0 110.433 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.41 -35.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.73 -38.38 90.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.229 -0.919 . . . . 0.0 109.208 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.01 -47.62 85.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.614 . . . . 0.0 109.739 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.83 -49.88 75.68 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.508 0.67 . . . . 0.0 110.052 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.98 -18.72 47.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.888 -0.507 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -57.04 -21.03 28.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.447 -0.783 . . . . 0.0 111.136 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.92 9.08 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.45 132.82 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.041 -1.27 . . . . 0.0 109.982 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -102.51 102.34 12.6 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.389 0.614 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -85.4 159.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.85 -176.79 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -71.67 -1.14 12.69 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.794 -0.566 . . . . 0.0 111.834 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -107.43 -12.07 15.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.13 . . . . 0.0 110.403 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.61 27.09 28.04 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.2 mt-10 -110.89 140.1 45.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.619 -0.93 . . . . 0.0 111.245 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.1 mp -130.86 142.39 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.89 113.04 5.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.971 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 26.0 p90 -62.84 -33.26 74.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.642 -0.661 . . . . 0.0 111.706 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 20.5 mttt -69.97 -35.05 74.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 110.712 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -69.95 -44.11 70.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.72 -0.613 . . . . 0.0 111.518 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.468 ' O ' HG23 ' A' ' 146' ' ' VAL . 12.7 t80 -74.33 -27.69 60.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.762 . . . . 0.0 111.077 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.33 -51.8 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.447 -0.783 . . . . 0.0 109.884 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -63.77 -26.43 68.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.439 -0.788 . . . . 0.0 110.791 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.34 -13.39 43.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.217 -0.927 . . . . 0.0 110.746 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 142' ' ' PHE . 46.2 t -95.83 -38.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' A' ' 86' ' ' PHE . 14.3 mt . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.954 -0.466 . . . . 0.0 111.406 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.8 pttt . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.611 0.72 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.45 148.93 24.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.797 -0.564 . . . . 0.0 110.445 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -100.75 168.52 9.61 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.95 0.881 . . . . 0.0 111.245 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.845 HG22 ' CG2' ' A' ' 87' ' ' VAL . 23.2 m -51.16 -31.19 19.09 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.45 0.643 . . . . 0.0 109.96 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -52.17 -37.92 56.14 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.709 -0.62 . . . . 0.0 111.033 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.59 -47.11 85.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.859 ' CD2' HD11 ' A' ' 147' ' ' LEU . 2.9 m-85 -76.03 -40.0 54.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.845 ' CG2' HG22 ' A' ' 83' ' ' THR . 65.7 t -61.5 -51.84 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.244 -0.91 . . . . 0.0 110.588 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' O ' HG23 ' A' ' 92' ' ' VAL . 48.0 tttp -56.96 -32.55 66.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.518 -0.739 . . . . 0.0 111.032 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -61.28 -59.92 4.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.503 -0.748 . . . . 0.0 111.934 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.726 ' CE1' HD12 ' A' ' 106' ' ' LEU . 65.3 m-85 -76.63 -53.67 7.71 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.188 -0.945 . . . . 0.0 111.951 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -48.16 -38.52 18.25 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.26 -0.9 . . . . 0.0 112.791 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 88' ' ' LYS . 56.5 t -59.62 -34.81 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.801 -1.187 . . . . 0.0 109.602 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -64.14 -41.01 97.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.4 81.41 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.448 -0.782 . . . . 0.0 111.083 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -63.26 -41.63 99.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.642 -0.661 . . . . 0.0 110.425 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -91.46 16.18 10.82 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.333 -0.854 . . . . 0.0 110.852 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 t 38.42 61.7 1.11 Allowed 'General case' 0 N--CA 1.502 2.175 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.8 p -90.5 -33.48 15.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.146 -0.971 . . . . 0.0 109.31 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.07 9.98 55.33 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.925 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.451 ' C ' HG13 ' A' ' 101' ' ' VAL . 2.1 mppt? -132.84 154.82 49.97 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.021 -1.282 . . . . 0.0 110.274 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 106' ' ' LEU . 31.3 m -150.02 159.92 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.258 -0.901 . . . . 0.0 109.964 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.1 p -81.38 144.21 31.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.093 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.8 p -56.92 -39.98 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.562 -0.711 . . . . 0.0 110.857 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -58.82 -41.58 96.13 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.59 -39.67 27.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.939 . . . . 0.0 110.453 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.726 HD12 ' CE1' ' A' ' 90' ' ' PHE . 29.0 tp -59.97 -49.88 75.94 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.687 -0.633 . . . . 0.0 110.168 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -65.87 -29.52 69.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.401 -0.812 . . . . 0.0 111.005 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -65.58 -48.29 72.85 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.491 -0.883 . . . . 0.0 110.093 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -40.53 97.5 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.111 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.678 HD23 ' HG2' ' A' ' 115' ' ' GLU . 4.1 tp -55.69 -44.74 77.65 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.266 -0.896 . . . . 0.0 108.702 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.9 m -60.85 -30.25 70.0 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.545 0.688 . . . . 0.0 109.622 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.59 -13.83 66.8 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.632 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 7.7 45.38 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.31 -1.112 . . . . 0.0 112.406 -177.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.39 31.67 5.17 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 110' ' ' LEU . 12.2 tp10 -113.25 119.93 39.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.873 -0.781 . . . . 0.0 110.281 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -122.39 59.51 1.02 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.955 0.883 . . . . 0.0 109.386 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.527 HD11 ' OE2' ' A' ' 115' ' ' GLU . 77.3 mt -90.99 148.62 22.28 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 m -111.01 141.89 43.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.258 -0.901 . . . . 0.0 109.88 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 34.5 t0 -40.08 -27.24 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.226 -0.921 . . . . 0.0 112.899 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -53.18 59.5 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.202 -0.936 . . . . 0.0 108.975 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.72 -42.68 40.37 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.531 -0.73 . . . . 0.0 110.414 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.522 HG12 HD12 ' A' ' 126' ' ' LEU . 58.9 t -60.01 -36.66 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.604 -0.685 . . . . 0.0 110.272 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -63.33 -38.37 90.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.207 -0.933 . . . . 0.0 109.069 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -62.95 -49.82 73.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.626 -0.671 . . . . 0.0 109.365 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.91 -49.43 77.74 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.576 0.703 . . . . 0.0 110.237 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.794 ' O ' HG12 ' A' ' 129' ' ' VAL . 46.6 mt -62.34 -15.99 51.6 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.938 -0.476 . . . . 0.0 111.257 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -57.26 -17.16 10.51 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.264 -0.897 . . . . 0.0 111.853 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.03 -10.19 14.46 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.071 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.794 HG12 ' O ' ' A' ' 126' ' ' LEU . 7.1 p -70.4 135.9 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.989 -1.301 . . . . 0.0 110.765 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -104.62 100.63 10.29 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.412 0.625 . . . . 0.0 111.267 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.7 p -84.27 158.31 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -95.34 -179.06 4.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.412 -0.805 . . . . 0.0 111.36 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 m -70.72 -1.55 11.77 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.942 -0.474 . . . . 0.0 112.032 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -107.14 -11.15 15.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.942 -1.099 . . . . 0.0 110.421 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.73 26.02 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.531 ' C ' HD12 ' A' ' 137' ' ' ILE . 87.2 mt-10 -110.61 137.92 47.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.568 -0.96 . . . . 0.0 111.14 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.7 mp -126.81 168.66 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.462 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.3 t70 -96.14 112.33 24.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.473 -0.767 . . . . 0.0 109.891 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.458 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 48.1 p90 -62.68 -29.12 70.41 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.533 -0.729 . . . . 0.0 111.632 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 15.7 mttt -73.1 -34.63 66.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.25 -0.906 . . . . 0.0 110.615 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -70.16 -45.98 65.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.689 -0.632 . . . . 0.0 112.183 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 146' ' ' VAL . 24.1 t80 -70.68 -28.37 64.72 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 0.0 110.8 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 110' ' ' LEU . 28.1 mm -74.58 -45.98 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.48 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -60.06 -27.43 66.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.187 -0.946 . . . . 0.0 109.985 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.68 -12.33 42.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 142' ' ' PHE . 60.7 t -95.71 -40.68 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.859 HD11 ' CD2' ' A' ' 86' ' ' PHE . 4.4 mp -55.49 -20.88 14.12 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.948 -0.47 . . . . 0.0 111.301 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -59.14 -40.02 84.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.381 -0.824 . . . . 0.0 110.364 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.195 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.6 tttm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.682 0.753 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.17 155.11 23.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.946 -0.471 . . . . 0.0 110.255 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -102.17 160.01 14.89 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.713 0.768 . . . . 0.0 110.843 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.708 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.2 m -51.13 -30.65 17.06 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.701 0.762 . . . . 0.0 109.337 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -52.24 -37.47 55.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.955 -0.466 . . . . 0.0 111.168 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -60.58 -50.04 75.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.592 -0.693 . . . . 0.0 109.856 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.697 ' CD2' HD11 ' A' ' 147' ' ' LEU . 1.2 m-85 -75.91 -40.06 55.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.783 -0.573 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.708 ' CG2' HG22 ' A' ' 83' ' ' THR . 83.5 t -61.92 -49.89 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.322 -0.861 . . . . 0.0 110.606 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 92' ' ' VAL . 24.0 mmtt -59.75 -34.33 72.82 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.566 -0.709 . . . . 0.0 110.801 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 113' ' ' LEU . . . -62.06 -51.82 66.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.677 -0.64 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' HD11 ' A' ' 143' ' ' ILE . 50.9 m-85 -77.23 -54.92 5.9 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 111.802 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.485 ' OE1' HG12 ' A' ' 87' ' ' VAL . 57.2 mt-30 -48.04 -35.57 11.39 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.504 -0.747 . . . . 0.0 112.954 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 88' ' ' LYS . 96.2 t -60.87 -29.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.679 -1.263 . . . . 0.0 109.122 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -92.81 23.16 4.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.679 -0.638 . . . . 0.0 109.698 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -132.02 78.47 1.82 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.247 -0.908 . . . . 0.0 108.941 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt -63.56 -45.48 90.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.765 -0.584 . . . . 0.0 111.435 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -88.99 17.68 5.55 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.014 -1.054 . . . . 0.0 111.389 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 t 38.27 39.82 0.3 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.597 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.8 t -63.47 -34.16 77.16 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.586 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.43 14.58 50.26 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.384 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.597 ' H ' HG23 ' A' ' 98' ' ' THR . 31.2 mttt -132.93 153.84 51.01 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.081 -1.246 . . . . 0.0 110.643 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 139' ' ' TYR . 30.9 m -150.29 160.02 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.428 -0.795 . . . . 0.0 110.01 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.6 p -84.74 147.34 26.93 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.553 -0.717 . . . . 0.0 109.711 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.871 HG13 HD13 ' A' ' 137' ' ' ILE . 21.6 m -63.35 -34.02 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.289 -0.882 . . . . 0.0 110.268 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.29 -42.49 99.79 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.49 -41.43 27.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.653 -0.91 . . . . 0.0 109.493 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.502 HD12 HG21 ' A' ' 101' ' ' VAL . 5.9 tt -59.96 -49.23 78.5 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -63.63 -32.51 74.01 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.693 -0.63 . . . . 0.0 110.543 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -66.72 -48.91 67.72 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.415 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -36.41 74.79 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.889 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 19.9 tp -53.72 -45.02 70.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.493 -0.754 . . . . 0.0 109.647 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -66.27 -18.77 65.55 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.018 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.7 -14.15 65.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.533 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -95.03 8.28 43.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.361 -1.082 . . . . 0.0 112.67 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.3 31.19 5.07 Favored Glycine 0 N--CA 1.503 3.104 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 49.5 mm-40 -114.88 121.76 44.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.957 -0.731 . . . . 0.0 110.165 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -122.83 61.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 109.899 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 70.5 mt -91.96 148.87 21.87 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.1 m -110.6 144.26 39.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.207 -0.933 . . . . 0.0 109.989 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 28.0 t0 -39.43 -29.28 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.667 0 O-C-N 121.361 -0.837 . . . . 0.0 112.598 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.54 -53.95 49.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.35 -0.844 . . . . 0.0 108.847 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -76.44 -39.93 52.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.714 -0.616 . . . . 0.0 110.284 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 58.1 t -64.2 -35.95 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.585 -0.697 . . . . 0.0 110.653 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -60.0 -39.92 87.45 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.075 -1.016 . . . . 0.0 108.927 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.71 -43.89 81.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.708 -0.62 . . . . 0.0 109.397 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.17 -50.04 74.77 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.657 0.741 . . . . 0.0 109.856 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.457 HD23 HG11 ' A' ' 129' ' ' VAL . 6.9 mt -67.67 -22.15 65.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.779 -0.575 . . . . 0.0 110.831 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -57.4 -19.72 25.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.501 -0.749 . . . . 0.0 111.358 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -119.65 -14.86 5.57 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.25 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.457 HG11 HD23 ' A' ' 126' ' ' LEU . 6.1 p -66.19 128.83 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 118.897 1.348 . . . . 0.0 110.517 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -86.05 99.86 11.77 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.407 0.623 . . . . 0.0 111.226 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.602 HG23 HD11 ' A' ' 137' ' ' ILE . 7.6 p -84.21 157.08 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -96.68 -174.35 2.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.495 -0.753 . . . . 0.0 111.206 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.2 m -71.67 -0.7 11.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.839 -0.538 . . . . 0.0 111.853 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -106.95 -11.32 15.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.887 -1.133 . . . . 0.0 110.352 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.19 25.32 44.67 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.77 ' C ' HD12 ' A' ' 137' ' ' ILE . 51.7 mt-10 -111.7 139.52 47.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.555 -0.968 . . . . 0.0 110.998 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.871 HD13 HG13 ' A' ' 103' ' ' VAL . 3.2 mp -126.56 146.48 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -69.09 114.38 7.31 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.146 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.51 ' HB3' HG21 ' A' ' 101' ' ' VAL . 49.9 p90 -67.55 -38.88 84.79 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.544 -0.722 . . . . 0.0 111.548 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.453 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.8 mttt -63.74 -38.0 89.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.0 110.102 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -70.02 -42.32 73.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.813 -0.555 . . . . 0.0 110.927 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.411 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.9 t80 -71.88 -28.13 63.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 110.54 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.634 HD11 ' CE1' ' A' ' 90' ' ' PHE . 92.3 mt -85.05 -52.25 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.324 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.454 -0.779 . . . . 0.0 110.74 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -87.63 -13.91 41.45 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -0.914 . . . . 0.0 110.56 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 142' ' ' PHE . 40.1 t -95.96 -38.29 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.697 HD11 ' CD2' ' A' ' 86' ' ' PHE . 22.3 mt -59.71 -19.82 52.38 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.896 -0.502 . . . . 0.0 111.258 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -58.18 137.8 56.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.34 -0.85 . . . . 0.0 110.272 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.202 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.652 0.739 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.46 154.59 26.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 122.018 -0.426 . . . . 0.0 110.252 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -103.43 162.23 13.2 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.922 0.868 . . . . 0.0 110.969 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.782 HG22 ' CG2' ' A' ' 87' ' ' VAL . 18.5 m -51.33 -30.69 19.26 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.608 0.718 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.66 -38.15 59.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.843 -0.535 . . . . 0.0 111.162 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.429 ' OD1' HD21 ' A' ' 113' ' ' LEU . 8.0 t70 -60.69 -50.18 74.53 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 109.871 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.657 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -74.29 -38.35 63.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.782 -0.573 . . . . 0.0 110.999 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.782 ' CG2' HG22 ' A' ' 83' ' ' THR . 97.0 t -63.99 -48.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.231 -0.918 . . . . 0.0 110.678 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.678 ' O ' HG23 ' A' ' 92' ' ' VAL . 39.2 ttmt -60.02 -35.75 75.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.628 -0.67 . . . . 0.0 111.019 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.613 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -59.95 -52.16 66.61 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 111.245 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -77.0 -53.3 8.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.378 -0.826 . . . . 0.0 111.249 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.518 ' OE1' HG12 ' A' ' 87' ' ' VAL . 55.6 mt-30 -48.7 -38.69 22.1 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 88' ' ' LYS . 95.8 t -59.17 -31.03 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 120.565 -1.334 . . . . 0.0 109.193 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.95 23.6 4.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -131.57 78.03 1.8 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.0 109.399 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -70.5 -10.46 59.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.767 -0.583 . . . . 0.0 111.355 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.22 11.65 15.21 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.125 -0.985 . . . . 0.0 110.963 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m 37.54 37.55 0.11 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.1 p -63.88 -34.53 78.15 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.424 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.07 14.91 53.83 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' C ' HG13 ' A' ' 101' ' ' VAL . 37.2 mttt -133.6 156.41 47.9 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.178 -1.19 . . . . 0.0 110.435 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.611 ' CG2' HD12 ' A' ' 106' ' ' LEU . 27.2 m -151.61 160.02 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -82.61 144.94 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.515 -0.741 . . . . 0.0 109.905 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.9 p -57.3 -39.92 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 110.746 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.01 -41.89 96.64 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.01 -42.6 23.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.528 -0.983 . . . . 0.0 110.336 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.611 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.2 tt -60.01 -49.75 76.45 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -64.89 -33.66 76.54 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -67.16 -49.04 66.18 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.336 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.18 -34.84 71.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.54 -0.725 . . . . 0.0 110.523 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.718 HD11 ' OE2' ' A' ' 115' ' ' GLU . 30.8 tp -54.66 -45.28 73.82 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.413 -0.804 . . . . 0.0 109.116 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.0 m -63.96 -19.04 64.85 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.346 0.593 . . . . 0.0 110.789 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.31 -14.57 63.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.657 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -94.13 7.38 45.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.448 -1.03 . . . . 0.0 112.649 -177.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.31 31.8 4.84 Favored Glycine 0 N--CA 1.5 2.932 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.718 ' OE2' HD11 ' A' ' 110' ' ' LEU . 6.4 mm-40 -114.79 121.02 42.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.941 -0.741 . . . . 0.0 110.116 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -122.23 59.64 1.01 Allowed 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.138 0.971 . . . . 0.0 109.755 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.99 148.83 22.13 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.5 m -111.06 141.63 44.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 110.224 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 39.5 t0 -39.63 -29.14 0.05 Allowed 'General case' 0 N--CA 1.513 2.701 0 O-C-N 121.417 -0.802 . . . . 0.0 112.487 -178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.84 -52.62 63.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.368 -0.833 . . . . 0.0 108.953 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -77.01 -42.61 37.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.632 -0.668 . . . . 0.0 110.295 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.423 HG12 ' CD1' ' A' ' 126' ' ' LEU . 62.8 t -60.02 -35.21 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.607 -0.683 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.52 -38.8 92.5 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.275 -0.891 . . . . 0.0 109.041 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.603 -0.685 . . . . 0.0 109.542 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.77 -45.5 93.64 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.692 0.758 . . . . 0.0 110.143 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.763 ' O ' HG12 ' A' ' 129' ' ' VAL . 67.1 mt -63.65 -18.45 63.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.899 -0.501 . . . . 0.0 111.304 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -56.67 -18.24 11.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.196 -0.94 . . . . 0.0 111.68 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.14 -9.62 15.29 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.944 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.763 HG12 ' O ' ' A' ' 126' ' ' LEU . 9.9 p -70.13 133.78 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.926 -1.338 . . . . 0.0 110.988 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -99.59 99.41 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.365 0.602 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.13 155.77 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.89 -176.9 3.71 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 111.18 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.04 -0.96 12.98 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.819 -0.55 . . . . 0.0 111.805 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -108.0 -14.02 14.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 0.0 110.439 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.04 28.98 16.33 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.56 ' C ' HD12 ' A' ' 137' ' ' ILE . 96.8 mt-10 -110.51 134.94 51.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.677 -0.896 . . . . 0.0 111.073 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.8 mp -125.28 142.63 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -69.66 112.41 6.12 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.247 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 41.5 p90 -68.11 -34.11 75.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.531 -0.731 . . . . 0.0 111.531 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 mttt -69.8 -32.73 71.33 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.272 -0.893 . . . . 0.0 110.426 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -73.2 -43.29 61.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.702 -0.623 . . . . 0.0 111.643 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.703 ' O ' HG23 ' A' ' 146' ' ' VAL . 30.8 t80 -70.73 -28.16 64.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.488 -0.758 . . . . 0.0 110.695 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.494 HG22 ' CD1' ' A' ' 147' ' ' LEU . 90.5 mt -75.18 -45.92 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.443 -0.785 . . . . 0.0 109.758 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.55 -26.83 65.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.213 -0.929 . . . . 0.0 109.808 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.91 -11.74 43.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.46 -0.775 . . . . 0.0 110.327 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 142' ' ' PHE . 65.9 t -95.97 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.617 HD21 ' CE2' ' A' ' 86' ' ' PHE . 87.2 mt -54.47 -21.33 9.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.913 -0.492 . . . . 0.0 111.379 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.7 mtt85 -58.62 -39.96 81.98 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.313 -0.867 . . . . 0.0 110.266 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.212 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.6 mttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.722 0.772 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.65 156.0 21.61 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.984 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -109.22 161.47 15.21 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.931 0.872 . . . . 0.0 111.319 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.786 ' O ' HG23 ' A' ' 87' ' ' VAL . 18.3 m -51.18 -30.32 16.6 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.663 0.744 . . . . 0.0 109.674 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -49.93 -37.64 32.69 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.717 -0.614 . . . . 0.0 111.146 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -59.12 -50.4 74.2 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.572 -0.705 . . . . 0.0 109.962 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.439 ' HB3' HD13 ' A' ' 143' ' ' ILE . 12.1 m-85 -76.18 -38.38 56.66 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.603 -0.686 . . . . 0.0 110.923 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 83' ' ' THR . 65.8 t -57.34 -55.39 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.177 -0.952 . . . . 0.0 110.49 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -59.99 -33.27 71.74 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.633 -0.667 . . . . 0.0 110.553 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.29 -51.88 67.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.682 -0.636 . . . . 0.0 111.429 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 106' ' ' LEU . 33.4 m-85 -78.74 -54.94 5.57 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.331 -0.856 . . . . 0.0 111.508 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -49.19 -39.98 31.51 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.585 -0.697 . . . . 0.0 112.69 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 93' ' ' PHE . 9.7 p -58.38 -38.57 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.071 -1.018 . . . . 0.0 110.072 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' N ' HG13 ' A' ' 92' ' ' VAL . 2.5 t80 -69.07 -44.83 71.78 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -61.74 82.78 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.516 -0.74 . . . . 0.0 111.018 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -69.1 -15.35 63.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.587 -0.696 . . . . 0.0 110.855 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.11 12.87 20.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.2 -0.937 . . . . 0.0 110.5 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m 38.27 62.8 0.93 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -91.28 -34.18 15.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.161 -0.962 . . . . 0.0 109.359 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.66 11.67 54.88 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.463 ' C ' HG13 ' A' ' 101' ' ' VAL . 83.0 mttt -132.21 154.66 49.36 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.054 -1.262 . . . . 0.0 110.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 106' ' ' LEU . 30.4 m -150.77 160.87 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.407 -0.808 . . . . 0.0 110.182 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.7 p -85.75 147.84 26.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 110.118 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.607 ' CG2' HD13 ' A' ' 137' ' ' ILE . 81.9 t -57.16 -40.2 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.336 -0.852 . . . . 0.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.16 -42.04 95.03 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.45 -44.17 19.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.512 -0.993 . . . . 0.0 110.4 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 HG21 ' A' ' 101' ' ' VAL . 8.2 tt -60.03 -49.96 75.6 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.714 -0.616 . . . . 0.0 110.001 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -64.08 -32.21 73.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -68.08 -47.83 67.21 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.516 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -40.33 95.45 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.144 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.604 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.98 -44.79 78.9 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.5 m -59.89 -30.5 69.06 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.59 0.71 . . . . 0.0 109.789 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.44 -14.62 63.44 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.27 7.3 46.6 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.301 -1.117 . . . . 0.0 112.602 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.82 32.4 4.76 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.604 ' HG2' HD23 ' A' ' 110' ' ' LEU . 21.2 tp10 -114.01 120.13 39.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.884 -0.774 . . . . 0.0 110.005 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -122.09 59.22 1.01 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.142 0.972 . . . . 0.0 109.518 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 92.5 mt -92.18 149.36 21.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.7 m -110.82 144.19 40.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.917 . . . . 0.0 109.663 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -40.13 -27.4 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.254 -0.904 . . . . 0.0 112.809 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 -52.66 62.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.278 -0.889 . . . . 0.0 109.028 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.59 -42.79 41.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -0.771 . . . . 0.0 110.382 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 60.3 t -59.93 -35.55 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.519 -0.738 . . . . 0.0 110.419 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -64.49 -37.74 88.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -60.05 -47.24 86.69 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.558 -0.714 . . . . 0.0 109.717 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.13 -50.13 74.43 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.631 0.729 . . . . 0.0 109.947 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.45 -19.58 56.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.893 -0.504 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -57.32 -22.01 39.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.486 -0.758 . . . . 0.0 111.203 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -113.81 -13.87 9.9 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.05 126.3 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.14 -1.212 . . . . 0.0 110.128 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -89.89 99.96 12.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.201 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 137' ' ' ILE . 8.1 p -83.32 155.67 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -96.6 -175.6 3.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.377 -0.827 . . . . 0.0 111.182 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -72.02 -0.85 12.68 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.829 -0.544 . . . . 0.0 111.863 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -107.23 -12.58 15.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.934 -1.104 . . . . 0.0 110.351 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.92 26.69 30.91 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.682 ' C ' HD12 ' A' ' 137' ' ' ILE . 44.2 mt-10 -111.92 136.12 51.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.491 -1.005 . . . . 0.0 110.963 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.682 HD12 ' C ' ' A' ' 136' ' ' GLU . 3.5 mp -124.71 142.55 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 138' ' ' ASP . 39.2 p-10 -69.74 109.07 4.19 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.378 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE2' ' CG ' ' A' ' 140' ' ' LYS . 49.9 p90 -65.28 -36.87 85.43 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.454 -0.779 . . . . 0.0 112.266 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 29.1 mttt -60.09 -31.52 70.1 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.337 -0.852 . . . . 0.0 111.904 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -84.2 -38.15 20.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.483 -0.76 . . . . 0.0 112.036 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 146' ' ' VAL . 22.7 t80 -70.42 -28.84 65.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.471 -0.768 . . . . 0.0 110.445 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 86' ' ' PHE . 90.6 mt -83.49 -50.14 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.557 -0.715 . . . . 0.0 110.326 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -62.88 -26.24 68.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.502 -0.749 . . . . 0.0 110.993 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.78 -15.83 33.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 111.014 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 142' ' ' PHE . 70.5 t -96.72 -41.66 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.058 -1.026 . . . . 0.0 108.709 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.93 -15.39 59.01 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.835 -0.541 . . . . 0.0 111.662 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.7 mtt-85 -60.2 -30.49 69.39 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.293 -0.879 . . . . 0.0 110.027 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.82 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.678 0.751 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.1 161.17 14.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.812 -0.555 . . . . 0.0 110.185 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -109.22 162.0 14.71 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.97 0.89 . . . . 0.0 111.213 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.685 HG22 ' CG2' ' A' ' 87' ' ' VAL . 5.5 m -50.54 -30.69 13.63 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.596 0.712 . . . . 0.0 109.777 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -52.56 -36.19 55.35 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.916 -0.49 . . . . 0.0 111.107 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.35 -50.01 74.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.602 -0.686 . . . . 0.0 109.92 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.594 ' CE2' HD21 ' A' ' 147' ' ' LEU . 5.6 m-85 -75.87 -40.01 55.41 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.707 -0.621 . . . . 0.0 111.254 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.685 ' CG2' HG22 ' A' ' 83' ' ' THR . 95.8 t -61.51 -50.01 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.267 -0.896 . . . . 0.0 110.365 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -57.95 -32.75 68.13 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.897 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -62.34 -58.27 8.29 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.565 -0.709 . . . . 0.0 111.867 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.876 ' CE1' HD12 ' A' ' 106' ' ' LEU . 95.7 m-85 -78.81 -55.85 4.85 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.203 -0.936 . . . . 0.0 112.105 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -48.58 -38.64 21.23 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.421 -0.8 . . . . 0.0 112.808 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -56.5 -38.6 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.993 -1.067 . . . . 0.0 110.222 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' VAL . 23.4 m-85 -67.13 -42.5 84.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.77 83.1 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.429 -0.795 . . . . 0.0 111.591 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PHE . 67.4 mmtt -68.57 -16.82 63.99 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.605 -0.684 . . . . 0.0 110.691 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -113.53 15.73 18.93 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.0 110.445 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 37.55 37.08 0.1 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.636 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.7 t -63.57 -33.14 74.94 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.101 -0.999 . . . . 0.0 109.626 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.35 53.59 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.121 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.636 ' H ' HG23 ' A' ' 98' ' ' THR . 1.8 mtpt -132.83 153.57 51.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.044 -1.268 . . . . 0.0 110.368 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.686 HG21 HD13 ' A' ' 106' ' ' LEU . 34.7 m -150.06 160.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.8 p -83.69 146.27 28.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.555 -0.715 . . . . 0.0 109.654 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.984 HG13 HD13 ' A' ' 137' ' ' ILE . 21.0 m -61.76 -34.81 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.303 -0.873 . . . . 0.0 110.283 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.43 99.79 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -79.62 -41.23 27.47 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.705 -0.879 . . . . 0.0 109.813 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.876 HD12 ' CE1' ' A' ' 90' ' ' PHE . 28.9 tp -60.04 -48.6 81.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -64.38 -30.98 72.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.48 -0.762 . . . . 0.0 110.67 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.679 ' O ' HG22 ' A' ' 111' ' ' THR . 61.1 t80 -65.52 -48.53 72.2 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.141 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -39.95 74.77 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.015 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 tp -54.17 -39.51 66.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.453 -0.779 . . . . 0.0 111.024 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 108' ' ' TYR . 8.8 t -73.01 -17.86 61.4 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.471 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.76 -13.94 66.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 8.52 42.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -1.121 . . . . 0.0 112.23 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.12 30.14 5.2 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 111' ' ' THR . 2.1 tp10 -114.17 121.48 43.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.81 -0.817 . . . . 0.0 110.273 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -123.02 61.11 1.02 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.095 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.6 mt -91.45 148.87 22.0 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -110.14 143.11 40.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.423 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 10.6 p-10 -38.5 -31.38 0.05 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.557 -0.715 . . . . 0.0 112.406 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.99 -54.05 50.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -76.97 -41.97 40.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.665 -0.647 . . . . 0.0 110.324 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 62.7 t -61.61 -36.33 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.545 -0.722 . . . . 0.0 110.608 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -59.95 -40.02 87.59 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.037 -1.039 . . . . 0.0 108.945 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.72 -43.72 80.88 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.62 -0.675 . . . . 0.0 109.57 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.405 ' HA ' HD13 ' A' ' 125' ' ' LEU . 3.6 mm? -61.92 -53.47 55.29 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.503 0.668 . . . . 0.0 110.253 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 mt -62.36 -21.13 65.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.793 -0.567 . . . . 0.0 111.032 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.37 -20.9 32.25 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.547 -0.721 . . . . 0.0 111.334 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.85 -14.2 8.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.24 126.27 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.094 -1.239 . . . . 0.0 110.102 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -92.58 102.19 14.62 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.103 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.419 ' CG2' HD11 ' A' ' 137' ' ' ILE . 7.7 p -86.47 159.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -95.68 -173.25 2.82 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.401 -0.812 . . . . 0.0 111.218 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.94 -0.64 9.69 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.878 -0.514 . . . . 0.0 111.913 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -106.09 -9.82 16.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.935 -1.103 . . . . 0.0 110.272 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.01 25.25 49.82 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.604 ' C ' HD12 ' A' ' 137' ' ' ILE . 71.9 mt-10 -111.45 143.0 42.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.483 -1.01 . . . . 0.0 111.135 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.984 HD13 HG13 ' A' ' 103' ' ' VAL . 2.6 mp -127.0 170.64 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.422 ' N ' HG22 ' A' ' 137' ' ' ILE . 40.1 t0 -94.41 117.62 30.4 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.421 -0.799 . . . . 0.0 110.344 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.586 ' HB3' HG21 ' A' ' 101' ' ' VAL . 49.0 p90 -68.47 -37.2 79.96 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.645 -0.659 . . . . 0.0 111.737 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 6.8 mttt -67.04 -41.0 87.27 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.58 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -69.94 -42.54 73.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.756 -0.59 . . . . 0.0 111.428 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.445 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.3 t80 -70.7 -29.36 65.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.502 -0.749 . . . . 0.0 110.348 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 139' ' ' TYR . 94.8 mt -85.35 -50.99 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 110.235 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -62.77 -26.68 68.83 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.528 -0.733 . . . . 0.0 110.85 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.25 -15.46 35.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.218 -0.926 . . . . 0.0 110.816 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 142' ' ' PHE . 58.1 t -95.98 -42.42 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.08 -1.013 . . . . 0.0 108.695 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.594 HD21 ' CE2' ' A' ' 86' ' ' PHE . 1.7 mm? -62.06 -15.61 46.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.674 -0.641 . . . . 0.0 111.693 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.4 mtp180 -59.36 141.26 54.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.193 -0.942 . . . . 0.0 110.056 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 . . . . . 0 N--CA 1.497 1.895 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.234 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.751 0.786 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.07 159.6 18.33 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.947 -0.47 . . . . 0.0 110.263 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -109.92 161.98 14.96 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.859 0.838 . . . . 0.0 111.184 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.86 HG22 ' CG2' ' A' ' 87' ' ' VAL . 28.2 m -50.98 -30.86 16.17 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.59 0.709 . . . . 0.0 109.73 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.94 -36.93 41.23 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.875 -0.516 . . . . 0.0 111.189 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -60.03 -50.06 75.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.598 -0.689 . . . . 0.0 109.996 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.825 ' CD1' HD11 ' A' ' 143' ' ' ILE . 3.6 m-85 -76.35 -39.6 53.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.644 -0.66 . . . . 0.0 111.025 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.86 ' CG2' HG22 ' A' ' 83' ' ' THR . 68.8 t -59.22 -53.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.25 -0.906 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.612 ' O ' HG23 ' A' ' 92' ' ' VAL . 38.4 ttpt -59.45 -33.15 70.93 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.608 -0.682 . . . . 0.0 110.955 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.658 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -62.49 -51.69 66.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.508 -0.745 . . . . 0.0 111.934 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.55 -54.87 6.1 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 111.505 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -48.46 -37.29 16.92 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.485 -0.759 . . . . 0.0 112.83 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 88' ' ' LYS . 76.6 t -60.29 -36.94 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 120.843 -1.16 . . . . 0.0 109.715 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -69.59 -46.98 65.07 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -62.28 82.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.507 -0.746 . . . . 0.0 110.827 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -64.13 -40.01 95.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.589 -0.694 . . . . 0.0 110.447 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -91.54 16.7 9.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.291 -0.88 . . . . 0.0 110.726 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 38.5 36.31 0.13 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 69.8 p -63.75 -34.6 78.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.076 -1.015 . . . . 0.0 109.37 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.81 11.28 55.4 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.131 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 29.2 mmtm -132.39 153.95 50.29 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.044 -1.268 . . . . 0.0 110.402 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 139' ' ' TYR . 35.8 m -149.98 161.2 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.344 -0.848 . . . . 0.0 110.09 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.4 p -83.85 145.77 28.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.571 -0.706 . . . . 0.0 110.035 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.3 p -56.94 -38.3 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.395 -0.816 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.92 -40.76 97.3 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.6 -39.96 26.61 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.602 -0.94 . . . . 0.0 110.355 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.89 -49.87 75.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.64 . . . . 0.0 110.025 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -64.66 -29.94 70.95 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.502 -0.749 . . . . 0.0 110.652 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.5 -47.68 69.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.424 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -39.19 93.65 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.016 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -55.59 -45.29 77.45 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 83.1 m -59.65 -30.42 68.73 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.571 0.7 . . . . 0.0 109.917 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.3 63.88 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.26 6.83 47.98 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.322 -1.105 . . . . 0.0 112.736 -177.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.66 32.35 4.83 Favored Glycine 0 N--CA 1.499 2.865 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.566 ' HG2' HD23 ' A' ' 110' ' ' LEU . 19.9 tp10 -114.16 120.25 39.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 122.034 -0.686 . . . . 0.0 109.896 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -122.06 59.5 1.0 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.203 1.001 . . . . 0.0 109.364 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.38 148.44 23.5 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -111.05 143.1 42.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -39.98 -28.26 0.05 Allowed 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.318 -0.864 . . . . 0.0 112.486 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.41 59.29 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 45.4 mt-10 -75.4 -29.32 59.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 110.584 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.85 -32.6 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.99 -41.93 77.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.328 -0.857 . . . . 0.0 110.454 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 125' ' ' LEU . 9.1 pt-20 -60.0 -40.06 87.93 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.139 -0.975 . . . . 0.0 109.898 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER -70.34 -44.06 68.97 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.394 -0.816 . . . . 0.0 110.354 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 129' ' ' VAL . 26.7 mt -60.18 -16.11 30.07 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.841 -0.537 . . . . 0.0 111.775 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -57.64 -19.24 25.06 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.276 -0.89 . . . . 0.0 111.304 -178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.64 25.09 9.26 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.438 HG21 HD23 ' A' ' 126' ' ' LEU . 58.6 t -106.7 124.5 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.301 -1.117 . . . . 0.0 109.549 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.03 105.85 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.474 0.654 . . . . 0.0 111.874 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.637 HG12 ' CG1' ' A' ' 137' ' ' ILE . 26.3 m -88.81 163.2 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -93.41 -175.05 3.68 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.794 . . . . 0.0 111.015 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.8 m -71.24 -1.35 12.36 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.899 -0.5 . . . . 0.0 111.776 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -108.26 -11.89 15.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.937 -1.102 . . . . 0.0 110.726 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.72 27.55 26.51 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.586 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.6 mt-10 -109.94 137.81 47.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.553 -0.969 . . . . 0.0 111.108 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.637 ' CG1' HG12 ' A' ' 131' ' ' VAL . 5.1 mp -129.68 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -69.33 110.65 4.77 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.941 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.464 ' HB3' HG21 ' A' ' 101' ' ' VAL . 45.6 p90 -62.84 -30.96 71.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.48 -0.763 . . . . 0.0 111.89 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 24.3 mttt -71.28 -33.41 69.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.333 -0.855 . . . . 0.0 110.466 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -72.34 -46.17 56.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.751 -0.593 . . . . 0.0 111.493 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.639 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.2 t80 -71.15 -29.0 64.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.467 -0.771 . . . . 0.0 111.329 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.825 HD11 ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -79.28 -44.62 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.163 -0.961 . . . . 0.0 110.366 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.45 ' N ' HG23 ' A' ' 143' ' ' ILE . 94.0 mt-10 -62.29 -26.25 68.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.126 -0.984 . . . . 0.0 109.856 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.42 -12.56 45.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.434 -0.791 . . . . 0.0 110.099 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 142' ' ' PHE . 59.5 t -96.36 -41.8 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.429 ' CD1' ' CE2' ' A' ' 86' ' ' PHE . 2.9 tp -58.49 -28.96 65.87 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.379 0.609 . . . . 0.0 110.758 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -52.87 -40.0 63.09 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.728 -0.607 . . . . 0.0 110.844 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.161 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.8 mttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.586 0.708 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.13 159.8 21.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.814 -0.554 . . . . 0.0 110.059 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -107.3 158.88 16.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 0.0 110.838 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.7 m -51.26 -30.28 17.26 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.799 0.809 . . . . 0.0 109.329 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -53.17 -39.09 63.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.907 -0.496 . . . . 0.0 111.286 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.45 ' OD1' HD21 ' A' ' 113' ' ' LEU . 7.7 t0 -61.77 -50.03 74.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.551 -0.718 . . . . 0.0 109.918 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.735 ' CE2' HD21 ' A' ' 147' ' ' LEU . 1.6 m-85 -72.82 -36.58 67.54 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.743 -0.598 . . . . 0.0 111.193 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 83' ' ' THR . 77.7 t -67.36 -46.15 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.16 -0.963 . . . . 0.0 110.79 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.598 ' O ' HG13 ' A' ' 92' ' ' VAL . 71.0 mmtt -59.27 -36.48 75.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.573 -0.704 . . . . 0.0 111.549 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 113' ' ' LEU . . . -59.75 -57.52 12.57 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 0.0 111.592 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -77.64 -53.63 7.34 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.278 -0.889 . . . . 0.0 112.028 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 139' ' ' TYR . 37.5 mm-40 -48.36 -38.71 19.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.175 -0.953 . . . . 0.0 113.14 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 88' ' ' LYS . 29.7 m -59.14 -34.54 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.754 -1.216 . . . . 0.0 110.164 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -68.38 -43.33 77.57 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -63.3 80.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.359 -0.838 . . . . 0.0 110.901 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.26 -39.92 92.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 0.0 110.482 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -92.44 20.14 6.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.343 -0.848 . . . . 0.0 110.811 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.3 m 38.14 65.04 0.63 Allowed 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 p -91.43 -33.78 15.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.17 -0.956 . . . . 0.0 109.148 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.53 15.12 57.48 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' C ' HG13 ' A' ' 101' ' ' VAL . 24.4 mmtp -131.93 153.1 50.61 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -1.217 . . . . 0.0 110.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.447 HG13 ' C ' ' A' ' 100' ' ' LYS . 35.9 m -148.98 159.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.313 -0.867 . . . . 0.0 110.047 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -81.85 144.8 30.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.624 -0.672 . . . . 0.0 110.083 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.7 p -56.41 -38.66 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.492 -0.755 . . . . 0.0 110.702 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.444 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -60.1 -40.6 97.36 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.52 -40.04 26.75 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.569 -0.959 . . . . 0.0 110.436 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 106' ' ' LEU . 10.4 tt -58.96 -49.62 77.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.667 -0.646 . . . . 0.0 110.212 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 52.5 ttp85 -64.95 -29.6 70.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.705 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -67.93 -48.08 66.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.389 -0.82 . . . . 0.0 110.684 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -37.68 69.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.22 -0.925 . . . . 0.0 111.041 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.68 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.4 tp -55.33 -42.85 74.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.222 -0.924 . . . . 0.0 109.388 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' GLU . 1.1 p -66.45 -20.5 66.07 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.45 -14.87 62.99 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.488 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -94.09 8.41 41.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.321 -1.105 . . . . 0.0 112.507 -177.318 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.08 31.31 4.77 Favored Glycine 0 N--CA 1.499 2.878 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.68 ' HG2' HD23 ' A' ' 110' ' ' LEU . 3.2 tp10 -113.97 120.27 40.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.985 -0.715 . . . . 0.0 109.734 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -122.07 59.33 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.158 -0.964 . . . . 0.0 109.909 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.0 mt -91.68 148.82 21.98 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.5 p -111.06 142.28 43.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -39.61 -29.21 0.05 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.422 -0.799 . . . . 0.0 112.482 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.03 -52.89 62.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.341 -0.849 . . . . 0.0 108.852 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.78 -43.18 37.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.714 -0.616 . . . . 0.0 110.304 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.32 -34.9 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.549 -0.719 . . . . 0.0 110.405 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -64.17 -37.44 87.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.216 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -59.99 -46.67 88.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.627 -0.67 . . . . 0.0 110.086 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 125' ' ' LEU . 10.9 mp -62.72 -41.18 99.04 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.524 -0.735 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 26.4 mt -62.98 -17.13 61.72 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.826 -0.546 . . . . 0.0 111.569 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -56.57 -22.51 34.01 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.259 -0.9 . . . . 0.0 111.084 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -116.98 25.29 8.94 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 66.2 t -106.54 128.74 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.363 -1.081 . . . . 0.0 109.911 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -102.38 102.94 13.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.448 0.642 . . . . 0.0 111.93 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.27 158.97 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -95.92 -177.54 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.355 -0.84 . . . . 0.0 111.333 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 p -71.22 -2.06 14.73 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.832 -0.543 . . . . 0.0 111.971 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -106.82 -10.52 16.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.994 -1.066 . . . . 0.0 110.241 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.09 26.98 32.37 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.57 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.6 mt-10 -111.13 139.2 46.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.649 -0.913 . . . . 0.0 111.14 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.628 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.0 mp -128.42 142.22 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.92 113.88 6.73 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.731 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.491 ' O ' HD12 ' A' ' 143' ' ' ILE . 30.9 p90 -63.95 -36.16 83.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.617 -0.677 . . . . 0.0 111.887 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.5 mmtt -70.01 -37.02 75.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.779 . . . . 0.0 111.029 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -70.27 -45.37 66.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.634 -0.667 . . . . 0.0 111.702 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.647 ' O ' HG23 ' A' ' 146' ' ' VAL . 24.7 t80 -71.3 -29.2 64.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.418 -0.801 . . . . 0.0 110.767 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.491 HD12 ' O ' ' A' ' 139' ' ' TYR . 96.8 mt -79.6 -47.53 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.484 -0.76 . . . . 0.0 109.611 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -60.31 -26.77 66.79 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.429 -0.794 . . . . 0.0 110.017 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -88.14 -12.28 44.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -0.786 . . . . 0.0 110.414 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 142' ' ' PHE . 55.2 t -95.57 -38.91 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.735 HD21 ' CE2' ' A' ' 86' ' ' PHE . 72.1 mt -56.16 -21.22 21.46 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.925 -0.484 . . . . 0.0 111.181 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -58.17 148.44 26.84 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.408 -0.807 . . . . 0.0 110.358 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.266 179.958 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.3 tttt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.825 0.822 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.35 159.55 17.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.941 -0.474 . . . . 0.0 110.211 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -109.96 158.89 17.76 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.754 0.788 . . . . 0.0 111.021 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.6 m -49.96 -29.99 9.54 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.533 0.682 . . . . 0.0 110.286 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -46.57 -32.47 3.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.822 -0.549 . . . . 0.0 112.144 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -62.48 -43.79 97.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.378 -0.826 . . . . 0.0 110.543 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.543 ' CD1' HD13 ' A' ' 113' ' ' LEU . 3.1 m-85 -77.45 -40.22 44.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.489 -0.757 . . . . 0.0 110.704 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.53 -57.46 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.411 -0.806 . . . . 0.0 111.077 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 92' ' ' VAL . 50.5 tttt -60.03 -34.35 73.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.638 -0.664 . . . . 0.0 110.815 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.586 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -60.42 -54.29 47.33 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.576 -0.703 . . . . 0.0 111.645 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.427 ' CZ ' ' HG ' ' A' ' 106' ' ' LEU . 24.5 m-85 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.219 -0.926 . . . . 0.0 111.615 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -48.69 -39.68 25.41 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.369 -0.832 . . . . 0.0 112.814 -177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 88' ' ' LYS . 71.5 t -60.05 -38.07 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.876 -1.14 . . . . 0.0 109.754 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -67.48 -44.89 77.47 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -61.36 82.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.558 -0.714 . . . . 0.0 111.04 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -64.21 -39.99 95.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.714 -0.616 . . . . 0.0 110.797 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -94.05 18.18 11.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.179 -0.951 . . . . 0.0 110.507 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.1 m 38.7 63.0 0.95 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.3 p -90.83 -34.77 15.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.981 . . . . 0.0 109.122 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.49 62.25 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.307 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 2.6 mppt? -129.83 150.03 51.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.113 -1.227 . . . . 0.0 110.074 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.456 ' CG2' HD12 ' A' ' 106' ' ' LEU . 35.2 m -150.15 164.69 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.376 -0.828 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 p -85.39 147.08 26.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.688 -0.633 . . . . 0.0 109.293 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 137' ' ' ILE . 35.5 m -62.43 -33.17 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.94 -42.25 99.72 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -79.9 -39.91 29.39 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.664 -0.903 . . . . 0.0 109.624 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.523 HD23 ' C ' ' A' ' 106' ' ' LEU . 9.9 tt -59.9 -49.19 78.68 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.827 -0.546 . . . . 0.0 109.527 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -63.9 -29.44 70.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 110.32 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.24 -48.41 67.85 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.391 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -40.03 95.77 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.682 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.551 HD23 ' HG2' ' A' ' 115' ' ' GLU . 1.5 mp -55.95 -44.29 78.28 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 57.0 m -60.04 -31.08 69.63 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.577 0.703 . . . . 0.0 109.754 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.14 -14.79 63.72 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -96.53 7.27 46.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -1.124 . . . . 0.0 112.557 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.95 31.53 5.05 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.551 ' HG2' HD23 ' A' ' 110' ' ' LEU . 18.2 tp10 -113.52 120.17 40.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.877 -0.778 . . . . 0.0 109.952 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -122.5 60.3 1.01 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.184 -0.948 . . . . 0.0 109.879 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.408 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 85.7 mt -91.41 148.8 22.06 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 m -110.76 142.75 42.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.193 -0.942 . . . . 0.0 110.115 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.419 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 28.6 t0 -39.37 -29.27 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 O-C-N 121.376 -0.827 . . . . 0.0 112.571 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.87 -53.04 61.24 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.332 -0.855 . . . . 0.0 108.808 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -76.75 -42.83 39.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.624 -0.673 . . . . 0.0 110.169 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 62.6 t -60.25 -35.82 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.495 -0.753 . . . . 0.0 110.568 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.63 -38.41 87.54 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.184 -0.947 . . . . 0.0 109.115 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -59.63 -45.36 92.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.591 -0.693 . . . . 0.0 109.527 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.33 -51.47 68.7 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.587 -0.696 . . . . 0.0 110.151 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.411 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 8.5 mt -59.99 -19.04 50.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.634 -0.667 . . . . 0.0 110.962 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -57.06 -24.0 50.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.501 -0.75 . . . . 0.0 110.93 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.27 25.41 8.74 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 62.0 t -106.74 120.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.308 -1.113 . . . . 0.0 109.659 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.52 103.0 15.45 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.487 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.71 HG12 ' CG1' ' A' ' 137' ' ' ILE . 23.6 m -86.74 161.38 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -95.87 -171.98 2.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.48 -0.763 . . . . 0.0 110.946 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 p -72.08 -0.21 11.2 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.84 -0.537 . . . . 0.0 111.752 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.68 -11.09 15.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.944 -1.098 . . . . 0.0 110.257 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.89 24.55 52.49 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.777 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.4 mt-10 -110.96 141.62 44.18 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.392 -1.064 . . . . 0.0 110.966 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 1.062 HD13 HG13 ' A' ' 103' ' ' VAL . 3.4 mp -127.05 147.22 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 121.311 0.577 . . . . 0.0 109.657 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -69.23 116.29 9.5 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.227 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.48 ' CZ ' ' HG3' ' A' ' 140' ' ' LYS . 7.2 p90 -68.15 -34.14 75.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.653 -0.654 . . . . 0.0 111.983 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 13.8 mttt -69.97 -28.85 65.87 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.342 -0.849 . . . . 0.0 111.278 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -80.42 -43.22 21.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 112.254 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.6 t80 -70.9 -30.72 67.14 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.0 111.727 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 86' ' ' PHE . 18.2 pt -83.69 -44.22 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.114 -0.991 . . . . 0.0 110.579 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.424 ' N ' HG13 ' A' ' 143' ' ' ILE . 65.3 mt-10 -67.33 -26.53 66.54 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.0 110.57 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.72 -13.98 46.73 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.273 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 142' ' ' PHE . 70.4 t -95.31 -37.82 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.02 -27.4 66.88 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.293 0.568 . . . . 0.0 110.933 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -51.31 133.8 28.59 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.626 -0.672 . . . . 0.0 111.018 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.275 179.906 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.695 0.759 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.44 160.69 19.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.94 -0.475 . . . . 0.0 110.464 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -109.21 160.71 15.88 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.81 0.814 . . . . 0.0 110.79 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.639 HG22 ' CG2' ' A' ' 87' ' ' VAL . 16.2 m -51.32 -31.08 20.42 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.698 0.761 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -51.39 -37.43 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.854 -0.529 . . . . 0.0 111.152 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.473 ' OD1' HD21 ' A' ' 113' ' ' LEU . 13.4 t0 -64.64 -45.55 86.3 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.682 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.658 ' HE2' HD21 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -74.65 -38.39 62.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.729 -0.607 . . . . 0.0 111.025 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.639 ' CG2' HG22 ' A' ' 83' ' ' THR . 64.8 t -66.56 -47.09 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.141 -0.974 . . . . 0.0 111.041 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 92' ' ' VAL . 24.1 tptt -60.06 -35.32 74.9 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.582 -0.699 . . . . 0.0 111.419 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 113' ' ' LEU . . . -61.74 -52.8 62.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.456 -0.777 . . . . 0.0 111.816 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -76.48 -53.61 7.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.266 -0.896 . . . . 0.0 111.367 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.417 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 35.3 mt-30 -48.09 -36.19 12.7 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.291 -0.88 . . . . 0.0 112.854 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 88' ' ' LYS . 85.5 t -62.25 -35.74 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.819 -1.176 . . . . 0.0 109.981 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.05 -50.97 35.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.363 -0.835 . . . . 0.0 109.276 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 91' ' ' GLN . 2.6 p30 -77.67 82.39 4.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.214 -0.929 . . . . 0.0 109.663 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -61.16 -26.86 67.99 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.817 -0.552 . . . . 0.0 110.745 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -89.65 17.97 5.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.17 -0.956 . . . . 0.0 111.015 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.6 t 38.5 37.11 0.16 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.1 p -63.9 -34.91 79.01 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.082 -1.011 . . . . 0.0 109.24 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.16 12.85 59.59 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' C ' HG13 ' A' ' 101' ' ' VAL . 48.0 mttm -131.77 153.38 50.15 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.266 . . . . 0.0 110.176 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.619 ' CG2' HD12 ' A' ' 106' ' ' LEU . 34.0 m -150.37 161.5 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.381 -0.825 . . . . 0.0 110.28 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -83.08 145.85 29.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.502 -0.749 . . . . 0.0 109.923 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.1 p -57.26 -39.99 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.423 -0.798 . . . . 0.0 110.741 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.67 -41.47 97.44 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -80.08 -41.87 24.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.512 -0.993 . . . . 0.0 110.539 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.619 HD12 ' CG2' ' A' ' 101' ' ' VAL . 9.8 tt -60.06 -49.76 76.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.639 -0.663 . . . . 0.0 109.959 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -64.24 -31.65 72.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.741 . . . . 0.0 110.265 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -67.45 -48.83 66.07 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -33.57 65.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.413 -0.804 . . . . 0.0 110.583 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 27.7 tp -54.57 -44.32 72.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' GLU . 25.4 m -67.41 -15.87 63.92 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.061 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.98 -14.51 64.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.499 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.7 OUTLIER -94.82 8.02 44.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.407 -1.055 . . . . 0.0 112.583 -177.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.59 31.0 5.05 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 58.5 mm-40 -114.18 120.72 41.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.929 -0.748 . . . . 0.0 109.638 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -122.8 60.45 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.39 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 72.6 mt -89.95 148.26 23.22 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.3 m -110.6 141.66 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.256 -0.903 . . . . 0.0 110.16 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 26.2 t0 -39.2 -30.83 0.06 Allowed 'General case' 0 N--CA 1.511 2.611 0 O-C-N 121.566 -0.709 . . . . 0.0 112.161 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.63 -51.75 67.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -77.28 -40.73 43.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.722 -0.611 . . . . 0.0 110.454 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 62.2 t -62.55 -35.36 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.607 -0.683 . . . . 0.0 110.466 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -64.21 -38.03 89.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.211 -0.931 . . . . 0.0 109.145 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -59.97 -46.86 88.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.619 -0.676 . . . . 0.0 109.521 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.6 mt -62.3 -46.95 86.47 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.659 0.742 . . . . 0.0 109.944 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.4 mt -60.97 -18.96 60.21 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.85 -0.531 . . . . 0.0 111.205 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -56.75 -21.32 27.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 0.0 111.218 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.43 -12.04 11.14 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.89 134.24 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.08 -1.247 . . . . 0.0 110.242 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -102.4 102.96 13.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.363 0.602 . . . . 0.0 111.804 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.427 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.4 p -85.69 157.31 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.05 -179.17 4.87 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.288 -0.883 . . . . 0.0 111.287 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -71.0 -2.61 15.95 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.874 -0.516 . . . . 0.0 111.854 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -107.33 -12.19 15.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.026 -1.046 . . . . 0.0 110.429 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.15 27.09 22.0 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' HD12 ' A' ' 137' ' ' ILE . 64.3 mt-10 -110.87 135.65 51.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.938 . . . . 0.0 111.068 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.556 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.2 mp -128.32 140.32 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -68.93 111.29 4.87 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.657 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.558 ' O ' HG23 ' A' ' 143' ' ' ILE . 18.6 p90 -64.48 -32.51 74.18 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.481 -0.762 . . . . 0.0 112.095 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 139' ' ' TYR . 2.2 mtmp? -71.22 -35.93 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.258 -0.901 . . . . 0.0 111.067 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -70.41 -44.51 67.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.684 -0.635 . . . . 0.0 111.659 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.616 ' O ' HG23 ' A' ' 146' ' ' VAL . 29.2 t80 -70.02 -29.15 66.13 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.431 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 139' ' ' TYR . 32.4 pt -80.27 -43.68 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.15 -0.969 . . . . 0.0 110.197 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.461 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.7 mt-10 -62.59 -26.84 68.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.266 -0.896 . . . . 0.0 109.929 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.1 -12.31 44.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.355 -0.841 . . . . 0.0 110.276 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 142' ' ' PHE . 54.5 t -95.92 -39.94 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.658 HD21 ' HE2' ' A' ' 86' ' ' PHE . 52.7 mt -57.53 -18.65 20.25 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.941 -0.474 . . . . 0.0 111.565 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -59.94 -40.09 87.78 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.245 -0.91 . . . . 0.0 110.22 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.294 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.8 tptt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.776 0.798 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.51 160.43 16.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.888 -0.508 . . . . 0.0 110.004 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -109.07 160.17 16.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.849 . . . . 0.0 111.001 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.88 HG22 ' CG2' ' A' ' 87' ' ' VAL . 23.8 m -51.15 -30.5 16.81 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.612 0.72 . . . . 0.0 109.54 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -52.3 -37.27 55.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.871 -0.518 . . . . 0.0 111.275 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -60.04 -51.05 71.28 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.56 -0.713 . . . . 0.0 109.865 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -75.62 -39.69 57.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.775 -0.578 . . . . 0.0 110.814 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.88 ' CG2' HG22 ' A' ' 83' ' ' THR . 99.8 t -61.25 -49.98 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.26 -0.9 . . . . 0.0 110.282 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.665 ' O ' HG23 ' A' ' 92' ' ' VAL . 37.8 mmtt -60.07 -36.16 76.76 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.651 -0.656 . . . . 0.0 110.923 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.491 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -62.32 -49.04 77.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.708 -0.62 . . . . 0.0 111.565 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.703 ' CE2' HD12 ' A' ' 106' ' ' LEU . 19.0 m-85 -77.41 -56.07 4.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 111.751 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.539 ' OE1' HG12 ' A' ' 87' ' ' VAL . 66.5 mt-30 -48.16 -34.27 9.7 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 88' ' ' LYS . 81.8 t -61.84 -34.55 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.814 -1.178 . . . . 0.0 109.657 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -72.58 -52.1 16.95 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.66 81.77 8.72 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -60.39 -21.16 61.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.688 -0.632 . . . . 0.0 111.002 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -89.97 18.91 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.147 -0.971 . . . . 0.0 111.044 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.5 m 38.73 37.43 0.19 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 35.5 p -64.24 -35.6 81.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.128 -0.983 . . . . 0.0 109.527 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.0 12.52 60.18 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.442 ' C ' HG23 ' A' ' 101' ' ' VAL . 89.2 mttt -131.74 151.61 51.52 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.079 -1.247 . . . . 0.0 110.155 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 100' ' ' LYS . 48.1 t -149.84 162.51 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.349 -0.844 . . . . 0.0 109.97 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 101' ' ' VAL . 8.9 p -84.95 148.16 26.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.517 -0.74 . . . . 0.0 109.991 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.775 ' CG2' HD13 ' A' ' 137' ' ' ILE . 98.1 t -56.23 -40.32 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.269 -0.895 . . . . 0.0 110.419 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.84 -41.34 94.03 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -81.05 -42.75 20.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.587 -0.949 . . . . 0.0 110.238 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.703 HD12 ' CE2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -60.08 -49.92 75.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.611 -0.681 . . . . 0.0 110.222 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -67.04 -31.01 71.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.581 -0.699 . . . . 0.0 110.792 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.7 -47.81 65.48 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.67 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -40.61 92.33 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.508 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.72 -45.07 77.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.474 -0.89 . . . . 0.0 108.675 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -59.94 -28.36 67.56 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.538 0.685 . . . . 0.0 109.9 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.5 -14.59 63.38 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.77 6.9 47.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.295 -1.12 . . . . 0.0 112.76 -177.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.11 31.46 5.03 Favored Glycine 0 N--CA 1.501 3.009 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -114.13 121.0 42.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.792 -0.828 . . . . 0.0 109.871 178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -122.33 59.89 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.051 0.929 . . . . 0.0 109.598 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.13 148.92 22.04 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.0 p -110.77 142.21 43.04 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.248 -0.907 . . . . 0.0 110.024 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.41 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 35.8 t0 -39.87 -28.46 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 O-C-N 121.297 -0.877 . . . . 0.0 112.543 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.95 -52.59 63.43 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.7 -43.01 39.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.591 -0.693 . . . . 0.0 110.312 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 119' ' ' ASP . 59.3 t -60.04 -35.53 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.497 -0.752 . . . . 0.0 110.562 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -63.21 -37.32 86.76 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.216 -0.927 . . . . 0.0 109.275 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.81 -46.03 90.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.559 -0.713 . . . . 0.0 109.578 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 129' ' ' VAL . 11.0 mp -61.19 -48.44 81.54 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.541 -0.724 . . . . 0.0 109.825 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.33 -21.34 66.58 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.859 -0.526 . . . . 0.0 111.05 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -57.19 -22.23 39.11 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.497 -0.752 . . . . 0.0 111.104 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.69 -14.32 8.13 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 125' ' ' LEU . 72.4 t -68.37 134.11 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.044 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -94.91 99.1 11.2 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 111.71 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 137' ' ' ILE . 7.4 p -82.33 156.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -96.51 -177.79 4.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 m -71.46 -0.92 11.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.773 -0.579 . . . . 0.0 111.954 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -107.5 -12.52 15.27 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.843 -1.161 . . . . 0.0 110.442 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.4 25.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 137' ' ' ILE . 46.2 mt-10 -111.91 136.14 51.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.564 -0.962 . . . . 0.0 111.086 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.775 HD13 ' CG2' ' A' ' 103' ' ' VAL . 4.0 mp -126.98 141.38 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.3 p-10 -69.41 106.67 3.03 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.433 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.487 ' O ' HD12 ' A' ' 143' ' ' ILE . 54.4 p90 -62.51 -35.8 80.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.301 -0.874 . . . . 0.0 112.128 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.459 ' CG ' ' CE1' ' A' ' 139' ' ' TYR . 19.4 mtpp -58.44 -56.57 20.44 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.278 -0.889 . . . . 0.0 111.052 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -59.91 -39.1 84.27 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.786 -0.572 . . . . 0.0 111.585 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 146' ' ' VAL . 18.4 t80 -70.05 -28.98 65.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 0.0 109.685 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 139' ' ' TYR . 69.3 mt -83.27 -50.03 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.713 . . . . 0.0 109.725 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.72 -27.01 67.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.466 -0.771 . . . . 0.0 110.11 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -87.85 -12.98 43.29 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.323 -0.861 . . . . 0.0 110.466 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 142' ' ' PHE . 41.7 t -95.82 -39.25 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.54 -27.29 62.49 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.318 0.58 . . . . 0.0 110.679 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.6 mtp-105 -53.01 140.21 25.68 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.664 -0.647 . . . . 0.0 110.801 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.267 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.776 0.798 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.91 160.59 16.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.838 -0.539 . . . . 0.0 110.198 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -109.58 159.66 16.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 0.0 111.084 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.78 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.3 m -50.89 -30.43 14.59 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.695 0.76 . . . . 0.0 109.564 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.62 -37.01 48.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.842 -0.536 . . . . 0.0 111.279 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.98 -50.5 73.49 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.618 -0.676 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HD13 ' A' ' 113' ' ' LEU . 2.0 m-85 -76.48 -40.57 49.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.687 -0.633 . . . . 0.0 110.944 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.78 ' CG2' HG22 ' A' ' 83' ' ' THR . 71.8 t -60.34 -57.21 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.373 -0.83 . . . . 0.0 110.958 -177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HA ' ' CG ' ' A' ' 91' ' ' GLN . 57.3 tptt -54.45 -32.55 57.83 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.451 -0.781 . . . . 0.0 111.022 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.575 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -65.17 -44.77 87.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.743 -0.598 . . . . 0.0 111.89 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 143' ' ' ILE . 14.3 m-85 -80.61 -56.88 3.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 0.0 110.916 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' CG ' ' HA ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -48.59 -36.56 15.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -176.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.3 p -60.01 -35.65 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.01 -1.056 . . . . 0.0 109.655 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -71.62 -47.41 54.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -64.72 80.6 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.444 -0.785 . . . . 0.0 110.593 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -60.52 -38.22 83.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.569 -0.707 . . . . 0.0 110.738 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.54 20.44 5.38 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.274 -0.891 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.7 t 37.98 36.85 0.12 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.1 p -64.17 -34.47 78.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.209 -0.932 . . . . 0.0 109.519 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.04 13.31 57.86 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' C ' HG23 ' A' ' 101' ' ' VAL . 48.8 mttm -132.47 151.89 51.73 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.196 -1.179 . . . . 0.0 110.095 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.434 HG23 ' C ' ' A' ' 100' ' ' LYS . 58.8 t -148.41 159.52 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.39 -0.818 . . . . 0.0 109.494 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 p -79.82 144.3 33.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.531 -0.731 . . . . 0.0 109.773 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.1 p -55.81 -38.76 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.417 -0.802 . . . . 0.0 110.542 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.446 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.98 -40.69 97.29 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -81.15 -40.0 24.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.695 -0.885 . . . . 0.0 110.511 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD23 ' C ' ' A' ' 106' ' ' LEU . 9.7 tt -59.18 -49.82 76.41 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.63 -0.668 . . . . 0.0 110.173 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -67.03 -28.87 68.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.787 . . . . 0.0 111.075 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -66.18 -48.51 70.46 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.372 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -40.78 98.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 0.0 110.06 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.68 HD23 ' HG3' ' A' ' 115' ' ' GLU . 0.5 OUTLIER -55.95 -44.64 78.61 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.7 m -60.06 -31.44 69.99 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.502 0.668 . . . . 0.0 109.619 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.79 64.79 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.575 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -96.15 7.85 45.33 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.269 -1.136 . . . . 0.0 112.475 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 31.78 4.91 Favored Glycine 0 N--CA 1.5 2.943 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.721 ' OE2' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -113.22 119.88 39.28 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.742 -0.858 . . . . 0.0 110.28 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.77 59.76 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.798 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.721 HD12 ' OE2' ' A' ' 115' ' ' GLU . 90.6 mt -90.02 148.72 22.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 m -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.04 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 11.6 t70 -40.06 -27.47 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 O-C-N 121.231 -0.918 . . . . 0.0 112.95 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.09 60.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.195 -0.941 . . . . 0.0 109.072 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -76.54 -41.95 44.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.578 -0.701 . . . . 0.0 110.262 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.485 HG12 HD12 ' A' ' 126' ' ' LEU . 62.6 t -59.97 -35.92 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.537 -0.727 . . . . 0.0 110.258 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.71 -37.11 86.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.085 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -63.71 -49.88 71.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.12 -48.12 83.07 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.577 0.703 . . . . 0.0 109.978 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.485 HD12 HG12 ' A' ' 122' ' ' VAL . 34.1 mt -61.87 -16.64 52.0 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.826 -0.547 . . . . 0.0 110.985 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -56.8 -20.58 23.28 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.398 -0.814 . . . . 0.0 111.173 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 25.65 8.29 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.41 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 62.6 t -107.32 129.98 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.294 -1.121 . . . . 0.0 109.783 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 100.54 11.38 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.885 0.85 . . . . 0.0 112.418 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.3 p -83.47 158.88 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -95.62 -179.04 4.6 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.835 0.826 . . . . 0.0 111.423 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.4 m -70.97 -1.67 12.74 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.833 -0.542 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -107.66 -11.96 15.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.998 -1.064 . . . . 0.0 110.434 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.94 28.79 17.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.487 ' C ' HD12 ' A' ' 137' ' ' ILE . 67.8 mt-10 -111.15 135.58 51.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.617 -0.931 . . . . 0.0 111.153 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.5 mp -125.35 168.55 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 137' ' ' ILE . 19.7 t0 -98.19 112.02 24.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.448 -0.782 . . . . 0.0 110.148 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.487 ' HA ' HD11 ' A' ' 106' ' ' LEU . 43.9 p90 -65.92 -34.22 77.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.471 -0.768 . . . . 0.0 112.171 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 15.7 mttt -70.04 -40.02 75.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.075 -1.016 . . . . 0.0 110.946 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -67.19 -43.82 81.18 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.629 -0.669 . . . . 0.0 111.391 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 146' ' ' VAL . 17.5 t80 -71.66 -27.87 63.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.578 -0.701 . . . . 0.0 110.993 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.6 HD11 ' CE1' ' A' ' 90' ' ' PHE . 96.6 mt -83.93 -51.41 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.4 -0.812 . . . . 0.0 110.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -61.93 -26.4 68.16 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.516 -0.74 . . . . 0.0 111.016 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.14 -16.44 31.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 0.0 110.873 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 142' ' ' PHE . 76.8 t -97.19 -42.88 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.14 -0.975 . . . . 0.0 109.187 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.465 HD11 ' HE2' ' A' ' 86' ' ' PHE . 4.0 mm? -66.71 -16.14 64.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.703 -0.623 . . . . 0.0 111.721 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -59.92 136.26 57.95 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.31 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.6 tptt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.754 0.788 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.03 161.18 13.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.829 -0.544 . . . . 0.0 110.07 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -108.56 154.48 21.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.283 -0.886 . . . . 0.0 110.94 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.641 HG22 ' CG1' ' A' ' 87' ' ' VAL . 5.3 m -50.75 -30.41 13.91 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.813 0.816 . . . . 0.0 109.337 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HA ' ' CG2' ' A' ' 87' ' ' VAL . 44.0 mt-10 -50.49 -35.87 31.15 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.687 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -65.89 -47.22 75.56 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.595 -0.691 . . . . 0.0 110.326 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CD2' HD11 ' A' ' 147' ' ' LEU . 21.3 m-85 -77.42 -39.95 45.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.656 -0.653 . . . . 0.0 112.692 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.641 ' CG1' HG22 ' A' ' 83' ' ' THR . 33.4 m -68.22 -41.87 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.826 -1.171 . . . . 0.0 110.801 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.517 ' O ' HG23 ' A' ' 92' ' ' VAL . 34.2 mttt -60.05 -33.7 72.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.487 -0.758 . . . . 0.0 110.187 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' A' ' 113' ' ' LEU . . . -58.75 -56.5 21.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.64 -0.663 . . . . 0.0 111.067 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' HD12 ' A' ' 106' ' ' LEU . 56.0 m-85 -77.34 -53.14 8.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 111.048 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -49.03 -42.71 39.2 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.497 -0.752 . . . . 0.0 112.436 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 88' ' ' LYS . 76.1 t -58.91 -39.26 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.861 -1.149 . . . . 0.0 109.611 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.03 -43.65 87.0 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.61 81.09 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.457 -0.777 . . . . 0.0 110.452 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -62.15 -37.38 84.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.606 -0.684 . . . . 0.0 110.868 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -89.94 17.06 7.18 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.259 -0.9 . . . . 0.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.3 t 37.69 37.44 0.12 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.6 p -63.78 -33.29 75.34 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.12 -0.988 . . . . 0.0 109.465 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 95.37 12.17 54.69 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.187 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' C ' HG13 ' A' ' 101' ' ' VAL . 81.3 mttt -132.19 153.41 50.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -1.191 . . . . 0.0 109.9 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.476 HG21 HD13 ' A' ' 106' ' ' LEU . 35.6 m -148.86 159.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.283 -0.886 . . . . 0.0 110.388 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.8 p -84.75 147.66 26.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.781 -0.575 . . . . 0.0 110.222 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.639 ' CG2' HD13 ' A' ' 137' ' ' ILE . 86.4 t -57.36 -39.42 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.366 -0.834 . . . . 0.0 110.238 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.42 -41.61 95.34 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.31 -39.79 28.04 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.579 -0.954 . . . . 0.0 110.216 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.689 HD12 ' CE1' ' A' ' 90' ' ' PHE . 28.7 tp -60.04 -49.0 79.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.75 -0.594 . . . . 0.0 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -66.77 -29.83 69.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.267 -0.896 . . . . 0.0 111.036 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -68.76 -48.85 62.68 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.659 -0.817 . . . . 0.0 111.078 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -38.57 77.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.368 -0.832 . . . . 0.0 110.667 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.585 HD23 ' HG2' ' A' ' 115' ' ' GLU . 6.3 tp -55.09 -44.2 74.65 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.4 m -61.49 -25.21 67.11 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.511 0.672 . . . . 0.0 110.081 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.39 -14.52 63.72 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.724 ' CD2' ' HB2' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -94.55 7.88 44.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.317 -1.108 . . . . 0.0 112.214 -177.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.63 32.5 4.78 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.585 ' HG2' HD23 ' A' ' 110' ' ' LEU . 3.5 tp10 -113.98 119.94 38.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.99 -0.712 . . . . 0.0 110.342 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -122.32 59.31 1.02 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.106 0.955 . . . . 0.0 109.579 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 90.3 mt -90.97 148.78 22.19 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 p -111.18 141.62 44.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.276 -0.89 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -40.09 -27.79 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 O-C-N 121.311 -0.868 . . . . 0.0 112.84 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.468 ' HB3' ' OE1' ' A' ' 121' ' ' GLU . . . -62.1 -52.56 63.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.294 -0.878 . . . . 0.0 109.16 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.468 ' OE1' ' HB3' ' A' ' 120' ' ' ALA . 1.3 mp0 -76.62 -42.92 40.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 58.5 t -59.99 -35.42 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.669 -0.644 . . . . 0.0 110.608 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.76 -38.09 89.81 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.294 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.01 -46.36 89.73 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.615 -0.678 . . . . 0.0 109.71 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.73 -50.02 74.1 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.559 0.695 . . . . 0.0 109.884 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.41 -18.98 43.64 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.772 -0.58 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -57.05 -21.96 35.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.471 -0.768 . . . . 0.0 111.161 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.23 -12.91 10.36 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.3 t -68.98 130.02 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.098 -1.237 . . . . 0.0 110.169 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 -99.15 103.64 15.55 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.437 0.637 . . . . 0.0 111.589 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -87.77 159.69 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -94.37 -177.05 4.13 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.273 -0.892 . . . . 0.0 111.491 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.8 p -69.58 -2.39 11.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.933 -0.479 . . . . 0.0 112.159 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -105.07 -6.26 20.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.948 -1.095 . . . . 0.0 110.225 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.83 23.23 60.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.451 ' C ' HD12 ' A' ' 137' ' ' ILE . 48.4 mt-10 -110.41 145.91 36.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.514 -0.992 . . . . 0.0 110.984 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.639 HD13 ' CG2' ' A' ' 103' ' ' VAL . 3.5 mp -131.55 170.09 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.442 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.6 t70 -95.24 116.91 29.38 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.477 -0.764 . . . . 0.0 109.85 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.62 ' O ' HD12 ' A' ' 143' ' ' ILE . 47.8 p90 -65.47 -39.83 92.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.56 -0.712 . . . . 0.0 111.751 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 7.2 mttt -64.56 -40.03 94.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.529 -0.732 . . . . 0.0 110.469 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -68.17 -43.94 77.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.779 -0.575 . . . . 0.0 111.225 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.607 ' O ' HG23 ' A' ' 146' ' ' VAL . 16.9 t80 -69.89 -28.67 65.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.523 -0.736 . . . . 0.0 110.357 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 139' ' ' TYR . 42.8 mt -76.15 -46.89 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.521 -0.737 . . . . 0.0 109.133 178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.6 -28.78 69.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.41 -0.806 . . . . 0.0 110.496 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -88.37 -12.0 44.59 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.252 -0.905 . . . . 0.0 110.861 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 142' ' ' PHE . 53.0 t -95.12 -38.15 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 143' ' ' ILE . 5.1 mp -55.93 -21.11 18.8 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.167 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -57.64 140.03 52.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.35 -0.844 . . . . 0.0 110.371 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.215 179.895 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 mttt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.885 0.85 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.01 159.77 17.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.905 -0.497 . . . . 0.0 110.381 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -108.81 161.62 14.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 110.895 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 87' ' ' VAL . 4.0 m -50.91 -31.35 17.31 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -50.97 -35.94 36.35 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.854 -0.529 . . . . 0.0 111.079 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.653 ' OD1' HD11 ' A' ' 113' ' ' LEU . 44.8 t0 -59.96 -50.61 73.08 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.62 -0.675 . . . . 0.0 109.834 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.651 ' CE1' HD23 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -76.53 -40.08 51.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.708 -0.62 . . . . 0.0 110.79 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 83' ' ' THR . 97.7 t -59.09 -53.3 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.272 -0.893 . . . . 0.0 110.344 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 92' ' ' VAL . 29.0 tttt -59.99 -34.24 73.05 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.681 -0.637 . . . . 0.0 110.402 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.94 -54.27 48.03 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 111.026 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE1' HD11 ' A' ' 143' ' ' ILE . 47.7 m-85 -77.63 -54.43 6.4 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.371 -0.83 . . . . 0.0 111.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -48.91 -39.56 26.52 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.503 -0.748 . . . . 0.0 112.922 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 88' ' ' LYS . 73.8 t -59.2 -37.69 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.852 -1.155 . . . . 0.0 109.652 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -69.44 -46.46 66.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -64.34 81.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.43 -0.794 . . . . 0.0 110.641 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -60.01 -39.34 85.46 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.5 -0.75 . . . . 0.0 110.577 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -91.61 20.7 5.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.314 -0.866 . . . . 0.0 110.899 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 p 38.36 37.95 0.2 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 p -64.06 -34.72 78.67 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.254 -0.979 . . . . 0.0 109.384 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 14.48 55.24 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 59.4 mttt -132.93 154.88 50.0 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.054 -1.263 . . . . 0.0 110.528 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.454 HG13 ' C ' ' A' ' 100' ' ' LYS . 34.0 m -150.08 159.98 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.402 -0.811 . . . . 0.0 109.783 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -81.98 144.57 30.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.426 -0.796 . . . . 0.0 110.007 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.4 p -56.75 -38.9 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.538 -0.726 . . . . 0.0 110.772 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.44 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.82 -41.32 97.6 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.53 -39.1 28.46 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.547 -0.972 . . . . 0.0 110.527 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.451 HD12 ' CG2' ' A' ' 101' ' ' VAL . 7.5 tt -60.08 -49.95 75.62 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.538 -0.726 . . . . 0.0 110.108 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -63.44 -29.61 70.87 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.517 -0.74 . . . . 0.0 110.313 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -68.32 -47.48 67.44 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -39.71 87.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.39 -0.819 . . . . 0.0 110.574 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.665 HD23 ' HG2' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -54.84 -44.82 74.28 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.8 m -60.83 -26.54 67.41 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.49 0.662 . . . . 0.0 109.966 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.06 -15.21 63.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.653 HD11 ' OD1' ' A' ' 85' ' ' ASP . 21.7 tp -95.65 8.08 44.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 112.399 -177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.91 33.48 4.34 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.665 ' HG2' HD23 ' A' ' 110' ' ' LEU . 4.6 tp10 -114.25 119.81 38.28 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 122.02 -0.694 . . . . 0.0 110.174 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -122.1 59.43 1.01 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.074 0.94 . . . . 0.0 109.612 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.53 HD11 ' OE2' ' A' ' 115' ' ' GLU . 61.5 mt -90.53 148.76 22.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 p -110.83 141.59 43.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 109.867 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -39.69 -28.89 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.35 -0.844 . . . . 0.0 112.62 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.73 -51.79 66.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.392 -0.818 . . . . 0.0 109.025 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -76.78 -43.12 38.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.581 -0.7 . . . . 0.0 110.549 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.0 t -59.97 -34.9 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.644 -0.66 . . . . 0.0 110.592 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -64.98 -36.82 85.64 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.138 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.76 -47.33 86.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.487 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.478 ' HA ' HD13 ' A' ' 125' ' ' LEU . 4.3 mm? -62.15 -46.63 88.15 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.69 0.757 . . . . 0.0 109.879 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.2 -19.52 63.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.907 -0.496 . . . . 0.0 111.278 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -56.74 -21.03 25.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 0.0 111.191 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.34 -11.95 11.37 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.36 130.48 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.091 -1.241 . . . . 0.0 110.211 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -101.82 104.17 14.92 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.409 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.541 HG12 ' CG1' ' A' ' 137' ' ' ILE . 19.9 m -87.96 161.0 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.22 -176.2 3.9 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.369 -0.832 . . . . 0.0 111.074 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -70.59 -0.92 9.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.834 -0.541 . . . . 0.0 111.901 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -107.73 -10.06 15.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.923 -1.111 . . . . 0.0 110.525 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.29 25.89 38.34 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.612 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.1 mt-10 -109.72 139.98 44.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.573 -0.957 . . . . 0.0 110.973 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.0 mp -130.64 140.98 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -68.88 110.77 4.55 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.813 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 43.8 p90 -62.76 -34.02 76.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.491 -0.755 . . . . 0.0 112.004 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.7 mtmt -69.31 -38.67 78.38 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.272 -0.893 . . . . 0.0 110.581 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.33 -45.01 70.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.744 -0.597 . . . . 0.0 111.587 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.613 ' O ' HG23 ' A' ' 146' ' ' VAL . 22.0 t80 -70.56 -28.8 65.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.449 -0.782 . . . . 0.0 110.645 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.548 HD13 ' CD1' ' A' ' 86' ' ' PHE . 85.5 mt -79.28 -47.95 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.509 -0.744 . . . . 0.0 109.646 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -60.41 -26.5 66.74 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.499 -0.75 . . . . 0.0 110.22 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.0 -13.29 39.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.373 -0.829 . . . . 0.0 110.656 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 142' ' ' PHE . 59.0 t -96.23 -43.22 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 143' ' ' ILE . 70.2 mt -59.06 -18.21 32.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.795 -0.565 . . . . 0.0 111.546 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 48.0 mmt-85 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.346 -0.846 . . . . 0.0 110.12 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 91.9 mttt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.749 0.785 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.06 159.92 16.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.866 -0.521 . . . . 0.0 110.108 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -110.03 160.02 16.8 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.878 0.847 . . . . 0.0 111.188 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.711 HG22 ' CG2' ' A' ' 87' ' ' VAL . 4.4 m -50.58 -30.95 14.44 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.706 0.765 . . . . 0.0 109.738 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -51.1 -36.45 40.42 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.752 -0.592 . . . . 0.0 111.322 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -65.44 -44.97 85.63 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.603 -0.686 . . . . 0.0 109.711 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.672 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER -76.63 -41.12 47.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.734 -0.604 . . . . 0.0 111.131 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.711 ' CG2' HG22 ' A' ' 83' ' ' THR . 67.5 t -63.7 -52.83 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.345 -0.847 . . . . 0.0 111.011 -178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.674 ' O ' HG13 ' A' ' 92' ' ' VAL . 61.3 tttt -55.73 -32.21 63.18 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.535 -0.728 . . . . 0.0 111.538 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HB3' HD11 ' A' ' 113' ' ' LEU . . . -68.22 -39.94 82.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.581 -0.699 . . . . 0.0 112.344 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' A' ' 143' ' ' ILE . 26.6 m-85 -80.11 -58.0 3.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.043 -1.036 . . . . 0.0 110.959 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.613 ' OE1' HG12 ' A' ' 87' ' ' VAL . 20.0 pt20 -48.52 -32.76 8.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 88' ' ' LYS . 29.0 m -61.55 -31.38 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 120.804 -1.185 . . . . 0.0 109.716 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.35 -49.0 29.68 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.71 80.15 0.07 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.292 -0.88 . . . . 0.0 110.503 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -62.29 -34.5 76.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.518 -0.739 . . . . 0.0 110.647 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.37 18.51 8.29 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.233 -0.917 . . . . 0.0 110.657 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.1 m 37.83 35.27 0.07 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.3 p -63.95 -33.74 76.4 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.198 -0.939 . . . . 0.0 109.316 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.32 12.08 58.99 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' C ' HG13 ' A' ' 101' ' ' VAL . 21.6 mmtt -131.72 153.65 49.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.19 -1.182 . . . . 0.0 109.933 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.522 ' CG2' HD12 ' A' ' 106' ' ' LEU . 31.9 m -149.98 159.76 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.308 -0.87 . . . . 0.0 110.018 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -80.77 144.85 31.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.632 -0.668 . . . . 0.0 109.887 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.7 p -56.09 -38.96 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.455 -0.778 . . . . 0.0 110.699 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.99 -40.68 97.29 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.044 -1.223 . . . . 0.0 110.044 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.29 -42.25 23.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.545 -0.974 . . . . 0.0 110.574 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.522 HD12 ' CG2' ' A' ' 101' ' ' VAL . 9.8 tt -60.04 -49.91 75.81 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.633 -0.667 . . . . 0.0 109.979 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -64.45 -33.06 75.0 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.537 -0.727 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -66.24 -48.03 71.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.946 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -25.74 59.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.489 -0.757 . . . . 0.0 110.68 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 115' ' ' GLU . 29.8 tp -60.02 -45.19 93.61 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.8 p -66.14 -16.73 64.21 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.301 0.572 . . . . 0.0 110.695 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.65 -14.42 65.51 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.57 7.45 45.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.416 -1.05 . . . . 0.0 112.102 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.59 32.99 4.61 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 12.4 mm-40 -114.73 120.98 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.897 -0.766 . . . . 0.0 110.851 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -122.19 59.94 1.0 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.088 0.947 . . . . 0.0 109.297 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.73 149.08 21.79 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.9 m -110.87 142.84 42.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -39.83 -27.8 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.814 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.85 -52.72 62.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.228 -0.92 . . . . 0.0 108.932 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -76.7 -43.3 38.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.588 -0.695 . . . . 0.0 110.425 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.99 -35.64 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.562 -0.711 . . . . 0.0 110.456 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.05 -39.1 93.72 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.24 -0.912 . . . . 0.0 109.171 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.07 -47.82 84.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.437 -0.789 . . . . 0.0 109.641 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.32 -48.4 81.89 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.984 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 35.1 mt -60.62 -18.14 51.39 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.799 -0.563 . . . . 0.0 111.191 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.56 -21.47 26.8 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.41 -0.806 . . . . 0.0 110.997 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.23 25.77 8.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 65.8 t -107.67 129.84 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -1.103 . . . . 0.0 109.855 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -102.59 103.03 13.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.751 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.64 HG12 ' CG1' ' A' ' 137' ' ' ILE . 20.1 m -86.05 161.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -95.28 -177.08 3.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -0.838 . . . . 0.0 111.281 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.7 p -70.23 -0.8 8.6 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.907 -0.496 . . . . 0.0 112.01 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -107.5 -9.08 16.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.94 -1.1 . . . . 0.0 110.365 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.59 28.41 29.72 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.617 ' C ' HD12 ' A' ' 137' ' ' ILE . 95.9 mt-10 -110.48 139.27 45.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.576 -0.955 . . . . 0.0 110.969 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.64 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.6 mp -127.63 143.37 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -69.3 115.23 8.33 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.037 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.488 ' O ' HD12 ' A' ' 143' ' ' ILE . 10.7 p90 -67.2 -35.26 79.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.723 -0.611 . . . . 0.0 111.769 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 25.3 mttt -70.98 -39.98 72.17 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.352 -0.842 . . . . 0.0 111.032 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.15 -44.57 83.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.674 -0.641 . . . . 0.0 111.705 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.497 ' O ' HG23 ' A' ' 146' ' ' VAL . 23.1 t80 -70.02 -28.0 65.14 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.491 -0.756 . . . . 0.0 110.42 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 139' ' ' TYR . 96.3 mt -79.57 -48.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.382 -0.824 . . . . 0.0 110.133 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -59.99 -27.74 67.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.486 -0.759 . . . . 0.0 110.278 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.4 -16.1 31.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 110.64 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 142' ' ' PHE . 54.1 t -97.52 -48.07 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.128 -0.983 . . . . 0.0 108.87 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -24.62 67.59 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.7 -0.625 . . . . 0.0 111.222 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -55.04 -48.05 73.94 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.486 -0.759 . . . . 0.0 110.597 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.274 -179.9 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.64 0.733 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.43 160.65 18.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.891 -0.505 . . . . 0.0 110.362 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.47 160.28 15.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -0.87 . . . . 0.0 110.973 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.742 HG22 ' CG2' ' A' ' 87' ' ' VAL . 7.4 m -51.18 -30.58 17.34 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.702 0.763 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -52.46 -37.07 56.18 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.841 -0.537 . . . . 0.0 111.28 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -61.05 -50.06 74.85 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.573 -0.704 . . . . 0.0 109.919 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.663 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.5 m-85 -75.97 -38.87 57.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.771 -0.581 . . . . 0.0 111.264 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.742 ' CG2' HG22 ' A' ' 83' ' ' THR . 76.4 t -64.17 -50.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.213 -0.929 . . . . 0.0 110.678 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -59.95 -34.17 72.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.547 -0.721 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.592 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -67.39 -44.28 79.25 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.664 -0.648 . . . . 0.0 111.736 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.524 ' CE2' HD11 ' A' ' 143' ' ' ILE . 8.9 m-85 -78.49 -58.91 3.01 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.093 -1.005 . . . . 0.0 111.654 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -48.35 -28.97 3.5 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -62.13 -32.68 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.999 -1.063 . . . . 0.0 109.848 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -71.53 -50.87 27.07 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -89.33 81.35 6.66 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.377 -0.827 . . . . 0.0 109.589 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -63.1 -17.16 62.0 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.715 -0.616 . . . . 0.0 111.047 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -88.83 16.11 7.36 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.05 -1.031 . . . . 0.0 110.945 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.4 p 39.1 35.84 0.15 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 100' ' ' LYS . 3.4 t -63.11 -33.99 76.65 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.097 -1.002 . . . . 0.0 109.588 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.52 9.66 58.72 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.014 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.637 ' H ' HG23 ' A' ' 98' ' ' THR . 1.5 mptt -132.16 154.94 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.093 -1.239 . . . . 0.0 110.382 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 106' ' ' LEU . 28.8 m -151.04 160.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.371 -0.831 . . . . 0.0 109.914 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -82.04 144.86 30.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.574 -0.704 . . . . 0.0 109.956 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 11.5 p -57.07 -40.0 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.493 -0.755 . . . . 0.0 110.836 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.33 -41.4 96.89 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -80.14 -39.84 28.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.579 -0.954 . . . . 0.0 110.282 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.582 HD12 HG21 ' A' ' 101' ' ' VAL . 5.8 tt -59.94 -49.73 76.53 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.67 -0.644 . . . . 0.0 110.102 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -64.46 -30.26 71.3 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.697 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -67.89 -48.01 67.24 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.591 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.26 -41.0 97.13 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.11 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.623 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.5 tp -55.78 -44.77 78.04 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 50.9 m -60.12 -30.61 69.39 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.616 0.722 . . . . 0.0 109.704 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.52 -14.65 63.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.663 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -95.42 7.09 47.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.327 -1.102 . . . . 0.0 112.762 -177.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.01 31.79 4.94 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.623 ' HG2' HD23 ' A' ' 110' ' ' LEU . 12.0 tp10 -113.75 119.97 39.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.925 -0.75 . . . . 0.0 109.992 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -121.96 59.22 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.002 0.906 . . . . 0.0 109.598 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 75.5 mt -90.85 148.58 22.4 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -111.17 141.36 44.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.295 -0.878 . . . . 0.0 110.156 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -39.9 -28.27 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 O-C-N 121.353 -0.842 . . . . 0.0 112.726 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.9 -53.0 61.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.434 -0.791 . . . . 0.0 109.0 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -76.71 -42.94 39.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.692 -0.63 . . . . 0.0 110.384 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 126' ' ' LEU . 57.5 t -60.02 -35.25 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.587 -0.695 . . . . 0.0 110.466 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.01 -39.44 94.78 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.255 -0.903 . . . . 0.0 109.004 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.09 -49.38 77.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.624 -0.673 . . . . 0.0 109.537 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.19 -49.97 75.51 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.571 0.7 . . . . 0.0 110.231 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.745 ' O ' HG12 ' A' ' 129' ' ' VAL . 63.2 mt -61.96 -17.22 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.915 -0.491 . . . . 0.0 111.333 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -57.47 -16.77 10.48 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.306 -0.871 . . . . 0.0 111.895 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.12 -11.06 11.22 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.051 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.745 HG12 ' O ' ' A' ' 126' ' ' LEU . 8.8 p -69.51 133.95 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.94 -1.329 . . . . 0.0 110.854 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -103.3 102.48 12.44 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.393 0.616 . . . . 0.0 111.093 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.691 HG12 ' CG1' ' A' ' 137' ' ' ILE . 21.5 m -86.38 160.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -94.91 -176.39 3.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.473 -0.767 . . . . 0.0 111.114 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.3 p -69.95 -0.99 8.37 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.866 -0.521 . . . . 0.0 112.055 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -107.28 -7.74 16.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.949 -1.095 . . . . 0.0 110.438 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.08 27.2 38.02 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.649 ' C ' HD12 ' A' ' 137' ' ' ILE . 88.4 mt-10 -108.62 140.07 42.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.598 -0.942 . . . . 0.0 111.125 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.691 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.4 mp -128.42 169.02 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 137' ' ' ILE . 47.0 t0 -96.98 114.05 25.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.368 -0.833 . . . . 0.0 110.134 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.488 ' HA ' HD11 ' A' ' 106' ' ' LEU . 47.6 p90 -66.12 -35.42 80.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.558 -0.714 . . . . 0.0 111.643 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 8.3 mttt -69.22 -37.05 77.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.308 -0.87 . . . . 0.0 110.661 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -70.06 -44.12 69.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.602 -0.687 . . . . 0.0 111.62 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 146' ' ' VAL . 25.3 t80 -70.36 -28.59 65.24 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.512 -0.743 . . . . 0.0 110.61 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.524 HD11 ' CE2' ' A' ' 90' ' ' PHE . 97.6 mt -76.46 -45.78 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.508 -0.745 . . . . 0.0 109.518 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.72 -26.74 65.88 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.262 -0.899 . . . . 0.0 109.738 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -88.97 -11.64 43.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.389 -0.82 . . . . 0.0 110.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 142' ' ' PHE . 62.3 t -96.01 -42.08 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 143' ' ' ILE . 15.2 mt -55.49 -20.35 12.54 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.895 -0.503 . . . . 0.0 111.395 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 72.6 mtp85 -58.91 -40.05 83.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.318 -0.864 . . . . 0.0 110.236 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.127 179.777 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.7 mttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.693 0.759 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.28 161.4 13.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.896 -0.502 . . . . 0.0 109.95 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 164.06 13.55 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.104 0.954 . . . . 0.0 111.225 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.724 HG22 ' CG2' ' A' ' 87' ' ' VAL . 3.5 m -50.23 -30.37 11.5 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.396 0.617 . . . . 0.0 110.215 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -53.17 -36.86 61.35 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.719 -0.613 . . . . 0.0 111.165 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.49 -50.88 71.81 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.53 -0.731 . . . . 0.0 109.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.805 ' CD2' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -76.44 -39.62 52.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 0.0 111.086 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.724 ' CG2' HG22 ' A' ' 83' ' ' THR . 97.5 t -59.98 -47.82 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.166 -0.959 . . . . 0.0 109.901 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 92' ' ' VAL . 16.1 tttp -59.42 -31.95 69.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.713 -0.617 . . . . 0.0 110.368 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' CB ' HD13 ' A' ' 113' ' ' LEU . . . -61.93 -59.33 5.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.528 -0.732 . . . . 0.0 112.016 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -77.12 -54.3 6.7 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.132 -0.98 . . . . 0.0 112.342 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.461 ' NE2' HG13 ' A' ' 87' ' ' VAL . 35.9 mt-30 -47.97 -37.87 15.56 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.365 -0.834 . . . . 0.0 113.163 -176.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 88' ' ' LYS . 27.7 m -60.1 -31.35 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.71 -1.244 . . . . 0.0 109.752 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -70.0 -45.46 67.22 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -63.25 81.27 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.458 -0.777 . . . . 0.0 110.892 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -62.81 -40.06 96.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.672 -0.643 . . . . 0.0 110.94 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -91.0 17.0 8.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.256 -0.902 . . . . 0.0 111.066 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 67.6 m 38.05 35.58 0.09 Allowed 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 75.8 p -63.73 -33.99 76.89 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.13 -0.981 . . . . 0.0 109.428 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.78 9.97 53.57 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.366 -0.921 . . . . 0.0 110.951 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' C ' HG13 ' A' ' 101' ' ' VAL . 23.4 mttp -132.86 154.98 49.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.068 -1.254 . . . . 0.0 110.349 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.563 ' CG2' HD12 ' A' ' 106' ' ' LEU . 35.1 m -150.16 160.08 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.028 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.5 p -82.72 145.64 29.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.515 -0.741 . . . . 0.0 110.077 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.6 p -56.95 -39.66 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.475 -0.766 . . . . 0.0 110.649 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.41 -41.11 96.87 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -80.41 -43.3 21.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.534 -0.98 . . . . 0.0 110.506 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.563 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.1 tt -59.97 -50.02 75.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.641 -0.662 . . . . 0.0 109.951 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -63.57 -31.88 73.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.569 -0.707 . . . . 0.0 110.353 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -66.06 -47.87 72.9 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.088 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.19 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.576 -0.849 . . . . 0.0 109.904 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.518 HD23 ' HG2' ' A' ' 115' ' ' GLU . 9.9 tp -56.2 -44.68 79.71 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.9 m -60.83 -31.39 70.82 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.577 0.704 . . . . 0.0 109.529 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.15 -13.87 67.86 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 86' ' ' PHE . 29.1 tp -95.09 8.44 42.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -1.086 . . . . 0.0 112.123 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.44 33.6 4.15 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.547 ' OE2' HD11 ' A' ' 117' ' ' LEU . 17.8 tp10 -114.91 120.4 39.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.952 -0.734 . . . . 0.0 110.769 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -122.27 59.67 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.063 0.935 . . . . 0.0 109.208 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.547 HD11 ' OE2' ' A' ' 115' ' ' GLU . 88.2 mt -92.0 149.74 21.37 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.3 m -110.86 144.14 40.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -40.11 -27.3 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.195 -0.941 . . . . 0.0 112.973 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.61 -52.1 64.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.33 -0.856 . . . . 0.0 109.279 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.35 -46.06 29.22 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 0.0 110.984 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 48.1 t -58.15 -33.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.352 -0.843 . . . . 0.0 110.513 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.85 -36.85 85.67 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -0.928 . . . . 0.0 109.001 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.75 -48.02 81.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.727 -0.608 . . . . 0.0 109.729 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 125' ' ' LEU . 11.0 mp -63.39 -28.36 69.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.544 -0.722 . . . . 0.0 110.884 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.1 mt -79.67 -15.78 56.95 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.656 -0.653 . . . . 0.0 112.12 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -18.74 20.94 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.259 -0.9 . . . . 0.0 111.654 -177.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.55 -11.63 11.43 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.237 -0.982 . . . . 0.0 110.665 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.92 129.51 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.083 -1.245 . . . . 0.0 109.936 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -106.03 105.7 15.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.346 0.593 . . . . 0.0 111.623 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.697 HG12 ' CG1' ' A' ' 137' ' ' ILE . 19.7 m -88.86 161.52 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -93.12 -171.89 2.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 111.29 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -0.96 15.02 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -108.57 -11.14 15.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.015 -1.053 . . . . 0.0 110.453 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.19 28.42 28.08 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.61 ' C ' HD12 ' A' ' 137' ' ' ILE . 48.8 mt-10 -109.08 138.04 46.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.909 . . . . 0.0 110.999 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.697 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.9 mp -129.25 140.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -69.54 108.61 3.88 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.816 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.461 ' CE1' ' HG3' ' A' ' 140' ' ' LYS . 50.7 p90 -60.57 -29.47 69.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.432 -0.793 . . . . 0.0 111.871 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' HG3' ' CE1' ' A' ' 139' ' ' TYR . 61.2 mttt -69.01 -39.99 78.95 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.222 -0.924 . . . . 0.0 110.598 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.87 -43.87 82.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.801 -0.562 . . . . 0.0 111.502 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 146' ' ' VAL . 14.6 t80 -70.46 -27.72 64.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.442 -0.786 . . . . 0.0 110.256 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.805 HD12 ' CD2' ' A' ' 86' ' ' PHE . 23.5 mm -80.29 -50.38 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.49 -0.756 . . . . 0.0 109.691 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.59 -28.72 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.49 -0.756 . . . . 0.0 110.755 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.69 -13.72 39.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.207 -0.933 . . . . 0.0 110.966 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 142' ' ' PHE . 43.1 t -95.97 -38.21 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 143' ' ' ILE . 3.3 mt -57.87 -19.24 27.88 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.468 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -59.84 139.93 56.97 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.302 -0.874 . . . . 0.0 110.237 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.2 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.4 tttt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.757 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.18 161.2 17.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.96 -0.463 . . . . 0.0 110.26 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -113.25 163.17 15.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.421 -0.799 . . . . 0.0 111.007 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.8 m -51.2 -31.29 19.85 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.485 0.66 . . . . 0.0 110.211 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -53.55 -38.68 64.08 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.648 -0.658 . . . . 0.0 111.111 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -65.52 -45.07 84.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.68 . . . . 0.0 109.571 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.582 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.63 -36.6 62.91 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.819 -0.551 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 83' ' ' THR . 84.1 t -70.9 -43.14 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.156 -0.965 . . . . 0.0 110.64 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -58.68 -35.84 73.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.415 -0.803 . . . . 0.0 111.455 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.446 ' O ' HG12 ' A' ' 92' ' ' VAL . . . -64.92 -49.75 69.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 111.989 -178.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -79.19 -57.73 3.58 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.021 -1.049 . . . . 0.0 111.681 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -48.9 -37.26 19.26 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.464 -0.773 . . . . 0.0 112.826 -176.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -58.05 -37.73 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.156 -0.965 . . . . 0.0 109.988 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' N ' HG13 ' A' ' 92' ' ' VAL . 59.4 t80 -66.1 -42.03 89.81 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 81.77 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.481 -0.762 . . . . 0.0 111.069 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -65.75 -24.99 67.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.563 -0.711 . . . . 0.0 110.479 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -106.15 15.69 25.97 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.373 -0.829 . . . . 0.0 110.661 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.7 t 38.2 63.06 0.88 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -91.65 -33.66 14.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 109.485 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.76 10.9 58.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.88 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' C ' HG13 ' A' ' 101' ' ' VAL . 43.2 mttp -132.27 154.49 49.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.13 -1.218 . . . . 0.0 110.071 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.598 HG21 HD13 ' A' ' 106' ' ' LEU . 30.9 m -150.36 160.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.321 -0.862 . . . . 0.0 110.228 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 p -82.35 145.95 29.64 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.652 -0.655 . . . . 0.0 109.974 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 104' ' ' GLY . 10.1 p -56.43 -39.67 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.461 -0.775 . . . . 0.0 110.629 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.463 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.9 -40.8 97.32 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.0 -40.31 28.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.537 -0.978 . . . . 0.0 110.392 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.598 HD13 HG21 ' A' ' 101' ' ' VAL . 13.1 tp -59.95 -49.79 76.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.584 -0.697 . . . . 0.0 109.934 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -63.87 -32.28 73.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 110.375 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -67.77 -47.51 68.97 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.192 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -30.55 63.07 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.825 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 tp -60.06 -42.04 93.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.862 . . . . 0.0 109.068 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.7 p -68.03 -18.81 64.8 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.49 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.46 -14.72 63.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -93.1 7.15 45.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.381 -1.07 . . . . 0.0 112.362 -177.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.1 32.82 4.51 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.92 120.68 40.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 122.03 -0.688 . . . . 0.0 110.131 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -122.1 59.64 1.0 Allowed 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.137 0.97 . . . . 0.0 109.815 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HB3' ' CG2' ' A' ' 122' ' ' VAL . 79.9 mt -91.05 148.91 22.06 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.4 m -110.87 142.55 42.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.908 . . . . 0.0 110.086 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 122' ' ' VAL . 32.7 t0 -39.4 -29.73 0.05 Allowed 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.402 -0.811 . . . . 0.0 112.406 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.79 -52.6 62.53 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -76.67 -41.93 43.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.63 -0.669 . . . . 0.0 110.227 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 117' ' ' LEU . 82.7 t -60.06 -34.44 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.599 -0.688 . . . . 0.0 110.312 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -65.31 -36.62 84.61 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.221 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.76 -48.85 77.4 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.462 -0.774 . . . . 0.0 109.37 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 125' ' ' LEU . 3.5 mm? -61.22 -47.14 87.45 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.615 0.721 . . . . 0.0 109.905 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.9 ' O ' HG12 ' A' ' 129' ' ' VAL . 33.0 mt -60.33 -17.28 41.9 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.842 -0.536 . . . . 0.0 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -56.39 -20.36 19.11 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.243 -0.911 . . . . 0.0 111.093 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.73 27.92 7.31 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.063 -1.065 . . . . 0.0 110.6 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 126' ' ' LEU . 10.9 p -107.23 128.72 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.132 -1.216 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -103.52 105.29 15.5 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.332 0.587 . . . . 0.0 111.575 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.683 HG12 ' CG1' ' A' ' 137' ' ' ILE . 21.2 m -89.43 161.26 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -92.26 -176.51 4.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.419 -0.801 . . . . 0.0 111.064 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.1 m -69.7 -1.61 9.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.798 -0.564 . . . . 0.0 111.973 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -107.71 -8.4 16.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.936 -1.102 . . . . 0.0 110.655 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.83 38.41 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 137' ' ' ILE . 66.0 mt-10 -109.06 139.84 43.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.964 . . . . 0.0 110.906 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.683 ' CG1' HG12 ' A' ' 131' ' ' VAL . 4.9 mp -130.03 168.81 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.47 ' N ' HG22 ' A' ' 137' ' ' ILE . 42.0 t0 -96.54 112.84 24.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.413 -0.805 . . . . 0.0 109.719 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 143' ' ' ILE . 42.8 p90 -62.78 -22.32 66.5 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.543 -0.723 . . . . 0.0 111.857 -178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' CG ' ' CE2' ' A' ' 139' ' ' TYR . 46.6 mtpt -83.18 -32.85 26.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.142 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.21 -46.85 66.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.662 -0.649 . . . . 0.0 111.604 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.623 ' O ' HG23 ' A' ' 146' ' ' VAL . 38.4 t80 -70.02 -28.6 65.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.542 -0.724 . . . . 0.0 111.572 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 139' ' ' TYR . 36.3 pt -79.13 -42.67 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.065 -1.022 . . . . 0.0 110.891 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.463 ' N ' HG13 ' A' ' 143' ' ' ILE . 63.9 mt-10 -65.09 -26.46 68.23 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.209 -0.932 . . . . 0.0 110.608 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -88.1 -12.46 44.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.325 -0.86 . . . . 0.0 110.646 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 142' ' ' PHE . 88.2 t -96.11 -41.1 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mp -59.24 -18.3 35.79 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.881 -0.512 . . . . 0.0 111.543 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -60.03 -39.98 87.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.37 -0.831 . . . . 0.0 110.224 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.213 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.753 0.787 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.39 159.45 20.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.93 -0.481 . . . . 0.0 110.354 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 mmtm -107.75 160.2 15.91 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.878 0.847 . . . . 0.0 110.992 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.731 ' O ' HG23 ' A' ' 87' ' ' VAL . 4.4 m -50.83 -30.6 14.75 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.666 0.746 . . . . 0.0 109.522 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -52.28 -37.49 55.74 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.839 -0.538 . . . . 0.0 111.209 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -61.26 -49.29 77.66 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.8 m-85 -76.02 -39.97 54.5 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.765 -0.584 . . . . 0.0 111.047 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 83' ' ' THR . 76.3 t -60.5 -51.29 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 110.272 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -58.49 -32.7 69.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.642 -0.661 . . . . 0.0 110.547 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.657 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -63.48 -55.35 24.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.788 -0.57 . . . . 0.0 111.725 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.505 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 47.6 m-85 -78.74 -56.76 4.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.098 -1.001 . . . . 0.0 111.737 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -48.67 -37.84 19.57 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.561 -0.712 . . . . 0.0 112.819 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 89' ' ' ALA . 9.1 p -57.86 -36.84 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.066 -1.021 . . . . 0.0 109.924 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.4 ' N ' HG13 ' A' ' 92' ' ' VAL . 53.5 t80 -67.67 -43.41 80.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.5 81.05 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.483 -0.76 . . . . 0.0 110.761 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -61.17 -39.78 91.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 0.0 110.621 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.41 20.1 6.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.257 -0.902 . . . . 0.0 110.829 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t 38.15 36.51 0.12 Allowed 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 42.1 p -63.83 -34.66 78.43 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.66 12.53 58.04 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.456 ' C ' HG13 ' A' ' 101' ' ' VAL . 84.1 mttt -132.42 154.68 49.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.036 -1.273 . . . . 0.0 110.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.562 ' CG2' HD12 ' A' ' 106' ' ' LEU . 26.8 m -151.07 160.16 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.365 -0.835 . . . . 0.0 109.896 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.1 p -80.5 144.06 32.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.567 ' HB ' HD13 ' A' ' 137' ' ' ILE . 10.2 p -57.21 -40.07 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 0.0 110.883 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.21 -41.25 96.63 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -80.45 -39.24 28.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.528 -0.984 . . . . 0.0 110.4 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.562 HD12 ' CG2' ' A' ' 101' ' ' VAL . 10.2 tt -60.05 -49.97 75.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.715 -0.616 . . . . 0.0 110.121 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -63.21 -28.95 70.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.436 -0.79 . . . . 0.0 110.605 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.51 -47.84 68.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.366 -0.833 . . . . 0.0 110.619 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -40.75 96.12 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.319 -0.863 . . . . 0.0 110.297 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.698 HD11 HD11 ' A' ' 143' ' ' ILE . 3.4 tp -55.85 -44.59 78.18 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.5 m -60.35 -30.1 69.33 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.557 0.694 . . . . 0.0 109.65 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.13 -14.21 64.79 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.657 HD11 ' CB ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -95.12 7.38 46.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.299 -1.118 . . . . 0.0 112.552 -177.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.58 31.89 5.03 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.62 ' OE2' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -113.82 120.32 40.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.988 -0.713 . . . . 0.0 110.249 178.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -122.45 59.74 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.042 0.925 . . . . 0.0 109.498 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.541 HD12 ' CD ' ' A' ' 115' ' ' GLU . 89.9 mt -90.92 148.65 22.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.4 m -111.09 141.84 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.331 -0.855 . . . . 0.0 110.011 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -39.87 -28.29 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 O-C-N 121.283 -0.886 . . . . 0.0 112.685 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.43 -52.84 62.91 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.37 -0.831 . . . . 0.0 109.059 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -77.01 -42.2 39.6 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.628 -0.67 . . . . 0.0 110.431 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.34 -36.36 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.602 -0.686 . . . . 0.0 110.295 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -63.19 -39.92 96.04 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.314 -0.866 . . . . 0.0 109.18 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -60.06 -47.51 85.57 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.63 -0.669 . . . . 0.0 109.839 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.94 -40.03 96.4 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.614 0.721 . . . . 0.0 110.669 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.698 ' O ' HG12 ' A' ' 129' ' ' VAL . 68.7 mt -67.84 -15.97 63.87 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.779 -0.575 . . . . 0.0 111.856 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -57.55 -17.02 11.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.197 -0.939 . . . . 0.0 111.877 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -114.65 -10.93 12.07 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.221 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 126' ' ' LEU . 8.7 p -70.65 132.36 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.953 -1.321 . . . . 0.0 110.522 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -101.48 100.06 10.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.367 0.603 . . . . 0.0 111.363 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.423 ' H ' HG12 ' A' ' 131' ' ' VAL . 7.8 p -83.82 159.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -95.88 -179.51 4.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.415 -0.803 . . . . 0.0 111.502 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.2 m -70.41 -1.49 10.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.849 -0.532 . . . . 0.0 112.13 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -107.83 -11.49 15.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.863 -1.148 . . . . 0.0 110.411 178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.02 29.05 16.17 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.437 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.7 mt-10 -110.43 135.7 50.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.649 -0.912 . . . . 0.0 111.328 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.567 HD13 ' HB ' ' A' ' 103' ' ' VAL . 4.0 mp -126.35 169.0 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.456 ' N ' HG22 ' A' ' 137' ' ' ILE . 10.7 t70 -97.83 114.75 26.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.44 -0.787 . . . . 0.0 110.468 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.56 ' HB3' HG21 ' A' ' 101' ' ' VAL . 46.6 p90 -68.32 -36.22 78.96 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.511 -0.743 . . . . 0.0 111.676 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 3.5 mttt -68.51 -40.0 81.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.294 -0.879 . . . . 0.0 110.798 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -67.3 -43.26 82.15 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.694 -0.629 . . . . 0.0 111.299 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.605 ' O ' HG23 ' A' ' 146' ' ' VAL . 20.2 t80 -70.74 -27.76 64.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.494 -0.753 . . . . 0.0 110.46 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.698 HD11 HD11 ' A' ' 110' ' ' LEU . 20.3 mm -78.5 -49.59 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.477 -0.764 . . . . 0.0 109.585 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -60.04 -27.51 66.99 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.462 -0.774 . . . . 0.0 110.384 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.06 -12.3 44.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.872 . . . . 0.0 110.502 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 142' ' ' PHE . 56.1 t -96.24 -39.14 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.544 HD12 HG22 ' A' ' 143' ' ' ILE . 13.4 mt -59.24 -22.43 61.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.912 -0.492 . . . . 0.0 111.204 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.4 mmt85 -57.92 141.99 47.62 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.464 -0.772 . . . . 0.0 110.46 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 118.02 -0.991 . . . . 0.0 110.152 179.916 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.774 0.797 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.02 159.56 17.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.882 -0.511 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -109.51 159.55 16.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.813 0.816 . . . . 0.0 111.009 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 87' ' ' VAL . 5.6 m -50.97 -30.81 16.0 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.666 0.746 . . . . 0.0 109.586 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -50.73 -36.89 38.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.851 -0.53 . . . . 0.0 111.274 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -57.64 -54.11 50.57 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.559 -0.713 . . . . 0.0 110.184 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.645 ' HB3' HD12 ' A' ' 143' ' ' ILE . 5.8 m-85 -76.59 -38.51 54.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.606 -0.684 . . . . 0.0 111.141 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 83' ' ' THR . 98.9 t -57.12 -51.55 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.113 -0.992 . . . . 0.0 110.328 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 92' ' ' VAL . 29.4 tttm -60.07 -32.13 70.65 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.687 -0.633 . . . . 0.0 110.255 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 86' ' ' PHE . . . -60.21 -56.56 20.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.643 -0.66 . . . . 0.0 111.805 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -77.02 -53.54 7.68 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.307 -0.871 . . . . 0.0 111.813 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -48.58 -40.24 26.63 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.424 -0.798 . . . . 0.0 112.759 -176.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 88' ' ' LYS . 74.7 t -59.8 -37.93 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 120.773 -1.205 . . . . 0.0 109.663 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -68.97 -45.97 69.29 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -62.12 82.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.431 -0.793 . . . . 0.0 110.937 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -62.57 -41.24 98.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -91.64 18.88 6.9 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.278 -0.889 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 52.1 p 38.48 37.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.3 p -63.72 -34.99 79.1 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.089 -1.007 . . . . 0.0 109.311 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.86 12.75 55.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.007 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' C ' HG13 ' A' ' 101' ' ' VAL . 27.7 mmtp -132.63 154.84 49.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.133 -1.216 . . . . 0.0 110.501 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 100' ' ' LYS . 32.2 m -150.72 160.4 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.389 -0.82 . . . . 0.0 109.855 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 p -83.21 145.55 29.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.548 -0.72 . . . . 0.0 110.081 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.5 p -56.96 -39.21 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.471 -0.768 . . . . 0.0 110.715 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.18 -41.04 96.48 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -80.53 -39.96 26.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.616 -0.932 . . . . 0.0 110.394 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.7 tt -59.9 -50.01 75.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.698 -0.626 . . . . 0.0 110.145 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -64.89 -29.57 70.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.457 -0.777 . . . . 0.0 110.551 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -69.0 -47.97 64.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.437 -0.789 . . . . 0.0 110.773 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -39.62 88.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.321 -0.862 . . . . 0.0 110.445 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.729 HD23 ' HG2' ' A' ' 115' ' ' GLU . 2.6 tp -55.36 -44.76 76.31 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.5 m -59.99 -27.87 67.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.546 0.688 . . . . 0.0 110.051 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.09 -14.62 64.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.55 8.3 42.7 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.33 -1.1 . . . . 0.0 112.287 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 33.01 4.52 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.729 ' HG2' HD23 ' A' ' 110' ' ' LEU . 6.0 tp10 -114.03 119.85 38.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.982 -0.716 . . . . 0.0 110.298 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -121.98 59.28 1.0 Allowed 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.198 0.999 . . . . 0.0 109.236 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.5 mt -90.11 148.7 22.85 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 m -111.05 143.9 41.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.422 -0.799 . . . . 0.0 109.252 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -40.33 -27.03 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.199 -0.938 . . . . 0.0 112.817 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.74 -51.9 55.5 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 124' ' ' GLU . 18.3 mp0 -75.15 -28.48 60.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.455 -0.778 . . . . 0.0 110.592 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.69 -33.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.819 . . . . 0.0 110.348 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -65.83 -45.12 83.44 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.182 -0.949 . . . . 0.0 110.252 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 121' ' ' GLU . 11.2 pt-20 -56.63 -42.39 78.77 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.168 -0.958 . . . . 0.0 109.83 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.417 ' N ' ' HG3' ' A' ' 124' ' ' GLU . 91.8 mt -64.05 -47.22 81.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 0.0 109.648 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . 41.1 mt -60.59 -18.04 50.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.888 -0.508 . . . . 0.0 111.07 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -56.79 -21.57 29.6 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.461 -0.775 . . . . 0.0 111.056 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -117.96 26.32 7.97 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 126' ' ' LEU . 66.2 t -107.9 129.88 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.314 -1.109 . . . . 0.0 109.671 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.96 101.87 13.09 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.437 0.637 . . . . 0.0 111.935 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 131' ' ' VAL . 8.8 p -84.04 158.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -95.85 -177.72 4.13 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.383 -0.823 . . . . 0.0 111.286 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.5 m -72.09 -1.27 14.2 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.941 -0.474 . . . . 0.0 111.805 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -108.21 -15.02 14.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.93 -1.106 . . . . 0.0 110.423 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.78 29.2 12.19 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.524 ' C ' HD12 ' A' ' 137' ' ' ILE . 96.1 mt-10 -111.03 133.7 53.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.624 -0.927 . . . . 0.0 111.167 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.8 mp -124.77 139.99 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -69.79 112.48 6.26 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.73 -0.606 . . . . 0.0 110.502 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.449 ' CG ' ' N ' ' A' ' 140' ' ' LYS . 32.7 p90 -69.96 -41.64 74.24 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.391 -0.818 . . . . 0.0 112.222 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' ' CG ' ' A' ' 139' ' ' TYR . 4.0 mttt -60.22 -29.87 69.02 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.605 -0.684 . . . . 0.0 111.652 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -84.12 -39.48 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 111.649 -178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 146' ' ' VAL . 23.1 t80 -70.01 -29.88 67.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.444 -0.785 . . . . 0.0 111.349 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.645 HD12 ' HB3' ' A' ' 86' ' ' PHE . 27.8 pt -83.17 -43.43 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.451 ' N ' HG13 ' A' ' 143' ' ' ILE . 66.9 mt-10 -68.91 -27.44 65.77 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.322 -0.861 . . . . 0.0 110.715 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -85.1 -15.79 42.73 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.319 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 142' ' ' PHE . 76.6 t -95.48 -37.41 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 86' ' ' PHE . 26.2 mt -61.05 -18.15 56.26 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.305 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -59.1 133.99 56.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.298 -0.876 . . . . 0.0 110.078 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.137 -179.85 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 67.4 mttt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.607 0.718 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.14 159.11 15.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.91 -0.494 . . . . 0.0 110.097 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -110.18 161.0 16.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 0.0 111.283 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.694 HG22 ' CG2' ' A' ' 87' ' ' VAL . 24.2 m -51.04 -30.37 15.33 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.636 0.731 . . . . 0.0 109.689 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -51.01 -37.61 46.17 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.883 -0.511 . . . . 0.0 111.222 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.18 -47.24 85.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.694 ' CD1' HD13 ' A' ' 113' ' ' LEU . 1.2 m-85 -74.94 -39.91 61.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.789 -0.569 . . . . 0.0 111.117 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.694 ' CG2' HG22 ' A' ' 83' ' ' THR . 71.6 t -60.75 -49.99 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.368 -0.833 . . . . 0.0 110.658 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 92' ' ' VAL . 97.3 mttt -59.58 -34.96 73.38 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.583 -0.698 . . . . 0.0 111.388 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' CB ' HD11 ' A' ' 113' ' ' LEU . . . -61.26 -56.61 18.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.605 -0.685 . . . . 0.0 112.005 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.77 ' CE1' HD12 ' A' ' 106' ' ' LEU . 57.0 m-85 -76.7 -54.1 7.1 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.188 -0.945 . . . . 0.0 111.976 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -48.41 -37.21 16.46 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.31 -0.869 . . . . 0.0 113.045 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 88' ' ' LYS . 77.9 t -59.94 -36.36 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 120.843 -1.16 . . . . 0.0 109.89 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.91 -42.78 89.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -62.1 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.43 -0.794 . . . . 0.0 111.249 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -61.44 -41.05 96.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.557 -0.714 . . . . 0.0 110.048 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.3 20.58 7.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.44 -0.787 . . . . 0.0 110.44 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 38.2 36.68 0.12 Allowed 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 100' ' ' LYS . 4.2 t -63.46 -33.39 75.46 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.128 -0.983 . . . . 0.0 109.566 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.17 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.31 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.605 ' H ' HG23 ' A' ' 98' ' ' THR . 1.4 mppt? -131.58 152.73 50.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -1.216 . . . . 0.0 109.736 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.596 HG21 HD13 ' A' ' 106' ' ' LEU . 35.8 m -148.89 160.0 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.233 -0.917 . . . . 0.0 110.46 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.9 p -81.37 145.93 30.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.719 -0.613 . . . . 0.0 110.068 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 104' ' ' GLY . 9.1 p -54.46 -39.52 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.484 -0.76 . . . . 0.0 110.658 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 103' ' ' VAL . . . -59.94 -40.04 96.36 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -80.58 -43.16 21.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.633 -0.922 . . . . 0.0 110.8 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.77 HD12 ' CE1' ' A' ' 90' ' ' PHE . 25.0 tp -60.0 -50.07 75.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.48 -0.762 . . . . 0.0 110.057 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -63.32 -31.64 72.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.541 -0.724 . . . . 0.0 110.165 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -67.73 -47.7 68.56 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.401 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -40.4 95.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.268 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.589 HD23 ' HG2' ' A' ' 115' ' ' GLU . 5.4 tp -55.73 -44.81 77.87 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.5 m -60.45 -29.68 69.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.585 0.707 . . . . 0.0 109.593 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.33 -14.25 64.32 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD13 ' CD1' ' A' ' 86' ' ' PHE . 0.6 OUTLIER -94.74 7.33 46.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -1.087 . . . . 0.0 112.545 -177.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.77 32.11 4.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.589 ' HG2' HD23 ' A' ' 110' ' ' LEU . 17.5 tp10 -113.87 120.16 39.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.932 -0.746 . . . . 0.0 110.204 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -121.92 59.51 0.99 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.203 1.002 . . . . 0.0 109.304 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.541 HD11 ' OE2' ' A' ' 115' ' ' GLU . 90.2 mt -92.03 148.96 21.79 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 p -110.95 143.25 41.89 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.261 -0.899 . . . . 0.0 109.854 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -40.08 -27.74 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 O-C-N 121.213 -0.929 . . . . 0.0 112.805 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.74 -52.99 61.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.287 -0.883 . . . . 0.0 108.982 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -76.69 -42.83 40.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.598 -0.689 . . . . 0.0 110.433 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.41 -35.66 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -63.73 -38.38 90.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.229 -0.919 . . . . 0.0 109.208 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -60.01 -47.62 85.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.614 . . . . 0.0 109.739 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.83 -49.88 75.68 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.508 0.67 . . . . 0.0 110.052 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.0 mt -59.98 -18.72 47.83 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.888 -0.507 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -57.04 -21.03 28.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.447 -0.783 . . . . 0.0 111.136 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.92 9.08 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.5 t -69.45 132.82 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.041 -1.27 . . . . 0.0 109.982 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -102.51 102.34 12.6 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.389 0.614 . . . . 0.0 111.8 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -85.4 159.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -95.85 -176.79 3.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 111.377 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -71.67 -1.14 12.69 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.794 -0.566 . . . . 0.0 111.834 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -107.43 -12.07 15.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.13 . . . . 0.0 110.403 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.61 27.09 28.04 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.608 ' C ' HD12 ' A' ' 137' ' ' ILE . 65.2 mt-10 -110.89 140.1 45.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.619 -0.93 . . . . 0.0 111.245 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.638 ' N ' HD12 ' A' ' 137' ' ' ILE . 5.1 mp -130.86 142.39 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -68.89 113.04 5.96 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.971 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 140' ' ' LYS . 26.0 p90 -62.84 -33.26 74.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.642 -0.661 . . . . 0.0 111.706 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.431 ' HG3' ' CE2' ' A' ' 139' ' ' TYR . 20.5 mttt -69.97 -35.05 74.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.481 -0.762 . . . . 0.0 110.712 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -69.95 -44.11 70.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.72 -0.613 . . . . 0.0 111.518 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.468 ' O ' HG23 ' A' ' 146' ' ' VAL . 12.7 t80 -74.33 -27.69 60.81 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.762 . . . . 0.0 111.077 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.33 -51.8 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.447 -0.783 . . . . 0.0 109.884 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -63.77 -26.43 68.63 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.439 -0.788 . . . . 0.0 110.791 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.34 -13.39 43.65 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.217 -0.927 . . . . 0.0 110.746 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 142' ' ' PHE . 46.2 t -95.83 -38.08 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' A' ' 86' ' ' PHE . 14.3 mt -57.22 -19.9 23.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.954 -0.466 . . . . 0.0 111.406 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -57.96 129.87 43.93 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.279 -0.888 . . . . 0.0 110.255 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.258 -179.898 . . . . . . . . 0 0 . 1 stop_ save_